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Abstract
Processes in manufacturing, services, and healthcare are complex socio-technical systems
composed of intricately sequenced activities supported by elements drawn from multiple
domains. While many of these processes offer high performance, their complexity can
make their design, improvement, troubleshooting, and change difficult due to the many
possible and unforeseen interactions between elements. This thesis develops a design
methodology and multi-domain network model for complex process design, change
management, process improvement, and troubleshooting. As part of the methodology a
feasibility analysis method based on solving the minimum cost flow problem for a network
of process alternatives is presented to identify feasible processes subject to stakeholder
requirements and constraints including performance, flexibility, modularity, and other
system properties. A model based on Multi-Domain Matrix (MDM) concepts is developed
specifically for process analysis called the Multi-Domain Process Matrix model (MDPM) to
enumerate and analyze the interactions between process elements such that process
performance under change and troubleshooting scenarios can be improved. The graph
theory basis of the MDPM model enables its analysis using a proposed set of metrics
derived from communications, social, and process network literature.
As a demonstration of the use of the methodology, a complex DNA sequencing based
surveillance process for Methicillin resistant Staphylococcus aureus (MRSA) in the US
healthcare system is designed and a prototype implemented. Rapid advances in DNA-based
technologies have greatly expanded the range of processes available to the clinical
microbiology laboratory, however, integrating these new processes into a comprehensive
surveillance system presents significant challenges. Many of these new technologies are
still in early stages of development, require multidisciplinary teams to support them, and
must undergo significant optimization presenting significant barriers to their rapid
adoption despite the pressing need to understand and control antibiotic resistance. Data
from the prototype MRSA surveillance process show significant variation at the DNA level
between patient cases, providing evidence for the urgent need for a DNA sequencing based
microbial surveillance process as part of clinical microbiology efforts in the US healthcare
system. However, results of applying the process design methodology and MDPM model
analysis indicate significant work remains to reduce complexity, further improve key
technology elements, gain acceptance, develop key organizational infrastructure, and
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redesign the process to efficiently absorb the rapid technology change expected in DNA
sequencing. The MDPM model is used to develop a roadmap of specific multi-domain
projects addressing these issues to accelerate the deployment of a national DNA
sequencing based surveillance system.
Thesis Supervisors:
Christopher L. Magee
Professor of the Practice, Mechanical Engineering and Engineering Systems
Deborah J. Nightingale
Professor of the Practice, Aeronautics and Astronautics and Engineering Systems
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1 Introduction
Nearly every human activity can be described as a process. Everything from cooking dinner
to launching a space shuttle to processing a loan can be broken down into a series of steps
and instructions for performing them. While we think of process models in modern terms
representing them as flowcharts and other sophisticated ways, human beings developed
the essential machinery to represent processes several millennia ago with the invention of
language. This enabled the codification and transmission of work instructions such that
valuable discoveries and experience could be transmitted without each individual having to
rediscover knowledge. This allowed for knowledge to build upon itself and for
improvement to take place. The verbal instructions for how to build a stone ax, find food,
and build shelter were the very first process models, useful abstractions of reality. The
ability to build processes gave humans an enormous advantage as hunting, farming,
construction, and social organization all became codified through "work instructions" of
various kinds including formal written ones, experiential (apprenticeship) ones, and verbal
ones. From that initial breakthrough of language humans have built ever more complex
processes to the point that modern processes defy comprehension by any single human
being, instead existing as distributed knowledge sets across multiple organizations and
individuals. Our ability to build processes as complex as the Apollo moon missions, air
traffic control, oil refining, heart transplant surgery, and modern supply chains necessarily
requires the distribution and modularization of knowledge. And around these processes
humans have built equally complex systems to support them. Our society relies on these
complex processes and infrastructure for everything from communications to
transportation to critical systems essential for its very survival, such as healthcare. It is
therefore essential that we understand and control the complexity in them. That is the
objective of process complexity research in Engineering Systems and the analysis tools
described in this thesis are a contribution to this endeavor.
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1.1 Motivation
The motivation for this thesis is two-fold:
1. To develop new tools and understanding relative to complex processes
2. To make progress in understanding antibiotic resistance, an important real world
problem area
These two motivations are made explicit here because this thesis was developed around
both as will be evident in reading this thesis. The first motivation stems from the author's
extensive involvement in process design from professional experience in the petrochemical
industry and high throughput DNA sequencing. The second motivation comes from the
author's belief, research experience, and growing evidence that antibiotic resistance is a
grave threat to human society, and must be addressed using systems approaches given the
magnitude, complexity, and multi-disciplinary nature of the problem. The two motivations
are connected where processes must be built to understand and manage antibiotic
resistance. The intersection of complex process design and antibiotic resistance research is
the focus of this thesis.
Bacteria are the oldest life form on planet earth, first appearing over 4 billion years ago,
they have adapted to every environmental condition imaginable and changed the earth
itself. Evolution over millennia has equipped bacteria to exploit every possible niche and
adapt as a group to a rapid change in environmental conditions. An estimated 107 to 109
bacterial species are thought to exist on the planet as estimated by various surveys
including (Curtis, Sloan et al. 2002), of which we have catalogued a minuscule 7,031 and
fully sequenced the complete genomes of approximately 600 species as of 2008 as
estimated by (Achtman and Wagner 2008). The vast majority of life on the planet is
bacterial. By comparison human beings are very recent arrivals to the planetary eco-
system, only appearing about 200,000 years ago. Our primate ancestors evolved in
symbiosis with bacteria, and every human, composed of 1014 human cells, co-exists with
101s bacteria in their body. The vast majority of these are beneficial, helping digest food,
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produce needed enzymes, and even fight infection from pathogenic bacteria. Only a tiny
fraction of the bacteria on the planet are human pathogens, but this small group has caused
enormous suffering over most of human history. It is only very recently, in the last 60
years, that bacterial infection has been controlled through modern antibiotics. But this
advantage may be short lived. Bacteria have been fighting antibiotic warfare for millennia,
and within all their species have evolved defenses against almost every chemical agent
possible. Already many of the antibiotics in our medical arsenal are ineffective against new
strains of pathogenic bacteria. The struggle to combat bacterial infection will be an
ongoing one, not a permanent victory. This thesis addresses a crucial element in this
struggle, the need for molecular level monitoring of pathogenic bacteria in hospital clinical
microbiology processes.
The healthcare system within which these processes are performed is perhaps the most
complex enterprise on the planet intertwined with nearly every infrastructure system from
transportation to power, continuously incorporating new technologies, and impacting
every person throughout their lives. The benefits of this system in the US have been
enormous, increasing life expectancy from 47.3 years in 1900 to 77.7 years in 20081. An
important portion of this gain can be attributed to the control of infectious disease through
vaccinations and antibiotics, which in turn facilitated the development of increasingly
complex surgical interventions including organ transplants, vascular repair, and assistive
devices. And as the interventions have grown more complex, so has the system supporting
them in terms of the number of stakeholders, technologies, reimbursement methods, and
organizational architecture. This growing system complexity makes the introduction of
new processes difficult because of the many elements that must be addressed from the
fundamental effectiveness of the technology to the reimbursement mechanism to the
organizational location. A key objective of this thesis is to develop a methodology to model
and analyze process complexity and feasibility in healthcare systems to identify key
bottlenecks and speed the implementation of critically needed processes such as
pathogenic bacteria surveillance.
1 Source: CDC Statistics, N. C. f. H. (2009). Health, United States, 2008.
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1.2 Research Opportunity
This thesis focuses on the analysis of healthcare processes from a multi-disciplinary
Engineering Systems perspective including social science, management, and engineering
dimensions. While disciplines such as chemical engineering have developed significant
knowledge bases in physical process design, relatively little attention has been paid to
"messy" socio-technical processes such as those found in healthcare. Yet, these processes
are the basis for our modern health care system, and if it is to be improved, these processes
must be improved. The work presented here combines three main research areas within
engineering systems: first, the critically important health care area of clinical microbiology
services delivery and its associated technology, second, enterprise architecture and tools
for stakeholder identification and alignment, and third, network and complexity science.
The research opportunity is in developing an integrated process analysis methodology that
can be used to visualize the true extent of a process within a system and analyze its true
complexity beyond the traditional analysis of physical workflow. This methodology is a
first step to the optimization and rational design of socio-technical processes from a
systems perspective in the engineering tradition.
1.2.1 Engineering Systems and Processes
As a new field of study, engineering systems has to date focused primarily on
understanding large-scale infrastructure systems such as air traffic control, power
distribution, petrochemical infrastructure, and manufacturing. However the processes
embedded within these systems have received less attention, and their understanding is
important as they can influence and even define their systems. Healthcare in particular is
an extremely large and growing fraction of the economy, and it is largely composed of
processes from routine checkups to vaccinations to heart transplants. Understanding the
interaction between these processes and the healthcare system is critical to the "macro"
perspective engineering systems can provide. Processes are in some sense the building
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blocks of healthcare delivery, since they are what is billed for, what is performed, what is
offered at each hospital, what is reimbursed, what the staff is organized around, and what
is trained for. One important goal of the research in this thesis is to expand the knowledge
around processes from an engineering systems perspective.
1.2.2 Big P Processes
Much like "big M" manufacturing, which expands the traditional view of manufacturing
away from the shop floor to include design, supply chain, finance, and other areas of the
enterprise, processes need to undergo a similar broadening. And so "big P" processes
expand away from the simple physical flowchart view to include stakeholders, information
flows, alternative paths, alternative designs, system infrastructure, and other system
elements. Including these other dimensions shows the true extent of a process, which
cannot be captured by simply describing the physical process steps. The way the
organization is structured can have a very significant impact on the structure of the
process, such as poorly communicating stakeholders leading to fragmented or suboptimal
processes. Conversely highly technically complex processes likely require substantial
stakeholder and organizational communication to manage their complexity. The need for
integration and coordination of multiple deep knowledge bases is critical to the
management of processes within complex systems. The need for substantial improvement
in modern processes, such as the significant cost performance now demanded from
healthcare in particular, places an even stronger emphasis on ensuring complex processes
are also able to change and adapt quickly despite their complexity. Understanding all of the
elements associated with modern processes and their interactions is an important first step
to managing change and enabling improvement.
1.3 Thesis
This thesis evolved from an initial desire to apply network theory to study processes in the
healthcare system. A number of methodology alternatives were explored to provide a
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meaningful engineering systems insight to the vast complexity contained in the healthcare
system. In particular, an approach to mine the national Health Care Cost & Utilization
Project (HCUP) databases which contain reported cost data for a representative sampling
of 20% of US hospitals for evidence of "learning curve" behavior following the adoption of a
new technology and whether the variation on learning curves could be explained in terms
of system variables such as stakeholder alignment, resource utilization, and process
control. However, billing variation and presumed "gaming" of prices made the data difficult
to correlate with any process improvement behavior in addition to the large complexity
(and variability) of technologies and their implementation. In mining this data some
interesting results did appear in terms of which procedures (processes) were associated
with the highest hospitalization cost (irrespective of learning curve behavior) in the
Nationwide Inpatient Sample (NIS, a subset of the HCUP databases). The top 20 categories
mainly consist of well-known diseases such as heart disease, births, diabetes, pulmonary
disease, and complications of aging. However, two related categories stood out as not
belonging with the others and these were all associated with presumably preventable
microbial infectious disease treatable with antibiotics. These cost categories in the HCUP
data were: Pneumonia and Septicemia highlighted in yellow in Figure 1 along with the
other top 10 categories.
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Figure 1 - Top 10 Hospitalization Cost Categories (NIS Data 2005)
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On further investigation of these categories there were enormously high costs per patient
for the septicemia category, which is defined2 as:
Septicemia: the presence of bacteria in the blood (bacteremia) and is often
associated with severe disease.
* Septicemia is a serious condition that requires a hospital stay. You may be
admitted to an intensive care unit (ICU).
* Fluids and medicines are given by an IV to maintain the blood pressure.
* Oxygen will be given. Antibiotics are used to treat the infection.
2 National Library of Medicine definition
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* Plasma or other blood products may be given to correct any clotting
abnormalities.
Based on this definition, the high costs seemed especially surprising given that antibiotics
are usually highly effective. The HCUP databases could also be mined to produce a
histogram of all associated procedure codes (i.e. what procedures were performed on
patients with Septicemia) and the results were also surprising as shown in Figure 2
suggesting that these patients were being admitted and treated with a wide range of
procedures not necessarily associated with antibiotic therapy. Or was it possible the
antibiotic therapy was not working and therefore all these other procedures were
necessary?
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25000
5000
. kth n ka.1, i 4 I -a a a a a... . . . . .
~~~~~- 4$"A ~A /A 4 4~4 d
Figure 2 - Septicemia Associated ICDS Procedure Frequencies
Further mining the HCUP databases, a time series was constructed for the Septicemia
category from 1997-2005 in terms of number of discharges, mean charges, and the
"National Bill" extrapolating the 20% sampling of the NIS database to 100%. The trends
were deeply concerning and pointed to some deeper and rapidly emerging system problem
as shown in Figure 3.
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Beyond the financial costs, the human costs of this problem were also deeply troubling as
not only was the cost of treatment rising, but the outcomes were not improving, rather the
contrary, as mortality associated with Septicemia increased from 14.2% to 18.3% over the
1997-2005 time period and not necessarily because of older or sicker patients as the
average age of these patients remained nearly the same as did the mean length of stay
shown in Figure 4.
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Figure 3 - Septicemia in US Hospitals 1997-2005
Septicemia Hospital Trends (1997-2005)
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Figure 4 - Septicemia Hospital Trends (1997-2005)
The author's involvement with DNA sequencing provided opportunities to ask practicing
Infectious Disease Physicians about the cause of these trends and the answer was that
rapidly increasing rates of microbial resistance were rendering antibiotics ineffective and
the spread of these resistant microbes provided further opportunity to generate resistance
as "last line of defense" antibiotics such as Vancomycin previously used only sparingly had
to be used in much larger numbers of cases. The rapid increase of resistant microbes can
be seen in Figure 5 from the Centers for Disease Control (CDC).
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Figure 5 - Incidence of Antibiotic Resistant Microbes in Hospital Settings (from IDSA)
As resistant microbes become more prevalent, treatment is more difficult and clinical
outcomes more uncertain. In addition as the prevalence of microbes has increased, their
impact in other areas of the healthcare system has also increased, so for example
complications associated with routine surgery can also increase if resistant bacteria cause
infection as part of the procedure. Of the resistant organisms, Methicillin Resistant
Staphylococcus aureus (MRSA) is the most famous with constant headlines about its spread
in both hospitals and in the community including schools and nursing homes. The impact
of MRSA alone is enormous and a study by (Noskin, Rubin et al. 2007) using many of the
same methods presented here including analysis of the NIS database estimated the
economic burden of MRSA per year: $14.5 billion in 2003. The first comprehensive
nationwide study was performed by the CDC as reported in (Klevens, Morrison et al. 2007)
to estimate the US burden of MRSA infections in 2005 estimated 94,360 patients had an
invasive MRSA infection (including Septicemia) of which 18,650 died from MRSA
infections. These estimates are for invasive infections only, such as Septicemia, which are
relative small compared to non-invasive infections, which could be an order of magnitude
larger as reported by Klevens et al.
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Of great interest in the Klevens et al. study was the attempt at molecular characterization of
the MRSA isolates from the surveillance sites, which used pulse-field gel electrophoresis
typing (PFGE) where the genome of a microbe is cut into a few (100-1000) fragments using
restriction enzymes able to cut at certain unique sites to produce a "fingerprint" for the
particular strain. This relatively crude method can distinguish gross differences between
strains, but not any gene level mutations or changes. But even PFGE showed significant
genome variation among the strains collected in the Klevens et al. CDC study despite all the
strains being phenotypically identical (i.e. all were resistant to antibiotics). Other studies
have shown that even small differences in gene sequence can lead to significant virulence
(ability to infect and survive) beyond the necessary antibiotic resistance, such as (Diep and
Otto 2008) who describe virulence mechanisms of Community Associated MRSA (CA-
MRSA) and their encoding genes, many of which would not be visible using standard PFGE
methods including variation in the Panton Valentine leukocidin (PVL) encoding genes
which are thought to be key virulence determinants. DNA sequencing can provide the
needed resolution to see these differences down to the nucleotide level, but it is a very new
and complex technology and although costs are rapidly decreasing is still expensive and
cumbersome for an MRSA surveillance application. The concept developed in this thesis is
to adapt existing processes to create a prototype DNA based surveillance process that
satisfies the various stakeholder constraints including cost, ease of use, integration into
existing workflows, and most importantly the ability to track the virulence and other
changes in the rapidly growing MRSA threat. This idea formed the basis for this thesis and
established a real world process to use in developing and testing the process modeling
approach. This idea was built upon the initial research done on learning curves in
healthcare processes, which although it represented nearly a year of work is only described
in this section to provide background for the current thesis and to describe the significant
exploration needed to tackle "systems" problems in healthcare.
1.3.1 Approach
The research approach for this thesis was to study deeply an existing process in healthcare,
specifically surveillance of Methicillin Resistant Staphylococcus aureus (MRSA), an
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increasingly common and dangerous microbe in hospital settings. The first step was to
observe current diagnostic processes in a hospital clinical microbiology laboratory to
provide a reference data set for the development of a process representation and analysis
methodology. The next step was to use this methodology to help develop and demonstrate
a new clinically important process in DNA sequencing based MRSA surveillance. This
demonstration provided a data set describing the true process complexity when
implementing a novel process in healthcare including the effect of other process elements
beyond the physical steps such as additional layers of information and organization, which
contain a large amount of previously unmapped interactions necessary in the initial stages
of process development that contribute to high complexity. This higher complexity is not
found in more mature processes as most of this "scaffolding" has been removed as a
dominant process design emerges and alternatives are culled out, design spaces refined,
and optimizations performed. One of the key issues encountered in complex processes is
the difficulty of change due to what some would argue is a fundamental level of irreducible
complexity. However, it is possible that the high complexity is not irreducible but is in fact
associated with poor process design to manage this complexity. While it is clear that deep
knowledge bases (specialties) are required to build modern processes and their existence
implies a certain level of irreducible complexity, one of the objectives of this thesis is to
show that if complexity is addressed as any other design variable (such as yield or
efficiency) that great improvements can be made to reduce complexity (and perhaps even
eliminate some previously "irreducible" complexity through novel design that minimize the
use of certain specialties). The methodology developed here is thus an effort to develop a
set of tools to manage this process complexity. The value of the demonstration is that it is
used to refine the process mapping and analysis methodology, as well as to guide
simulations on representative process designs to suggest enterprise and process
alternatives to better manage process complexity.
1.3.2 Scope and Limitations
This thesis is interdisciplinary in nature, attempting to provide an integrative framework
for process design spanning engineering, management, and social sciences domains to
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properly reflect the actual complexity of processes in industry using MRSA surveillance as a
specific example. Figure 6 shows the contributions of this thesis mapped onto the
Engineering Systems Research Space, including its impact on a critical healthcare
infrastructure, extended enterprises, and network methods. Because of the dual focus of
the thesis on network based complex process analysis tools and DNA sequencing based
MRSA surveillance, each category is highlighted in Figure 6.
Energy & E Etprie Heltcare Delivery critical infrasSustainabilitylI I I
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Flows
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Standards
Figure 6 - Thesis Contributions Mapped onto ESD Research Space
A key objective of this thesis was to provide a network based analytical framework for
"extended enterprise" process design encompassing not just the process steps, but also the
organizations, information, and design alternatives that exist in real processes. This
framework is specifically applied to the MRSA surveillance process also developed in this
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thesis and the value of the method is demonstrated in this case. Although the framework
can likely be generalized, and specific future directions are described in chapter 7, the
scope of this thesis is limited to the initial development of both the process analysis
framework and the MRSA surveillance process, which are both prototypes. This thesis
builds on established process design, network analysis, microbiology, and DNA sequencing
methods but extends each of these through interdisciplinary connections and also develops
new methods in each area. The thesis emphasizes finding "feasibility" over "optimization"
since the initial goal is to fully capture process design spaces and identify feasible
alternatives. Optimization can be performed at later stages and using extensions of many
of the methods developed here, but optimization (other than to make processes work as
prototypes) is outside the scope of this thesis. Significant enhancement and improvement
is possible through further optimization and ongoing technology and process
improvement, and it is indeed the author's hope that this will happen, but much work
remains. This thesis is nevertheless a first step and an initial roadmap to get there.
1.3.3 Thesis Outline
The thesis combines elements of both main objectives in every chapter: new tools relative
to complex processes and application of these tools to the critical healthcare need of an
MRSA surveillance process. The development of the thesis is as follows:
Chapter 1: A general description of the research, along with the important motivation
behind MRSA surveillance and complex processes.
Chapter 2: Literature review and background on the range of disciplines and topics
addressed in this thesis including on the surveillance side: MRSA biology, Clinical
Microbiology, Antibiotics, Antibiotic Resistance, Virulence. And on the process tools side:
process models, process improvement methods, network models, network analysis, and
network applications in processes.
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Chapter 3: Describes the Multi Domain Process Model (MDPM) developed in this thesis to
analyze complex processes and describes each of its elements in the organizational,
information, and process domains. Chapter 3 also provides a listing of potential metrics
that might be used in the analysis of process network models.
Chapter 4: Shows the potential uses of the MDPM model including metrics sets useful in the
analysis of each domain as well as use of the MDPM model to describe and manage process
improvement methodologies such as Lean.
Chapter 5: Applies the MDPM model to the real-world MRSA surveillance process design
and implementation performed in this thesis. This chapter also describes the associated
methodology to select feasible processes, identify model elements, describe critical process
sub-networks, and demonstrates the use of network analysis tools to understand the
surveillance process. This Chapter also highlights potential process configurations to
improve performance under rapid technology change conditions or complex
troubleshooting based on the MDPM model.
Chapter 6: Presents the biological results from the V1 Surveillance Process, including a
comparison of the MRSA samples to references and identification of differences between
samples. Recommendations for improvements in a V2 process are also made in terms of
the MDPM model.
Chapter 7: Describes a roadmap from the V1 and V2 processes described in this thesis to
further versions including a national and global surveillance system. Future work related
to the MDPM model is also presented including the concept of process options.
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2 Background and Related Work
Processes form a part of every Engineering System, from supply chain fulfillment to
gasoline production in refineries to the manufacturing of commercial jet aircraft and
everything in between. Understanding these processes is a critical part of understanding
these complex socio-technical systems. Healthcare processes in particular have emerged
as an important research area because of their direct impact on human wellbeing but also
societal resources. A number of tools have been brought to bear on the understanding of
processes and the systems that support them, and network theory has emerged as a
potentially very useful analysis methodology to understand and manage the complexity of
these processes. This chapter presents some background information on existing process
analysis methodologies, network analysis methods, and the healthcare system to support
the analyses presented in subsequent chapters.
2.1 Processes
At its most basic level, a process is a series of steps or tasks required to produce a product
or deliver a service. In manufacturing this might mean the series of tasks required to build
an aircraft or produce refined gasoline. In the service economy this might mean the series
of steps needed to fulfill a customer order or process an insurance claim. In healthcare it
can be the series of steps to correctly diagnose a bacterial infection or perform an x-ray.
The majority of services provided by the US healthcare system can be described as
processes, where a series of steps delivers a diagnosis, treatment, monitoring, insurance
collection, vaccination, and many others. These simple examples obscure the real
complexity of healthcare processes, where multiple stakeholders, multiple technical
disciplines, complex feedback loops, information rather than physical products, and
infrastructure items from other processes are required. Some of this complexity arises
from the multiple disciplines needed to fully utilize the highly scientific and technologically
advanced procedures now offering real improvements in health care but some complexity
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arises because our organization of health care has evolved in a way that often ignores the
challenge of controlling complexity.
Traditional process definitions from chemical engineering focus largely on efficient
physical transformation of raw materials into higher value chemicals and materials and the
optimization of physical process steps. These processes rely on highly detailed
specifications for the equipment involved and the particular operating values of the
variables involved at each step. Typical chemical engineering process representations such
as flow sheets are diagrams showing the final selections for process steps, control systems,
operating parameters, input materials, and product yield. While, highly useful for the
operation of these processes these diagrams do not show the many design alternatives,
stakeholder preferences, regulations, design choices, design space explorations, designer's
tacit knowledge bases, optimizations, explicit physical knowledge bases, and other
information sources needed to build them. These additional elements are critical to the
development of processes but most process representations and models do not show them
focusing instead on "final" processes where the "messy" design and implementation stages
are complete. The greater complexity of processes in these early stages is a potentially very
significant barrier to adoption that is not commonly modeled although some effort exists
within the chemical engineering community as described in (Nagl, Westfechtel et al. 2003),
(Heller, Jager et al. 2004), and (Sargent 2005) who state the importance of "big P" process
encompassing organizations, information, and physical steps.
The business process reengineering efforts championed by Hammer (Hammer and Stanton
1999) and others in the 1990s brought many of the engineering process concepts to the
business realm and expanded them to the enterprise and system view. The working
definition used by these efforts for processes included the following from (Davenport
1993) "Process Innovation: reengineering work through information technology":
"a structured, measured set of activities designed to produce a specific outputfor a particular
customer or market. It implies a strong emphasis on how work is done within an organization,
in contrast to a product focus's emphasis on what. A process is thus a specific ordering of work
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activities across time and space, with a beginning and an end, and clearly defined inputs and
outputs: a structure for action.... Taking a process approach implies adopting the customer's
point of view. Processes are the structure by which an organization does what is necessary to
produce value for its customers."
And from Michael Hammer (Hammer and Champy 2003) "Reengineering the corporation, A
manifesto for business revolution",
"a collection of activities that takes one or more kinds of input and creates an output that is of
value to the customer."
These definitions imply the need to clearly define: process steps, relationships between
steps, objectives of the process, stakeholders, organizations in which the process exists,
and the policy environment in which the process is executed. Implicit in these process
definitions is the need for a model and representation such that a process can be precisely
described and analyzed. In addition to the chemical engineering representations, a number
of methods for business process representation have been developed including flow charts,
petri nets, event driven process chains, simulation including system dynamics, role activity
diagramming, and information systems based techniques including IDEF and data flow
diagramming. However there is no accepted standard for process representation and
analysis, and each of the existing methods has strengths but also significant shortcomings
especially in the areas of process design, change, and optimization. The lack of an accepted
and comprehensive process modeling methodology makes it difficult to manage process
design and evolution in areas with significant technology change, which is the case for
many healthcare processes. This thesis focuses on the dynamic nature of processes where
steps and their order may change due to technology advances, enterprise architecture
optimization, regulatory environment, and most importantly in response to changing
needs. Improving the dynamics of process evolution is critical to rapid adaptation and
faster implementation times for improvements, but is often not explicitly the goal of
process analysis.
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As described in Chapter 1, this thesis also expands on the traditional view of processes as
the transformation of materials into useful products or the series of steps associated with
delivering a service in the business world. Big "P" processes are defined to encompass the
physical steps of a process in traditional definitions but also the entire set of process
related activities, environment (physical and regulatory), and infrastructure needed to
support the process. In complex processes this set of process related elements is especially
important because these elements may interact with the process in unintended or
emergent ways not initially predicted by process designers. Similarly changes to one of
these elements can propagate through the system in unforeseen ways impacting elements
throughout the process that may not have previously been considered. The following
sections describe current practice in complex process analysis as well as describing
improvement methodologies critical to the ongoing operation (and change) of complex
processes.
2.1.1 Definitions
The definition of process depends on the particular field it is applied to. The following is a
brief listing of process definitions from various fields:
Thermodynamic Process Transition of a thermodynamic system from
an initial state to an allowable final state
Thermodynamic space
diagram (P-V, h-s)
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Mathematics: Stochastic A variable whose time development is Markov chain, Monte
Process analyzable in terms of probability Carlo Simulation
... ....  . .................. .... ... ....... ....... -------- .
Computer Science Process An instance of a computer program of one or Process state diagram
more threads being sequentially executed
Table 1 - Process Definitions
This thesis focuses primarily on the first three definitions of Table 1, as the complex
process studied necessitates that we combine elements of each. The main emphasis of this
thesis is in providing a process design methodology for clinical microbiology processes,
and because of their similarity to other diagnostic processes in the healthcare system. The
physical steps associated with these diagnostic (and surveillance) processes share much in
common with chemical engineering process design as they can be thought of as a series of
physical unit operations to produce data as a product such as a diagnosis or surveillance.
Business processes take more consideration of the Enterprise and the tasks associated with
delivering services beyond the physical steps in generating the data, since there are still a
number of "non-engineering" steps between the delivery of the raw diagnostic or
surveillance data and the processing of insurance forms, updating of medical records,
patient consultations, etc. This set of "business" processes at the start and end of the
"physical chemical engineering" are necessary to integrate the diagnostic process into the
Enterprise, but can add significant complexity. Finally, there is the "Systems Design
Process" where a new process (or system) is created according to a set of design rules that
ensures the overall system is considered rather than individual elements. The design of the
MRSA surveillance system and the design methodology developed can thus be thought of as
a "system design process" which has as an outcome a "business process" that contains a
"physical, chemical engineering - like process".
2.1.2 Processes in Engineering Systems
Contained within most engineering systems are processes and many engineering systems
are built for the processes they support. For example, critical infrastructures such as
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Process Type Definition Typical Model
airports and air traffic control support the process of air transportation from one location
to another. And much effort has gone into streamlining that process including the
"physical" process elements (or series of tasks) such as improved routing, navigational aids
to simplify pilot workload, and more efficient aircraft able to directly connect almost any
two airports on the globe. But the "business" processes have also been improved such as
airline operations and airport demand management. Many of these improvements have
come from "systems thinking" such as the application of system design methodologies or
processes.
Many extended enterprises are also created to support processes such as the design and
manufacturing of Boeing's new 787 which has a globally distributed supply-chain but more
importantly also globally distributed its "design chain". The manufacturing process of
every component of the 787 had to be integrated with the overall assembly process and
Boeing suffered significant difficulties due to the lack of integration of these distributed
processes with the final assembly process. Energy production and distribution are
engineering systems that contain many chemical engineering processes such as the
extraction of crude oil and refining into gasoline. However, there are many layers of
"business processes" to manage this physical process such as demand forecasting, capital
expense planning, and supply-chain management.
The processes within these engineering systems are different from products or enterprises
as they are performed within enterprises and are dynamic. One of the goals of the
Engineering Systems Division is to develop a body of knowledge around healthcare
delivery systems issues, which is mainly the study of processes. Yet, many of the tools to
study processes do not capture their systems nature, focusing strictly on the steps rather
than the complex socio-technical enterprises they are performed in. The interaction
between process and enterprise is a fundamental research area for Engineering Systems,
and is especially important for the study of healthcare
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2.1.3 Process Design and Improvement
Given an existing process an enterprise's ability to improve is critical to its long-term
success in modern competitive markets. A number of methods for manufacturing process
improvement have been described in the literature such as lean production methods
derived from the Toyota Production System described by (Womack, Jones et al. 1990) in
"The Machine that Changed the World". Womack et al. found that while lean production
had certain structures to be followed these were mainly to enable learning and at the core
of this methodology is a learning organization and one where the people on the frontlines
have much greater accountability (and knowledge) for how to improve a process. Quoting
from Womack et al.: "The truly lean plant has two key organizational features: it transfers
the maximum number of tasks and responsibilities to those workers actually adding value
to the car on the line, and it has in place a system for detecting defects that quickly traces
every problem, once discovered, to its ultimate cause." This implies that vital process
knowledge exists closest to the process activities but also that the organization must strive
to ensure that the workers on the "frontline" have access to as much of the enterprise's
knowledge network as possible.
So for example, a separate R&D team that hands off new designs to frontline production
workers but is not continuously engaged with production is not lean as any problems that
may occur due to the designs (and found in production by front-line workers) must be
quickly resolved and this requires access to any specialized R&D knowledge or the R&D
team itself. In addition the rapid response to problems and the deployment of resources to
resolve them also requires that the lean enterprise have a highly efficient and highly
connected network (both formal and informal) to support its processes. Process changes
are also an important element of lean production and indeed the original genesis for the
Toyota production system came from the need to rapidly switch production between
various vehicle models at a single production plant. However, in complex processes change
propagation can be a very difficult problem as the effects of a small and seemingly
inconsequential change can have significant impacts on the rest of the process. This is in
some sense a corollary to the need to quickly trace problems and find root causes in a
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"troubleshooting mode" but in a design change mode requires the same highly connected
(networked) infrastructure needed for troubleshooting.
Lean production has proven to be an enormous competitive advantage to enterprises that
have adopted this methodology as an "infrastructure" that enables them to keep improving
and even adapt the methodology to their changing needs. That is to say simply adopting
"just-in-time" or "kanban" ideas is not enough nor is it the basis of lean production but
rather it is to recognize that there is always room for improvement, that improvement
takes effort and is the responsibility of the entire organization, and that every activity must
create value throughout the process. These ideas have been continuously refined and
adapted to other industries than car manufacturing such as aerospace, healthcare and
semiconductor manufacturing. These other industries are also highly complex and yet
there are certain companies and organizations within them that consistently outperform
others despite the enormous complexity of their industries and products. A recent book
"Chasing the Rabbit" by (Spear 2008) describes the characteristics of these higher
performing enterprises, and finds that improvements on some of the core ideas of lean
production explain many of these performance differences. Spear describes 4 main
capabilities for these high performing enterprises:
* Capability 1: Specifying Design to Capture Existing Knowledge and Building
in Tests to Reveal Problems
e Capability 2: Swarming and Solving Problems to Build New Knowledge
* Capability 3: Sharing New Knowledge Throughout the Organization
0 Capability 4: Leading by Developing Capabilities 1, 2, 3
As with Lean Production all of these capabilities require a significant "process
infrastructure" in the form of highly connected organizations that can rapidly deploy
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resources where needed and learn from problems. This is especially important when
dealing with complex processes that require multi-disciplinary efforts such as DNA
sequencing, which can be depicted as a series of "silos" using Spear's ideas shown in Figure
7.
Computer Science
Mathematics
Biology
Chemical Engineering
Mechanical Engineering
Electrical Engineering
Operations Research
Molecular Biology
Polymer Physics
Laser Optics
Many More...
Figure 7 - Disciplines in DNA Sequencing
High throughput DNA sequencing originally developed to complete the human genome
project requires a multitude of disciplines for the complex process to function. Just like
many modern manufacturing processes, each of these "silos", as described by Spear, have
grown deeper and deeper as each area specializes. The integration of all these silos
requires connections ideally composed of very efficient networks where both the
individuals and the information produced can be accessible. In order to facilitate this,
integrated project teams are routinely used at one large-scale sequencing center, the Broad
Institute, for new process development in order to facilitate the efficient networks needed.
The integrated project teams are very similar to ones described in "The Machine that
Changed the World" and serve a similar purpose: connecting the process, organization, and
information domains such that communication can be efficient.
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2.1.4 Process Models
Just as with process definitions, there are a large variety of process models corresponding
to the different process types such as chemical, business, or design. This section presents
an overview of the relevant process models considered in this thesis mainly aimed at
physical, business, and design. The goal of all these process models is ultimately to produce
an analytically useful representation of reality. No model however can fully represent every
dimension of a complex process and the models described here are useful in their
particular applications but no single model will provide all the answers a process designer
or operator might need. The network-based process model developed in this thesis and
described in Chapter 3 falls into the same category and while it provides a useful
representation of the many information, organizational, and physical elements involved in
complex processes, this model does not eliminate the need for other process models
especially physical ones such as process flow diagrams. Some humility is necessary, as
(Sterman 2002) writes in an introduction to his lecture accepting the Jay W. Forrester
Prize:
"Most important, and most difficult to learn, systems thinking requires understanding
that all models are wrong and humility about the limitations of our knowledge. Such
humility is essential in creating an environment in which we can learn about the
complex systems in which we are embedded and work effectively to create the world we
truly desire."
2.1.4.1 Flowcharts
Modern flowcharts can be traced back to the work of Frederick Taylor, Frank Gilbreth, and
others who by 1911 held the first formal conference on "Scientific Management" as
described in (Graham 2004). Gilbreth is mostly credited with the idea of a flowchart as
part of the set of work analysis (and improvement) tools he and his wife, Lillian, developed
in search of the "one best way". Gilbreth presented "Process Charts - First Steps in Finding
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the One Best Way" (Gilbreth and Gilbreth 1921), which described most of the elements of a
modern flowchart at the 1921 ASME Annual meeting using the symbol set in Figure 8.
Operation Do Operation Transportation Inspection Storage/Delay
(Value Added)
Figure 8 - Gilbreth's Basic Work Elements
The fundamental goal of flowcharts is to represent process activities, their precedence
relationships, and properties such as duration with a standardized set of symbols such that
the overall process can be analyzed, such as the "Do Operation" which emphasizes "value
added" activities. This remains a useful tool in Industrial Engineering as it can quickly
identify bottlenecks or non-value added activities and provides a process designer with an
overall view of the relationships between process activities and their contribution to global
process properties. But the emphasis on activities and the need to simplify the complexity
of the process so it can be represented in a comprehensible diagram purposely omits other
"views" as described by (Browning and Ramasesh 2007) such as the relationship networks
between individuals, the information networks the work instructions for each activity were
derived from, and the environment (policy or organizational) that the process is performed
in. Indeed Gilbreth's symbol set contained no elements for information or people.
Browning and Ramasesh's survey of process development models (including flowcharts
and scheduling Gantt charts) finds that:
"...models place a disproportionate emphasis on actions rather than interactions..."
and "However, activity interactions, particularly the flow of deliverables (including
information), give rise to a large portion of a PD process's behavior, such as
iteration."
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Browning and Ramesh also note that most process development models assume that all
activities are known a priori, which is often not the case even for established processes (i.e.
operating processes not in a development phase) where changes (and improvement) may
lead to unforeseen interactions and uncertainty. In these cases it is likely that the elements
flowcharts do not capture such as the organizational networks, information networks, and
environment of the process facilitate the resolution of the problems by providing
alternative paths (i.e. not explicitly defined links) between process elements such that they
can be resolved (as in troubleshooting).
Manufacturing process flowchart ideas were later adapted to other fields including
information processing, notably in the work of Herman Goldstine and John von Neumann
(Goldstine and Von Neumann 1947) who used them to describe early computer programs
on a successor to the ENIAC computer, the EDVAC. These computer science flow charts
developed a different symbol set for each of the computer program "activities" including
circles to represent start and end points, arrows to show "flow control" program elements,
parallelograms for input/output, diamonds for conditional branches or decisions, and
rectangles for processing steps. Many of these computer science focused flow chart
symbols and enhancements formed the basis for modern flow chart techniques such as
Unified Modeling Language (UML) which expands the modeling scope (and symbol set) to
include not just computer programs but to model entire software intensive systems
including "business processes" that are reliant on software. From a 2005 presentation on
the UML standard by Satish Mishra, Humboldt University, the UML scope includes:
* Data Modeling concepts (Entity Relationship Diagrams)
* Business Modeling (work flow)
e Object Modeling
* Component Modeling
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A criticism of these modern flow chart techniques is their significant complexity in
attempting to model many different activities, processes, and elements, along with the
correspondingly steep learning curve practitioners must go through to learn these
methodologies. For example, the latest version (2.2) of the UML standard is composed of
14 different "diagrams" that represent "structural information", "behavior", and "aspects of
interactions" as shown in Figure 9 to produce a master diagram.
I I
Class Component
Diagram Diagram
Profile Composite DepkS StructureiaDiagram Diagram fpi
Notation 
UML
Figure 9 - UML Class Diagram
The closest of these diagrams to the original flow chart concept is perhaps the Activity
diagram, which describes how objects in the UML diagram flow through a single process.
Other diagrams may represent other interactions between the elements in the activity
diagram such as information links, classification, etc., and the entire set of diagrams is
intended to represent the system. For example Figure 10 shows an activity diagram for a
customer interacting with an ATM machine.
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Figure 10 - UML Activity Diagram Example
A number of other business process and information systems modeling techniques exist,
and a useful taxonomy was proposed by (Giaglis 2001) for the design of information
systems including business process models. Giaglis classified models according to four
dimensions:
* The functional perspective represents what process elements (activities)
are being performed.
* The behavioral perspective represents when activities are performed (for
example, sequencing) as well as aspects of how they are performed through
feedback loops, iteration, decision-making conditions, entry and exit criteria,
and so on.
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* The organizational perspective represents where and by whom activities
are performed, the physical communication mechanisms used to transfer
entities, and the physical media and locations used to store entities.
* The informational perspective represents the informational entities (data)
produced or manipulated by a process and their interrelationships.
The various modeling techniques were then described according to their "Depth" in each of
these dimensions as shown in Table 2. It is apparent from the table that no single technique
covers all the dimensions proposed by Giaglis, partly because a single all-encompassing
modeling methodology would generate complex difficult to maintain and interpret models.
Giaglis proposes using each type of model as appropriate according to the stage of process
development from initial scoping to execution. Of particular interest in Table 2 are the
functional (process activities themselves), the organizational (who does the activities), and
the informational (the data needed to perform or produced by the activities), which this
thesis focuses on. Highlighted in blue in Table 2 are only the models surveyed by Giaglis
that cover each of the functional, organizational, and informational dimensions. Of the
models surveyed by Giaglis only the highly complex UML model, data flow diagrams,
system dynamics, discrete event simulation, and IDEF3 cover all 3 dimensions of
functional, organizational, and informational. But they do so covering at least one of the
dimensions in a limited fashion. Yet, the connections between these 3 dimensions are
exceedingly important as they define the true "static" structure of the process in terms of
all the elements needed to perform it. Associations between any 2 dimensions are not
enough as these may be connected through the third in ways that will be invisible in any "2-
dimensional" analysis.
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Modeling Perspective (Depth)
BPM/ISM Techniques Functional Behavioral Organizational Informational
Flowchart Yes
Petri nets Yes
Knowledge-based
techniques
Role activity diagram
Entity-relationship diagram
State-transition diagram
IDEFlx
No
No
Limited
Yes
Yes
Yes
Yes
Limited
No
No
Limited
No
Limited
No
No
N
No
No
No
No Limited
No
No
No No
No No
Yes
U
No
No
No
No
Yes
Limited
Yes
Table 2 - Dimensions of Modeling Techniques (Adapted from Giaglis 2001)
A description of the process models surveyed by Giaglis is given in Table 3 and many of
these are derivations of flow charts with particular emphasis on data or other process
elements.
Flowchart
Graphical model to snow tne tiow ot worK tnrougn a process
and highlight key processing and decision points emphasizing
the functional dimension
Functional modeling technique to describe decisions, actions,
IDEFO and activities of an organization with a single construct (ICOM)
emphasizing the functional dimension
IDEF3 Complementary technique to IDEFO to describe order and
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sequences of events as flow models with a time dimension
emphasizing the informational and behavioral dimensions
System modeling technique adapted to process consisting of a
Petri nets bipartite graph of concurrent states and transitions emphasizing
the functional and behavioral dimensions
A computer based model of a real system described as a
Discrete event simulation chronological series of events that change the state of the system
emphasizing functional and behavioral dimensions
System modeling technique to describe the causal relationships
System dynamics between system elements based on feedback and other control
systems concepts emphasizing the behavioral dimension
A modeling technique based on artificial intelligence methods
Knowledge-based techniques where knowledge bases are built to represent system operation
emphasizes behavioral dimension
Modeling notation describing roles as primary unit of analysis
Role activity diagram within organizations and showing the interactions between
roles, emphasizes organizational dimension
Technique for depicting the flow of data among external entities,
Data flow diagram internal processing steps, and data storage elements in an
enterprise emphasizes functional and informational dimensions
Network based model describing the stored data layout of a
Entity-relationship diagram system and the interrelationships in a manner independent of
any processing, emphasizing informational dimension
Modeling technique derived from the analysis or real-time
State-transition diagram systems showing focusing on the time-related sequence of
events, emphasizes behavioral and informational dimensions.
Extension of the IDEF modeling family to analyze data
IDEFix structures in and out of computer systems to show relationships
between entity classes, emphasizes informational dimension
Multi-notation modeling technique providing multiple diagrams
UML to address different system elements but which can be integrated
into a single diagram. Covers all dimensions but complex.
Table 3 - Description of Information Systems Models (Adapted from Giaglis 2001)
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Description
I
BPM/ISM Techniques
When the "depth" along each of these dimensions is matched to particular applications
(such as process improvement), which Giaglis calls "Breadth" the lack of a single modeling
tool for all possible applications is apparent as shown in Figure 11 from (Giaglis 2001)
where no single tool is listed in all (or even a majority of categories). The multi-purpose
modeling tools such as UML or the Integration DEFinition (IDEF) family do cover several
elements in that matrix, but at the expense of complexity. Based upon analysis of existing
diagnostic processes, a major goal of this thesis was to develop a network based model that
could tie together the informational, organizational, and functional dimensions, across each
of process improvement, process management, and process development application
dimensions. The Unified Modeling Language (UML) described in Chapter 3 is intended to
fill these areas in the Giaglis taxonomy. Note that the IDEF family of models cover a large
part of the same space the MDPM model, and indeed there are significant common
elements as will be described in Chapter 3.
Informational
(data)
Organizational
(where, who)
Behavioral
(when, how)
Functional
(what)
Simulation
DFD
Entity relationship
State transition
IDEF I X
UML
Petri nets
Simulation
Knowledge based
(State transition)
........................
Petri nets
Simulation
DFD
LML
I U U I I
Understanding &
communicating
Process
improvement
Process Process Process
management development execution
Figure 11 - Taxonomy of Modeling Techniques (from Giaglis 2001)
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(Flowchart)
(IDEF3)
DFD
Entity relationship
State transition
IDEFIx
UML
(IDEFO)
(Simulation)
System dynamics
RAD
(IDEF3)
Simulation
System dynamics
RAD
Flowchart
IDEFO
(IDEF3)
Simulation
(System dynamics)
DFD
(UML)
(Simulation)
DFD
Entity relationship
State transition
IDEFI x
UML
(lDEFO)
Simulation
System dynamics
RAD
(IDEF3)
Simulation
System dynamics
RAD
Flowchart
IDEFO
(IDEF3)
Simulation
System dynamics
DFD
(UML)
Simulation
DFD
Entity relationship
State transition
IDEFIx
UML
(IDEFO)
Simulation
System dynamics
RAD
(IDEF3)
Simulation
System dynamics
RAD
FlowchartIDFF0
(IDEF3)
Simulation
Simulation
DFD
Entity relationship
State transition
IDFF lx
UML
Simulation
(UML)
(RAD)
Petri nets
Simulation
System dynamics
Knowledge based
(State transition)
IDEFO
Petri nets
Simulation
DFD
UML
Other techniques are also available, and although the MDPM model developed here has the
much in common with IDEF, a brief description of these techniques is given in the following
sections including ones not listed in the Giaglis taxonomy (which emphasized information
systems) such as chemical engineering flow diagrams.
2.1.4.2 Process Flow Diagrams - Chemical Engineering
Unlike many of the Business Process Models discussed so far in this section, chemical
engineering processes are bound by physical laws, which are integral to the process flow
diagrams commonly used. These types of physically constrained models are especially
relevant to this thesis, since unlike business process models or even models of product
development tasks, the activities in chemical engineering flow diagrams must follow the
physical reactions and processing steps and are not amenable to easy re-organization to
improve task connectivity or sequence. The MRSA surveillance processes developed in this
thesis is a physical process, and can be thought of as a series of bio-chemical reactions
monitored by sensors which extract the DNA sequence information. The particular
sequence of steps can be re-organized to a limited extent, but many steps are "fixed" in the
sense they must be performed in particular order, and certain steps must be performed
without exception (such as the lysis of MRSA cells). This is not to say that new technology
cannot completely change the steps performed and perhaps even their sequence, but that
within a technology process "sequence" there are certain physical constraints. An example
of this might be from (Utterback 1996) which describes process innovation in plate glass
manufacturing where a series of technological advances made the process successively
simpler and more efficient as shown in Figure 12 with the series of processes (labeled as
"steps") that were combined or eliminated through innovation.
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Evolution of Plate Glassmaking Process
Original Grind &
Process Mix Melt Cast Anneal Polish
Step 1
continuous mixing and melting tank
Step 2
continuous annealing lehr
Step 3
continuous casting
Step 4
float process
End Result
Figure 12 - Evolution of Plate Glassmaking Process (Adapted from Utterback 1996)
Pilkington, the glass manufacturer, made a massive and uncertain investment in developing
the "Float" process which greatly simplified the number of steps involved although the
development process was very complex in finding the right combination of variables and
equipment to produce glass in this manner. This massive R&D effort required many
additional resources beyond those needed to operate the eventual stable process in terms
of personnel, information, and experimentation. And while the eventual process was
simpler, there was a temporary increase in the "complexity" of the process, something akin
to the "scaffolding" used during the construction of ships or buildings. However, at any
given moment in between these major process innovations, the physical steps are "fixed" to
a large extent and are not as easily changed as in the "business process" examples where
the processing of a loan can be readily streamlined by moving personnel or arranging for a
single representative to handle the overall processing of the loan as described in (Hammer
and Champy 2003). Also because the steps in complex physical processes tend to be fixed,
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there is also a need for "fixed" organizations and procedures around each one that may
require specialized knowledge and as a consequence can easily become "silos" resistant to
change and not well integrated with other parts of the process. Ensuring that these silos
are well connected and are able to understand the impact of their activities and changes on
the rest of the process is a critical feature of "High-Velocity" organizations as described in
(Spear 2008).
A significant benefit of the physical process centric view of process flow diagrams is the
ability to perform significant optimization as the entire process can be modeled as a
simultaneous set of equations subject to physical constraints and operational settings. A
typical example taken from (Howell, Hanson et al. 2002) is given in Figure 13, a process
flow diagram used in the optimization of a monoethylene glycol (MEG) regeneration
system for use in a large offshore oil platform off Norway. MEG mitigates the formation of
hydrates in oil recovery and is injected directly into the wellheads to be recovered on the
platform, regenerated, and re-injected as the flow diagram shows. Extensive simulation
and optimization of this process was performed prior to installation on the platform given
the difficulty of post-installation redesign and the high capital cost associated with the
facility. As reported by Howell et al, the process performed per the simulations once in
operation, a tribute to nearly a century of advancement in chemical engineering modeling
and our understanding of the physical laws that govern the chemistry and physics in each
of the unit operations symbols shown in the MEG regeneration flow diagram.
But what of the personnel and the work instructions needed to operate the MEG
regeneration process? Flow diagrams are not typically concerned with these other
domains of a process other than to specify alarms in control systems, user inputs, and
maintenance access valves and controls. Design exercises are always performed in
offshore platform design to anticipate failure modes and many of these are often
operational errors that the process design should anticipate and be robust to. However,
the human operators and work instructions (i.e. operational rules) are often not explicitly
described as part of a process flow diagram yet can have a very significant impact on the
performance of a process. This is also true in a positive sense as even in physically difficult
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to change processes such as an offshore platform it is often possible to find ways to
improve yields, quality, and reduce cost through control system adjustments, operational
improvements, careful scheduling, and other means. These improvements happen through
mechanisms not clearly specified in a process flow diagram, often through social networks,
experimental observation, and planned experiments. A central part of the MDPM model in
this thesis is to shine light on these "hidden networks" so critical to process change and
improvement.
Figure 13 -Flow Diagram for the Asgard B Platform MEG Regeneration Process
Much like the plate glass making process evolution, but at an extraordinarily faster pace,
measured in months, many of the DNA sequencing processes considered in this thesis for
the MRSA surveillance system are improving in performance. However, because of the
rapid pace of evolution much of the R&D "scaffolding" necessary to make major changes in
process has remained in place making these processes enormously complex. And like the
MEG regeneration process each evolutionary DNA sequencing process has a given physical
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configuration set by the biochemical steps needed that cannot immediately be reconfigured
for greater simplicity. Successive generations and refinements can reduce complexity
however, as in the plate glass example, but this requires ongoing effort, metrics to measure
the complexity, and models to evaluate potential improvements. The proof of concept
surveillance system developed in this thesis is the first step in an evolutionary chain that
will eventually result in a much simpler, more efficient, and elegant process, just as the
original plate glass process was the first step in that chain. The MDPM model developed in
this thesis is a means to manage and accelerate this evolution using rational engineering
tools.
2.1.4.3 Petri Nets
Of the process models described so far, Petri Nets developed by Carl Adam Petri as part of
his 1962 PhD thesis are the closest to a network based process model (Van der Aalst 1998),
and indeed are mathematically described as directed bipartite graphs where the nodes
represent transitions or places and arcs connect each place to a subsequent transition. The
elements of a Petri Net are shown in Figure 14 and the network is bipartite because it
includes only places or transitions as nodes with arcs connecting places to transitions (but
not places to places or transitions to transitions). Places are "passive" elements
representing buffers, queues, physical locations (i.e. a warehouse), or communications
mediums (a computer network). Transitions are active elements such as events (starting
an operation, a traffic light change), transformations (a chemical reaction, updating a
database), or transporting an object. Arcs are causal connections between places and
events, which follow certain rules as shown in Figure 15. Finally, tokens represent the
elements subject to change such as physical objects (a product or drug), information
objects (a message), collections of objects (a warehouse with parts), an indicator of a state
(process state), or an indicator of condition (order fulfillment). The simplicity of Petri Net
elements and the directed bipartite structure allows for mathematical formalism and
analysis of workflows constructed using them.
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Elements
(name)
place
(name) transition
-- arc (directed connection)
0 token
Figure 14 - Petri Net Elements (Adapted from van der Aalst)
free
Rules .0
wait enter Y before makepcture after-
occupied
leave gone
" Connections are directed.
- No connections between two places or two transitions.
- Places may hold zero or more tokens.
- A transition is enabled if each of its input places
contains at least one token.
Figure 15 - Petri Net Rules (Adapted from van der Aalst)
Business process modeling in particular has seen significant adoption of enhanced Petri
Nets with some additional elements such as "color", "time", and "hierarchy" to represent
more complex business processes that classic Petri Nets as described here cannot
represent (Giaglis 2001). The mathematical framework of Petri Nets allows for the
construction of many computer science constructs such as AND, OR, iteration, and non-
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synchronous processing using tokens. And because Petri Nets are networks, a number of
network algorithms can be used to test the integrity of workflows modeled using them,
such as the "reachability" of the places (i.e. can a workflow be executed or are there parts
that can't be performed because there are no arcs connecting them). A number of other
network algorithms can be deployed, but the Petri Net emphasis on functional (activities)
and behavioral (timing of activities) makes the use of Petri Nets to also describe
organizational or informational aspects difficult. Nevertheless they are presented here in
further detail because of their network nature and associated network metrics for their
analysis with similarities to the analysis of the MDPM model described in Chapter 3.
2.1.4.4 Event Driven Process Chains
As part of the development of large-scale Enterprise Resource Planning systems such as
SAP, a number of business process workflow methodologies emerged including ARIS
(Architecture of Integrated Information Systems) developed by Prof. August-Wilhelm
Scheer who also founded IDS Scheer, an information systems consulting company that
popularized the method. ARIS models workflows using events, functions, interfaces, and
connectors in what are called event-driven process chains (EPC). Events drive the process
such that a temporal and logical representation of the business process can be made.
Function elements capture the activities of a process. Event elements capture the pre-
conditions and post-conditions of a function (an activity). An interface links multiple EPCs.
And finally connectors can specify AND, OR, and XOR logic branches. For comparison,
Figure 16 shows an example infection diagnosis and antibiotic treatment using both an EPC
notation and a Petri Net notation. Because of their significant use in ERP systems, EPCs
have received significant attention as business process models in part because they can
also be analytically verified for consistency and errors using similar algorithms to software
error checking as described in (Mendling 2009). In addition because EPCs are networks,
many graph theory analysis algorithms can be brought to bear including density as a proxy
for complexity as described in (Mendling 2006). A number of the MDPM model analysis
metrics proposed in this thesis are based on validation metrics proposed by Mendling and
others for EPC models. One significant limitation of EPCs and Petri Nets is the significant
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formalism required to build the models, as shown in Figure 16 with process activity
sequences such as "diagnostic is requested" followed by "record diagnostic request". While
highly useful to translate business processes into computer algorithms and workflows, the
familiarity of most users, in healthcare for example, with such formal pseudo-computer
languages is limited. The more familiar flowcharts or organizational charts being perhaps
better alternatives to capture stakeholder inputs directly without the need to translate
stakeholder knowledge directly into pseudo-code which likely requires the assistance of a
"programmer" familiar with the language.
Place
(with token)
Transition
recommend
monitoring
monitoring is
requested
Event Driven Process Chain (EPC)
diagnostic is
requested
record diagnostic
request
request is
recorded
perform
diagnostic
Figure 16 - Comparison of EPC and Petri Net Models (Adapted from Mendling 2008)
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2.1.4.5 OPM, CLIOS, and COIM
The Object Process Methodology (OPM) developed by (Dori 2002) is a recent systems
product design and systems engineering methodology allowing for the hierarchical
decomposition of systems into objects whose states can be specified and processes. The
relationships between objects and processes are specified by structural and procedural
links that transform objects. Objects, processes, and links joining them are shown in an
Object Process Diagram (OPD), which is used in OPM as a tool (rather than simply a
diagram) to visualize the complexity of a system by "zooming in", "folding and unfolding",
and "suppressing or expressing states". The ability to zoom in corresponds in some sense
to layers, where the macro level view of a process may hide many of the details that
zooming in to higher levels (layers) of detail might show. One advantage of OPM is that the
system can be represented by one diagram (albeit with multiple "zoom" levels). However,
OPM's focus on entities and process leaves out the organizational dimension (Osorio, Dori
et al. 2009), where individuals may have important connections but which are perhaps not
relevant to the process (and therefore not specified).
A general problem with many of the models described so far in terms of representing real
processes is the need to formally represent process specific structures (that is only the
elements needed to carry out the process in its "deterministic" or normal operational
mode). However, it is under "non-standard" operations, such as during troubleshooting,
attempts at improvement, and rapid process technology change that the "unspecified"
connections become vitally important in the organizational and informational dimensions
as it is not always possible to predict in a deterministic fashion the effects of changes or
problems on complex processes. OPM can be useful in decomposition of systems (and
processes) from high levels of abstraction to high levels of detail and this ability combined
with another complementary modeling methodology that might address the limitations of
OPM could yield a powerful hybrid methodology. The Complex Large Interconnected Open
Socio-technical (CLIOS) methodology described in (Sussman, Sgouridis et al. 2005) is one
such complementary methodology, which was joined with OPM into a hybrid methodology
as described in (Osorio, Dori et al. 2009), called the CLIOS-OPM Integrated Method (COIM).
Page 62 of 385
The CLIOS model separates a socio-technical system into a physical domain nested inside
an "Institutional Sphere" allowing for layering of the physical domain into subsystems if
necessary to provide more detail as shown in Figure 17 from (Dodder, McConnell et al.
2006).
Spher
Source: Dodder, Susmm et aL (2005)
Figure 17 - CLIOS System Representation
The CLIOS system modeling methodology is divided into 3 phases: system representation,
design and evaluation, and implementation. The initial representation phase contains a
useful methodology to describe a system's goals, elements, and connections between
elements, and the initial steps of this methodology will be adapted for use in the MDPM
methodology described in Chapter 5. The second CLIOS phase of design and evaluation
also contains many useful elements for the development of the MDPM methodology
although the DSM based MDM models and other network analysis tools are used in the
MDPM methodology. The CLIOS representation phase has the following steps as described
by Dodder et al.:
e System Description. The objective of this step is to describe the system, its
major characteristics, goals, and the main issues at stake.
e Identification of major subsystems of the physical domain and major actors of
the institutional sphere. In this step, we identify the major subsystems of the
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CLIOS System, their nature, and relationships among them. An important
aspect here is the definition of the Institutional Sphere and the identification
of actors within this sphere.
* Populating the physical domain and the institutional sphere. In this step the
functions and elements of each subsystem are described in greater detail.
This is done by nesting the physical systems in the institutional sphere,
layering the physical system into different subsystems and, if more detail is
necessary, exploring some subsystems by expanding the analysis of some
subsystems at finer granularity.
Dodder et al. defined four types of system components as shown in Figure 18
representing physical components, policy levers, common drivers, and an
external factor
Physical Component Polcy Lever Comnon Drlver Extermal Factor
ExaMples
Electric Utility Generator Rights of VY Reliablity National GOP
Management
Intemet Service Internet internet Backbone
PrvdrRouter TUiocommunicationsProidr ouerAct of 1996 Protocol Provider
Sourcs: papred based an Dodder, Susums Eal (205)
Figure 18 - CLIOS Process Symbols (from Dodder et al.)
* Describing components in the physical domain and organizations in the
institutional sphere. In this step we add detail and understanding by
describing in detail the components on the physical domain and
organizations in the institutional sphere. Detailed description results from
gaining deep understanding of each component and organization's dynamics,
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behavior, relevance, critical factors for performance, and insights about their
relationships.
e Identifying links among components and organizations. In this step, we
identify the types of relationships between components, subsystems, and the
various actors.
Three classes of links are defined by Dodder et al.:
(i) Class 1 links - links among elements of the physical system,
(ii) Class 2 links - links between the physical system and institutional sphere
(iii) Class 3 links - links among components of the institutional sphere.
* Gaining insights about system behavior. A major objective of CLIOS system
representation is to understand its structure and behavior, at least to first
order achieved by understanding its subsystems, components, relationships
among them, and relationships with components of the IIS (internal
institutional sphere) and the EIS (external institutional sphere).
A key limitation of the CLIOS method for process use is the lack of activity representation.
With a focus on the elements of a system, CLIOS does not have an explicit task element for
use in process description. However, CLIOS does have significant value in systematically
enumerating all of the system goals, key physical elements, policy levers, major actors, and
definition of the system environment. The MDPM model and the design methodology used
in chapter 5 follows several of the steps in CLIOS to systematically identify, enumerate,
classify, and link process elements but with a specific focus on process. The COIM model
(Osorio, Dori et al. 2009) brings together elements of both CLIOS and OPM adding
additional CLIOS elements to represent not just the physical element but also its function
which could be modified to represent process activities as a potential process modeling
technique. However, the central focus of COIM on systems as opposed to processes
requires further development for this application and an expanded modeling notation to
describe process activities specifically rather than components of a system.
Page 65 of 385
2.1.4.6 DSM, DMM, MDM, and ESM
The Design Structure Matrix (DSM) is a systems analysis method based on matrix
representation of graphs. DSMs can trace their history to early papers by (Steward 1965)
and (Warfield 1973). The fundamental idea of a DSM is that design tasks (or subsystems in
a product) can be enumerated along the rows and columns of a matrix, which corresponds
to the adjacency matrix of a graph as shown in Figure 19.
Figure 19 - DSM Model (from DSMweb.org)
The DSM model can be extended to represent the mapping of two domains to each other
such as people to tasks by forming a rectangular adjacency matrix that also represents a
graph as shown in Figure 20. These models are called Domain Mapping Matrices (DMM) to
distinguish them from the task or product element based DSM.
AtaKk5
Figure 20 - DMM Model (from DSMweb.org)
Individual DSM and DMM models can be joined together into Multiple-Domain Matrices
(MDM), which can show the relationships between various elements across an entire
system. A representative MDM is shown in Figure 21 of a series of tasks and people with a
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resulting matrix sharing the interactions between all combinations of people-tasks, tasks-
tasks, and people-people.
X~~~ I x x X
Figure 21 - MDM Model (from DSMweb.org)
Improvements to the DSM have most recently found valuable application in the design and
development of complex products (Eppinger, Whitney et al. 1990) emphasizing the proper
sequencing of tasks in product design processes. Algorithms can be applied to find more
efficient task sequences in design processes such that the overall design cycle time can be
reduced or the overall system knowledge can be managed. However, the DSM requires
significant existing system knowledge (Dong 2002) and a mature product since any new
tasks or new relationships between tasks cannot always be predicted a priori. This is
especially problematic for the application to physical processes where for any given
version of the process it may not be possible to re-sequence tasks and in complex new
processes some of the tasks may not be fully specified. Also for troubleshooting or process
improvement there may be in need to find (and rely upon) novel connections between
process steps and the organization in order to find the root cause of a problem or model
the impact of a change.
Multiple-Domain Matrices (MDM) however overcome some of the limitations of DSMs by
mapping the "non-process specific" elements as additional domains such that the
relationships between the process infrastructure and the "scaffolding" necessary during
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process development. These critically important connections between people, information,
and the process represent a more realistic model of modern processes. In particular
(Maurer and Lindemann 2008) describe the use of MDM models to address complexity in
modern product design due to the growing number of necessary linkages across domains
including technologies, components, process steps, and organizations. Maurer describes
the application of MDM to represent an example of three different domains, which interact
with themselves and with each other as shown in Figure 22. These domains might be
product components, information, and people represented by the red circles, green
triangles, and blue squares. There are linkages between elements of the product
components for example represented by red circles and shown in the upper left corner of
the MDM. However, there can also be cross-domain interactions such as product
components with information as in the middle and right upper quadrants showing the
interaction of product components (red circles) with people (green triangles) and
information (blue squares). The overall matrix formed is an adjacency matrix representing
the graph on the left of (figure), and the matrix can also be directed to show directionality
in the linkages between elements and domains.
Although not found until much later in the execution of the research in this thesis, the MDM
ideas presented by (Maurer 2007) have significant similarity to the MDPM model described
in Chapter 3. The MDM ideas are seen to have significant potential to describe complex
processes, which the MDPM model emphasizes. The ability to span multiple domains
addresses many of the limitations of business process models described in the (Giaglis
2001) taxonomy since all of the domains (behavioral, organizational, functional, and
informational) could be represented in an MDM as additional matrix elements. Despite
these advantages there is limited literature on MDM modeling and application as this is a
new and developing area of research with few "real world" examples to date in the MDM
area, due in part to the significant complexity associated with the models.
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Figure 22 - MDM Graph and Matrix (from Maurer 2007)
Similarly, the Engineering Systems Matrix (ESM) model proposed by (Bartolomei 2007) is a
multi-domain model with the same properties as MDMs that explicitly takes into account
many of the system elements not traditionally considered by process models. Bartolomei
describes an MDM structure that considers the system driver, stakeholders, objectives,
functions, objects, and activities as domains each along the columns and rows of an MDM as
shown in Figure 23 taken from (Bartolomei, Hastings et al. 2006). The relationships
between elements in each of these domains can then be represented using the same tools
as MDM analysis, such as the interaction of stakeholders with activities. Bartolomei's work
also contains similarities to the MDPM model developed in chapter 3. The ESM model
explicitly includes the system objectives (i.e. what a process must do), objects (physical
infrastructure elements), and functions (things a system must do to fulfill its objectives),
which are considered part of the initial methodology in specifying the MDPM model rather
than parts of the model due to the significant additional complexity they would add.
However, the ESM model does not address one critical dimension, the work instructions
associated with processes, which are essential to every activity. Explicitly accounting for
these protocols is essential since they are how design changes are propagated and must
reflect the needs of stakeholders, objectives, and other domains just as any other of the
elements described in the ESM. The MDPM model explicitly accounts for these work
Page 69 of 385
...................
.. . ...... "I'll, ... ..... ....... ......
instructions and their interaction with the rest of the process. The product and system
focus of the ESM limits the "process" view, but it is the author's view that these explicit
work instructions should be accounted for in the "standard" Engineering Systems version
of the ESM.
Figure 23 - Engineering System Matrix (adapted from Bartolomei 2007)
Despite the potential limitations of DSM models to represent new processes as described in
(Dong 2002) creative approaches have appeared to extend the utility of DSM (and by
extension DMM and MDM) models to manage technology change. One such application is
demonstrated in (Smaling 2005) who used DSM models to quantify the impact of
"technology insertions" into existing systems. While the focus of these models is on product
development, there is significant potential application on physical process design (i.e.
MRSA diagnostic processes as opposed to product design processes). The approach taken
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by (Smaling 2005) is to augment a DSM by linking additional matrices of the same
dimension as the original DSM to indicate a variety of technology architectures and types of
changes such that a weighted sum of the changes corresponding to each of the
architectures can be calculated which Smaling calls the "technology invasiveness" level.
One limitation of this approach is that either all potential elements of all architectures must
be listed in the original "baseline" DSM from which the technology invasiveness is derived,
or changes must be limited to variations of an existing "mature" configuration. This might
be a problem in technologies (and processes) that are rapidly changing and where design
alternatives correspond to radically different process elements and sequences of these.
Nevertheless the "technology invasiveness" methodology may have important applications
in process design as developed in this thesis.
The literature surveyed on multi-domain models specifically applied to proceses finds
some related research in the MDM models of (Maurer 2007) as described previously who
apply DSM like tools to the mapping of multiple domains (and layers). However, Maurer's
emphasis remains on design and products rather than "real" processes and there is no
associated methodology for the enumeration of elements in each domain or the evaluation
of feasible alternatives prior to mapping each of the domains. If all possible design
alternatives and configurations are to be considered, the MDM models could be become
inordinately complex or not meaningful as they are largely concerned with mapping other
domains onto a single product or design process to identify interactions. Another related
work using MDM like models is given by (Bradley and Yassine; Bradley and Yassine 2008)
who also use MDM models to map product development efforts attempting to link people,
product elements, and manufacturing steps. Once again, the focus is on understanding the
multi-domain impacts of existing processes without mention of a methodology to select
feasible processes or how to enumerate and identify the necessary elements. The existence
of these efforts is exciting as they already show alternative applications for MDPM-like
models and could facilitate the wider adoption of these methods. In addition, although the
MDPM model was developed independently, the similarities in the model, if not the
methodology, provide some validation to the approach.
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2.1.4.7 IDEFO
The IDEF family of system modeling languages traces its roots to the Integrated Computer
Aided Manufacturing (ICAM) initiative of the United States Air Force and an initial contract
to Doug Ross and his company SofI'ech to develop an industry wide model of how
aerospace products are built (Feldmann 1998). This resulted in the Structured Analysis
and Design Technique (SADT), a subset of which became the Air Force's ICAM language.
The ICAM language in turn generated the Integrated DEFinition (IDEF) languages. A series
of languages were developed from the initial ICAM set as shown in Table 4. The most
relevant to this thesis are IDEFO for functional (process) modeling, IDEF1 as a complement
to IDEFO for information modeling, and to an extent IDEF1x for data handling modeling.
IDEF2 and IDEF3 are mainly intended for time-based modeling of systems and user
interfaces (and user views) of the system. IDEF4 was intended as a design tool for software
designers involved in object-oriented design. IDEF5 was intended for the capture of
domain ontologies, which are used to capture objects in particular domains. Note that in
Table 4 only languages IDEFO to IDEFS have completed (and accepted) standards while the
majority of the other IDEF languages remain in various stages of development partly due to
the very large and ambitious scope of the IDEF program.
Function Modeling Accepted Standard
IDEF1 Information Modeling Accepted Standard
IDEF1X Data Modeling Accepted Standard
IDEF2 Simulation Model Design Accepted Standard
IDEF3 Process Description Capture Accepted Standard
IDEF4 Object-Oriented Design Accepted Standard
IDEF5 Ontology Description Capture In Development
IDEF6 Design Rationale Capture In Development
IDEF8 User Interface Modeling In Development
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IDEFO
IDEF10 Implementation Architecture Modeling In Development
IDEF11 Information Artifact Modeling In Development
IDEF12 Organization Modeling In Development
IDEF13 Three Schema Mapping Design In Development
IDEF14 Computer and Communication Network Design In Development
Table 4 - IDEF Modeling Language Family
IDEFO, developed originally to represent manufacturing processes, represents processes
with a single generic process block that defines the activity, inputs, outputs, controls
governing the activity, and mechanisms with which the activity is executed as shown in
Figure 24. The "call" arrow represents the ability "drill down" into a more detailed
expansion of the activity. This language is most relevant to this thesis due to its emphasis
of process.
Control
Input
Mechanism
Output
Call
Figure 24 - IDEFO Modeling Block
Shown in Figure 25 is an example IDEFO diagram describing a design process. Note that
while the activities are connected to each other as a graph, the "controls" and
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"mechanisms" have no such connection to each other and are shown as appearing on the
diagram as needed such as the "designers" and the "drawing standards". This is a
limitation of the IDEFO language partly addressed by IDEF1 which can show the
connections between information such as the "drawing standards" and "standard designs"
in Figure 25, but this is not done so explicitly. The MDPM model developed in this thesis
separates the "controls" and "mechanisms" into distinct domains and explicitly describes
the linkages between all these elements in a manner similar to a Multiple-Domain Matrix
(MDM) model.
Customer
requirements Changes in requirements
Standard C1
designs
Drawing standards
Node: MFO / Al1 Tftte: Agree design C-Number: HES006
Figure 25 - Example IDEFO Diagram (from syque.com)
The literature on IDEFO tends to use the model as a complement to other analytical
techniques and mainly to elicit system structure in terms of sets of activities. For example
(Liu and Fang 2006) combine IDEFO and Petri nets in developing a hybrid methodology
called TTIPP to analyze processes as shown in Figure 26 where the IDEFO model serves to
define the places and transitions of the Petri Net which in turn allows for behavioral
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(performance) analysis. An IDEFO example model developed by Liu and Fang is shown in
Figure 27 for a model of emergency response.
Lexical lVwl mod cmucep*ua lcvd MOdel S)mbl leve model
Figure 26 - TTIPP Methodology (from Liu and Fang 2006)
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Figure 27 - IDEFO Model of Emergency Response (from Liu and Fang 2006)
In healthcare IDEFO models have been used to elicit system requirements from users prior
to the development of a data model for a hospital information system as described in
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(Staccini, Joubert et al. 2001) who modeled a hospital blood transfusion process. Staccini et
al used a variation of IDEFO to first categorize and enumerate all of the process elements in
blood transfusion as shown in Figure 28 to force stakeholders to explicitly describe all of
the process elements. Staccini et al also complement IDEFO with a time-based description
of the process as well as a data flow diagram as the IDEFO diagram on its own did not
provide sufficient detail.
tpud SAD A**sentir
tibttpa ltunnuuum itsm: itsman: Geokna:
r~~7LA~J
Figure 28 - Modified IDEFO Model of Blood Transfusion (from Staccini et al 2001)
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2.2 Network Analysis
As described in the previous section networks form an integral part of the structure and
analysis of some process models and an extensive literature spanning more than 250 years
exists for networks and graph theory in general. Network analysis has recently entered a
modern Renaissance being applied to fields as diverse as biology, organizations, marketing,
and economics. But the roots of the field are quite old dating as far back as 1736 to Euler's
solution of the bridges of K6nigsberg problem using graph theory ideas. This first period of
network science, called the "Pre-Network period" from 1736 to 1966 as described in
(Lewis 2009), saw the development of mathematics of graphs including formal
descriptions of the mathematical objects used today such as vertices (nodes) and edges
(links) with many of these fundamental concepts tracing back to Euler himself. An
important but seemingly unrelated to networks discovery (Lewis 2009) occurred in 1927
with the publication of the first mathematical model (Anderson 1991; Kermack and
McKendrick 1991) for the spread of infection in a population which although not in itself a
network model relied on network ideas to explain the spread of infection along links
connecting nodes and also formed the basis for models describing new product adoption
where products (or information) spreads like an infection through a social network. Paul
Erdos also made significant contributions to the mathematics graphs during this period
including the analysis of random graphs and the Erdos-Renyi (ER) algorithm to generate
random graphs.
The next major period of network science called the "Meso-Network period" from 1967 to
1998 (Lewis 2009) is marked by the significant application of graph theory to understand
social structures such as Stanley Milgram's 1967 "6 degrees of separation" experiment
(Milgram 1967) that showed social networks were not random but had certain "small
world" properties that enabled large numbers of seemingly disconnected people to be
connected with each other in less than six "hops". Much later (Watts and Strogatz 1998)
would formally define small world networks and show that for small world networks the
diameter (the longest number of hops between two nodes) increases as ln(n) while its size
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increases by 0(n) where n is the number of nodes. A related idea was proposed by
(Granovetter 1973) who postulated that a few "weak ties" (long-distance connections
between acquaintances) help tie together groups of "strong ties" (direct connections
between family and friends) in social networks. Granovetter suggested that these "weak
ties" help explain why it is possible to connect large sparse people networks in just a few
hops as Milgram had found. Additional applications of network science to other fields
occurred during this "Meso-Network period" including further work to relate infectious
disease propagation models to new-product adoption network and technology diffusion
models (Bass 1969; Norton and Bass 1987).
As described in (Lewis 2009) the current "Modern Period" of network science from 1998 to
the present has seen further application to many other fields and a deeper understanding
of the properties of networks including the analysis of both static properties (i.e. diameter)
and dynamic properties (i.e. states and preferential attachment). A landmark publication in
the "Modern Period" was (Watts and Strogatz 1998; Watts 1999; Watts 2003)
demonstration of the universality and utility of "small world" networks and the Watts-
Strogatz small world network generation algorithm. The discovery that biological networks
such as the neural network of the nematode worm C. Elegans, the US electric power grid,
and social networks all had small world properties further sparked interest in the "New"
network science and a rediscovery of the graph theory in development for over 250 years
since Euler. Other network types have been found such as "scale free networks" (Baraba'si,
Dezs6 et al. 2003) which contain a few hubs of high degree (i.e. number of links) connecting
many other nodes of much lower degree following a power law distribution. The small-
world and scale-free network models produced an explosion of research and applications
of network science in many fields but particularly relevant to this thesis in models of
enterprises, communications networks, distribution of knowledge, and system complexity.
The following sections describe selected network background and literature relevant to
this thesis.
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2.2.1 Properties
Graphs are defined mathematically as a 3-tuple: G=(N,Ef), where N is a set of nodes, E is a
set of Edges (Links), andfis a mapping function (matrix) that maps edges onto node pairs
and can indicate directionality from one node to another. For example, Figure 29 shows a
directed graph with nodes A-E and the corresponding adjacency matrix (the mapping
function) listing all nodes and corresponding linkages between them as ones in the matrix.
The location of matrix entries above or below the diagonal indicates directionality. All of
the graph based process models (DSM, DMM, MDM, Petri Nets, EPCs) can be represented in
this manner.
0 0 1 1 0
0 0 0 1 0
0 0 0 0 1
0 0 0 1 0
Figure 29 -A Directed Graph and Corresponding Adjacency Matrix
The advantages of the matrix representation are that a number of metrics can easily and
directly be computed in terms of graph properties. For example, the "in-degree" of a node
(number of links "entering" the node) can be computed as the sum of that node's column
entries and the "out degree" (links exiting that node) can be computed as the sum of that
nodes row entries. A degree distribution for the network can then be calculated from
individual node degrees. The diameter of a network can also be calculated as the longest
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path through the network (for the Figure 29 example path A-B-C-D-E with length 5). The
shortest path length between every pair of nodes can similarly be found via search
algorithms for more complex networks. Note that the network shown in Figure 29 is
"weakly connected" which means that if we ignore the directional arrows (i.e. allow for
things to go the "wrong way") then every node is connected to every other. But, if we
follow the "rules of the road", node A cannot be reached from node E (or any other node).
Directionality is especially important in network based process models, as activities must
follow certain precedence and it is not always possible to go backwards in a process (i.e.
many of the processing steps in a medical diagnostic are "irreversible" such as cell lysis).
More sophisticated graph metrics can be calculated such as density of the network, which
is the ratio of the actual number of links present in a network to the maximum possible
density (i.e. the number of links to connect every node to every other node in a complete
graph).
A number of additional and increasingly sophisticated metrics can be computed
(Wasserman and Faust 1994; J. Carrington, Scott et al. 2005; Lewis 2009) but many of these
are strictly associated with the type of network being studied to be meaningful. For
example physical networks (i.e. a road network) require a different interpretation of path
length (actual distance) than a social network (acquaintances in between) or a
communications network (number of server hops). The relevant process network metrics
used in the MDPM model are discussed in Chapter 4, where the network properties of the
MDPM are exploited. Significant effort already exists to classify process networks
according to sets of metrics for EPCs, Petri Nets, and others (Cardoso, Mendling et al. 2006;
Gruhn and Laue 2006; Mendling 2009) and some of the metrics presented in Chapter 4 are
based on such prior work. In addition there is a growing body of research on metrics to
characterize the complexity of networks according to various measures (Costa, Rodrigues
et al. 2005), although no single measure (or even set of measures) appears to be suitable
for all network types and applications. Yet all of them are based on the fundamental
concept that graphs can be represented as mathematical objects and matrices in particular
as shown in Figure 29.
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2.2.2 Organization Models
A fundamental need in models to represent all dimensions of complex processes is the
representation of organizational elements in addition to the process activities. This is a
particular strength of social network analysis, which traces its roots to Georg Simmel and
other sociologists in the early 1900's interested in describing the relationships between
individuals in groups such as classrooms, workgroups, and other interpersonal
relationships. However, it took some time to develop analytical underpinnings for the
sociological concepts and it wasn't until the 1960s that groups such as Harrison White, his
students, and others (including Milgram and Granovetter) that modern analytical social
network analysis was born. Among the areas of application for social network analysis are
the diffusion of ideas "how quickly does an idea spread", collaboration patterns "who
works with whom" as shown for scientific networks in, influence networks "who can
influence who", and communication networks "who talks to who". All of these types of
applications have significant importance in addressing the organizational dimension of
complex processes as a key concept of this thesis is that any single dimension is not
sufficient to model a real process. The relationships between individuals associated with a
process are critically important to the "nonstandard" operation of processes such as
troubleshooting, process improvement, and change since by definition these nonstandard
events cannot be neatly specified a priori and require some "exploration" and "search" of
necessary information and resources to resolve.
Social network analysis (J. Carrington, Scott et al. 2005) can represent these social elements
(people and organizations) such that the relationships between elements can be specified
but also key components identified and the efficiency of "searches" calculated. The
elements of a social network are nodes, which represent "actors", and ties, which represent
relationships between the actors. There may be multiple kinds of ties between actors such
as work, social, and personal relationships but these can all be represented as graphs using
adjacency matrices similar to Figure 29. From the network representation and adjacency
matrix defining the relationships between nodes on number of useful measures can be
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calculated for individual actors in the social network as described in (Freeman 1979;
Borgatti 2005) including:
* Betweenness: A measure of how important a node (actor) is to the
communication paths in a network. Formally it is a measure of the number
of shortest paths in a network that pass through the given node relative to all
shortest paths. An actor with a high betweenness value is a part of more
communications paths than others and is therefore more "important".
* Closeness: The degree an individual has shorter path lengths to reach other
nodes and reflects the ability to get "information" from other actors.
Both of these measures might be particularly important to identify key individuals in
processes to consult troubleshooting problems with, as they are more likely to either know
information or know who might know. A number of other measures are available that
define cliques in social networks, key players who can serve as hubs, and others as
described in (Wasserman and Faust 1994). Some of these measures are used in Chapter 5
to identify key elements of the process that can help transfer knowledge because of their
high betweenness centrality or elements that are highly disconnected and must have ties
added (people communicating with them) to improve the communications performance
and robustness of the network.
2.2.3 Information Models
Just as the organizational dimension is essential the informational dimension must be
represented in a complete process model. Network science has also been applied to model
information and knowledge networks including maps of citation networks, patent
networks, communications networks, and nearly all computer networks. Some overlap
exists with social networks in that these also contain knowledge and network analysis of
firm collaborations as in (Owen-Smith and Powell 2004) to represent knowledge networks
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blur some of the distinctions. In this thesis information is treated as explicit knowledge
meaning written policies, guidelines, work instructions, algorithms, and other strictly
documented forms of information. This distinction is useful in process models because
nearly every activity has an explicit knowledge component (i.e. a written protocol) and a
tacit knowledge component (i.e. the operators experience). This explicit distinction also
allows for the tracing of information "genealogies" where a particular work instruction
might be derived from a local hospital guideline, which in turn might be derived from an
industry-standard. When a change occurs such as a new industry standard, these changes
must be propagated throughout the information network all the way down to the work
instruction associated with a particular activity.
However, in complex processes the effect of a particular change as it propagates through
this information network cannot always be predicted and is part of the reason to explicitly
model information. An elegant description of network-based explicit information change
analysis can be seen in (Giffin, de Weck et al. 2009) who mapped change requests during
the design of a complex sensor system with the largest component of this change
propagation network shown in Figure 30. In similar fashion the information domain of the
MDPM model described in chapter 3 focuses on tracking work instructions associated with
process activities and the associated information (guidelines, other protocols, and changes)
these work instructions are derived from (and affected by).
Communications networks that transmit information have been modeled extensively in the
literature, notably starting with (Shannon and Weaver 1948) and a line of literature
developing information theory to apply to many other fields including biology. A key
concept from the information theory literature is entropy, defined as the amount of
information needed to know the state of a random variable, and can be used to quantify the
amount of information contained in a message across a communication network in bits.
These ideas have been extended to quantify the amount of information needed to search
networks as described in (Rosvall, Gronlund et al. 2005), which is of particular importance
to MDPM model developed here as most complex processes will require extensive searches
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during troubleshooting, improvement, and change conditions to find root causes of
problems or find the impact of changes on the rest of the process.
Figure 30 - Largest Engineering Change Request Network in a Complex System Design
Program (from Giffin, de Weck 2009)
2.3 Healthcare as a Complex System
The US healthcare system is a vast collection of services, products, organizations,
stakeholders, and regulatory agencies representing 16.2% of the US economy in 20073. To
constrain the scope of this thesis, the focus is on clinical microbiology, microbial
surveillance, and DNA sequencing processes within the healthcare system and background
on these is provided in the following sections. As described in Chapter 1, microbial
surveillance has regained importance with rates of antibiotic resistant microbes including
3 Source: National Health Expenditures - HHS 2008
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MRSA and background is provided on the state of the antibiotic arsenal, which is nearly
depleted, and MRSA such that the importance of the demonstration project described in
chapters 5 and 6 can be understood.
2.3.1 Healthcare Processes
All of the diagnostic, therapeutic, and business processes in the healthcare system can be
cast as processes within organizations subject to policy and system constraints. The
healthcare system is in fact already organized around processes, although not explicitly
described as such. In an effort to provide a means to classify disease and procedures to
treat disease, catalogs were developed in the late 1800's. These evolved in the US into the
"International Classification of Diseases, Adapted for Indexing of Hospital Records and
Operation Classification" (ICDA), first published by the US Public Health Service in 1948.
The current version used in the US is ICD-9-CM (clinical modification) published by the
Department of Health and Human Services (HHS). This catalog contains codes to group and
identify diseases, symptoms, and medical parameters, but also for purposes of this thesis
codes to track health interventions (processes) performed by medical personnel. The ICD-
9 is mainly aimed at disease diagnosis classification, however, and most insurance
reimbursement for procedures is performed using the American Medical Associations'
Current Procedural Terminology (CPT).
The CPT forms the basis for the Healthcare Common Procedure Coding System (HCPCS),
which is the Federal standard for coding Health Care and includes everything from a
routine blood pressure check to heart transplants, and are the means by which hospitals
track, bill, and reimburse for procedures performed. HCPCS was first established in 1978
to standardize codes for insurance reimbursement of items and services primarily for
Medicare and Medicaid. With the implementation of the Federal Health Insurance
Portability and Accountability Act (HIPAA) in 1996 the use of HCPCS became mandatory.
HCPCS is divided into 3 levels:
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Level I - Comprised of AMA's CPT numeric coding structure, and further divided
into 3 categories:
Category I - Medical, Surgical, and Diagnostic Services: "consistent with
contemporary medical practice and performed by many physicians in
multiple locations" 4.
Category II - Performance Measurement: Optional codes used to track
certain measures "agreed upon as contributing to good patient care"
Category III - Emerging Technology: Temporary codes used for new and
emerging services and procedures.
Level II - Primarily non-physician services including ambulances and prosthetic
devices. Alphanumeric.
Level III - Local (State Medicaid) codes for use in specific programs but use is now
discontinued.
The majority of US insurance claims are contained within Level I and Category I of the
HCPCS structure. The introduction of new technologies however can be lengthy and
complex, and new codes start with a request for a temporary code in Level I Category III,
where the AMA CPT Editorial Panel will review the request subject to the following
requirements:
- A protocol for a study of procedures being performed
- Support from the specialties who would use the procedure
- Availability of U.S. peer-reviewed literature
a Descriptions of current United States trials outlining the efficacy of the procedure
Once sufficient data has been gathered, a new technology category III procedure can be
reviewed for inclusion the "standard" category I codes, subject to the review of the
Editorial Panel, and the following requirements:
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4Source: AMA Website
- That the service/procedure has received approval from the Food and Drug
Administration (FDA) for the specific use of devices or drugs;
- That the suggested procedure/service is a distinct service performed by many
physicians/practitioners across the United States;
- That the clinical efficacy of the service/procedure is well established and
documented in U.S. peer review literature;
- That the suggested service/procedure is neither a fragmentation of an existing
procedure/service nor currently reportable by one or more existing codes; and
- That the suggested service/procedure is not requested as a means to report
extraordinary circumstances related to the performance of a procedure/service
already having a specific CPT code.
The cycle time for this process is long, and is not the end point for widespread adoption.
Once a procedure has made it into category III, hospitals can bill insurers (and medicare)
for these services. As an example of relevance in this thesis, CPT code 87641, DNA probe
PCR based detection of MRSA, was only introduced into the standard CPT codes in 2007,
and not all hospitals and insurers classify this procedure as "medically necessary" further
delaying adoption. Partly due to the slow adoption the costs for this diagnostic remain
high, $272 per one hospital system5 . This compares to less than $5 per culture-based
assay. To emphasize the long cycle times in adoption of new technology, the basic
technology for the Polymerase Chain Reaction (PCR) was invented in 1984 as described in
(Mullis and Faloona 1987), and the specific quantitative PCR (qPCR) technique used in this
assay was invented in 1992 as described in (Higuchi, Dollinger et al. 1992). Applied
Biosystems introduced the first commercial quantitative PCR system in 1996. While qPCR
found numerous applications in other diagnostic areas, its use in MRSA diagnosis has
lagged due to a number of factors:
1. Cost compared to culture based assays
2. Non-standard MRSA screening practices (not required in most hospitals)
s Source: UMC Health System, Texas: https://www.umchealthsystem.com/patientfinancialservices/pricing/
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3. No perceived need (antibiotics working for most cases)
4. Physician training (how to interpret)
5. Laboratory training (how to perform and troubleshoot)
6. Workflow (speed of assay slowed by centralized laboratory handling,
negating advantages)
7. Limited commercial availability (partly due to reimbursement restrictions)
8. Not phenotypic (detects resistance gene, but does not specify antibiotic to be
used)
9. No accepted validation (no "authority" certified its validity, various studies,
but AMA and others slow to certify)
10. Highly specific to particular genes and cannot detect changes in resistance or
virulence (mutations or adaptations)
The cycle time for the qPCR assay can be represented by a series of phases from discovery
to adoption as follows:
40
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Figure 31 - Time to Widespread Adoption for Various Medical Technologies
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Over 25 years elapsed from initial discovery of PCR to an approved reimbursable
procedure. And while the exact start dates of each phase are somewhat arbitrary the main
issue is the overall length of time from initial publication to a reimbursable procedure is
exceedingly long. By contrast MRIs took longer, over 34 years as described in (Filler 2009)
, but are also a more complex process with significant training, capital cost, facilities, and
development requirements. DNA Sequencing of the type used in the Human Genome
Project is plotted in Figure 31 and also had a lengthy maturation, and although it uses many
of the same techniques as PCR, it is still not an "approved" procedure and the validation
and adoption phases in Figure 31 are estimated. The lengthy development of DNA
sequencing and high initial costs before new technologies appeared are described in
numerous articles including (Hutchison 2007). These phases are representative of what
most processes in healthcare must go through before they become commonplace best
practices.
1. Discovery: Initial creation of a process and feasibility demonstration
(discovery of PCR 1984 to application in qPCR 1992)
2. Development: Developing a prototype process (developing prototype qPCR
1992 to commercial product ABI 1996)
3. Implementation: Commercial robust process (product in the field and
improvements 1996-2002)
4. Validation: Evaluation by multiple sites under real conditions (evaluation of
qPCR for MRSA specifically 2002-2006)
S. Certification: AMA grants level I code for routine medical use (2007)
6. Adoption: Dissemination of the technology into routine medical practice
(2007-2010?)
The adoption of qPCR into routine MRSA diagnosis is a particular example of the lengthy
cycle-time for process adoption in healthcare due to the complexity of the processes and
the system they are performed in. And by comparison to other processes it is not
particularly complex. Sequencing has taken even longer from initial discovery and is still in
an implementation phase. The work in this thesis is one of the first to demonstrate a
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robust process for using sequencing as an MRSA diagnostic, but likely it will still take
several more years to pass through certification and adoption phases. Other industries
have much faster process discovery to adoption cycle times, and have developed process
focused design and development methodologies largely absent from healthcare. One of the
objectives of this thesis is to show that the significant initial complexity of healthcare
processes greatly slows their adoption, and it is only once the complexity of these
processes has been reduced either through technology improvement or organizational
changes that these processes can be adopted. Changes to the way processes are created,
designed, implemented, and diffused should focus on ways to reduce this process
complexity which many organizations in healthcare simply do not have the resources to
deal with. One of the problems is that this complexity is largely hidden and only becomes
apparent in initial implementations and it makes the barrier to entry significantly higher.
2.3.2 A Brief History of Microbiology and Antibiotics
One of the key processes in the healthcare system is the control of microbial infection, and
for the last 60 years human beings have held temporary advantage in the fight against
bacteria. But as discussed in chapter 1 this advantage is rapidly diminishing, and without
significant effort to develop new antibiotics and perform much greater surveillance and
research into the mechanisms of resistance we may lose this advantage entirely. Today we
take for granted the ability to control infection during surgery, but this was not always so
and returning to the terrifying situation before antibiotics would render our entire
healthcare system inoperative. It is worth describing what the world was like before
modern antibiotics as well as trace through the history of microbiology for some
perspective, summarized from (Porter 2001; Kennedy 2004).
Microbiology begins in earnest with the development of the microscope in the Netherlands
in the 1600s. Robert Hooke was the first to use the microscope as a tool and in 1665
published "Micrographia" in which he coined the term "cell". Further work followed with
Von Leeuwenhoek and others who catalog the various cellular structures in nature and the
human body. In the 1800s Germany took the lead in the development of advanced
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microscopes that further enabled the development of modern pathology, including catalogs
of disease tissues for the education of the first generation of pathologists. The 1800s also
sees the development of anesthesia and enabling the first internal complex operations, but
also exposing the need for sterile conditions during surgery. Because of the poor
understanding of bacterial infection in the mid 1800s many physicians resisted calls for
antiseptic technique. In particular, Boston physician and Harvard anatomy professor,
Oliver Wendell Holmes was one of the first to consider infection as caused by germs
transmitted by attendants in hospital ward. He recommended washing with chlorinated
water and changing clothes. However, other physicians disputed his theory and scoffed at
the need for antiseptic technique.
At about the same time, Ignaz Semmelweiss at the Vienna General Hospital noted that the
two maternity wards there had very different rates of infection. Ward 1, staffed by medical
students, had a 29% mortality rate, whereas Ward 2, staff by midwifery pupils who did not
attend autopsies had 3% mortality rates. Semmelweiss switched the medical students to
Ward 2, and the mortality rate jumped following the medical students. In May 1847 he
ordered handwashing with chlorinated water and mortality rates plummeted. His
colleagues resisted these changes and in 1851 he resigned and moved to a Budapest
hospital where he introduced chlorine disinfection and mortality rates in the maternity
ward fell below 1%. But even there he could not convince his colleagues of the hazard of
the microscopic organisms they could not see. Bacteriology was still in its infancy and it
would not be until Pasteur that wide acceptance of antiseptic technique would occur. Yet
despite modern knowledge of the causes of microbial infection, resistance to "process
change" including changes to attitudes, work instructions, and technology remains
pervasive even today where hospitals with significant patient isolation and transmission
control (hand-washing etc.) programs have lower rates of MRSA infection (Harbarth 2006).
Semmelweiss was fighting system change with only empirical evidence, but even today
similar themes appear.
The next significant milestone in our understanding of microbiology came from the efforts
of Joseph Lister, a surgeon in Glasgow, and Louis Pasteur a French chemist. Following
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surgeries Lister often encountered sepsis, which was believed to be caused by "miasma" or
bad air. Lister noticed that when wounds healed cleanly results were good but anytime an
infection developed it was likely to lead to sepsis and death. At about the same time John
Snow, a leading physician of the time, established a clear connection between cholera
outbreaks and sewage-contaminated water. In a famous and elegant epidemiological effort
Snow was able to map cholera outbreaks on a London city map as shown in Figure 32 and
track these outbreaks to local water pumps. In particular, Snow found 89 deaths associated
with the Broad Street pump and advised the city to close the pump. Legend has it that when
the city refused to close the pump, Snow stole the handle in the middle of the night and the
epidemic in the neighborhood stopped. Later investigation showed that the Broad Street
pump well was not deep enough and had been contaminated by an adjoining cesspool.
Figure 32 - John Snow's Map of Cholera Outbreaks in London
Snow became convinced that a living organism was causing cholera and not miasma.
Following Snow's work the city of London greatly improved its water distribution and
sewage systems greatly reducing cholera outbreaks. As part of the sanitary improvements,
carbolic acid was found to have antiseptic properties and to greatly reduce the smell
emanating from cesspools the city of London. Carbolic acid became widely used as a result,
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and with the sanitation improvements would today be thought of as a significant system
change to critical infrastructures in response to microbial threats. Ironically, the rapid
increase in resistant organisms not just in hospitals but also in food production may
require similar changes in our food supply chains to manage growing resistance and the
potential spread as described in (Soulsby 2007).
Lister in the meantime was looking for ways to reduce sepsis among his patients and
became aware of the carbolic acid use. Lister began trials on patients with compound
fractures where he would use lint soaked in carbolic acid linseed oil as a dressing. Lister
expanded on this including the bathing of the wound in carbolic acid, spraying carbolic acid
into the air during surgery, and the changing of dressings to ensure fresh carbolic acid
covered the wound. As before with Semmelweiss, acceptance was not immediate and
skeptics abounded amongst other surgeons. Some of this may have had to do with their
reluctance to admit that they themselves could be the cause of high mortality rates in their
wards with unclean hands and clothes. Continuing the theme of organizational resistance
to process change, which must be addressed as part of any process change, especially today
with far more complex but also harder to change processes. Other surgeons had adopted
hand washing and clean operating rooms because of Florence Nightingale's efforts to
improve antiseptic technique but refused to accept the "germ theory". Some German
surgeons did adopt Lister's ideas however and in one Munich hospital the surgery
mortality rates plummeted so much that the new "Listerism" rapidly won converts. Yet
back in England, adoption was much slower. Lister and others had found ways to treat the
source of infection but the cause remained unknown. John Bennett, professor of surgery
and Edinburgh, said, "where are these little beasts? Show them to us and we shall believe in
them. Has anyone seen them yet?" Today there is widespread belief that MRSA infections
are caused by particularly well-adapted clones (i.e. all MRSAs of a particular outbreak are
the same) and therefore the need for surveillance may not be as great. One of the key
technical objectives of this thesis was to show significant variation even among MRSA
samples that were thought to be phenotypically the same. Although we now know
microbes cause disease we actually know very little about how they are able to adapt so
quickly.
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The cause of bacterial infection remained unknown and subject to much debate until the
experiments of Louis Pasteur. Working on ways to improve fermentation Pasteur identified
microorganisms for souring wine and showed that heating wine to 55 degrees centigrade
killed the microorganisms and prevented the souring. Eventually, the "Pasteurization"
principle was applied to commercial production of beer and milk. Pasteur followed this
work with a demonstration that pebrine, a silkworm disease, was caused by protozoan and
not "spontaneous generation". On February 19, 1878 he appeared before the French
Academy of medicine to present the germ theory of disease and predicted that specific
organisms would be found to produce specific diseases. In rapid succession Pasteur
working with others including Robert Koch, isolated the organisms responsible for anthrax
and rabies.
Koch continued the work begun by Pasteur and established the principles of modern
bacteriology. The basic idea that bacteria must be identified and classified, then connected
to the appropriate clinical disease became the basis of bacteriology. Koch developed many
of the modern microbiology techniques including growing organisms on solid media such
as agar, a Japanese seaweed extract that remains solid at body temperature. At about the
same time Richard Petri invented a flat round dish to support these bacteriological studies.
Koch and his lab went on to discover organisms responsible for tuberculosis, diphtheria,
typhoid, pneumonia, gonorrhea, meningitis, leprosy, plague, tetanus, syphilis, whooping
cough, Streptococcus, and Staphylococcus aureus, which would eventually evolve into
today's MRSA.
Paul Ehrlich, a German pathologist joined Koch's Institute of infectious diseases and began
searching for molecular mechanisms that might affect bacteria. In particular, Koch
reasoned that since certain dyes could be used to differentiate human and bacterial cells,
such as Gram's stain, so too might other chemicals affect microbes. He began to look for
chemical agents that were toxic for bacteria but did not harm the host (which is a key
constraint of antibiotic discovery). His work eventually led to a drug named "chloroquine"
which provides effective prophylaxis against the malaria parasite. Ehrlich went on to tackle
Page 94 of 385
syphilis whose parasite had by then been identified along with a specific blood test in 1906.
However, the only treatment at the time was Mercury in use since the 1500s. Ehrlich had
been working on arsenical drugs to treat previous diseases and he decided to try variants
of these going through over 600 until number 606 showed efficacy. Clinical trials of sorts
began using "606" using volunteers and by 1910, over 10,000 syphilitics had been treated.
The drug was commercially named "Salvarsan" and in 1914 an even more effective variant
called Neo-Salvarsan was introduced although being arsenic-based remained toxic. Despite
these advances it would be another 21 years until the first modern antibiotic was
discovered.
The antibiotic properties of the Penicillium notatum mold had been observed before
Fleming's discovery but Fleming was the first to fully investigate its properties. His
observation of the growth inhibition of Staphylococcus and the presence of a Penicillium
notatum mold colony was serendipitous since it required a particular sequence of
temperatures to allow the mold to grow first for a number of days and then the
Staphylococcus. The famous Petri dish left on a bench contained Staphylococcus on which
mold spores from the lab below formed a Penicillium notatum colony. It also happened that
London was suffering from a heat wave that would have prevented the Penicillium mold
from growing, but the heat wave broke for 12 days allowing the mold to grow and then
returned for two days allowing the Staphylococcus to grow. It was this particular sequence
of events, a lab below Fleming's working on Penicillium notatum mold, Fleming forgetting
to place the Petri dish in the incubator (which would have prevented Penicillium from
growing), and the particular sequence of the London heat wave with 12 cool days and two
hot ones that provided Fleming with his "discovery" of penicillin upon his return from
vacation. Fleming then went about purifying and testing penicillin and found it effective
against Staphylococcus, Streptococcus, Gonococcus, and Meningococcus. However,
Fleming's purification methods meant his preparations quickly lost potency and Fleming
put penicillin aside as nothing more than a topical agent similar to carbolic acid in an
article summarizing his work. However, others read this article and asked Fleming for
samples of his antibacterial mold. But it would be several years until Fleming's discovery
was transformed into a mass-produced drug.
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In the meantime Gerhard Domagk in 1935 reported the antibacterial effects of Prontosil a
type of azo dye, which Paul Erlich had predicted might have antibacterial properties. In a
poignant anecdote, Domagk's daughter became gravely ill with a Staphylococcus infection
during his early studies of Prontosil (which was only marginally effective). In desperation
he injected his daughter with Prontosil and she recovered. A derivative of this dye, where
Prontosil is cleaved in half, became the first of the effective "sulfa" drugs, sulfanilamide.
These worked by competing with active compounds within bacteria preventing these
compounds from doing their work. Domagk was awarded the Nobel Prize in 1939 for this
work although the Nazi government prevented him from receiving the prize at the time (he
would later receive the Nobel in 1947). Work on Sulfa drugs continued during the war in
other countries with the development of very effective drugs against pneumococcal
infection (pneumonia).
George Dreyer, chairman of the school of pathology at Oxford had obtained a sample of
Fleming's Penicillium culture after the 1929 paper to determine if penicillin was a
bacteriophage on which he was an expert. He discontinued his research on finding
penicillin was not a bacteriophage, but kept the culture nevertheless. A few years later
Dreyer died and was replaced by Howard Florey who had earlier received reports of a
successful penicillin broth treatment in his previous position as professor of pathology at
Sheffield University. Florey assembled a team at Oxford enthusiastic about clinical
research, and one of its members was Ernst Chain, a biochemist and fugitive from the Nazis.
Through another remarkable series of coincidences and serendipity the Penicillium culture
at Oxford caught the attention of Chain who suggested they investigate its antibacterial
properties. Norman Heatley another team member found ways to measure the activity of
penicillin and Chain was able to purify, crystallize, and stabilize it. The team then
performed the critical experiment that had eluded many others before including Fleming.
The team injected eight mice with lethal doses of streptococci, and then injected four of
those with penicillin. The four mice that received the penicillin survived proving penicillin
was an effective antibiotic. Further animal and then human trials (starting with the team
themselves) followed during which the team identified effective dosage and necessary
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purity. However, large-scale production was still not possible when he was asked to treat a
policeman dying of septicemia. They used what drug they had and the policeman improved,
but they ran out before treatment was complete and the policeman died. Florey and the
team focused on ways to increase production and subsequent trials were extremely
successful. They sought American assistance in scaling up production providing details of
their methods to the United States, which made significant improvements in penicillin
production but incredibly refused to share these with the British as they were considered
military secrets. Nevertheless, Britain was able to manufacture sufficient quantities of
penicillin during the war using the Oxford team's methods. Fleming, Florey, and Chain
received in 1945 Nobel Prize in medicine for their work on penicillin.
The success of penicillin inspired others to seek new antibiotics from other organisms in
competition with bacteria including molds, fungi, and other bacteria. In 1944, Selman
Waksman and his colleagues at Rutgers discovered a second antibiotic called streptomycin
from Actinomyces bacteria. Waksman and his team discovered another species called
Streptomyces griseus from which he isolated another antibiotic, streptomycin, which was
especially important because it was effective against gram- negative bacteria and
tuberculosis. Waksman was awarded the 1952 Nobel Prize in medicine for his discovery.
In rapid succession Lederle laboratories announced Aureomycin in 1948 and Pfizer
announced Terramycin in 1950, the first of a new class called tetracyclines. Parke-Davis
developed chloramphenicol in 1949, which proved highly effective against typhoid fever.
These antibiotics were seen as wonder drugs and used indiscriminately, yet very quickly
the first cases of bacterial resistance were seen, and the first reported case of MRSA was
given by (Barber 1961) in the United Kingdom. Sufficient modification potential existed in
these classes of antibiotics to stay ahead of bacterial resistance but very few new classes
were discovered following this golden age. The last of these "golden age" classes was
discovered in 1962, the quinolones, and for 38 years no new classes were discovered
(Walsh 2003). It was only until the oxazolidinones in 2000 and lipopeptides in 2003 that
new types were introduced. And bacteria are already showing resistance to these new
classes (Walsh 2003).
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Why has there been a nearly 40-year gap in the discovery of new antibiotics? Some of the
explanation is related to the economics of antibiotics which are not nearly as profitable as
other drugs as described in (Christoffersen 2006) in addition to high effectiveness of
"older" antibiotics until recent times. Now that there appears to be an incentive (growing
markets due to growing resistance) there are still many regulatory hurdles that decrease
the economic attractiveness of antibiotic R&D as reported in (Nathan 2004). But even
without the economic and regulatory hurdles, the technical challenge of developing new
antibiotics are enormous and highlight just how much of a gift the antibiotics discovered
during the "golden age" were. Consider: an antibiotic must target only the pathogenic
bacteria without damage to any human cells or other human flora (symbiotic bacteria). It
must do so quickly and must be easily administered orally via stable compounds packaged
in tablet form. Very few molecules can do this, partly because pathogenic bacteria are so
similar to other useful bacteria but also carry many of the same cellular machinery as our
own cells as described in (Walsh 2003). Enormous concerted effort will be required to
develop new antibiotics, and an essential first step is to catalog all of the potential
mutations and changes in the target microbes as part of a surveillance system, as there may
be other gene targets in pathogenic microbes, such as virulence genes, that may allow for
novel antibiotics as described in (Clatworthy, Pierson et al. 2007; Kristiansen, Hendricks et
al. 2007; Cegelski, Marshall et al. 2008).
The devastating effects of bacterial infection as recently as 1941 have been forgotten, but
the bacteria remain with us, continually working on new ways to defeat our weapons. The
unimaginable return to the days of Florence Nightingale, Lister, and WWI field hospitals
could return if we lose the battle against resistance. And we are starting to lose: the rates
of healthcare associated bacterial infection have shown significant increases in the past 10
years, leading to increased costs and mortality as described in Chapter 1. But it is not just
about developing new antibiotics, as significant process change will have to accompany any
efforts to manage resistance. Changes in current practices of antibiotic overuse (Gonzales,
Malone et al. 2001), improved hospital transmission control procedures, patient screening,
and surveillance will be needed. The convoluted history of microbiology and antibiotics
has many lessons to teach us, including the need for systems and processes to be able to
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change quickly and learn from observation. Even without antibiotics how many lives could
have been saved by following Lister's and others ideas? Would we be in the precarious
position we are now with few antibiotics left in the pipeline if we had actively "tested" the
system to reveal resistance problems early on? The first patients with MRSA could have
been isolated and the spread of this microbe controlled had there been a greater emphasis
on testing and surveillance. Hindsight is of course very clear, but many of the problems
encountered in microbiology and antibiotic development could have been lessened if more
of the "process improvement" capabilities such as those described by (Spear 2005; Spear
2008) had been applied. This thesis provides some tools to apply these capabilities.
2.4 Clinical Microbiology
The focus of modern clinical microbiology labs is to support physicians in diagnosing and
controlling patient infection. Patient samples are cultured, organisms isolated, and either
tested for identity or effect of anti-microbial agents. Due in large part to the success of
antibiotics, diagnostics are performed only when necessary and are not part of the routine
healthcare of most individuals. Epidemiological surveillance is typically performed on an
as needed basis, using whichever bacterial typing tools are available to the particular lab.
Although some molecular based (i.e. reading a portion of the microbial genome) techniques
are available, culture-based methods not much different from the Agar plates of Koch and
Petri dishes dominate because they offer low cost and the ability to directly characterize
the phenotype of the organism (i.e. which antibiotic to use which is the main concern of
many clinicians). These culture-based methods essentially rely on the isolation of a
microbe from a patient sample by a trained technician, followed by the growth of that
isolate on petri dishes containing growth media but also a series of antibiotics in small
disks on the surface of the petri dish. If the microbe does not grow around a particular
disk, the microbe is susceptible to that antibiotic, but if they do and overrun it, they are
resistant.
Cultures are also able to empirically determine the degree of resistance of a microbe by
measuring the distance of growth inhibition around the disks, which should be
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proportional to the concentration gradient of the antibiotic, but these measurements
require careful monitoring of growth conditions, measurement, and also take several days
to complete. For the majority of the 20th century through today, hospital infection
diagnostics have relied on these bacterial cultures. A sample is taken from a patient,
incubated overnight, pathogenic bacteria are isolated, these bacteria are then incubated
against antimicrobial agents, and the inhibition of growth is measured. Some automation
has been introduced such as the Vitek system, and others, but the principles are largely the
same and the cycle time is still measured in days, which can be problematic for critically ill
patients such as those suffering from Septicemia. A sample non-automated workflow for
the measurement of antibiotic resistance using the Bauer-Kirby disk diffusion method is
shown in Figure 33 along with an image of the final product of this workflow, which is a
petri dish with zones of inhibition around disks containing antibiotic and a ruler to
measure the degree of inhibition as shown in Figure 34. These culture-based techniques,
while tested and reliable, only provide phenotypic information and cannot identify any
genotypic characteristics. A number of identification techniques are available to the clinical
microbiology lab including methods based on cultures, restriction digests, Polymerase
Chain Reactions (PCR), and partial sequencing (multi-locus sequence typing) but culture
based methods dominate because of their low cost and integration with current practices
(interpreting the other molecular-based methods is harder and not well established).
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Figure 33 - Culture Based Antibiotic Sensitivity Workflow
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Figure 34 - Measurement of Antibiotic Disk Based Inhibitory Concentrations
This process was automated to a degree with the Vitek series of microbial diagnostic
instruments originally developed for NASA by McDonnell Douglas during the space race,
and eventually spun-off to Bio-Merieux in the 1980s. This instrument is largely the
standard within hospital diagnostic laboratories, although traditional bacterial cultures are
still performed using antibiotics disks on Petri dishes. The inhibition of growth around
these antibiotic disks is then measured as the Minimum Inhibitory Concentration (MIC).
This traditional procedure is labor intensive and subject to error due to the multi-step
isolation of the bacteria required and the measurement error associated with manual
measurement of the MIC. This traditional procedure also cannot identify or isolate
organisms that may be nearing resistance but may are still inhibited by the antibiotic as
shown by the different size regions in Figure 34. Nevertheless culture based methods have
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been the basis for recognizing the evolution of antibiotic-resistant bacteria starting in the
1970s and provide no information as to the genetic basis of resistance. More importantly,
microbes, especially MRSA have a number of other adaptations beyond just resistance.
Their ability to colonize skin and live longer in difficult environments allows them to
spread more easily, and these virulence factors are thought to be critically important in the
epidemiology of MRSA as discussed in (Chambers 2005; Diep and Otto 2008; Queck,
Jameson-Lee et al. 2008). This has significant implications for clinical microbiology
processes since only focusing on resistance (with culture based assays) will ignore any
changes in virulence (genes encoding for improved adaptations to environment) that may
allow certain strains of MRSA to spread faster, colonize patients, or simply adapt more
quickly to antibiotic treatment. It is important to note however, that both genotype and
phenotype of MRSA will be needed, at least until a comprehensive catalog of all possible
mutations and changes exists (the so called "pan genome" describing all mutations in all
strains of MRSA). Until then, techniques will have to coexist while this thesis emphasizes
the need for complete whole genome sequencing as this information has previously not
been available, many of the other existing technique can find application in patient
screening and phenotype observations. The available phentoype and genotype methods in
clinical microbiology are described in the following sections.
2.4.1 Microbial Phenotype
It is necessary to both characterize the genotype of the microbe, but also to match the
genetic data with the phenotype of a microbe describing its physical properties: shape, cell
wall, internal structures, metabolic pathways (nutrients, intermediates, and wastes),
growth conditions (temperature, pH, time), and response to external agents (antibiotics,
chemicals, and other bio-molecules). Microbes were first classified according to visible
properties such as shape (rods - bacilli or spheres - cocci) and these properties are still
useful classifications in a modern microbiology laboratory using similar microscopy
techniques pioneered by Robert Koch over a century ago. Other physical classifications
include various chemical stains that react with structures present in certain organisms
only. The most famous of these staining methods is the Gram stain which groups
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organisms into gram-positives which turn violet from Methyl Violet 10B absorption and
contain large amounts of peptidoglycan but no outer membrane, and gram-negatives which
turn pink when exposed to the counter-stain safranin (which stains all cells) and have an
outer membrane and less peptidoglycan. The majority of pathogenic bacteria are gram-
negative, although there are notable exceptions: streptococcus and staphylococcus. These
stains are clinically important as they provide fast assays not requiring significant
preparation. Several other stains are available to modern clinical microbiology
laboratories to assay patient samples, including some stains for MRSA (CHROMagar), which
can provide relatively fast results (24h).
The next level of phenotype characterization involves metabolic pathways of the microbe
including growth conditions, nutrients, and most importantly for clinical laboratories:
antibiotic sensitivity. In routine clinical microbiology practice few tests are performed on
metabolic pathways for clinical sample isolates, the focus being on antibiotic resistance,
with most assays being the Bauer-Kirby disk diffusion type where microbial isolates are
grown on solid media in the presence of disks containing antibiotics. This assay is usually
read as a binary "yes/no" test to indicate the presence or absence of a microbe (i.e. MRSA)
but can be used to estimate the degree of resistance to a particular antibiotic based on the
diameter of the inhibition region around the antibiotic disks. Automated instruments are
able to perform similar functions in liquid media to produce Minimum Inhibitory
Concentration (MIC) curves, which can be useful in identifying both specific antibiotic
regimens but also to identify borderline resistant organisms that may become threats.
Using these methods a clinical lab can prepare an antibiogram showing the particular
strain's resistance to various types of antibiotics.
Other phenotype assays are available to test various properties of microbes such as
response to changes in nutrients, which activate secondary pathways, but because these
are not clinically relevant they are not commonly performed. Implicit in all of these
phenotype identification processes is the need to correctly isolate an organism and avoid
contamination throughout the assay. The process of isolation also limits the ability to look
for any other microbes that may be associated with the surveillance target, such as
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commensal bacteria, partially resistant microbes, and other pathogenic microbes. The
primary clinical phenotype identification processes include:
* Antibiotic susceptibility - disk diffusion
e Antibiotic susceptibility - automated (Sensititre)
e Antibiogram - disk diffusion
e Antibiogram - VITEK
* Identification - disk diffusion
* Identification - automated liquid culture
2.4.2 Microbial Genotype
The availability of complete microbial genetic information for individual strains is
relatively recent, dating from 1995 when the first bacterial genome, Haemophilus
Influenzae, was fully sequenced (Fleischmann, Adams et al. 1995). Elements of bacterial
genetics were well understood prior to that forming the basis for many biotech processes,
but a complete genotype was only possible with the availability of fully sequenced
genomes. Initial efforts to determine the genotype of microbes trace the evolution of
molecular biology tools starting with restriction enzyme digests discovered in the 1970s on
DNA extracted from cultured microbial isolates. These restriction digests cut microbial
DNA at specific locations yielding a set of fragments read out on pulse field gel
electrophoresis (PFGE) and are unique to particular species, although the resolution of this
method is limited to large scale features on genomes and cannot distinguish nucleotide
changes not affecting fragment length or genome size changes smaller than its resolution.
This is particularly significant in distinguishing mutations in genes or recognizing the
addition of genetic information from horizontal gene transfer (from another organism). In
addition this method requires careful adherence to protocols as damage to the DNA in
preparation can easily confound the results. The discovery of PCR in the mid 1980s
enabled the identification of microbes based on PCR amplification of select regions in a
microbial genome. These methods rely on either the amplification of a unique gene in a
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microbial genome, such as the mecA gene that confers methicillin resistance in MRSA, or
the amplification of conserved but strain specific regions such as the 16s ribosomal RNA
region. However, both of these PCR methods do not provide any information on other
genes that may contribute to virulence or pathogenesis or provide accurate enough
discrimination between strains.
An improvement on single locus PCR (i.e. mecA only) is multi-locus sequence typing
(MLST) where as the name implies multiple regions in the genome are amplified via PCR to
provide grater discrimination. The MLST approach is an intermediate to full genome
sequencing largely driven by cost considerations as it is significantly cheaper only looking
at a small fraction of the genome. Full genome sequencing was the first approach to
provide complete genotype information, but was only possible with the advent of
automated Sanger sequencing and capillary technology developed for the human genome
project in the late 1990s when the sequencing of a single microbe could still cost nearly
$1M. The rapid decrease in cost, faster than Moore's law, has enabled large scale
sequencing using Sanger-based methods but also new highly efficient technologies
including 454, Illumina, and others. The cost per microbial (3Mb) genome could approach
less than $500 by the end of 2010. These whole genome sequencing approaches provide
access to the entire genotype, eliminating many of the problems with partial genotype
approaches such as PFGE, PCR, 16s, and MLST. The full sequence ensures mutations in all
genes can be identified, especially ones associated with greater pathogenesis, identifies any
genetic information transferred from other strains, species, or phages, and ensures that
strains can be identified unambiguously. Nevertheless the rapid technology change in
sequencing means many of the earlier approaches are in widespread use. Integration of
new processes given an existing infrastructure is a problem and is a fundamental research
objective of this thesis. The primary clinical genotype identification processes include:
0 Restriction Digest PFGE
* PCR typing
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The following are the available DNA sequencing methods for bacterial genotype:
* Sanger Sequencing (including MLST and 16s typing)
* 454 (recent)
e Illumina (recent)
Additional detail on the DNA sequencing methods is provided next:
Sanger Sequencing: The human genome project helped accelerate the development of
sequencing technology to a rate surpassing the famed Moore's law in semiconductors. The
current generation of sequencing technology began with Fred Sanger's invention of the
chain termination sequencing method, for which he won his 2nd Nobel Prize in chemistry.
This method relies on the construction of a template fragment with a specific primer
sequence, followed by chain elongation and termination at a labeled nucleotide. This cycle
is then repeated until labeled nucleotides exist at the end of chains matching every position
on the template DNA. These fragments are then separated by size and the label of each
chain terminator is read as the original DNA sequence. The industrialization of this
technique and the supporting infrastructure around it, is largely what enabled the human
genome project. Progressing from the manual early versions of this process, handled by
high level scientists (Fred Sanger sequenced the phage f-X174 genome of 5,386 bases over
a 2 year span from 1975 to 1977). The technique was gradually improved over the next 20
years, and by 1997 it was possible to imagine reading the entire 3Gb human genome with
the development of automated fluorescent detection based capillary sequencing invented
by Lee Hood, et. al. Yet, a limitation of this method is that the chain termination constrains
the length of DNA that can be read in a single reaction to -700 bases and reactions must be
performed individually at significant expense.
454 Sequencing: Automated gel and capillary sequencing of fluorescent Sanger reaction
products dominated the period from 1986 to 2006, but in 2005, 454 Life Sciences
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introduced the first of the next generation instruments. This technology relied on an
entirely different technology, pyro-sequencing, which triggers emission of light through an
enzyme cascade as each nucleotide is incorporated. Each burst of light is read out through
a fiber optic plate as each type of nucleotide is introduced successively. A significant
improvement of all the next generation technologies, including 454, is that the reactions
occur in massively parallel 2-dimensional plates rather than "1-dimensional" gels or
capillaries. The transition to 2-D means that efficiency increases are no longer a linear
function of the number of capillaries or length of capillaries, but rather the square of the
edge length of the surface. Doubling the dimensions of the plate quadruples the surface
area and the amount of data produced. At its introduction, this technology approached the
efficiency of the highly refined capillary methods, but its performance was not yet sufficient
to displace the incumbent technology. Yet in the period 2005-2008 this technology
improved sufficiently to represent an order of magnitude improvement over the existing
technology following technology displacement curves similar to (Utterback 1996).
Capillary technology vendors have tried to improve the performance of their systems to
avoid displacement, but have proven unable to do so. Most capillary systems are being
displaced and moved into lower performance applications in hospitals outside of high
performance genome centers. 454 Workflow is greatly simplified over the traditional
capillary sequencing workflow. Beads containing a single segment of the target DNA, but
PCR amplified (all copies of DNA on the bead are the same) are deposited onto wells etched
from a bundle of fiber optic fibers. The cycle time is also much shorter than traditional
(capillary) sequencing methods (2 days vs. 2 weeks under optimum conditions for single
samples). The plates on which the sequencing occurs are made from fusing a fiber optic
bundle together, slicing it into plates, and then etching wells from the core of each fiber
optic strand. DNA containing beads and enzyme beads are then deposited in each well. An
enzymatic cascade then triggers light emission with the incorporation of each nucleotide
on the DNA labeled beads. The 454 method has numerous advantages over traditional
capillary sequencing including cost, speed, and quality of data. Because the 454 method is
an entirely in-vitro method, none of the bacterial transformation steps leading to potential
bias are required. This enables the 454 method to accurately represent DNA sequences
that may not be present in traditional bacterial cloning and capillary sequencing methods.
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The 454 method is also the most suitable of the next generation methods for in-hospital
infection diagnosis, due to its speed, it is the only method that could generate data in the
same day.
Illumina Sequencing: Following the introduction of the 454 process, another next
generation company, Solexa introduced a revolutionary improvement to the Sanger
fluorescent chemistry. Rather than separate fragments on gels or in capillaries, this
technology produces clusters of identical DNA molecules on glass slides via PCR, then uses
a variant of the Sanger chemistry to sequence each cluster. The input DNA is fragmented
and adapters are added to bind the DNA onto glass slides and allow them to be amplified
and then sequenced. This technology has significantly greater throughput per run than 454,
and relies on well understood Sanger sequencing where each base receives a unique color
(dye) making identification easier. However, the cluster amplification has some limitations
in terms of the cluster density that can be achieved. Also, the cycle time to produce data is
longer than 454, up to 12 days per run. However, the data output is much greater, upwards
of 30Gb per run and will likely be higher in the near future.
2.5 DNA Sequencing Rate of Change
The historical cost data through 2009 and projection for 2010 of the cost of DNA
sequencing using the best available technology in each year are shown in Figure 35 which
plots the cost to produce 1 Megabase of DNA sequence. A Moore's law curve is plotted for
reference starting with the cost per genome in 1999. A bacterial genome is on the order of
(3-5Mb) suggesting that the cost to fully sequence a microbe to 30X depth (a standard level
of redundancy needed for the assembly algorithms would have cost -$1.5 Million in 2000
versus less than $30 as projected at the end of 2010. However, this is the cost for just the
raw sequence without any of the additional sample acquisition, algorithm processing,
assembly, and annotation, which can add significant additional cost. Nevertheless the cost
of sequencing is rapidly approaching the cost of routine clinical microbiology procedures,
suggesting a paradigm shift is possible where sequencing may rapidly displace more
traditional approaches. This graph served as significant motivation for this thesis as it
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suggest the costs of whole genome sequencing appeared to rapidly be reaching the point
that routine surveillance of microbes could be performed.
Figure 35 - Historical and Projected (2010) Cost per Megabase of DNA Sequence Compared
to What Moore's Law Would Have Been Starting in 1999. There has been an 88,000 fold
decrease since 1999.
2.6 MRSA Surveillance
Most of the MRSA surveillance efforts to date have focused on documenting cases,
associating culture based (phenotype) data, or in certain efforts to characterize MRSA with
PFGE or MLST methods (Klevens, Morrison et al. 2007) which have shown some gross
differences, but have not had the resolution to find nucleotide level differences. Recent
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studies using a related DNA probe technology have shown significant differences although
not with sufficient nucleotide level resolution (Kennedy, Otto et al. 2008). Fortunately,
some of these efforts have yielded clone collections and samples that could be re-grown
and used for sequencing efforts. The CDC surveillance efforts have focused on reporting
infections associated with healthcare procedures as part of the National Nosocomial
Infections Surveillance System (NNIS), which is a voluntary reporting system in -300
hospitals in 42 states. NNIS focuses on high-risk units (intensive care) collecting data on
infection rates and certain (voluntary) follow-up as to the organisms and degree of
antibiotic resistance. However, no data on genotype is collected to identify differences in
strains or other characteristics influencing changes in phenotype. NNIS is being replaced
by an expanded system called the National Healthcare Safety Network (NHSN), which
expands in scope to include electronic record submission but still focuses on infection rate
and phenotype reporting to the exclusion of genotype as described in (Tokars, Richards et
al. 2004). However, neither NNIS nor the new NHSN are surveillance systems of the type
discussed in this thesis, as they do not have a sample collection or genotype collection
procedures. The closest national CDC system is called the Active Bacterial Core
surveillance (ABCs) part of the CDC Emerging Infections Program Network (EIP)6. The
ABCs is a collaboration between CDC, state health departments, and universities in 10
states charged with determining the incidence of MRSA (and other select pathogens) and to
"determine molecular epidemiologic patterns and microbiologic characteristics of public
health relevance for isolates causing the above invasive infections". The ABCs do collect
some MRSA isolates, as a sampling and these are sent to the Network on Antimicrobial
Resistance in Staphylococcus aureus (NARSA), which distributes the isolates. The ABCs
system produces data on the surveillance elements for MRSA described in Table 5:
CDC-ABCs MRSA Strain Characterization Notes
Confirmatory identification of all isolates Culture-based to determine if isolate grows
in the presence of antibiotic.
Antimicrobial susceptibility testing, Quantifies the degree of resistance via Bauer-
6 Source: Centers for Disease Control, www.cdc.gov
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Pulsed field gel electrophoresis and PFGE based method with associated
analysis using PulseNet methodology, limitations in resolution and reproducibility
selected isolates
SCCmec cassette typing, selected isolates PCR based assay looking for genes associated
with methicillin resistance
Toxin testing for PVL and TSST-1, selected PCR based assay looking for gene encoding
isolates PVL
Table 5 - CDC MRSA Surveillance Elements
While valuable, the limited genotype information collected as part of the ABCs cannot
distinguish variation within a strain but can identify gross differences between some
strains (but not all). Yet, the techniques described in the ABCs require significant skill on
the part of technicians, as PFGE is an intricate protocol despite its limitations suggesting
that more complex processes such as DNA sequencing could be inserted into the ABCs
workflow. The literature does not yet contain a reference describing whole genome based
microbial surveillance, but some literature exists on "partial sequencing approaches"
where a locus on the MRSA genome such as the S. aureus protein A gene (spa) might be
chosen for sequencing and serve as a "fingerprint" for that particular strain as described in
(Mellmann, Friedrich et al. 2006). However, all of the surveillance approaches to date
suffer from a key flaw, from the lack of resolution of PFGE to the inability of PCR or "partial
sequencing" approaches to find novel genes or mutations elsewhere on the genome present
significant limitations for the use of this surveillance data to help develop new antibiotics
or help understand MRSA biology. DNA sequencing is completely backwards compatible to
all these approaches as the PFGE, PCR, and "partial sequencing" results can be generated on
a computer from the complete genome. Because this produces a universal solution, whole
genome DNA sequencing is the process pursued in this thesis, which could generate a "step
change" in clinical microbiology.
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selected isolates Kirby tests (culture based)
2.7 MRSA
Methicillin resistant Staphylococcus aureus was first identified as a new strain in 1961 in
the United Kingdom (Barber 1961). However, it did not appear in large numbers of cases
in the US until the 1980s associated with intravenous drug users. The long time period
between initial appearance and the growing epidemic suggests additional factors
contributed to this, such as virulence genes among others. The genome of MRSA is
relatively small, only 2.8Mb in size containing approximately 2,600 protein coding
sequences (Lindsay and Holden 2004) with about 75% being highly conserved between
isolates associated with metabolism and other housekeeping functions. The remainder and
additional plasmids outside the core genome show much greater variability and also carry
the majority of virulence genes identified to date including leukocidins such as PVL. The
cell walls of MRSA are especially thick in some cases as part of its defense for antibiotics
that bind cell wall proteins and peptides, which makes their lysis significantly more
difficult than other species.
In terms of MRSA surveillance using DNA sequencing the literature is much more limited.
Most of the approaches detail the sequencing of full genomes as a single research effort
rather than focusing on building a process for surveillance. All of the reported fully
sequenced MRSA genomes which number less than 20, are different from each other, and
nearly every study using the less detailed but still useful PFGE or MLST techniques also
show significant variation. The emphasis on building a process rather than producing a
genome for research is also not found in the literature in exactly that focus.
The next chapter will describe in greater detail the matrix based MDPM model, and much of
the specific case study of MRSA surveillance will be used to highlight its use.
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3 Multi-Domain Process Matrix Model (MDPM)
The goal of a process model is to represent reality in an analytically useful way according to
the needs of the user recognizing that any model is an abstraction and simplification. A
chemical engineer requires a process model that represents the physical flow and changes
of reaction products as in a process flow diagram. A business consultant requires a process
model that shows the interactions between tasks and individuals as in a swimlane process
diagram. A software designer requires a process model that describes information flows
from various modules in a computer program as in a control flow diagram. Each of these
models is useful to their users, providing analytical value in a particular analysis
dimension. However, none of these by themselves addresses the system level view needed
to manage complex processes that these processes operate in. A process owner
responsible for the physical, organizational, and information flow control of a process
needs access to all of these domains and especially the interaction between them. The goal
of the Multi-Domain Process Matrix model (MDPM) presented here is to provide a
synthesis of these domains for system level process analysis, while preserving the ability to
individually analyze each domain. This is accomplished by developing individual set
representations for the activities (process steps), organization (stakeholders), and the
necessary information (work instructions) then combining these onto a single analysis
domain (matrix), which shows the connections between them. This model is fully
described in this chapter.
3.1 Multi-Domain Process Matrix Model Description
The multi-domain process model used in this thesis expands on traditional process
definitions and models such as flowcharts and other activity focused models described in
chapter 2. The model separates processes into 4 distinct domains: information (work
instructions), process (tasks), organizational (social network), and an integrative
projection domain where all elements and interactions are described together. Each of
these domains can be thought of as a graph with a corresponding matrix representation.
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The goal of this decomposition is to capture the true range of activity, information, and
organizational dimensions for the process. The integrative projection domain is the overall
matrix describing the process, information, and organization domains and their
interactions to represent the entire process in a single connected network that can be
analyzed using many of the traditional network algorithms. This is possible because each of
the other three domains in the model, process, information, and organizational have
network representations. Processes have been modeled as networks in petri nets,
workflow state diagrams, and in DSM methods as described in chapter 2. Information flows
have been modeled as networks in software design, concept mapping, and communications
networks as described in chapter 2 and especially in (Giffin, de Weck et al. 2009).
Organizations have also been modeled as networks in sociology and the emerging field of
social network analysis. These three domains can then be jointly analyzed in the overall
matrix, which is a single "projection layer" that represents the complete process network
as conceptually shown in the Figure 36. Each domain of the model is essentially a DSM,
representing each of the domains (layers), and the overall model is a multi-domain matrix
(MDM) model showing the links between elements in each of the domains.
Figure 36 - MDPM Model
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In the MDPM model, elements in each of the domains can have interactions with other
elements in the same domain, or with elements in other domains. However, each domain
can be analyzed independently to facilitate observation, analysis, and interpretation. The
projection domain is an aggregation of each of the domains above it, but also of the
interactions across domains shown conceptually in red. In MDM model terms, the
projection domain is the entire matrix showing all connections simultaneously. The
projection domain is "special" in that all the elements from each domain are treated as if
they were the same, such that they can be analyzed as a single network. This abstraction is
important in applying many of the network algorithms and metrics to quantify overall
search, complexity, and connectedness of the process (and network). A key advantage of
this approach is to show that individual elements, which may appear disconnected on a
given domain, may in fact be connected to each other through elements in another domain.
In complex modern processes many of the individuals performing the process are likely not
directly connected to each other through direct social connections but through work
instructions, information, and process steps. Likewise, the tacit knowledge of an individual
operator may not readily flow into work instructions in the information domain or to
process designers and other stakeholders appearing and the network representation as an
isolated node. The projection domain is thus a useful abstraction that can represent the
process activities, work instructions, and the various stakeholders all as networks. The
domains described in this process model have a correspondence to the control, mechanism,
and activity elements in the IDEFO process modeling methodology as described in Figure
37 and the IDEFO language description in Chapter 2. The individual domains are further
described in the following sections.
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Figure 37 - IDEFO Element
Input
Control (information domain)
Information (Instructions)
Mechanism (organization domain)
Ognization
Figure 38 - IDEFO and MDPM Correspondence
The explicit modeling of the process work instructions associated with process activities is
a key element of the MDPM model which does not yet have a corresponding category in the
Engineering Systems Model currently under development by Bartolomei and others.
Explicitly adding these work instructions and associated information will be a necessary
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addition to extend the application of the ESM model to process including manufacturing.
The MDPM model can nevertheless be thought of as a subset of the ESM model and is
completely compatible with it. Some ESM model elements not considered in this thesis to
limit its scope, such as the object domain (physical elements of a system) could readily be
added, and would bring additional model richness as well as provide additional
troubleshooting and search capabilities to process stakeholders. The key differences in the
MDPM modeling approach are an emphasis on activities as a distinct element and the
connection of other domains around the activity elements. IDEFO does not connect
organization and information elements to each other. And other multi-domain approaches
do not specifically emphasize processes.
3.2 Process Domain
As described in Chapter 2, a number of different process modeling methods exist. Their
general goal is to represent the sequence of activities needed to perform a process,
however their particular representations differ. The process domain is similar to
traditional flowchart workflow representations, describing the process in terms of a series
of activities with well-defined inputs, outputs, work instructions, and control systems.
IDEFO activity notation conveniently represents the process activities in this model, as only
the activity, inputs, and outputs are described in the process domain. The IDEFO control
(information) and mechanism (organization) inputs are described in other domains. The
particular process representation used as part of the model is "activity on node" or "AoN"
where each node of a directed graph represents an activity from a traditional process flow
diagram. The edges in the graph represent the inputs and outputs from each activity and
can be mapped onto a separate layer if desired, where the mapping would be "activity on
edge" and the nodes represent the inputs and outputs. To facilitate the integration and
analysis with the information and organization domains, AoN provides a more useful
representation. A notional process is shown below in flowchart form, showing the request
of an antibiotic diagnostic. This process has only one branch point, and can be
straightforwardly represented by the AoN directed graph shown in Figure 39.
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perform it again. This is shown conceptually in the flow chart in Figure 40 adding a rework
loop to the baseline diagnostic request process. This is represented on the AoN directed
graph as a loop. Rework is not the only type of loop structure; others such as iteration
during design refinement and optimization have similar structures. The additional graph
structures associated with design and optimization is referred to in this thesis as
scaffolding"' necessary during the development of processes and can add significant
complexity. These ideas are discussed later in this chapter.
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Figure 40 -Activity on Node Graph with Rework
Processes can also have significant operational choice where multiple steps are possible
and traces must be made between them. For example, the conceptual process flowchart
shown below adds three choices to the type of diagnostic to be performed. Implicit in this is
the existence of a set of decision rules associated with the choice step, which in the MDPM
model are explicitly represented in the information domain. Also implicit is the existence of
an individual in the organization responsible for this decision, and in the MDPM model this
is explicitly represented in the organization domain. The AoN directed graph is in Figure 41
and shows the additional graph structure associated with the three diagnostic choices.
Figure 41 - Activity on Node Graph with Branching
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Choice and rework are shown together in the following conceptual flowchart indicating the
traditional representation. Certain workflow modeling techniques explicitly label decision
points, such as connectors in EPC notations. For simplicity the use of these additional
elements is avoided in this model, although branch points can be readily found in directed
graphs. The branch points can be useful in assessing the "decision complexity" of a process,
as a large number of branch points should correspond to high process complexity. The
AoN graph representing the combined choice and rework process is shown in Figure 42.
Figure 42 - Activity on Node Graph with Rework and Branching
Using the directed graph, all of the basic network properties can be calculated including
node degree distribution, number of edges, average path length, diameter, and others. The
basic network properties for the MDPM model will be described later in this chapter as
well as the proposed complexity measures. Chapter 4 will describe in detail the application
of the MDPM model to the real world process of DNA sequencing-based MRSA surveillance
and a portion of that process is shown in Figure 43 in swim lane flow chart form. This
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particular flowchart was developed using a standard commercial tool, called iGrafx, for
business process representation and modeling. The notation is the same as in the
conceptual flowchart models shown in this section and the translation to a directed graph
follows the same procedure of activity on node, AoN as will be shown in chapter 4.
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Figure 43 - Conceptual MRSA Surveillance Process in Flowchart Form
Some important considerations for the process layer relate to its scope, or "what to
model?" In order to capture the true complexity of processes, it is important to enumerate
all of the possible process paths within the system. So for example rarely used but feasible
paths should be modeled since associated with these paths are a set of work instructions
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and individuals needed to "maintain" these paths. Indeed in quality control or safety, it is
the least used paths that are most in need of definition and maintenance to ensure they will
be available when needed. A manufacturing analogy is the need to maintain production
lines for older products that may even be obsolete but still require parts for products still
used by customers in the field. For microbial surveillance, the specific example is the need
to maintain specialty or "reference" processes that while not used in everyday practice are
occasionally used for difficult or "calibration" cases. This is another example of the
"hidden" complexity of processes that basic flowcharts cannot capture in their effort to
present a simplified version of a process. Similarly when there is not yet a "dominant"
design and multiple viable alternatives exist it is important to show these as they represent
the true complexity of the process. The existence of viable alternatives for steps in a
process requires that someone in the organization whether it is users, designers, or the
suppliers themselves maintain a corresponding set of work instructions and the processes
themselves. In this model much of the complexity associated with the "scaffolding" early in
the process lifecycle comes from the existence of these design alternatives and their
supporting information and organizational networks.
3.3 Organization Domain
The organizational domain follows social network analysis models describing the
interaction between the various stakeholders of the process. Each of these stakeholders
can interact with multiple process elements, information domain elements, and with each
other, such as communication between stakeholders, control of an individual process step,
design responsibility for a process step, or as a source of information for one of the
elements in the information domain. The organization domain is intended to represent
individuals but may also represent organizations and other group entities. The goal of the
organization domain is to show the rich and deep social network associated with every
process but not normally shown in traditional process representations. The real social
networks represented by this layer can have a very significant impact on the actual design,
capabilities, and operational performance of a process and should therefore be explicitly
Page 124 of 385
shown as part of a process representation. In health care, organizational complexity can be
particularly severe.
The diagram in Figure 44 again shows the conceptual example of a diagnostic request
process but adds the individuals associated with each of the activities. Both the interactions
with the activities and interactions between the individuals are shown. The IDEFO
notation uses the term "mechanism" to indicate the means by which the activity happens,
and in this example the activity requires the individuals. It is possible to imagine that an
additional domain might be included in the model to describe the infrastructure or
equipment that represents the "mechanism" such as the "Objects" domain in the ESM, but
that is not described here to limit the scope of the model. The interactions between the
individuals and the process activities are shown here and will be carried over to the
"projection" domain.
Figure 44 - Interaction of Process and Organization Domains
However, the interactions between individuals can be modeled separately in this layer as
shown in Figure 45. These interactions can be modeled as a network where the nodes are
the individuals and the edges represent communication between them. Note that not all the
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graph nodes are connected to each other, and although all of these individuals form part of
a single process to lack of communication between them in this example could present
problems in managing this process. For example, what if there was a significant quality
issue with the diagnostic leading to a higher fraction of false negatives? Unless the
technician reports the problem to the lab manager, who in turn has to take corrective
action either by reporting the problem to the physician or explicitly adjusting the
diagnostic confidence values the problem may go unnoticed. The physician may then
recommend monitoring rather than antibiotic therapy with potentially serious
consequences. This is an interesting observation as to the properties of social networks
supporting processes: it's likely very important that all the individuals be connected and be
reachable in relatively few steps. This becomes more important as the complexity of the
process increases measured in either the number of activities or amount of information
that needs to be processed. Small world networks may be characteristic of stable processes
since changes and problems at various process activities impact all other downstream
activities and the faster information can be exchanged the better.
Patient
Nure L ab
Figure 45 - Organization Domain as a Social Network Graph
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Thus for example, a "process owner" could be designated to provide a connection between
the lab technician and lab manager to the physician and nurse manager. This addition is
shown in Figure 46, connecting the graph. And although a person has been added to
connect the graph, an existing individual could just as easily have been designated to serve
as the "process owner", such as the lab manager. This provides for a connected set that
also means that every individual including the patient is reachable in the social network.
These types of "design changes" may not be readily apparent from traditional flowchart
process views that are critical to the implementation of change and troubleshooting in
processes. While adding an individual such as the process owner to the social network will
increase certain complexity measures such as number of nodes and edges it is likely to
significantly reduce others such as connectivity, average path length, and diameter. The
various complexity measures will be further discussed later in this chapter.
Lab
Technician
t
Figure 46 - Organization Domain with Addition of a Process Owner
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This simple example does not show the additional organizational complexity found in real
processes. However, one can imagine that the same framework can be used to represent
the many additional stakeholders present in healthcare processes. For example, the
organization domain for a healthcare diagnostic process should include representatives
from hospital insurance reimbursement, senior hospital medical staff, hospital
administrators, insurers, medical policy groups such as the AMA, representatives from the
diagnostic manufacturers, government regulatory agencies such as the FDA, and others.
The vast complexity of the social network associated with real healthcare processes is not
often modeled but contributes directly to the performance and adaptability of these
processes. These social networks are highly fragmented and distributed throughout
lengthy processes (when viewed across their entire value and supply chains). Complexity
reduction measures such as adding "process owners" as in the simple example to improve
the search characteristics across the network by reducing the path length may prove
valuable. A real example of this complexity is shown in the test case for the process model
in this thesis.
3.4 Information Domain
The information domain describes all of the explicit knowledge needed to perform the
process. It can also be interpreted as describing the data flow needed to manage the
process in terms of all the work instructions, process data (i.e. metrics), design documents,
operational observation logs, policy documents, regulations (ASME), physical models (i.e.
steam tables), six sigma optimization results, vendor performance specifications, and any
other sources of information needed. Unit operations in chemical engineering flow
diagrams are information domain models of the physical properties of chemicals as they
undergo certain transformations along with work instructions describing the particular set
of parameters for the transformation. In a service business, the work instructions to
process a loan can also be abstracted onto the information domain. The interactions
between stakeholders of the organization domain can also be abstracted onto the
information domain as is done for social network analysis describing individual
stakeholders as nodes and various types of information exchange as different links
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between the nodes. The information domain can also be used to describe the complexity
faced by process designers in considering the many alternatives available for each activity
and the design effort associated with making choices amongst these alternatives to produce
the final work instructions for activities in the process domain.
An important distinction of the information domain is that tacit knowledge, such as that
held in a technician's head about he best way to hold a pipette (but not explicitly stated in
the protocol) resides in the organization domain unless a specific mechanism for
knowledge capture exists. So, for example if there is a formal process review where
technician experience is to be captured into a design document, this design document
resides in the information domain. Otherwise, every activity performed in the process
domain is a combination of explicit information (such as a protocol) and tacit knowledge
from a technician, physician, or other specialist whose entire tacit knowledge base cannot
be easily transferred to explicit information. Every activity in the process domain thus
requires a connection to at least one information domain item and one individual in the
organization domain. This is the same as the IDEFO definition where each activity requires
both a control input and a mechanism input. Again, most traditional process flowchart
representations hide the complexity associated with imperfect information, assuming that
each activity (task) is fully specified and known as was described in chapter 2. In reality,
the capture of this tacit information is critical to all process improvement methodologies
such as lean and six Sigma, and in most process representations it is not explicitly
identified or modeled.
The diagram in Figure 47 shows the now familiar process flowchart but adds the necessary
work instructions associated with each of the process activities. Note that every activity
must have a corresponding work instruction, but each work instruction can be derived
from multiple explicit knowledge sources. A key goal of the information domain is to map
the genealogy of the work instructions needed to perform the process. This is critically
important in fast-changing technologically complex processes because work instructions
should reflect changes in the policies, procedures, data, guidelines, and other knowledge
sources they are derived from. For example a change in insurance reimbursement policy or
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a protocol change by a vendor must be reflected in the actual work instructions used to
perform the process. The interaction between knowledge sources is also an important
concept in the information domain. Thus in the example in Figure 47 hospital policy for
diagnostic requests is influenced by insurer policies (what they will reimburse) and also
American Medical Association guidelines as to standards of care (best practices). These
guidelines and policies are "constraints" and instructions that are reflected in the actual
treatment protocol work instructions. This correspondence between knowledge sources is
critical to map since alignment of process steps subject to the constraints of policies and
guidelines can be difficult if they are rapidly changing.
Another key concept in the information domain is the derivation of work instructions from
vendor protocols and available literature evaluating a particular process step (activity).
The goal is to capture the real process by which vendor instructions, such as equipment
manuals, and available medical literature, such as validations, get synthesized into actual
day-to-day work instructions. The synthesis process becomes even more important when
there are numerous design alternatives (and changes) as conceptually shown by vendors A,
B, and C. A single vendor was selected through some design process whose output is
represented by the "Design Documents", from which the actual work instructions are
derived. Once again in processes with rapidly changing technology, the explicit
enumeration of the design alternatives from which the final day-to-day protocol was
derived is critical to understanding the true process complexity. This is partly because until
a "dominant design" emerges, the organization must still monitor and be aware of the
performance of the available alternatives, as one of these could become the "dominant
design". Of course these design alternatives could also be part of the process, as part of a
decision branch in which case there would be direct work instructions associated with each
one, and the design document would be associated with the decision branch. An important
distinction should be made about the inherent process complexity and that brought on by
having many design alternatives for each process step. Inherently complex processes will
have difficulty incorporating rapid change, a phenomenon often seen in healthcare.
Complex processes will also have difficulty fully optimizing their process steps as the "cost"
of exploring all available alternatives increases with complexity. This problem gets worse
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as processes resistant to change because of their high complexity are faced with new
design alternatives, sometimes coming from different fields or affecting only certain steps.
The complexity of the overall process will now increase as the inherent process complexity
is still there, but the new design alternatives must also be explored.
The question again arises as to whether processes, healthcare in particular, may have a
certain level of irreducible complexity which cannot be engineered around and this is the
fundamental problem facing many processes. Yet, before irreducible complexity can be
accepted as an explanation, it should be measured to analyze the true extent of this
complexity and whether it is in fact "irreducible" or whether its current configuration is
merely not well designed to take into account complexity reduction. This thesis is an effort
to provide tools to measure process complexity such that it can be assessed and managed
like any other engineering variable. Like any engineering system, a process will be a set of
compromises where greatly reducing the complexity may also significantly reduce the
performance. Process designer will have to make these trade-offs, but they should do so
with tools to allow them to analyze process complexity. Just as a Cessna 172 is much less
complex than a Boeing 777 but it also has much lower performance, some processes are
simpler but have much lower performance. Tradeoffs must be made and "complexity"
should be "spent" wisely where it greatly improves performance rather than preventing
improvement.
Many processes have also not been designed to accommodate change, just as many systems
have not been designed in flexible and modular ways such that they can be modified in the
future without becoming obsolete. The design of real options for systems is identical in
concept to the real options that might be designed for processes where additional
infrastructure in the form of personnel, steps, or other elements, might be built in to ensure
processes remain flexible and adaptable. Often processes are not changed in their entirety,
but in modular ways where the technology associated with one of their activities is
changing rapidly and must be incorporated into the process. This is in many ways the
example studied in this thesis where the insertion of DNA sequencing, a complex and
rapidly changing technology is being inserted into standard clinical microbiology
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processes. And while complex, DNA sequencing processes are rapidly changing due to the
enormous investment being made in R&D but also because no single "dominant design" has
emerged to use Utterback's ideas.
Figure 47 - Interaction of Process and Information Domains
The elements contained in the information domain are connected with directional arrows
indicating which elements are derived from which. In cases where elements are derived
from each other (or are influenced) bidirectional arrows are shown. For example the
infection treatment protocol is derived from AMA standard of care guidelines, insurer
policy, and hospital policy but these three items also influence each other and are so
represented. The diagram in Figure 48 extracts only the information domain elements and
shows their network representation below. This representation is similar to the activity on
node (AoN) representation but places information elements on nodes and the edges
represent the genealogy (sources from which a particular element was derived). Each of
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the information domain elements can interact with organization domain individuals, and
these interactions represent "familiarity" or "knowledge" of the particular information
domain element. This is particularly important when analyzing the overall projection
domain network as it impacts the "search" properties of the network. The "reachability" of
information domain elements through either the way in which they are derived in the
information domain or how well connected individuals are in the organizational domain is
critical to the design, implementation, and troubleshooting of complex processes. This will
be discussed later in this chapter.
V
Figure 48 - Information Domain as a Network
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3.5 Projection Domain
Having defined the process, organizational, and information domains it is possible to define
the projection domain. The connections between the individuals and process activities
have already been shown, as have the connections between the information domain and
the process. The only remaining pairing is the set of connections between the information
domain and the organization domain, which represents the interaction between individuals
and the explicit knowledge they are either aware of, responsible for, or subject to. The
interaction between the organization domain and the information domain is conceptually
shown in the diagram in Figure 49. Note that not all the elements in the information
domain can be reached and certain information such as the knowledge of the protocols,
and performance of vendors A, B, and C is held by the lab manager and not directly by the
lab technician. However, the operational experience of the protocol is held by the lab
technician and in this example explicitly codified in operational logs rather than as tacit
knowledge.
II-
Figure 49 - Interaction of Organization and Information Domains
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It is now possible to put all of the elements together in the projection domain using the
graph representations of each of the domains and projecting them onto a single one. The
projection domain is called a separate "domain" because it has different properties than the
other domains in that every element and link is abstracted to be the "same" such that global
network properties of the overall process can be calculated. It is of course possible to label
and identify each type of node and link in the projection domain such that differences in
links can be identified but a central goal of this thesis was to provide global properties of
the process, which abstracting all elements onto the "projection domain" allows. Figure 50
is the combined projection domain for the example developed so far. This projection
domain now contains all of the intra-domain connections but also the cross-domain
connections for each of the pairings.
While many graph-based process analysis methods have focused strictly on the process
(functional) domain it is clear from this example that although the process domain can
have very little complexity, the supporting structures of information and organization
contribute significant "hidden" complexity. And this additional complexity is not an artifact
of the model developed here since all of the elements described in each of the domains
exist in reality and are necessarily connected for the process to exist and operate. This
model is an attempt to describe these connections such that they can be modeled and
managed. As will be seen in Chapter 5, real-world processes have much greater complexity
than is apparent from "process only" representations which may not include all of the other
elements needed for a process including information and organization.
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Figure 50 - Graph Representation of Projection Domain
3.6 Graph Properties
The first step to analyzing the projection domain matrix developed thus far is to translate it
into a true graph representation. For convenience, the graph was input into NodeXL a
prototype software package from Microsoft research that uses an Excel front end to input
graph edges and vertices, and can then compute basic measures or output adjacency
matrices for use on other platforms including Matlab, UCINET, and others. The same
Powerpoint drawing developed thus far for the conceptual projection domain is
represented in NodeXL in Figure 51 where red squares represent elements of the process
domain, blue triangles, elements of the information domain, and green circles elements of
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the organization domain. This diagram is the same projection domain network developed
thus far.
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Figure 51 - Projection Domain with Individual Domains Highlighted
Using this formal graph representation, basic graph metrics can be computed, such as the
number of elements, number of connections, average degree of the graph (number of
connections per element), given in Equation 1. A higher average degree should correspond
to a process where it is relatively easy to search for information and the stakeholders are
well connected.
-1d(G) =-Xd(v)
where G is the graph set, V is the set of all vertices, d(v) is the degree of vertex v
Equation 1 - Average degree for a graph
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Using the properties of graphs, an equivalent formula for average degree using the set of
Edges is given in Equation 2.
2.IEI
where E is the set of all edges in the graph and V is the set of all vertices in the graph
Equation 2 -Average degree as a function of edges and vertices
A higher average degree should also correspond to a more connected process network
better able to absorb changes, but like any metric these should be balanced with others. It
is possible that too high an average degree could lead to difficulties in managing the
information flow and make the network also be resistant to change. The graph density: the
number of edges over the maximum possible number of unique edges in a complete graph
is given in Equation 3.
| E|A (G)= JEVI -(|V- 1)
where G is the graph set, E is the set of Edges, and V is the set of vertices
Equation 3 - Graph Density
A very high density could mean the network has exceeded "bandwidth" limits for
individuals as nearly every vertex is connected to every other. The shortest distance
matrix d(u,v) between pairs of vertices can be found by search algorithms, and the overall
average distance for a connected graph can then be computed from the distance matrix,
given by Equation 4.
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S(G)= 3(u,v)IVI-(VI-1)
where V is the set of all vertices, 8 is the shortest path set between each vertex pair (u,v)
Equation 4 - Graph average distance
The average distance metric can provide insight as to the number of "steps" that an
individual (or work instruction genealogy) would have to go through before reaching
another element of the process. Shorter is likely better, but requires more vertices (nodes)
as in the example of the process owner. Similarly, using the distance matrix, the diameter
of a connected graph can be computed as the maximum distance between the sets of vertex
pairs given by Equation 5.
diam(G) = max{(u,v)|u,v E V}
where G is the graph set, 8 is the shortest path set between each vertex pair (u,v)
Equation 5 - Graph diameter
Other interesting measures can be calculated such as the "Cyclomatic complexity" M, which
was originally developed to identify the maximum number of independent paths through
software programs (McCabe 1976) as an estimate of their complexity, but can be applied
here to the MDPM model as the maximum number of information exchange paths or the
number of process paths, given by Equation 6.
M(G )=E|-|IVI+ P
where E is the set of edges, V is the set of vertices, and P is the number of connected components in
the graph
Equation 6 - Cyclomatic Number
Other measures can be defined based on the number of branch points in traditional Event
Process Chains, although no explicit connectors are used in this model. However, branch
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points in the process domain could be used as a proxy for the "connectors" to indicate AND,
OR, or XOR branches, such that the same definition applies as given in Equation 7.
dc (G)= d(c)
1C ec
where G is the graph set, C is the set of connectors, d(c) is the degree of connector c
Equation 7 -Average degree for EPC connectors
And a calculation of the maximum degree of the branch points (connectors) as given in
Equation 8 can indicate the magnitude of the decision branches that need to be considered
in the process.
d( (G) = max {d(c)c C}
where G is the graph set, C is the set of connectors, d(c) is the degree of connector c
Equation 8 - Maximum degree of EPC connectors
Using these measures it is possible to calculate basic complexity measures of the example
projection domain (and overall MDPM model) and compare these measures to changes that
might be made to improve the communications performance of the process network or to
reduce the complexity of the process. So for example, the addition of a process owner to
communicate directly between the lab manager, the physician, and the nurse manager, as
well as be aware of the key design and operational documents for the process can greatly
improve the "search process" or "reachability" as given by a reduction in the average
distance between nodes. In grid format, the original baseline process without a "process
owner" is given first, and then the addition of a process owner in Figure 52 and Figure 53
below:
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Figure 52 - Baseline Projection Domain
Figure 53 - Projection Domain with Addition of a Process Owner
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Other more sophisticated graph measures can be defined including some from information
theory as discussed in chapter 2, such as the Shannon entropy of a graph as a function of
the degree distribution. This is a measure of the randomness of a graph and is in units of
"bits". The Shannon entropy of a graph is given in Equation 9.
maxd
n= dI (G)= -i ,(log2 (h,)
Where hi is the fraction of nodes with degree i
Equation 9 - Information (Structural) Entropy (from Shannon)
These measures are calculated for the baseline graph and for the one where a process
owner has been added. The results are in Table 6:
Baseline Baseline+Process Owner
Average Degree 5.53 6.65
Cyclomatic Complexity 54 73
Size 30 31
Entropy 2.61 2.78
Max. Average Distance 4.14 3.17
Table 6 - Basic Metrics for Example Projection Domain
Adding a process owner to improve the connectivity of the graph reducing the maximum
average distance between nodes to 3.17 from 4.14. There is some "cost" to this, as the
cyclomatic complexity, the number of possible paths, increases significantly, but the benefit
to reachability is significant. This can be clearly seen by calculating the geodesic (shortest
path) distances across the network for every pair of nodes, as shown in the heat map in
Figure 54:
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Figure 54 - Reachability Matrix for Baseline Example
Note that not all nodes are reachable (blank squares) in Figure 54, and the maximum
distance is 8 between various elements of the projection domain network. For comparison,
the geodesic distance heat map for the case where a process owner is added is shown in
Figure 55 with clear benefits to reachability. All nodes are now connected and reachable in
a maximum of 7 steps.
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Figure 55 - Reachability Matrix for Process Owner Example
What might this mean in a real process? If individuals in the organization domain are
unaware of upstream activity information (whether it be changes, operational
performance, or problems) it can make change, improvement, and troubleshooting difficult.
Similarly if the information used to perform downstream steps has not been derived (or
"aligned") with policies and previous experience (i.e. design reviews) the process will
underperform, fail to satisfy stakeholder needs, and potentially fail. A side effect of low
connectivity in the projection domain is that processes are more likely to resist change
since it is difficult to evaluate the overall impact of changes at any given activity. This may
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cause processes to be "frozen" in sub-optimal configurations that have been demonstrated
to work, but for which further optimization and change is difficult to manage due to a lack
of connectivity (search) between the various organizational, process, and information
domains.
3.7 Multi-Domain Process Matrix Metrics
A goal of this thesis was to provide a graph based model of complex processes such that
many of the metrics used to understand graphs could be brought to bear in the analysis of
the various process domains. Graph metrics used in this thesis can generally be classified
in the following categories based on (Costa, Rodrigues et al. 2005):
- Distance metrics of graph "size" such as shortest (geodesic) paths between nodes
= Structure metrics of graph "organization" such as degree distribution or clustering
- Entropy metrics of graph "randomness" such as Shannon entropy of degree
distribution
These metrics categories are further described in the following sections and are intended
to provide a set of metrics that can be used in the comparison of multi-domain process
matrices (MDPMs) associated with processes. The ability to measure properties of MDPM
models is essential to their utility as an engineering tool in order to quantifiably analyze
improvements to a process. With the set of metrics proposed in the following section it
may be possible to design processes according to desired specifications and build Design of
Experiments (DOE) models like those described by (Box and Liu 1999) for engineering
systems that identify the key variables in the process subject to the response surface
defined by the following metrics. The application of multi-domain matrices is still evolving
however and greater experience and research will be needed to fully characterize the most
relevant set of graph metrics to describe complex processes as in the MDPM model and
similarly in the larger ESM model. The objective of this thesis was to provide a
comprehensive set that could be used on the MDPM model and other similar models such
as the ESM model. These metrics are shown to have utility by comparing improvements in
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the MRSA surveillance process test case in Chapter 5, but other test cases will be needed to
converge on a useful set. Also while the focus of this thesis is on the study of complex
processes, not all of these metrics are necessarily associated with complexity as some are
simply properties of a process that can nevertheless be used analytically in designing and
optimizing processes.
For each of the metrics proposed in this section a complete description is given including
the metric name according to convention found in the relevant literature, a brief definition,
the metric formula, its potential application in the analysis of MDPM domains, any potential
limitations in the use and interpretation of the metric, a hypothesis for the interpretation of
the metric, and related literature references. Again, the goal of the following sections are to
provide a comprehensive description of available network metrics some of which will be
used in Chapters 4 and 5, but the entire listing in this chapter can serve as a future
reference for others wishing to use the MDPM methodology.
3.7.1 Structural Metrics
Structural metrics describe fundamental properties of the graph and its associated
adjacency matrix including numbers of nodes, edges, graph density, and degree
distribution. These metrics can provide process designers with the basic description of a
process, such as the number of process steps (nodes in the process domain), how well
individuals are connected to each other in the organizational domain (graph density), and
the number of potential paths through a process (cyclomatic number). Each structure
metric is described in the following tables.
Metric Sv
Definition Number of vertices (nodes) in the domain graph corresponding to the
number of distinct elements
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Formula
Application
Limitations
Hypothesis
Related Work
Metric
Definition
Formula
Application
Limitations
Hypothesis
Sv (G)= |Vi
where V is the set of vertices in graph G
Equation 10 - Number of Vertices Metric
The greater the number of elements in the graph the higher the
complexity is likely to be, but need to use with other measures. Can
also be used to compare absolute sizes of element sets between
processes (i.e. numbers of activities).
Process domain graphs that are sequential can have large numbers of
activities but low structural complexity. Similarly "small world"
organizational networks may have large numbers of individuals but
low communication complexity.
High Sv corresponds to higher complexity
(Costa, Rodrigues et al. 2005; Mendling 2009)
Number of edges in the domain graph
SE(G)=|E|
where E is the set of vertices in graph G
Equation 11 - Number of Edges Metric
The greater the number of connections in the graph the higher the
complexity
Process domain graphs that are sequential can have large numbers of
activities but low structural complexity. Similarly "small world"
organizational networks may have large numbers of individuals but
low communication complexity.
High Sv corresponds to higher complexity
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Related Work (Costa, Rodrigues et al. 2005; Mendling 2009)
Metric
Definition
Formula
Application
Limitations
Hypothesis
Related Work
Metric
Definition
Density of a graph. Number edges divided by the maximum possible
number of edges given the number of nodes. Note that this is the
directed graph density.
IElA(G) = ' 'VI- i )
Equation 3 - Graph Density Metric
In a very dense graph in any of the domains, a large number of
interconnections may be associated with a higher complexity. Can
compare overall process MDPM models to evaluate "infrastructure".
Ability to compare across graphs with varying numbers of vertices
since density is proportional to 1/V2. Also, high density may not
correspond to "complexity" since better communication may actually
decrease complexity (increase reachability) to a point. Also may not be
comparable across domains.
High density corresponds to higher complexity and cost of maintaining
links especially in organization and information domains.
(Costa, Rodrigues et al. 2005; Mendling 2009)
M, Cyclomatic Complexity
Number of linearly independent paths through a graph
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Formula
Application
Limitations
Hypothesis
Related Work
Metric
Definition
Formula
Application
M(G)=|EI -IVI+ P
Where E is the set of edges and V the set of vertices in graph G, and P is the
number of components (if graph is strongly connected)
Equation 12 - Cyclomatic Complexity Metric
A domain with a high cyclomatic complexity suggests there are a large
number of linearly independent paths through the graph and therefore
complexity in "knowing" which route to take. This measure is derived
from software complexity analysis (McCabe 1976), and is directly
relevant to the process domain although likely applicable to the others
in some fashion as well. Note also the contribution of disconnected
components, which can be substantial in organization and information
domains for comparison between MDPM models.
High M graphs may not correspond to high complexity if alternative
paths are not frequently used, or in organization domains where paths
are not "pre determined"
High M corresponds to higher complexity
(McCabe 1976)
Average degree of a vertex
d(G)=. |Vi
Equation 1 - Average degree for a graph
A domain with a high average degree should be more complex as a
greater number of connections must be maintained. A high average
degree may also correspond to "bandwidth" problems as elements may
not be able to communicate or process the information from many
nodes they are connected to.
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Limitations
Hypothesis
Related Work
Metric
Definition
Formula
Application
Limitations
Hypothesis
Related Work
High average degree graphs may not correspond to high complexity if
reachability is improved. Also high average degree may be misleading
if the graph is scale-free with a few very high degree nodes and many
relatively low degree ones.
High average degree corresponds to higher complexity and decreasing
bandwidth of each element.
(Costa, Rodrigues et al. 2005)
P(k)
Degree distribution of vertices (random binomial, poisson, power law,
and others)
P(k) ~ k 4
where k is the degree and y is the power law constant
Equation 13 - Power law degree distribution Metric
A domain with a power law distribution will have less complexity than
a randomly distributed (binomial) one and be easier to navigate.
Power law distributions may not correspond to lower complexity since
some nodes may require hierarchical structures to deal with the many
incoming and outgoing "connections". Many other distributions are
possible, each with their own rationale.
Information exchange is easier in power law "scale free" networks
(BarabAsi, Dezs6 et al. 2003)
3.7.2 Distance Metrics
Distance metrics describe the spatial properties of the graph and its associated adjacency
matrix including average geodesic distance between pairs, shortest (geodesic) distance
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between individual pairs, network efficiency, and network vulnerability. These metrics can
provide process designers with knowledge about the relationship between nodes and the
"information transmission" properties of the MDPM, which may be used in understanding
how hard (or easy) it is to propagate change or troubleshoot problems in the process. Each
structure metric is described in the following tables.
Metric
Definition
Formula
Average geodesic distance between vertex pairs
- I
|V|-(IV|- 1
Application
Limitations
Hypothesis
where V is the set of graph vertices, and d is the shortest geodesic path
between two vertices
Equation 14 - Average Geodesic Distance Metric
For a connected graph this measure provides an estimate of the
average number of "hops" between vertex pairs and should correspond
to the difficulty to transmit or receive information across the network.
Distances can have different meanings in each of the domains, such as
number of people along a communication path (organization) or
number of process steps (process). This metric also works primarily
for connected graphs as highly fragmented disconnected graphs will
show a low average distance for each connected group but "infinite"
distance between disconnected vertices. The organization and
information domains are often highly fragmented so this metric may be
difficult to interpret except for the overall projection domain.
Efficient information transmission may make this measure less
meaningful. Also, does not take into account vertex capacity (i.e.
overload) or channel capacity.
High value corresponds to higher difficulty of transmitting information,
and potentially greater difficulty in controlling a complex process
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(Latora and Marchiori 2001; Costa, Rodrigues et al. 2005)
Metric
Definition
Formula
Application
Limitations
Hypothesis
Related Work
Metric
Definition
Average network "efficiency" of transmitting information
1 1
e = --I
IV|-(IVI-1) dI
where V is the set of graph vertices, and d is the shortest geodesic path
between two vertices
Equation 15 -Average Network Efficiency Metric
For a connected graph this measure provides a distance-weighted
estimate of the efficiency to transmit or receive information across the
network. The efficiency is assumed to be inversely proportional to the
distance between pairs and provides a measure of the "degradation" of
information if it passes through many levels (i.e. as in a hierarchy).
The falloff of efficiency may not be as severe as the inverse of the
distance. Metric is likely only meaningful for connected graphs.
The farther away a node pair is on a graph, the more difficult it is to
receive information and the lower the quality.
(Latora and Marchiori 2001; Costa, Rodrigues et al. 2005)
Network vulnerability
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Related Work
Formula
Application
Limitations
Hypothesis
Related Work
Metric
Definition
Formula
p =max( I)
where e is the overall network efficiency and Ei is the efficiency minus the ith
vertex
Equation 16 - Network Vulnerability Metric
For a connected graph this metric provides an estimate of the decrease
in information transmission efficiency from the loss of critical nodes.
Highly connected process networks will be presumably less vulnerable
as there will be other "paths" that communication can go through
although at some cost in maintaining all of these other connections.
Some of the domains in the MDPM model such as the actual activities in
the process layer are "essential" and thus the vulnerability metric may
not be as meaningful in the process domain.
A process network with a high vulnerability suggests much of the
information travels through a few hubs, which should be supplemented
with additional paths through other nodes.
(Latora and Marchiori 2005)
Distance weighted fragmentation
2 -
F -1- di
FD =1VI- (V -1)
where V is the set of graph vertices, and d is the shortest geodesic path
between two vertices (1/oo set to 0)
Equation 17 - Distance Weighted Fragmentation
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Application
Limitations
Hypothesis
Related Work
Metric
Definition
Formula
Application
Limitations
Measure of fragmentation, but weighted to account for greater
"fragmentation" with longer path lengths. Accounts for the "limited
horizon" of individuals who may not be able to "see" very far into the
network, effectively fragmenting it. May be useful for the analysis of
the organization domain.
The falloff fragmentation effect due to distance may not be as severe as
the inverse of the distance.
The farther away a node pair is on a graph, the more difficult it is to
receive information and the lower the quality effectively fragmenting
that node from the rest of the network.
(Borgatti 2006)
diam
Longest path between pairs of vertices in the graph
dian(G) = max{(u,v) |u,v e V}
Equation 5 - Graph diameter metric
In a process, where every step can impact the outcome, long
information transmission paths produce higher the complexity and
make it mode difficult to manage. Especially relevant to the process
domain where the number of activities needed to be performed in
"sequence" along a path suggests a greater probability of an individual
link in the chain failing (and needing troubleshooting efforts).
Process domain graphs that are sequential can have large diameters,
but have low structural complexity. Can describe the complexity to
information transmission in the organizational and information
domains.
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Hypothesis High diam corresponds to higher complexity and the potential for
alignment problems between stakeholders separated by many process
steps (or other domain steps such as organization).
Related Work (Mendling 2009)
3.7.3 Information Metrics
Information metrics in communications networks (and graphs) derive largely from
(Shannon and Weaver 1948) where Shannon describes the information entropy as a
measure of the amount of information needed to "know" the value of a random variable
transmitted in a given communications channel. The Shannon entropy has been abstracted
to describe the amount of information needed to fully specify or "know" the current state of
a system and increases with the number of available states. An analogy might be the
amount of information needed to fully specify the states of atoms in a solid near absolute
zero will be less than the amount of information needed to specify the state of the same
material at a much higher temperature in a gaseous state where many more states can
exist. Applied to the MDPM model (and potentially to the ESM model as well) Shannon
entropy ideas could be used to describe the amount of information needed to fully describe
the "state" of a complex process including which individuals are talking to which, what
process steps are being attended to, etc. The Shannon entropy ideas applied to network
analysis have to a large extent focused on the "structural entropy" of a network, treating
the degree distribution as the random variable and defining the amount of information that
would be needed to "know" the exact degree distribution. These structural entropy ideas
have been used to describe the robustness of networks and resilience as described in
(Costa, Rodrigues et al. 2005).
However, the Shannon entropy concepts have been extended to describe the amount of
information needed to "search" networks such as finding a particular node or finding a
route through a network as described in (Sneppen, Trusina et al. 2004; Rosvall and
Sneppen 2006). This "search information" can be thought of as the number of "yes/no"
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questions that an agent traversing the network between an origin and destination node
would have to ask at each edge start on each node in the path to follow the shortest path.
Thus at a node of degree 4, the agent would have just entered the node from one of the
edges, but would have to "ask" for each of the other 3 edges "is this along the path for the
shortest route?" and when one is yes, goes to that next node and so on until the destination
is reached. This is done for every pair of nodes on the network and the sum is the "search
information" for the network, measured in bits, so that the "yes/no" questions are a base 2
to the search information value for a network (which can be very large 210 or more for
some of the complex MDPM models in chapter 5). Most process networks will not have
completely "blind" searches performed on them, and in many cases individuals in the
organization domain will have an idea of who to talk to in order to obtain information.
However, as processes become much more complex and people working on a process start
to become only distantly connected (i.e. the technician in the lab will not usually be
connected directly to the physician) measures of search information can provide a sense
for how difficult it is to find information in an MDPM process network. This is essential for
many of the process improvement, change, and troubleshooting activities in complex
processes that may be more difficult (or not happen at all) if the "horizon" of information
about other elements of the process is limited as described for other networks in (Rosvall
and Sneppen 2006). Change propagation in complex process networks is equally affected
by the "information horizon" as a small change in one part of the process, which does not
appear to have an immediate or local impact can have a very significant impact
downstream, yet if the network is not easily searched identifying the impacts a priori may
be difficult and similarly troubleshooting the network from the affected downstream
element may be just as difficult. Each of the entropy metrics is described in the following
tables.
Metric I
Definition Graph entropy is a measure of the randomness of graph structure
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Formula
Application
Limitations
Hypothesis
Related Work
maxd
I(G)=-X h,(Iog2 (h,))
where h is the degree distribution as a funtion of i, over all degrees
Equation 18 - Graph Entropy (Structural)
A domain with high graph entropy (measured in bits) suggests less
structure tot eh organization of the domain, which should correspond
to higher complexity as the network can be in many "states" leading to
less effective search and communication
Highly fragmented domains will have relatively low graph entropy
(most of the nodes have similar degree) but the overall process will be
harder to manage. Randomness in the degree distribution may not
necessarily correspond to "higher randomness" of the process. High
graph entropy may also mean the process is less vulnerable. This
metric also assumes all nodes are in a single "state" with randomness
coming from the degree distribution only which may not always be the
case.
High graph entropy corresponds to higher complexity and harder to
manage processes as the structure is not well ordered.
(Costa, Rodrigues et al. 2005; Latora and Marchiori 2005)
Metric Is
Definition Graph entropy (with states) is a measure of the randomness of the
process not just in structure but also in state. This includes the idea of
"tstates" of the elements in the graph such as machines that may be idle,
working, or down.
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Formula
Application
Limitations
Hypothesis
Related Work
max s maxd
is(G)=-X h (log2 (h))
j=1 i=1
where h is the degree and state distribution as a funtion of i and j, over all
degrees and states
Equation 19 - Graph Entropy (Structural with States)
An MDPM model or domain with high graph and state (i.e. each element
can be in multiple states) entropy (measured in bits) should
correspond to greater complexity and difficulty to manage as the
system has a much greater number of configurations to be searched
leading to less effective search and communication. Alternatively this
definition could also be extended to replace states with "transactions"
and conditional probabilities for the interactions of each domain with
each other (i.e. not all information needed for every transaction,
therefore probability of certain nodes being useful under different
conditions changes).
The states of the process will likely be Bayesian in nature, as each state
will be influenced by the state of another, suggesting that the entropy
may be less than the estimate from independent states would suggest.
High graph and state entropy corresponds to higher complexity and
harder to manage processes as the structure and state space is not well
ordered.
(Frizelle and Woodcock 1995; Basole and Rouse 2008)
Metric
Definition
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Average search information, or amount of information needed to
identify the shortest paths between two vertices.
Formula
Rationale
Limitations
Hypothesis
Related Work
1 1 1
|V|2  k,,,' k k-i
IV 12 ii {POi-b)} k jczp(i,b)k j
where k is the vertex degree, p(i,b) is the set of all shortest paths from i to b,
and V is the set of vertices in the graph
Equation 20 -Average Search Information Metric
High information requirements to identify shortest paths in a network
correspond to greater difficulty in managing change.
The amount of information does not account for "Bayesian" behavior,
such as once a path has been found, it will be followed and the next one
will more closely match shortest path.
High information requirements likely make the control of a complex
process difficult. The ability to easily search and find information
across the domains of the MDPM (and ESM) models is essential to the
rapid troubleshooting and management of change in complex products
and processes. A high search information value both overall and for
each element may be useful in understanding how to design processes
such that they can be more flexible and easier to improve.
(Rosvall, Minnhagen et al. 2004; Rosvall, Gronlund et al. 2005)
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4 Model Exploration
Using the metrics developed in chapter 3 it is possible to explore the model in further detail
and identify sets of metrics relevant to each of the domains. The sets of metrics and MDPM
model features developed in this chapter are then applied to the demonstration case of
MRSA surveillance in Chapter 5.
4.1 Process Complexity
Typical processes have linear graph structures that would appear to have relatively low
complexity. In addition, processes usually have well-defined start and end points with
directional flow between each of the activities. The basic graph properties such as graph
density, number of edges, average degree, and average distance are usually a linear
function of the number of activities. Delving deeper into a process, however, can uncover
significant complexity. For example, the linear process A through M shown in Figure 56
would appear to have very little complexity if each of the activities can only happen in one
way, or "state", and the processing times are identical.
Figure 56 - Sequential Process
For simplicity the graphs used in the process model development examples so far have
assumed single-states, but real processes can exist in multiple states and have variable
processing times depending on the state and input. So for example the sample collection
step for MRSA diagnosis will vary significantly depending on the location of the infection,
the condition of the patient, and the type of patient attended to immediately prior. For
simplicity, multiple states are not shown in this model, but could be added as additional
matrices of the same dimension as the MDPM but each corresponding to a particular state.
The increase in complexity for manufacturing processes from modeling states has been
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shown in (Zhu, Hu et al. 2008), who uses applies the ideas of state and graph entropy to
describe the increase. Future extensions of the MDPM (and the ESM) model would likely
require states and the modeling of multiple simultaneous processes, which introduces
additional complexity. Multi-process multi-state complexity is discussed later in this
chapter.
Certain conditions typical of real world processes can also introduce significant complexity
to the process domain. For example, the idea of rework loops where an activity or series of
activities must be repeated following a decision activity is represented in Figure 57. The
corresponding activity on node graph will be topologically very different from the simple
linear graph, adding additional edges, which increase graph entropy, density, and path
length.
A B C D E F G H I K L M
Figure 57 - Sequential Process with Rework
Similarly branch points can increase process domain complexity and eliminate
"reachability" of nodes on different branches as shown conceptually in Figure 58, Figure
59, and Figure 60. Implied in these tree structures are decision rules associated with
certain branch points. Although not all branch points need be decisions as it is possible that
the product from one activity can be split between branches. Certain business process
modeling languages explicitly model decision points as "connectors" such as EPCs.
However for simplicity connectors are not modeled separately in this thesis.
D E F G H
A B C
IK L M
Figure 58 - Process with Single Branch
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Figure 59 - Process with Multiple Branches
A B M
H I J K L
Figure 60 - Process with Branch and Rejoin
Process domain maps with greater numbers of tasks, paths, and loops are of course
possible, but for the majority of diagnostic processes considered in this thesis, there are
single start and end points and there is a single "objective" for each path in the process
network. It may be necessary however to describe multiple "support" processes in the
process domain, such as the gathering of production information, the preparation of
reagents for use in an activity, or the training of personnel, and these processes can be
disconnected in the process domain (but connected in other domains). In order to analyze
the process domain, the set of metrics in Table 7 is proposed. The process domain also has
distinct properties relative to other domains, as the density for any real world processes is
unlikely to be very high (.05-0.2) as in practice this would correspond to enormous
amounts of rework, branches, and re-processing not commonly found.
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Metric
Sv
SE
A
diam
T
B
Table 7 - Proposed Process Domain Metrics
Typical sequential process graphs such as those depicted thus far will have densities less
than 0.1 as can be seen from Figure 61 comparing 3 different process graph conditions.
-- PotenUa Rewo Every Actvya
Rfta tia wk Evey Amtvfty aow Bac to Stan [ ]* - C~ -*E
Se"atial
Sequential Potential reo evevy activity
Sequential potential rework every activity
and potential rework back to start
U.IU,
0 10 20 30 40 50
Figure 61 - Plot of Process Domain Density for Various Process Types
Process domain densities are in the majority of cases low, compared to networks where
every node can connect to any other node, such as communications networks (the
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Feasible Values
2-IVI
1-|El
0-1
1-|VI
1-avg(I)
0-1
0-[V12-2|VI+1]
0-max(I)
x
..................................... 
Description
Number of activities: higher should equal greater complexity
Number of transfers: higher should equal greater complexity
Fraction of total possible transfers: higher = more complex
Number of activities in longest process path (assuming no cycles)
Average path length, longer if rework exists
Distance weighted fragmentation, long processes can seem
disconnected from start to end
Cyclomatic Complexity, more paths should = greater complexity
Graph entropy (associated with structure), higher more complex
internet), or even social networks. Not every process step can logically be connected to
another in the process domain, as for example a patient sample cannot go directly to the
physician without actually going through the diagnostic process. Physical processes likely
follow this pattern in the majority, although business processes where no "physical" steps
are involved such as loan evaluation may have higher densities as they are more like
communication networks (and in fact are processing information). The focus of this thesis
however, is on physical healthcare diagnostic processes where activities must be connected
in a certain order. However for all process domain networks, the number of states and
paths can be significant and is an important measure of the true complexity of the process
domain. States are not considered in this thesis, as they would require additional matrices
to describe the state of each element as well as an additional physical object domain as in
the ESM model to describe equipment and other infrastructure items in addition to people
and information. However, modeling these additional states would allow for "behavioral"
time-based simulation of the process as the state of elements (such as a machine that may
be idle, under repair, or working) could be described. For healthcare diagnostic processes,
the number of possible paths through the process domain is considered indicative of the
"combinatorial" complexity faced by the organization and which must be captured in the
work instructions. Thus, paths which are rarely used (i.e. a special request diagnostic using
an older but still available technique) or potential paths (i.e. by mistake someone may skip
an activity) must be dealt with by work instructions describing what to do in these rare
paths, and by the organization being staffed to respond to them.
These metrics can serve as a guide to assess various properties of the process domain such
that a designer could make tradeoffs between number of steps, alternative paths, and
complexity as measured in various metrics. These process domain metrics must be used
with caution as the process domain can contain disconnected activities (processes) that
may only connect through other domains (i.e. individuals). The goal of the process model
described in this thesis is to generate a complete view of the process and not just activities
without the necessary work instructions and organization to carry them out. The
information and organization domains are described next. These metrics are also only
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meaningful in the context of a matrix (graph) representation of a process such as the
MDPM model or other MDM models.
4.2 Organizational Complexity
In contrast to process domain complexity, which is bound by the directionality and the
largely sequential nature of many processes, the organizational domain can have a greater
density and less directionality as many (but not all) of the links will be bi-directional.
Additionally there may be many individuals that are not connected directly to an activity
but which form part of the process either by managing people involved in activities,
providing tacit knowledge, or who set policy that influences the work instructions.
Traditional social network analysis metrics can be used to define the social relationships in
this domain such as centrality, betweenness, path length, density, but also more
sophisticated measures such as efficiency. An important concept of the organization
domain is the full enumeration of all individuals required to manage a process, and is akin
to stakeholder identification in current Enterprise Architecture methods as described in
(Nightingale and Rhodes 2004). It is possible (and likely) in complex processes that the
stakeholders are not directly connected to each other as part of the social network in the
organization layer, but may influence policy on the information layer, which then
influences other individuals, or they may be responsible for another activity on the process
layer. For example, the technician preparing the reagents at the diagnostic vendor factory
likely has no social network connection to the infectious disease physician treating a
patient, but the two are linked through the diagnostic process and the actions of the
technician can alter the behavior of the complex diagnostic process in unpredictable ways.
What if the technician dispenses a slightly smaller amount into the kit, which in turn
slightly decreases the sensitivity of the assay leading to a larger number of false negatives?
This might lead the physician to lose trust in the diagnostic after a few close calls and start
prescribing antibiotics without the diagnostic, expressing a lack of trust of the diagnostic
through his or her social network, and eventually leading to widespread over prescription
of antibiotics, which in turn can lead to increased resistance. This chain of events is one of
many plausible unintended behaviors of complex healthcare processes, and the importance
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of mapping the interactions on the organizational domains is that these unintended
scenarios can be better managed. To continue the example, what if a "process owner" as
described in chapter 3, were introduced into the organization domain. This person might
be able to connect the technician and the physician in far fewer steps, allowing for the
possibility that the under-dispensing by the technician might be recognized as the root
cause for the underperformance of the diagnostic and demonstrate this to the physician
through a structured set of experiments. Good processes allow for organizations to rapidly
identify and then "swarm" problems bringing multiple resources (and necessary
stakeholders) to bear on a problem as described in (Spear 2008). But this is only possible
if problems can be quickly identified, resources rapidly deployed to find the root cause of a
problem, information about the root cause is added to the explicit body of knowledge, and
process changes put in place to ensure it never happens again. Good processes should all
share certain characteristics in the organization domain that facilitate this.
And what might these characteristics be? Well the average distance between nodes is
likely small in high-performance Enterprises, but without too many links. This might be
similar to the characteristics of "small world" networks where a few additional links can
connect local neighborhoods to greatly reduce the average distance without the expense of
too many connections linking vertices directly as in a complete graph. However, each of
the neighborhoods must likely be very densely connected to deal with the enormous
amount of information in managing a complex process, which in a computer network might
require the use of "hubs" to reduce the number of connections any single node experiences.
But real human "hubs" cannot have enormous numbers of connections (edges) as in the
extremes of power law distributions. Real "process" networks have caps on how many
simultaneous streams of information, actual work (in performing an activity), and
communication (with others in the organization domain) can be sustained. This "cap" on
the degree of vertices in a process network likely applies to all elements including the
activities and the information elements. An activity with too many connections should be
expanded into several sub-activities as too many individuals, activity inputs, and work
instructions interacting simultaneously suggests a lack of control as no single individual or
work instruction can be identified as "controlling" the activity. Likewise a work instruction
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in the information domain with too many individuals providing input, derived from too
many other work instructions, and covering several activities likely means there are
significant ambiguities and lack of "control". And how many is too many? This will depend
on the "bandwidth" available but for individuals in process organizations the maximum
interactions with other "nodes" would appear to be in the tens to perhaps a maximum of
100s, but very rarely in the 1,000s and above needed for a power law distribution.
How can this be resolved with human elements in the process? Hierarchies is one answer.
These are commonly found in many organizations, and while much maligned serve a useful
purpose in balancing the "small world" reachability in few steps with overload at a hub.
For example, a single manager with 24 direct reports would likely be "overloaded" with
just brief 30-minute meetings already taking 30% of a 40-hour workweek before doing any
"actual" work. Dividing those same direct reports across 3 managers however reduces the
number of interactions each one has to 9 (7 direct reports + 2 for each of the other
managers), a much more manageable number. Note that extending the hierarchy in
traditional "bureaucratic" ways does not reduce path length, but rather increases it.
Rather, the idea here is that for process networks, "hierarchical" hubs are needed to
attenuate hub overload as shown in Figure 62. These "hierarchical" hubs in this process
model replace single vertex hubs that might be found in other "power law" networks. And
empirically, these hierarchies are real features of processes, where coordinators,
supervisors, managers, and directors, serve (when properly used) to reduce the individual
degree of a hub member, but can effectively appear to be a large hub with only a small (1
hop in this case) penalty. In Figure 62 there are 24 edges associated with each hub, but the
degree of the single vertex hub is 24, versus the hierarchical hubs whose average individual
vertex degree is 9 (although with a 1 hop penalty for traversing the hub) and 8 with a true
hierarchical hub (although the hop penalty increases to 2).
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degree 8
Figure 62 - Hub Structures
In order to analyze the organization domain, the set of metrics in Table 8 is proposed:
Feasible Values
2-IVI
1-|E
0-1
0.5-IV|-1
0-IVI
O- T
0-1
0-1
1-|VI
Description
Number of individuals: higher should = more complexity
Number of connections: higher should = more complexity
Fraction of total possible connections: higher = more complex
Average degree for a vertex, higher = more complex, less
bandwidth per connection however
Longest path between vertex pairs. Longer means communication
more difficult
Average path length: lower = faster communication but at some
expense to maintain connections
Distance weighted fragmentation, higher means more parts of the
organization are "isolated"
Fraction of nodes that cannot reach each other, which means they
can only reach each other indirectly though work on the process
Number of weakly connected components, how well connected is
the network.
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Metric
Sv
SE
A
diam
T
B
degree 24 degree 9
M 0-[IVI2-2|VI+1] Cyclomatic Complexity, number of potential communication paths
e 0-1 Efficiency: higher = faster more direct communication but at some
expense in terms of short distances.
Table 8 - Proposed Organization Domain Metrics
Because the elements of the organization domain are individuals, the properties of the
domain are different than the process or information domains. For one, this organization
domain has a much stricter "cap" on bandwidth, although as discussed previously, the
other domains have similar caps. Ultimately the objective of this domain is to capture the
full range of person-person communication needed to manage a complex process. And it is
likely that the structure of this domain has a very strong influence on the structure of the
process and information domains. For example, a hospital microbial diagnostic process
staffed primarily by technicians who are familiar with older (culture-based) diagnostic
technology, and who are not strongly connected to key stakeholders in the hospital
organization, may not be able to absorb rapid change very easily. In contrast, a laboratory
group with a highly connected lab manager and technicians that participate actively with
physicians in comparing results will be more likely to absorb rapid change and to more
easily resolve problems with a complex process by rapidly identifying problems and
finding the necessary resources to solve them. The metrics described here can be used for
this purpose, such as the average path length or efficiency indicating how well connected
the organizational domain is.
Much of the additional complexity "hidden" in traditional process models is contained in
this domain in the set of interactions necessary for the smooth operation of a process
outside of the "routine" operations. While the direct interaction of a technician with an
activity is a necessary part of the process, the occasional interaction of an expert in the
activity (perhaps the activity designer) with the technician can improve the process by
providing direct feedback from the technician or providing insight from the designer. These
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"occasional" interactions are not typically captured in process maps but do in fact occur
and form the basis of much of the innovation, process improvement, and troubleshooting
that occurs in real processes. Formal, but perhaps unrecognized, interactions must also be
captured such as the organizational domain connections (or lack thereof) between
insurance reimbursement analysts working for an insurer and the physicians and
laboratory technicians on the front lines of medicine. The actual complexity of the
organizational domain for healthcare processes is significantly greater than comparable
processes in manufacturing due to the highly fragmented Enterprise of health care. A single
hospital must produce a wide range of services from surgeries to checkups to diagnostics
as opposed to a semiconductor factory that has been highly optimized to produce a single
type of product.
There are a number of other measures from social network analysis that can be applied to
better understand the MDPM model, such as centrality metrics like betweeness and
closeness discussed in chapter 2. These will be used in Chapter 5 to identify MDPM nodes
that are most "connected" to the rest of the process but not in a global network sense. The
graph-theoretic definition of betweenness centrality is given in Equation 21 and closeness
centrality is given in Equation 22.
CB(k) Y Ik
Where gikj is the set of all paths from i to j that pass through node k, and gij is the set of all paths
between node i and j.
Equation 21 - Betweenness Centrality
Cc (k) = V-
X d
ktj
Where dkj is the set of geodesic shortest paths and V is the set of all nodes
Equation 22 - Closeness Centrality
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Both of these centrality measures can be used to identify key elements in the MDPM model
as will be shown in chapter 5.
4.3 Information Complexity
The main objective of the information domain is to represent the explicit information
needed to manage the process. This can take the form of work instructions, design
documents, operational logs, process data, metrics, policies, and other documents needed
to support the process. The lack of many "elements" in the information domain for a
complex process is likely a potential problem as it means the process is not sufficiently
documented, monitored, or controllable. This also means that the process knowledge
largely resides as tacit information in the organizational domain. Excessive numbers of
elements however may unnecessarily increase the process complexity as each of these
elements must be "processed" in some fashion either by an individual in the organizational
domain or connected to another information domain object via an information mapping. It
is worth noting that much like the connections in the organizational domain, the
connections (edges) in the information domain represent links of various kinds between
objects. The objective is to show the relationship between them, to in a sense understand
the "genealogy". The edges represent various kinds of mappings from one information set
to another, such as data to algorithms, readouts to information summaries, and policies to
detailed day-to-day protocols. Much like all edges in the organizational domain represent
communications, which can also be considered mappings of one data set (a person's
knowledge) to another. This idea that all edges in each of the domains represent the
mapping of information from one set to another is what enables the construction of the
overall MDPM model which in the initial prototype version in this thesis considers the
edges between all vertices to be information mappings including the process domain edges.
Future refinements to the MDPM model could differentiate between the edges in order to
show different types of relationships but this would require additional matrices each of the
same dimension as the MDPM model they are derived from to show the "attributes" of each
of the edges in the "master" adjacency matrix. This refinement could add significant
richness to the model.
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The information domain can provide significant insight into "hidden" information not
commonly represented in process models. Much like the organizational domain, real world
complex processes require far more information than the work instructions (protocols)
associated with each activity. The hospital policies, FDA policies, the performance
specifications for diagnostic kits, performance comparison documents of diagnostic kits,
are all needed to manage the process. And understanding their interaction, and most
importantly the information genealogy of work instructions directly associated with an
activity is critical to managing the process. For example, imagine the case of having to
troubleshoot a complex diagnostic process in healthcare. The first step might be to review
the protocols to understand what variables are the most important. However the
relationship between variables and experimental results for these are likely contained in
the design documents the protocols were derived from. As part of the troubleshooting It
might be important to understand the design envelope for a particular process step, which
would then require access to the optimization documents associated with the protocol or
perhaps vendor documentation indicating the performance limits of that particular process
activity. In addition, it will be necessary to review any metrics or operator logs associated
with that process activity, which requires understanding not just the logs or metrics but
also the algorithms the metrics are derived from. Again all of this information is not visible
in the very first level of a process representation but the policies and other documents can
have a very significant impact on how the process is run, and most importantly is changed
and improved. Much like the influence of a particular organizational structure on the
structure of the process, the structure of the information domain can have a significant
impact on the structure of the process.
The ideas of information entropy are most useful in the information domain, in particular
measures associated with search. For example the average search information, or the
amount of information needed to identify the shortest path between two vertices can be
used to identify nodes that have the greatest "difficulty" in reaching targets through the
particular network and will therefore not have good visibility over the impact of any
changes or problems in their particular part of the process on the rest of the process. But
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why go through the trouble of enumerating all of the information associated with a
process? The answer is that when the process is operating normally only the work
instructions and some direct tacit knowledge from the individuals directly connected
activities are needed. But as soon as changes, troubleshooting events, improvements, or
new technologies are introduced there is a necessary search through the information
associated with the process to understand the impact, manage the change, or find the root
cause. This is why the enumeration and genealogy of the information is so critical: it
provides the network to be searched. Table 9 contains some of the proposed complexity
measures for the information domain, with a similar set of metrics to the organization
domain but with different interpretations of these.
Values
2-IVI
1-JEl
0-1
0.5-(tVI-1)
0-tV'
0-I
0-1
0-1
1-tIV
0-[|Vt2-2tV|+1]
0-1
Description
Number of information elements: higher should = more
complexity
Number of connections: higher should = more complexity
Fraction of total possible connections: higher = more complex
Average degree for a vertex, higher = more complex, information
is highly interdependent
Longest path between vertex pairs. Longer means search is more
difficult
Average path length: lower = faster search but at some expense to
maintain connections
Distance weighted fragmentation, higher means more elements of
information are "isolated"
Fraction of nodes that cannot reach each other, which means they
can only reach each other indirectly though work on the process
Number of weakly connected components, how well connected is
the network.
Cyclomatic Complexity, number of potential search paths
Efficiency: higher = more complex but more efficient
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Metric
Sv
diam
Table 9 -Proposed Information Domain Metrics
4.4 Multi-Domain Complexity
The projection domain, which is also the entire graph described by the full MDPM matrix,
captures all of the connections between elements of the different domains and thus can
have significant complexity as measured by the metrics developed thus far. For the
purposes of analysis the objects and links in the full MDPM matrix (the projection domain)
are treated as equal although a relatively straightforward model extension could add rules
and classes for the elements and relationships between them as discussed previously. But
in order quantify the real complexity that exists in processes and measurement of the
projection domain containing all of the elements in the information, organization, and
process domains is a useful proxy. The projection domain will also, by definition, have a
greater complexity than the domains it is derived from and metrics calculated on the full
matrix describe the overall process properties including proxies for complexity. Also
because many of the "hidden" connections between elements of the process are shown in
the projection domain the complexity of this domain will be higher but more
representative of the "true" process complexity.
The projection domain network is an abstraction of reality but measuring properties such
as density, average distance, degree distribution, and reachability can provide significant
insight into the performance of the network associated with the process. In addition, one
can use the projection domain to identify "weak points" in the process where process
activities are unmonitored, difficult to reach (in a network sense), individuals are
overloaded, work instructions are not being properly updated to reflect changes elsewhere
in the process, and other problems. These will be further discussed later in this chapter, in
showing how this model can represent traditional process problems. The metrics used to
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analyze the projection domain are similar to those already described and shown in Table
10:
Metric
Sv
Description
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diam
Cn
Values
2-IVI
1-IEI
0-1
0.5-(IVI-1)
0-IVI
1-I
0-1
0-1
1-|V|
0-[1V12-2|VI+1]
0-2/V-1
0-1
Number of elements: higher values should correspond to higher
complexity and difficulty for change as every node must be
"updated" or "pinged" in the case of troubleshooting
Number of connections: higher values should mean the network is
more easily searched but come at some cost of complexity
Fraction of total possible connections: higher values should
correspond to better communication and search but at some cost
to maintain connections.
Average degree for a vertex, higher values may correspond to
bandwidth limited processes that do not have more "bandwidth"
to deploy on changes and troubleshooting
Longest path between vertex pairs, a high value may correspond
to long search and communications paths making change and
troubleshooting difficult
Average path length: lower = faster search but at some expense to
maintain connections
Distance weighted fragmentation, higher means more elements
are "isolated"
Fraction of nodes that cannot reach each other, which means they
can only reach each other indirectly though work on the process
Number of weakly connected components, how well connected is
the network.
Cyclomatic Complexity, number of potential communication paths
Directed efficiency: larger = more complex but more efficient
Network vulnerability, high if it is composed of a few hubs
0-4 Search information needed: higher values mean a network is
harder to search and will make change and troubleshooting
difficult
I 0-max(I) Graph structure entropy: higher values may suggest the network
is not well structured and may be vulnerable to failures of
individual elements
Table 10 - Proposed Projection Domain Metrics
4.5 Multi-Process Complexity
One of the biggest contributors to process complexity is the need to run multiple processes
simultaneously. This is especially common in the healthcare environment where nurses,
physicians, laboratory technicians, and other staff are responsible for multiple process
activities, their work instructions, and the necessary organizational interactions to perform
them. The MDPM model can be extended to include other processes and ascertain the total
"enterprise" complexity associated with running all of these simultaneous processes.
Previously in this chapter the concept of "bandwidth" was discussed in the context of a
single process, where a certain maximum number of connections for a given node (its
degree) should not be exceeded in real processes. In a hospital enterprise for example with
multiple processes the same idea applies, such as a nurse that is in the organization domain
for two processes will have a higher "effective" degree as connections must be made to
activities, work instructions, and individuals in both processes. Similarly information
domain elements, such as hospital policies, and other "enterprise" documents will likely be
shared, as shown conceptually by the overlaps in Figure 63, amongst multiple processes
and these connections will have a higher degree for those nodes. Note that it is possible,
and even likely that certain information domain elements can have a high degrees, but
these are "one step removed" elements such as references or policies rather than direct
work instructions (associated with an activity) which should closely match the activity
number and degree.
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Organization (for process A) Organization (for Process B)
Information (for process A) Information (for process B
Process A Process B
Projection A oelp Projection B
overla p recin
Enterprise (Combined Projection A+B) overlap
Figure 63 - Conceptual Model of Multiple MDPM Model Interaction
While fully exploring the entire set of processes in the hospital is beyond the scope of this
thesis, identifying which elements of a given process have significant demands from other
processes is critical to understanding the performance of a single process. So for example
one could imagine performing sensitivity analyses on key nodes of the projection domain
to understand the process performance subject to varying "bandwidth" demands of these
nodes. It is likely that for these key nodes a "fault tolerant" hierarchical and highly
connected node structure would be better to replace a single node with high demand or
potential for failure.
Additionally, this same idea of multi-process analysis could be used to better understand
how to transfer processes to other locations. For example, the clinical microbiology
organization of a rural hospital in Oregon will likely be very different than the organization
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of a research hospital in Boston, and yet it is important that the Oregon hospital receive up
to date process and methods to combat rising antibiotic resistance. It is possible to use the
MDPM model to map the process, information, and organization domains of the teaching
hospital onto the Oregon rural hospital organization to identify which individuals need to
talk to which and perhaps to re-arrange the process and information domains of the
Oregon hospital to better match their (likely fixed) organizational structure.
4.6 Process Improvement Methodologies Viewed Through
the MDPM Model
Many of the traditional process improvement methodologies can be represented using the
MDPM model. For example, the basic lean idea that processes should be simple, but can
and should continuously be improved requires first a process map of the entire value chain
in terms of activities (process domain) but also of the many stakeholders (organization
domain) and furthermore an understanding of what information flows between activities
and individuals (information domain). Process improvement necessarily requires
observation and identification of problems as a first step and organizations that do not
have good means to rapidly identify problems and make sure they are resolved quickly
have little hope of making improvements in complex processes. So, for example, a process
where the technicians performing the activity have no communication to troubleshooting
resources (perhaps a design team) and do not document their process observations would
show up in the organization domain as disconnected individuals and the adjacency matrix
would show that the technicians are not "reachable" from R&D or even perhaps senior
management such that corrective actions may be taken. Contrast this to what an MDPM
model would look like for a Toyota factory, where all of the "frontline" workers are
reachable within a few nodes of senior management and "troubleshooting" resources such
that any problems can be identified, escalated, and resolved quickly. In addition a Toyota
factory MDPM model would show the existence of monitoring metrics documents and
operational logs in the information domain and connected to the majority of the workforce
such that performance and problem resolution are visible. Likely the Toyota factory would
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have a short average distance, higher density, but a much higher average efficiency such
that problems throughout the process can be readily "reached" in few steps (in any of the 3
domains).
The model can also be compared to some of the "high-velocity organization" characteristics
of market leading companies and organizations that deal with complex processes and
products as described in a recent book by (Spear 2008), "Chasing the Rabbit" as four core
capabilities. These are described next from the perspective of the MDPM model.
Capability 1: Specifying Design to Capture Existing Knowledge and Building in Tests
to Reveal Problems
Applying best practices to processes and ensuring that their goals and the supporting
organization are well aligned requires the identification of best practices, the organization,
and the specific design documents for the process. The MDPM model can be used to
identify the necessary communication links such that best practices are actually
transmitted. For example, an organization may have a series of "experts" that have built
processes before and ensuring that in the organization domain, these "experts" are
reachable over short distances from the individuals at the front lines (those directly
connected activities) will make possible the transmission of best practices. But as Spear
points out it is not only about best practices but also about clearly specifying the work to be
performed, the manner in which the work is to be performed, and what outcomes are
expected. The information domain can be used to identify all of these "information"
elements, or to identify their absence such that processes can be better specified from the
start and all stakeholders can have visibility into these specifications to facilitate alignment.
A corollary of this capability is that the process infrastructure should enable the rapid
identification of problems as they occur which means a network with a high information
transmission efficiency. Processes with long average distances in the projection domain
will have difficulty in rapidly identifying problems as the number of steps between any two
nodes (either information, organization, or process) will make it hard to transmit accurate
(undistorted) information in a timely manner. Most importantly for the management of
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complex processes is that the individuals and work instructions directly on the front lines
(directly associated with an activity) must be "supported" by the process infrastructure to
provide short network distances to report problems and resolve them. This includes
connections across the various activities as well as to the "design" and "troubleshooting"
resources.
Capability 2 Swarming and Solving Problems to Build New Knowledge
Once a problem has been identified, the rapid deployment of resources to resolve the
problem, identify its root cause, and document (as explicit knowledge) its resolution is
essential to sustained process improvement. However, this is only possible if the additional
resources are connected over relatively short network distances to first the identification
of the problem and second the location of the problem in network space. For example, if no
specific additional resources are shown in any of the model domains it is clear that
resolution involving learning is not possible. But even if these resources are available they
must be reachable in the projection domain network and any knowledge created must
explicitly exist in the information domain as "resolution" logs or other information
elements readily accessible to other elements of the network. Timely resolution of
problems is also critical and complex processes as the "evidence" can have a very short
lifespan making lengthy or delayed investigations problematic and inconclusive. This
emphasis on rapid resolution requires high efficiency networks with relatively short path
lengths, which must of course be balanced against individual bandwidths that cannot
practically be exceeded but maybe balanced by hierarchical structures. For example, a
problem with a particular diagnostic reagent might not normally involve a physician
downstream of this problem and yet the assay quality can directly impact the physician.
"Swarming" this problem might require the involvement of a physician, a technician, a lab
manager, and perhaps a "process owner" to ensure the nature of the problem was
identified and the resolution was both understood and satisfactory to the end-user, the
physician. These types of connections can be explicitly documented and modeled in the
projection domain.
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Capability 3: Sharing New Knowledge Throughout the Organization
Once the root causes of problems and their resolution have been found it is essential that
they be communicated and shared throughout the organization. While the MDPM model
developed in this thesis focuses on a single process, the model can be used in an
"enterprise" fashion to ensure local knowledge, both tacit and explicit, is shared across
multiple processes in the enterprise as conceptually shown earlier in this chapter.
However, this is important even across a single complex process where knowledge of the
"local" resolution of a problem in an upstream activity may benefit the resolution of
problems and downstream activities. In addition, the critically important work of
transferring new and complex processes to other locations (i.e. between hospitals) requires
that a formal "mapping" of the two processes be done to ensure knowledge will actually be
transferred and shared. For example, a new diagnostic process developed in a teaching
hospital with significant resources should be explicitly mapped onto a community hospital,
which may not have the same resources, organizational structure, or distribution of skills
and where some people may do double duty or some knowledge areas may not exist. The
MDPM model can help identify these "holes", or areas that must be supplemented to
facilitate the knowledge transfer.
Capability 4: Leading by Developing Capabilities 1, 2, 3
The greater the emphasis in network efficiency, reachability, and bandwidth utilization the
better the capabilities of the organization will likely be. Continuously working to ensure
that individuals on the "front line" of the process can rapidly flag problems and swarm
them with resources from the "process infrastructure" will help ensure the process
continues to improve. Further rationalizing the process to make sure individuals are
correctly assigned (have sufficient bandwidth) and work instructions have the proper
mechanisms for updating as changes happen is also critical and can be done with a network
view of the process.
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4.7 Process Evolution
The process examples and analysis developed thus far have mainly focused on static
processes, but the time evolution of processes can also provide great insight into their
structure and properties. The dynamic nature of processes has been implied in the
previous section, which describes process improvement and change in existing processes
to produce new processes. Mapping these changes can be readily accomplished by
expanding the MDPM model matrix to include previous versions of processes and the
"genealogy" of elements from one version to another. Figure 64 shows the conceptual
evolution of a process from an initial version (V1) to a fourth (V4) and successive versions
of the MDPM representation of each version of the process. Each of the process versions is
captured in a "master" MDPM matrix, which includes all of the domain elements from each
version of the process but also mappings from one version of the process to another, which
are called "Domain Version Matrices" (DVM). These DVMs map the relationship of each
element in a MDPM version to another. As processes evolve the dimension of the MDPM
matrix will likely change as elements are added or subtracted in each of the domains and a
master MDPM including all previous versions of a process would have dimensions equal to
the sum of dimensions of each MDPM version contained within it. Also note that the DVM
matrices are shown on both sides of the diagonal indicating version mapping relationships
can exist in both "forward" and "reverse" directions. A "reverse" mapping might be used to
show "reuse" of elements from previous versions or to show references to information
elements in previous versions that current work instructions may impact if the previous
version is still in use.
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VI V2 V3 V4
V11
Figure 64 - Evolution of Process Versions in Time and Representation as Domain Version
Matrices
The evolution of processes can also be tracked with all of the metrics developed thus far to
provide a rate of change for processes along key dimensions. This might be particularly
helpful to understanding the dynamics of process lifecycles from original creation through
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development and into maturity as described in (Utterback 1996). For example, mapping
some of the key metrics developed thus far onto process lifecycles like the Pilkington float
glass evolution described in Chapter 2 and others such as the evolution of petrochemical
refining might provide insight as to the impact of process complexity and structure on
process innovation and adoption. Extensive literature exists as to the pattern of adoption
for innovation, with a classification of adopters into early, middle, and late as notably
described in (Rogers 1995). However, for processes the rates of adoption may also be
strongly associated with the degree of complexity of a process as measured by the set of
metric proposed in this thesis. Because complex processes require such significant
resources spread over multiple groups, disciplines, locations, and resource levels, adoption
may be less a function of the "desire" to adopt than a "feasibility" to adopt. Individual
groups in a complex process may want to be early adopters, but without the coordination
with all of the other process stakeholders and elements, complex process adoption may not
be feasible. This is especially true in early stages of process development and adoption due
to the need for lots of "scaffolding" in the MDPM network as additional design,
optimization, and other knowledge resources are needed to support changes and
troubleshooting. As a process matures the need for this "scaffolding" is lessened and the
process network becomes simpler facilitating adoption for organizations without the
additional resources to support the substantially higher complexity of the initial process.
This might provide some explanation for the resistance to change of other complex
processes in healthcare as the "activation energy" needed to build the additional
scaffolding to manage changes is often beyond the resources of most organizations unless
it is specifically provided for. As will be seen in Chapter 5, this initial complexity can be
very high and the necessary combination of resources, activities, and motivation to build a
new process can be hard to build and manage.
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5 Case Study Model: DNA Sequencing Based MRSA Surveillance
In order to apply and test the MDPM model under real-life conditions a test case was
sought that would have real-world impact. It would be difficult to evaluate the usefulness of
a methodology such as the MDPM method without a real world case. As described in
Chapter 2, MRSA infections are a serious threat to the health care system and yet molecular
level surveillance has seen limited implementation despite the availability of many of the
necessary technologies. While certain gene focused MRSA surveillance technologies such as
PCR are starting to become more widespread their adoption has been relatively slow and
more importantly do not provide a full picture of the genetic diversity in MRSA as they can
only confirm the existence or absence of selected antibiotic resistance genes. Whole
genome sequencing technologies can provide a full picture of the genetic diversity
necessary for surveillance but many of these technologies are still in the early stages of
their development requiring complex processes and infrastructure to support them. Yet,
these technologies are also evolving very rapidly and while they may be complex, they are
rapidly becoming cost feasible and even cost competitive with existing clinical
microbiology surveillance processes. And with the rapid rise in MRSA infections and the
enormous healthcare cost associated with them, the need for whole genome DNA
sequencing surveillance processes is becoming critically necessary. The objective of this
thesis was thus to design, develop, and implement a prototype whole genome DNA
sequencing-based MRSA surveillance process for The Brigham and Women's Hospital, a
large 746 bed research hospital in Boston.
However, this complex process spans numerous organizations, knowledge domains,
activities, and information beyond the hospital most notably, the Broad Institute a leading
genomics research center, but also various MIT departments, numerous technology
vendors, and other organizations associated with MRSA, genomics, microbiology, and
healthcare. Beyond being just a data gathering and modeling exercise, this process was
actually built and implemented providing significant value to clinical microbiology
research and our understanding of MRSA. However, in also being a real process, it has
provided enormous insight into the MDPM model and the primary engineering systems
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research objective, which was to develop an analytic methodology for complex process
design and analysis. This chapter details the design, development, design iteration,
implementation troubleshooting, and initial pilot production of the MRSA DNA sequencing
surveillance process from the perspective of the MDPM model and also develops the
associated methodology to use the model.
5.1 Design Methodology
The MDPM model developed in Chapter 3 requires an associated methodology to be useful
in analyzing complex processes. Borrowing from the CLIOS system analysis process
described in (Dodder, Sussman et al. 2004) and Engineering Systems Analysis for
Transformation (ESAT) described in (Nightingale 2009), a methodology is developed for
process analysis using the MDPM model, called the MDPM methodology. This methodology
follows some of the initial CLIOS methodology steps described in Chapter 2 to define the
process, identify stakeholders, enumerate the process elements, and identify connections
between elements. While CLIOS is mainly focused on systems, the key CLIOS step of
"Identifying links among components and organizations" is also a key element of the MDPM
process analysis methodology and the basis for the MDPM model. However, the MDPM
methodology differs in that it includes steps to identify feasible processes and reduce the
size of the design space to manage the complexity of the MDPM model to be analyzed. The
analysis of the MDPM model itself also differs from the CLIOS methodology in using MDM
and other network analysis tools. However, significant opportunity exists for integration of
the MDPM methodology developed here specifically for processes with the broader
systems analysis perspective of CLIOS. Similarly, the ESM model offers significant potential
to capture many of the elements described by CLIOS as additional elements in the matrix
although work would still be needed to capture some of the nuances of CLIOS such as
different classes of links. These ideas will be further discussed in Chapter 7 indicating
future research directions. The MDPM methodology is described in table Table 11 with
notes describing the rationale of each step.
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1.) Description ot
process, stakeholders,
and goals
The first step in designing and analyzing a process is to
describe its purpose, stakeholders, and general
characteristics. Similar to CLIOS System Issue and Goal
Identification and ESAT System Description and
Stakeholder Identification.
2.) Identify macro Objective is to identify the macro level activities for the
process activities and process described in step 1. Part of specifying the design
define boundaries space is also to define the system boundaries (or what will
not be modeled). Similar to CLIOS Identification of Major
Subsystems.
3.) Identify potential The objective of this step is to identify all potential process
process alternatives and design alternatives that could satisfy the goals but at
design space "macro" level without detailing all of the elements in each.
This step requires searching through available processes
and technologies to identify existing processes that might
be adapted, creating new ones from existing elements, or if
none are available putting "placeholders" for missing
elements corresponding to activities in step 2.
4.) Identification of This step captures stakeholder preferences, physical
design specifications and constraints, and overall process specifications as set of
constraints variables in a vector, which can be used to numerically
describe the properties of each macro process element.
5.) Selection of macro The network composed of the macro processes identified in
level feasible processes Step 2 can then be analyzed using the property vectors,
against design which define a "cost" to traverse the network. The
specification minimum cost flow problem is solved for the network to
requirements find the most feasible process combination according to the
overall system specifications and constraints.
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6.) Enumeration of Once a feasible process has been identified, this step
process elements onto expands each macro activity into its detailed elements and
detailed process map for connections such that an MDPM model can be constructed.
selected process Similar to CLIOS step: Develop the CLIOS Diagram: Nesting,
Layering, and Expanding
7.) MDPM creation from The MDPM model domains can then be populated from the
detailed process map detailed process map and the enumeration of elements
corresponding to the rows and columns of the MDPM. Links
between elements are also populated at this step as entries
into the MDPM matrix.
8.) Analysis of MDPM The MDPM model can then be analyzed using the metrics
model sets developed in chapter 4 and graph based tools.
Table 11 - Description of the MDPM Methodology Steps
One of the primary goals of the case study demonstration was to build upon existing
infrastructure such that the surveillance process could be readily integrated into routine
clinical microbiology practice and could also be up and running in a much shorter time than
a "from scratch" process. However, this required the identification of the existing
infrastructure as well as the design alternatives (or design space) where no current
infrastructure existed. This modular incremental approach has numerous advantages
including the potential for greater ease of integration with existing processes, a greater
focus on necessary innovation (rather than re-creating existing elements), potentially
lower development costs (as only "new" elements are targeted), and potentially shorter
cycle times. However, the reuse of existing elements also limits opportunities for global
optimization, since the majority of elements in a process will be largely unchanged and can
therefore lead to lower performance than a fully optimized system. In addition, reuse of
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existing elements does not necessarily mean that they will all function adequately when
used in a new process and they must all be reviewed for suitability.
The system designer must therefore first identify the available process elements, and then
review them for feasibility within an initial version of the process. Subsequent optimization
is of course possible, but the primary goal of this design effort was to provide an initial
working prototype of a MRSA surveillance system, which could begin to provide useful
information and also serve as a starting point for additional optimization. A secondary but
very significant benefit of this methodology is that it can filter significant complexity out of
the initial process prototype. As will be seen later in the MDPM model development
processes can have enormous inherent complexity without also introducing the additional
complexity of process design alternatives. Thus, the methodology allows for the selection
of a best feasible process according to a set of stakeholder preferences. The most feasible
process is demonstrated and modeled with an MDPM, but the design space is much larger
as there are multiple competing technologies for many of the intermediate MRSA
surveillance process steps, each representing a highly complex process.
Selecting the "best feasible" processes from the available process elements greatly reduces
the complexity that needs to be considered in the modeling of a process, but it is important
to note that this complexity still exists in reality, as improvements in the alternatives may
change the selection of which is "best" and designers must be aware of information or
connected to individuals that can appraise these changes. Thus, in the prototype MDPM
model of the surveillance system, the design alternatives discarded are still explicitly
modeled, not as process steps, but as information elements that process owners must be
aware of. The full complexity of design alternatives could be modeled in subsequent MDPM
models if so desired, but in practice it is likely that system designers will prefer to first
narrow the design space to a few (or a single) design alternative and then use the MDPM
model to manage the complexity associated with even a single design alternative.
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However, in reducing the design space this methodology also captures the stakeholder
preferences such that they can be used in later evaluations for changes or new
technologies.
The design methodology is summarized in Table 12 with individual steps divided into two
major categories (feasibility + enumeration and network analysis). The "Process
Feasibility and Element Enumeration" category contains all the methodology steps needed
to identify the process goals, stakeholders, design space, to select a feasible process from
the design space, and to enumerate all of the elements in the selected feasible process. The
"Network Analysis" category contains the methodology steps needed to create the MDPM
model from the process elements and analyze it.
Process
Feasibility and
Element
Enumeration
4
Network Analysis
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
3.) Identify potential process alternatives and design space
4.) Identification of design specifications and constraints
5.) Selection of macro level feasible processes against design
specification requirements
6.) Enumeration of process elements onto detailed process map for
selected process
7.) MDPM creation from detailed process map
8.) Analysis of MDPM model
Table 12 - MDPM Methodology Categories
Each of these steps is further described for the MRSA surveillance process. It is important
to note that this process design methodology necessarily requires (and implies) significant
stakeholder input in the form of requirements, description of goals, and understanding of
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the many interactions between layers. Throughout the following section, the table
describing the steps in the methodology will be shown with the particular step highlighted.
5.1.1 Description of process, stakeholders, and goals
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
Process Feasibility 3.) Identify potential process alternatives and design space
and Element 4.) Identification of design specifications and constraints
Enumeration 5.) Selection of macro level feasible processes against design specification
requirements
6.) Enumeration of process elements onto detailed process map for
selected process
Network Analysis 7.) MDPM creation from detailed process map8.) Analysis of MDPM model
The fundamental goal of the MRSA surveillance process is to provide a cost feasible method
to read the complete genome of MRSA microbes associated with hospital infections such
that the genotypic characteristics can be tracked, new strains can be identified, and the
continued adaptation of Staphylococcus aureus to antibiotics can be monitored. Implicit in
this goal is that the process must be scalable to high throughput in order to match the large
number of cases that may exist in a large hospital. The overall cycle time the process must
also be relatively short (within weeks) in order to provide timely information to
epidemiology efforts. The process must also provide highly reliable tracking and
prevention of misidentification to ensure clinical histories (phenotypes) can be associated
with the resulting whole genome genotypes. The resulting data must be consistent with
existing MRSA diagnostic processes (cultures), be easily interpreted by medical staff
(physicians), and have a high sensitivity and specificity. Where possible, the surveillance
process should integrate with existing clinical microbiology workflows such that the
process can be more easily adopted in multiple locations.
The MRSA surveillance process stakeholders were categorized into "internal" ones directly
associated with the process and inside the MDPM model boundaries and "external" who
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can still impact the process but who are either indirectly associated with the process or
outside the model boundaries. The internal vs. external stakeholder classification follows
that of (Bartolomei 2007). The full list and description of external stakeholders is given in
Table 14 and internal stakeholders in Table 14 along with a description of their role in the
MRSA process. Note that the stakeholders are listed as organizations or groups in most
cases rather than individuals as at this initial step of the methodology the goal is to identify
the "macro" stakeholders with a detailed enumeration to the individual level once a
feasible process has been identified. The surveillance process was developed at the
Brigham and Women's Hospital, the Broad Institute, MIT, and with the support of a variety
of technology vendors and research groups. The internal stakeholders described in Table
14 are represented by these organizations in this thesis, and the specific process
preferences, constraints, and goals described in the remainder of the methodology are
based on this specific subset of all the stakeholders. A national surveillance system would
require a thorough analysis of the goals, constraints, and specifications of the entire set of
stakeholders including the external ones, but given the prototype nature of the surveillance
process described in this thesis, the specific stakeholders are taken as representative of the
larger set of internal stakeholders.
Examples of internal stakeholders in the MRSA surveillance process are patients, hospital
epidemiologists, physicians, clinical microbiologists, DNA sequencing staff, and key hospital
administration such that data from the surveillance can be used to control potential
outbreaks. Examples of external stakeholders are insurers (who would potentially benefit
from this process through lower infection claim rates), drug manufacturers (who could use
the data to design improved antibiotics), diagnostics manufacturers (who could design
better diagnostics based on new strains), and government agencies such as CDC.
Centers for Disease Control (CDC) CDC has responsibility for national infectious
disease surveillance systems including potential
MRSA ones
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National Institutes of Health (NIH) NIH oversees research efforts of various institutes
investigating MRSA
American Medical Association (AMA) Sets procedure codes for physicians and general
guidelines including infectious disease
Infectious Diseases Society of America Represents physicians, scientists, and other
(IDSA) healthcare professionals specializing in infectious
diseases. Sets general guidelines
American Society for Microbiology Provides training, guidelines, and information for
(ASM) microbiology labs including MRSA diagnostic
techniques
Health and Human Services (HHS) Oversees key government agencies such as FDA,
CDC, NIH, and CMS (medicare) impacted by MRSA
related
State Health Agencies Responsibility for state infectious disease
surveillance systems and control
Genomic Data Analysis Vendors Provide software tools to annotate MRSA genomes
following sequencing
DNA Extraction Vendors Provide reagents and equipment to extract DNA
from MRSA cells
LIMS Vendors Provide software to control sample tracking
throughout lab processes
Data Storage Vendors Provide storage to handle the data produced by
sequencing processes
Liquid Handling Automation Vendors Provide robots to automate molecular biology and
other process steps
Bacterial Diagnostic Vendors Provide MRSA diagnostics based on PCR and other
technologies
Clinical Microbiology Vendors Provide reagents and equipment for standard
clinical microbiology processes
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Insurers Reimburse approved procedures including MRSA
treatment but only select MRSA diagnostics
Hospital Administration Set policies for hospital processes including MRSA
treatment and surveillance but also responsible for
overall budgeting
Hospital Pharmacy Staff Responsible for ensuring appropriate antibiotic use
and control
Hospital Services Responsible for hospital infrastructure including
sample transport, sterilization, and computer
support
Antibiotic Researchers Discover new antibiotics and virulence inhibitors to
counteract MRSA
Antibiotic Vendors Responsible for developing and commercializing
new antibiotics to counteract MRSA
Table 13 - MRSA Surveillance Process External Stakeholders
Patients Ultimate beneficiaries of improved knowledge
gained from MRSA surveillance
Primary Care Physicians First to encounter many MRSA infections and
prescribe antibiotics or order diagnostics
Nursing Staff Primary patient care responders including obtaining
samples for MRSA diagnostics
Specialty Physicians Also encounter MRSA infections as part of other
specialty care and prescribe antibiotics or order
diagnostics
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Specialty Nursing Staff Primary patient care responders also for specialty
care including obtaining samples for MRSA
diagnostics
Hospital Support Staff Provide essential services such as transport of
samples, replenishment of supplies, disinfecting of
hospital equipment, etc.
Clinical Microbiology Lab Staff Provide clinical microbiology sample processing for
available MRSA diagnostics
Clinical Microbiology Researchers Develop new methods to provide MRSA diagnostics
and surveillance
DNA Sequencing Lab Staff Provide DNA sequencing sample processing using
available technology
DNA Sequencing Researchers Develop new DNA sequencing processes and
technology
Bio-Informatics Analysis Staff Provide analysis of DNA sequence obtained for
various MRSA samples using various technologies
Bio-Informatics Researchers Develop new analysis methods for DNA sequence
obtained using various technologies
DNA Sequencing Technology Provide processes to sequence DNA including MRSA
Sequencing Technology Vendors genomes
Alignment Algorithm Research Groups Develop algorithms to align MRSA genomes to
references in order to find mutations
Assembly Algorithm Research Groups Develop algorithms to assemble MRSA genomes de
novo without a reference
Genomic Data Analysis Research Develop algorithms to annotate MRSA genomes
Groups following sequencing
Bacterial Genomics Researchers Discover mechanisms of resistance, virulence, and
evolution in MRSA genomes
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Infectious Disease Researchers and
Epidemiologists
Process Sponsors (Owners)
Discover mechanisms of infection for MRSA
microbes
Manage overall process development and
implementation for DNA sequence based MRSA
surveillance
Table 14 - MRSA Surveillance Process Internal Stakeholders
5.1.2 Identify macro process activities and define
boundaries
i.
Process Feasibility
and Element
Enumeration
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define
boundaries
3.) Identify potential process alternatives and design space
4.) Identification of design specifications and constraints
5.) Selection of macro level feasible processes against design specification
requirements
6.) Enumeration of process elements onto detailed process map for
selected process
7.) MDPM creation from detailed process map
Network Analysis 8.) Analysis of MDPM model
From the process description, stakeholders, and goals a macro level design space can be
built identifying the "macro" activity categories the process must go through in order to
deliver the genotype information from patient samples. The potential alternative processes
can be mapped onto the general activity categories. The full enumeration of these design
alternatives produces the "design space". This conceptual process map also serves a very
important function as it defines the process boundaries that will be modeled to match
external and internal stakeholder boundaries identified in the previous step. There are a
number of activities in the MRSA surveillance process demonstrated in this thesis that are
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not explicitly modeled such as how the infections occurred, how the patients were
admitted to the hospital, what their particular insurance and payment situation may be,
and the particular procedures the patients might be undergoing. These activities also
correspond to external stakeholders not considered in the MDPM model. The MDPM model
could be used to model all of these other processes and the interactions between them as
part of a larger "enterprise" model, but the goal of this thesis is to demonstrate the MDPM
analysis on a single process and this initial boundary setting and selection is essential in
reducing the modeling complexity. For the MRSA surveillance process the general activities
(without macro design alternatives) are as shown in Figure 65, along with representative
activities not modeled in the MDPM (and corresponding to external stakeholders).
Insuanc Patient Bed Pain M Antibiote PtincAdioi
Veiaion Patient Nh~ i a 1~M ton L.
Patient Pain Patient Histonry Physician. Edm Iog Patn
Admission P a Recordin Exaination Ai s oniitoin
Process Boundaryf sampIC IMRSA IltonDNA Extraction DNA Molecular Sequendl~
collection Pre t io Barcodi Pryera ion. ... J..
Figure 65 - Surveillance Process Boundary
The macro activities in the process are described in Table 15. With the process boundary
defined and the general macro process steps identified, it is possible to construct the macro
design space, which is the identification of design alternatives for each of the activities
inside the process boundary identified in Figure 65.
Sample Collection Collect sample from patient, label, and transport to lab
MRSA Isolation Process sample to obtain single MRSA isolate and grow culture
DNA Extraction Lyse culture cells, extract DNA, and purify DNA
DNA Preparation Prepare extracted DNA for sequencing according to technology
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Add molecular barcode to each DNA sample
Sequencing Preparation Process barcoded sample into sequencing ready DNA
Sequencing Read DNA sequence according to technology
Data Analysis Analyze DNA sequence
Table 15 - Steps in Macro Surveillance Process
5.1.3 Identify potential process alternatives and design
space
Process Feasibility
and Element
Enumeration
4
Network Analysis
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
3.) Identify potential process alternatives and design
space
4.) Identification of design specifications and constraints
5.) Selection of macro level feasible processes against design specification
requirements
6.) Enumeration of process elements onto detailed process map for
selected process
7.) MDPM creation from detailed process map
8.) Analysis of MDPM model
As described in the methodology description, the objective of this step is to identify all
potential process design alternatives that could satisfy the goals but at a "macro" level
without enumerating all of the detailed elements in each. This step requires searching
through available processes and technologies to identify existing processes that might be
adapted, creating new ones from existing elements, or if none are available, putting
"placeholders" for missing elements corresponding to activities in step 2. The macro
process steps and design alternatives for each are detailed in the following sections with a
process diagram indicating which step is being described.
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Molecular Barcoding
Sample collection
The first activity in the process to be modeled is sample collection from a patient infection.
Again, the particular infection process or treatment process the patient might be
undergoing is not modeled and the process starts with a physician request for surveillance.
The surveillance process would likely happen in parallel to standard diagnostic requests,
but physicians might request surveillance in especially difficult cases, as part of standard
hospital procedures, or in response to outbreaks. From this request a nurse (or physician)
would then collect a sample and send it to the clinical microbiology laboratory. Many of
these procedures and processes are already in place for culture based diagnosis and likely
require little change as they can already produce MRSA isolates in routine culture based
diagnosis. However, a large variety of them exists corresponding to each potential
infection location.
Available Processes: Current practice
Design Alternatives: None required
MRSA Isolation
From the sample the clinical microbiology laboratory would then prepare the sample,
process it, and isolate a MRSA microbe. As with the clinical sample collection, the majority
of clinical microbiology processes used for culture based diagnosis sample isolation remain
nearly identical and current practice may be used. Some change may be required to satisfy
the other "ilities" such as adaptability when sequencing other organisms, but this is not
part of the "baseline" process. And in the case of needing to sequence other similar
organisms, clinical microbiology procedures exist for their isolation, which can be used "off
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the shelf'. Nevertheless, the variety of sample preparation procedures matches the variety
in the upstream sample collection locations (infection sites).
Available Processes: Current practice
Design Alternatives: None required
DNA extraction
MRSA DNA Mweculau 5qudg SeqUenC* Data AmIwl"
The process begins to deviate from standard procedures at this point since for the majority
of clinical microbiology procedures large amounts of DNA are not required. Processes exist,
such as PCR diagnostics, that do require DNA extraction but this is usually in much smaller
amounts and of lower quality. There exist a number of commercial kits for the extraction of
DNA from tissues but these are not specifically designed for large quantities of high
molecular weight DNA from MRSA microbes, which are notoriously tough with thick cell
walls making them difficult to lyse. Development will likely be needed for this activity as
there are some process elements to draw from but nothing that is directly "off the shelf' as
in previous activities. In particular, methods to properly lyse the cells without damaging
the DNA and then subsequently removing the DNA from the cellular debris will likely be
required for a range of MRSA strains. Note that this activity is the first "placeholder"
activity in that it is not part of an existing "off the shelf' process, but the "desired" activity is
put into the process design space to determine if it is needed or the "standard" process will
suffice.
Available Processes: Existing heat, enzymatic, and alkaline lysis methods
Design Alternatives: Optimization of current methods for MRSA application (Placeholder)
DNA preparation
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This process activity category is a significant branch point in the process as the growing
number of different sequencing technologies branch off from here, each requiring a specific
DNA preparation process for use in their technology. The only "off the shelf' technology
available is ABI Sanger sequencing originally developed for use in the human genome
project, but likely prohibitively expensive for a whole genome surveillance application.
Available emerging technologies include Roche 454, ABI SOLiD, Illumina, Helicos, and
Polonator. A number of others are on the horizon further complicating the design challenge
as these will each bring particular advantages, but only commercially available
technologies are considered here. Each one of these requires a different DNA preparation
process and the downstream process steps are thus "locked in" to that particular
technology depending on the particular choice at this step. Selection of a single technology
will be necessary for the initial prototype demonstration as the additional complexity
introduced by running multiples of these highly complex sequencing processes is very
significant and the relative performance of each is continuously changing. Starting with a
single technology choice allows for optimization from that point rather than continuous
change without a baseline.
Available Processes: ABI Sanger
Design Alternatives: Roche 454, Illumina, ABI SOLiD, Helicos, Polonator
Modular Barcoding
One of the advantages of next-generation sequencing technologies is their enormous
throughput, measured in the giga bases per run scale. These large batch sizes are also
critical for the greater efficiency of these new sequencing technologies. Yet, MRSA
microbial genomes are only 2.8 mega bases in size and therefore require some mechanism
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to multiplex many microbial genomes into a single sequencing run. This mismatch in batch
size can be addressed by "barcoding" the microbial genomes at the molecular level such
that they can be pooled together into a large-scale run but later the data can be
disambiguated based on the barcodes. This is brand-new technology that must be
developed and likely significant development will be needed. Note also that due to its
lower throughput, no molecular barcoding method is required for the ABI Sanger process,
but a method specific to each one is required for the other next generation processes. This
is another example of a "placeholder" that must be placed in the design space to represent a
not yet invented, available, or tested activity that is nevertheless necessary to build a
process. The "target" specifications can then be put in place to determine if the overall
process is feasible with this placeholder, and if it is, the feasibility of the individual
placeholder can then be assessed.
Available Processes: ABI Sanger
Design Alternatives: Roche 454, Illumina, ABI SOLiD, Helicos, Polonator (Placeholder)
Sequencing preparation
Once the barcodes have been added to each sample and these have been pooled, these
"libraries" of MRSA microbial DNA can be put through the necessary molecular preparation
such that they can be read on detection instruments. This is again specific to each
technology and follows depending on the branch path chosen at the DNA preparation step.
These processes are relatively straightforward in terms of their workflow structure but are
continuously being optimized and improved as the competition between sequencing
technologies intensifies. However, the current version of these processes is used for the
process mapping exercise, and potential opportunities for complexity reduction are
explored later in this chapter and in chapter 7.
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Available Processes: ABI Sanger
Design Alternatives: Roche 454, Illumina, ABI SOLiD, Helicos, Polonator
Sequencing
Once the DNA has been prepared for the particular sequencing technology, it must be
"read" on the particular technology's detection instrument. While this is again relatively
straightforward from a process mapping point of view, each of the steps is continuously
being improved and optimized requiring significant "scaffolding" on the part of the
organization. This step is also where the boundary from DNA molecules to biological data is
crossed, as a number of algorithms process the raw signals coming from the detection
instruments and process these into DNA sequences stored in computer files. And as before,
the particular choice made at the DNA preparation step commits the process a particular
branch up to and including the data type produced.
Available Processes: ABI Sanger
Design Alternatives: Roche 454, Illumina, ABI SOLiD, Helicos, Polonator
Data analysis
In this final step, the differing data types produced by each technology can be merged as
they should all represent the fundamental biological information. However, complete
equivalence is not practically feasible and each of the data types has different properties
including error modes and quality. Algorithms must be designed to interpret these, identify
false positives and false negatives, and properly report potentially important biological
changes in the MRSA genomes. The data must of course also be associated with the original
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surveillance request such that the clinical observations can be correlated to the genotypic
data. This is also an area where the state-of-the-art is rapidly changing and brand-new
technology will be required, and the activity is represented as a "placeholder".
Available Processes: None
Design Alternatives: New Method Development (Placeholder)
Design Space
The macro level design space can be constructed from these elements showing the number
of design alternatives. While this full design space (i.e. every detailed activity associated
with the macro activities described) could be mapped in an MDPM model skipping this
step, the goal of first producing a macro design space is to list potential design alternatives
without exhaustively enumerating every activity. This is especially important due to the
complexity of the processes and that some of the process alternatives may not be feasible
when subject to stakeholder constraints. Thus, an initial "filtering" in the design process
such that only the process most suited to the particular application is fully developed in the
MDPM model can greatly reduce this design complexity and ensure resources are focused
on the necessary optimizations and connecting technologies to make it work rather than
working on multiple designs at once. As will be seen later even a single configuration
(choice of process path) through the design space can represent enormous complexity. The
synthesis view of the macro process design space is shown in Figure 66 in comparison the
macro process, which can be thought of as the "generic" process one is seeking design
alternatives for. The corresponding activities for each design alternative are also shown in
Figure 66. Note also that the "placeholder" activities are marked in yellow showing
activities that will have to be developed to "connect" the existing activities of the process.
These activities will require specific attention in the initial phases of the process
development to assess their technical feasibility. And this methodology allows for their
early identification and verification that all other existing elements in the path are feasible.
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Figure 66 - Design Space of Surveillance Process Alternatives
5.1.4 Identification of design specifications and
constraints
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1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
3.) Identify potential process alternatives and design space
Process Feasibility 4.) Identification of design specifications and
and Element constraints
Enumeration 5.) Selection of macro level feasible processes against design specification
requirements
6.) Enumeration of process elements onto detailed process map for
selected process
7.) MDPM creation from detailed process mapNetwork Analysis 8.) Analysis of MDPM model
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The MRSA surveillance process has a set of specifications and constraints that must be
satisfied in order for it to be feasible. These are based on internal stakeholder interviews,
initial design considerations, and comparison to existing surveillance systems. As
described in section 5.1.1, the stakeholders for the prototype process developed in this
thesis are a subset of all possible internal stakeholders but they are likely representative
and the specification variables come from these. Among the specifications are throughput,
genotypic information coverage, infrastructure requirements, cycle time, data quality, and
most importantly cost per sample. Many of the process "ilities" are described here as the
surveillance process must satisfy a number of factors such as scalability to higher
throughputs, transferability to other locations (i.e. a San Francisco hospital), flexibility to
accept samples from various sources, adaptability to produce genotype information for
other microbes, and modularity such that change in one area does not require a global re-
optimization of the process. These global specifications can be applied to each of the
process categories described in the conceptual process map in order to filter (select)
suitable existing processes or identify the need for new ones to satisfy the specifications
and constraints. The set of specifications and constraints is described in the following
section. The specifications and constraints are developed for a feasibility selection model
which identifies the "cost" of each path in the design space network developed above and
consist of a properties vector that calculates the sum of the product of the individual
specifications (for that activity) times a weighting of the relative value of that activity. Thus
in the feasibility selection model, the throughput constraints identify the maximum feasible
throughput through each edge connecting two activities and the properties vector
calculates the "cost" of traversing that edge according to the properties vector. Thus, the
feasibility determination and selection of the path can be established as a minimum cost
network flow model as will be described in the next section. Each of the specification
variables and constraints on these variables is briefly described in Table 16 and fully
detailed in the next sections. Note that these specifications apply to each activity in the
macro process.
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Number of MRSA samples that can be processed per week
Cost Cost per sample processed
Cycle Time Time for activity to complete
Infrastructure Infrastructure requirements for activity
Data Quality Error rate contribution from activity
Data Completeness Fraction of total genome that is covered by the activity
Scalability Ability to rapidly increase throughput if needed
Transferability Ease with which activity can be transferred
Flexibility Ability of activity to respond to varying demand
Adaptability Ability of activity to work with other microbes
Modularity Degree to which activity is independent of other activities
Table 16 - Specification Variables for MDPM Model of MRSA Surveillance
Throughput
Constraint: >200 samples per week
Range: 0 to Hospital Patients per week
A fundamental requirement for the MRSA surveillance process is that large numbers of
microbes must be sampled. Typically, a large academic hospital will have between 500-
1,000 beds (source: AHA) but will perform several times that number in outpatient
procedures (>4,000) and several times that number again in patient consultations every
week (>12,000). Assuming a surveillance rate of 10% of all cases and on the order of
20,000 potential surveillance cases yields greater than 2,000 potential samples processed
through the surveillance system every week. Individual hospitals may choose to lower the
surveillance rate or may simply be smaller than a large academic hospital, but even so the
minimum weekly throughput for a hospital MRSA surveillance system is on the order of
200 samples per week corresponding to a community hospital with -200 beds and -2,000
potential surveillance events.
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Throughput
Cost
Constraint: <$100 per sample
Range: 0 to 10 (normalized to highest cost activity at 10)
A key performance specification for the surveillance system is the cost per sample, which
must compete with the cost of culture-based diagnostics that are on the order of $10-20
per sample. While DNA sequencing costs have decreased dramatically, these costs require
relatively large "batch" sizes 2 to 3 orders of magnitude larger than the size of an individual
microbial genome. This performance specification is especially important to the wider
adoption of surveillance since even at a relatively modest throughput of 200 samples per
week still represents a cost of over $1 million per year at $100 per sample.
Cycle Time
Constraint: <2 weeks
Range: 0 to 10 (normalized to highest cycle time activity at 10)
Although the focus of the surveillance process is not to replace more immediate diagnostic
tests, the cycle time must still be relatively short for any epidemiological efforts to be
timely. A total cycle time of less than two weeks from sample collection to analysis results
is set as the minimum specification. Shorter cycle times are better and that the limit very
short cycle times (within a day) could potentially replace current culture based and even
PCR-based diagnostics.
Infrastructure
Constraint: None, specified in properties vector
Range: 0 to 10 (0=no infrastructure needed, 10=maximum)
The ease with which the surveillance process can be integrated and adopted into existing
hospital infrastructures depends to a large extent on its requirements. Based on the initial
process map, the fewer changes upstream in the "high transaction" environment of patient
interaction the less infrastructure requirements. If physicians and nurses do not have to
significantly change their workflows in order to provide surveillance samples, the easier it
will be to integrate the process. Similarly if the majority of the existing clinical
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microbiology workflows can be "reused" the easier it will be to integrate the process. There
is unavoidable additional infrastructure in the new technologies of DNA sequencing and
analysis but if this can be contained to just those categories in the conceptual process map
such that fewer links need to be made between activities in the process the easier it will be
to adopt the process and preserve significant modularity and flexibility.
Data Quality
Constraint: None, specified in properties vector
Range: 0 to 10 (O=highest data quality, 10=minimum data quality)
Ensuring there are a minimum of false positives and false negatives in the genotype data is
critical to establishing a robust and reliable surveillance process. In a 2.8Mb genome even a
1% error rate would lead to an unacceptably large 28,000 errors in the sequence data.
More importantly, the error rate of the process must be significantly less than the mutation
rate of the microbes such that true mutations can be identified which for E. Coli has been
estimated at between 2 X 104 and 2 X 10-9 per replication per cell per position in the
genome (Denamur and Matic 2006). In a single bacterial infection there may be millions of
microbial cells at a 30min division rate in less than 12 hours, and for a genome size of
2.8Mb that means that every base in the genome of the infection colony will have had a
"chance" for mutation in a 30 hour period which means that many of the bases investigated
could be real mutations and the system error rate must be low enough to detect them.
However, it appears that not all parts of the genome are equally susceptible to mutation,
with some parts highly conserved and others subject to "hyper mutation" as described in
(Blazquez and Eliopoulos 2003). The surveillance process is set initially to a specification of
total "system" error rate less than .01% which is less than the estimated upper bound on
mutation rate as estimated by (Denamur and Matic 2006). Note that this does not
necessarily mean that each piece of data produced has that error rate, but that once the
data has been filtered and processed the net data produced has that level of confidence that
a particular base is correct. One way to do this is to "over cover" bases with relatively lower
quality (i.e. ~1% error rate) bases but which have randomly distributed errors such that
the probability of the same mistake being made multiple times is very low and the "true"
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signal from the mutation can be properly interpreted. This can of course affect the cost
since more data might be needed if the sequencing technology has a higher intrinsic error
rate. This "consensus" alignment is the basis for much of the analysis performed in chapter
6.
Data Completeness
Constraint: None, specified in properties vector
Range: 0 to 10 (0=complete data, 10=no data)
Unlike other diagnostic and surveillance processes to date the goal of this process is to
provide data for the entire genome of a microbe rather than a small portion as in PCR,
MLST, or restriction mapping. Visibility into the entire genome is important to identify
novel mutations or gene transfer from other organisms, which methods that target known
genes cannot find (such as PCR). The surveillance method should thus cover 100% of the
genome and any plasmids contained within the microbe.
Scalability
Constraint: None, specified in properties vector
Range: 0 to 10 (0=completely scalable, 10=not scalable)
The process must be scalable such that if a hospital might need to increase its surveillance
rate beyond 10% or need to provide services to associated facilities or other hospitals this
can be readily accomplished. Ideally economies of scale might be achieved such that
increasing scale actually lead to decreased costs, but most importantly the process could be
scaled to sample 100% of the potential cases should the need arise. This might happen for
example if a particularly dangerous new strain of MRSA emerged and the hospital might
need to rapidly implement quarantine procedures or identify the source of the new strain.
Transferability
Constraint: None, specified in properties vector
Range: 0 to 10 (O=completely transferable, 10=not transferable)
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The surveillance process must eventually be transferred to other locations and this will
require that the majority of work instructions be in "explicit form" since tacit information
transfer (i.e. mentoring) cannot be easily performed to more than one location. This also
requires that the majority of process activities be relatively stable such that users without
significant "scaffolding" infrastructure can operate the process without continuous
changes. In order to provide a quantitative measure the process must have all activities
documented (protocols exist) and must have operated in stable configuration for more
than six months.
Flexibility
Constraint: None, specified in properties vector
Range: 0 to 10 (O=completely flexible, 10=not flexible)
The process must also have significant flexibility in order to accept samples from multiple
sources (different departments of the hospital or different infection surveillance requests).
In addition process must be flexible enough to operate under varying demand from each of
the surveillance requests without losing efficiency. This can be quantified by saying that the
process can accept greater than 50% of samples from any single source in a given week (i.e.
50% blood samples). Conversely the process should be able to accept less than 5% of its
samples from a given source.
Adaptability
Constraint: None, specified in properties vector
Range: 0 to 10 (0=completely adaptable, 10=not adaptable)
The process should also be adaptable to produce information from other microbes as a
common mechanism for new strains is horizontal gene transfer from another microbe. It is
therefore important to have the ability to sequence other organisms that could potentially
contribute resistance genes such as enterococci. The measure for this is the percent of the
process that would need to be changed to accommodate other organisms with a target of
less than 10% (as measured by the number of activities).
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Modularity
Constraint: None, specified in properties vector
Range: 0 to 10 (0=completely modular, 10=not modular)
The degree to which changes in one section of the process impact another is a measure of
the modularity for each section and overall the process. The measure used for the
surveillance process is that less than 10% of the activities downstream of a module should
need to change if there is sufficient modularity.
5.1.5 Selection of macro level feasible processes against
design specification requirements
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
Procss Fasiblity 3.) Identify potential process alternatives and design spaceProces enty 4.) Identification of design specifications and constraints
anduEmeon 5.) Selection of macro level feasible processes against
design specification requirements
6.) Enumeration of process elements onto detailed process map for
selected process
7.) MDPM creation from detailed process mapNetwork Analysis 8.) Analysis of MDPM model
With this defined set of specifications and identified constraints it is possible to construct a
linear programming model to identify a feasible preferred process path based on "macro"
information. The particular model to be used is commonly known as the minimum cost
network flow (MCNF) model normally used to find optimal minimum cost routes through
transportation networks as described in (Jensen and Bard 2003; Winston and Albright
2008). A generic MCNF model is conceptually illustrated in Figure 67 where flow enters
node A, and has a cost associated with traversing each edge, before finally leaving at node
E. The minimum cost flow is the path through the network whose sum of "costs" is lowest
as shown in red in Figure 67. The MCNF algorithm is adapted here to identify the
"preferred path" through the design space network developed in step 3 and shown in
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Figure 66, where the "costs" for traversing each edge in the graph correspond to the
particular set of specification variables associated with that activity. The model is not
intended to provide an optimum path but rather identify which paths are feasible and also
satisfy the greatest number of preferences according to the "specifications" vector
composed of the individual specifications described in the previous section.
inflow
k 3
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L 3
3
outflow
( 3
outflow
Flow Network Minimum Cost
Flow Solution
Figure 67 - Network Flow and Minimum Cost Solution
The standard formulation of the minimum cost network flow problem consists of a linear
program for a directed, connected graph with m nodes and n arcs. At least one inflow node
and one outflow node is specified as in Figure 67. Then the flow through a particular edge
k from node i to node j is denoted as k(ij) and thus the particular throughput through edge
k is denoted by a decision variable x, as:
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Xk = flow (throughput) through edge k(i,j) from node i to node j
The costs associated with flowing, or transporting, through edge k(i,j) is denoted by,
Ck = unit cost of flow through edge k(i,j)
The net flow balance variables are denoted by,
bi= net supply (edge flow out - edge flow in) at node i
where bi>O if i is an inflow node, bi<O if bi is an outflow node, and bi=O for all other nodes
The maximum capacity of each edge is denoted by,
uk = capacity of edge k(i,j)
And the set of edges entering node i, or leaving node i, are given by,
KL = set of edges leaving node i
KTi = set of edges terminating at node i
With these definitions, the minimum cost network flow objective function can then be
formulated in Equation 23 as the path (or paths) through the network that minimizes the
overall cost to flow (or transport) inflows to the outflow nodes. Implicit in the formulation
is the existence of an adjacency matrix defining the allowable paths through the network
and of the same dimension as the "cost" matrix defining cost values ck.
n
min I Ckxk
k=1
Equation 23 - Objective Function for Minimum Cost Flow Problem
Page 214 of 385
Xx X Xk=b,
subject to *"eL **KE for all i = 1... m
Oxk Uk for all k=1...n
Equation 24 - Conservation of Flow for Minimum Cost Flow Problem
And for this application, it is assumed that all samples enter the process and leave with no
accumulation or creation inside the network, thus the sum of all node balances must equal
0, as given in Equation 25.
m
Xb, =0
i=1
Equation 25 - Flow Balance for Pure Network Flow Problem
This formulation of the MCNF can be adapted to find feasible processes within the design
space graph constructed in step 3 made up of the macro activities, which have edge "costs"
based on the properties vector defined by the specification variables identified in step 4 of
the methodology and a certain number of samples flowing through them as indicated by
the decision variables x, shown in Figure 68. Note that the MCNF formulation corresponds
to an "Activity on Edge" AoE network as opposed to the "Activity on Node" AoN network
used in the MDPM model in this thesis. Thus each edge contains the "cost" to performing
that activity which can be interpreted as a "cost" to flow samples through that activity in
the process. The costs are derived from the particular set of values in the specifications
vector for that particular activity but adjusted by a weighting to indicate which of the
process properties are most important to the stakeholders as shown in Figure 69. Thus
rather than let cycle time have the same weight as modularity, the weighting allows for
cycle time to have a higher importance according to the stakeholder preferences.
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Figure 68 - MDPM Methodology Design Space as a Minimum Cost Network Flow Problem
Only a portion of the flow network graph is shown in Figure 68 to highlight the
correspondence between the "design space" process graph created previously and the flow
graph to be used in finding feasible processes according to activity parameters and
stakeholder preferences and constraints. It is important to emphasize once again that the
use of MCNF model to filter out design alternatives is primarily required to reduce the
complexity of the full MDPM graph to be developed in the following steps of the
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methodology. Each of the macro activities in the design space decomposes into a
significantly more complex set of processes, individuals, and work instructions making the
initial reduction of design alternatives necessary. However, the application of the MCNF
design alternative is fully compatible with the MDPM model to be developed further as
each of the detailed activities within the macro activities could be analyzed in the same way
to perhaps to find a new improved path through a series of design changes to the baseline
process. If new design alternatives (i.e. other processes) were to appear following an initial
design the MCNF model could be re-applied at the macro level to find a feasible set. Note
also that this thesis has emphasized the finding of "feasible" solutions rather than "optimal"
ones since the level of detail at the macro level and the nature of new prototype processes
means there will be large uncertainties as to the actual performance of these processes.
The property values associated with each activity as shown in Figure 69 are estimates and
can also have large uncertainties. Ultimately it is up to the process designers and owners to
make a selection of which processes to pursue further into full MDPM modeling and real-
world implementation, but the methodology developed here can help reduce the set of
design options that need to be considered.
Specification Specification Weights
Vector for MRSA Vector for Overall Process Sample MRSA DNA Extraction
Isolation Activity (stakeholder preferences) sample Collection Isolation Standard
10 Cost 0.4
2 Cycle Time 0.05
Infrastructure 0.1
2 Data Quality 0.05
3 x Data 0.1 =5.7= "Cost" CCompleteness BC
5 Scalability 0.05
5 Transferability 0.1
2 Flexibility 0.05
3 Adaptability 0.05
2 Modularity 0.05
Figure 69 - Example of Edge Cost Calculation for Adapted MCNF Model
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Variable Isolation
Vadlue
Stakeholder Vadlue
Specification
Weights
Another advantage of developing a graph based feasibility identification tool is that many
processes are built from a series of existing "off the shelf' technologies joined together to
form a process, but many alternatives may exist for each of the technologies. The MCNF
enables the identification of feasible processes from each of these individual "modules" that
may not have a priori been considered. The design space presented in Figure 66 contains
relatively few modules except for the DNA sequencing technologies but it is possible to
imagine that there could be many more alternatives for DNA extraction, data analysis, and
perhaps sample collection in the future, making the number of possible permutations very
large. The MCNF analysis allows for the "finding" of feasible paths through all of the
possible combinations of modules (i.e. technology alternatives for each macro process
activity) as illustrated by the conceptual "best path" in Figure 67.
The MCNF problem can then be solved using a linear programming algorithm, such as the
one in Solver for Excel (Winston and Albright 2008). Some preparation and formatting is
necessary first however, including the construction of vectors and matrices containing the
structure of the graph itself as an adjacency matrix, each of the stakeholder weights, the
activity costs, the capacity constraints, and the decision variables (i.e. the number of
samples to be processed through each activity). The properties vector was purposely
designed to be non-dimensional and for scales to correspond to "high" is "worse" such that
higher costs can correspond to less desirable paths. Certain values such as actual monetary
cost were normalized to the highest cost item such that they can also be onThe the same 0-
10 scale. The weighting of each of the activity properties are given as fractions adding up
to 1, such that the relative impact of each property can be specified according to the
stakeholder preferences (i.e. if cost is more important). An adjacency matrix containing the
costs can then be constructed, which when multiplied element by element with the
decision variable matrix (flow quantities) and summed yields the total process cost, which
is also the objective function as shown schematically in Figure 70 with the excel elements.
The capacity constraints in Figure 70 define the maximum number of samples that could be
processed through the system. In order to determine feasibility, all process paths are
assumed to have the same maximum expected capacity, but the "cost" associated with an
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infrastructure to support that maximum capacity is reflected in the activity cost vector.
This ensures that all processes are compared at the same maximum expected capacity
(same scale). However, this could be modified to better reflect variation in capacity
between processes.
Figure 70 - Minimum Cost Flow Algorithm Input Matrices and Setup in Excel and Risk Solver
The MCNF problem in Figure 70 can then be solved for a minimum objective function value
subject to the capacity, non-negativity, and other constraints. The resulting solution
corresponds to the process path in the design space network that best minimizes the set of
"process costs" and is feasible. Note that for infeasible values are tested at the creation of
the Edge Cost matrix, where if an activity has an infeasible value exceeding some limit in a
particular parameter, the particular cost is set to an arbitrary high "infeasible" value
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exceeding the scale of 0-10 (10,000) such that "flow" could not traverse through that
activity.
The resulting solution describes a process that is selected for further modeling in the
MDPM methodology. The next step is detailed enumeration, filling in the "details" from the
macro process activities. As previously stated, the goal of this feasibility check and initial
selection is to reduce the number of design alternatives going into the MDPM model in
order to reduce the model size. However, the "discarded" processes out of the selection are
retained as elements in the information layer as process designers and participants will
need to remain aware of these design alternatives should one improve in performance and
become a better solution. Note again that in principle it is possible to perform the same
selection process performed here once a full MDPM model had been built enumerating in
detail every alternative. This might be worthwhile for "enterprise models" where multiple
processes must be managed or when many design alternatives are being considered and an
initial "filtering" cannot significantly reduce the number of design alternatives.
For the design space graph detailed in Figure 66 the specification variable values for each
of the system activities were then filled in resulting in a 28 X 28 adjacency matrix such that
the "im" activity dimension in Figure 70 is 28 and the "p" parameter dimension is 10. This
also meant that for this relatively straightforward example the number of individual
decision variables was 28 X 28 or 784, which is already a significant number.
Simplification of the algorithm such that zero elements in the adjacency matrix are not
considered would likely be required for larger models as this number of variables is
already beyond the capability of the standard Excel solver and an advanced version7 was
needed.
An important note is that that the activity values and selected processes correspond to the
suitability of the particular technology for a MRSA surveillance system only and do not
reflect the suitability of a particular process path or technology for other purposes where a
7 Risk Solver Platform, Frontline Systems
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different set of values would need to be input. The weights in Table 17 were used to value
the relative contribution of each global process property.
Cost 0.4 0-10 (norm.) <$100/unit Most important consideration
Cycle Time 0.05 0-10 (norm.) < 2 Weeks Not critical for surveillance
Infrastructure 0.1 0-10 Important to adoption rate
Data Quality 0.05 0-10 Can be overcome with over sampling
Data 0.1 0-10 Important for whole genome
Completeness
Scalability 0.05 0-10 Scale up to 100% sampling not likely
Transferability 0.1 0-10 Important to adoption rate
Flexibility 0.05 0-10 Not critical for surveillance
Adaptability 0.05 0-10 Not critical for MRSA focused system
Modularity 0.05 0-10 Not critical for surveillance
Table 17 - Preferences for MCNF Algorithm
The resulting MCNF model was solved and yielded the solution shown in Figure 71 with a
feasible and preferred path going through the "optimized" DNA extraction and Illumina
Sequencing. However, sensitivity analysis on the model showed that small variation in the
weights shown in Table 17, could result in the Roche 454 technology being the feasible and
preferred path, although both paths selected the optimized DNA extraction design
alternative. The "second-best" Roche 454 alternative is shown in a different shade along
with the lower process cost path in Figure 71.
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Figure 71 - Feasible and Next Feasible Surveillance Processes
The Roche 454 was a close second best despite a significant cost disadvantage per Gb of
data produced. A sensitivity analysis revealed that a small change in the infrastructure
variable weighting from 0.1 +/- 0.01 could change the outcome of the preferred path
between Illumina and Roche 454. When considering all of the other "ilities" contained in
the properties vector, the Roche 454 technology does have significant advantages in terms
of infrastructure requirements, transferability, and cycle time which nearly make up the
cost disadvantage deficit for this particular MRSA surveillance application when global
system properties are considered. Given the relatively small size of MRSA genomes, the
raw per Gb costs may not be as important as the other process "ilities" that could affect the
speed and efficacy of the overall surveillance process. Marginal improvement of some of
the Roche 454 system parameters could change the preferred path results and is a reason
for the MDPM model to be developed in the next section to retain "second-best" paths as
information elements the "process owners" must be aware of. More advanced technologies
are on the horizon that could further improve on the design alternatives considered here,
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the impacts of which will be considered in Chapter 7. In addition, it is also possible to use
the MCNF model in "reverse" to calculate what properties would be needed for process
paths with certain desired characteristics and produce a "pareto front" of these alternatives
to guide the design of new technologies and processes. This idea will be further explored in
chapter 7. The feasibility analysis in this step of the MDPM methodology greatly reduces
the number of alternative paths through the design space but also ensures "global" system
constraints are met and a feasibility test has been performed. The design methodology
then continues in the next section, which "fills in" the detail of the selected macro process.
5.1.6 Process Element Enumeration
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
3.) Identify potential process alternatives and design space
4.) Identification of design specifications and constraints
and Element 5.) Selection of macro level feasible processes against design specification
Enumeration requirements
6.) Enumeration of process elements onto detailed
process map for selected process
7.) MDPM creation from detailed process mapNetwork Analysis 8.) Analysis of MDPM model
This section describes the identification of all necessary process elements to fully expand
and flesh out the feasible preferred process path developed earlier. Each of the process
elements described in this section represent the detailed decomposition of the macro
process steps described previously. The particular process path selected at the macro level
is shown in Figure 72, and each of the process activities will be further decomposed in the
following sections. Also it is important to note that some description of the results from
actually having run the process and knowledge from this is incorporated into the
narratives for the enumeration of each of these macro activities. This is mainly done to
help the reader, but the methodology would normally be run a priori without any
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knowledge of the downstream results, and likely would require iteration as new
knowledge is found and is incorporated into the model.
Process Boundary
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Figure 72 - Selected Feasible Process and Macro Process Elements Considered for
Enumeration into MDPM Model
5.1.6.1 Sample Collection
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The initial step in the process is the identification of a MRSA infection by a physician and
their request for surveillance as shown in the decomposition of the macro step in Figure
73. Note that in every day hospital operation this first step is typically a request for
diagnosis rather than surveillance, but in mapping this process the physician would
request a "parallel" surveillance process to go along with any diagnostic request. A primary
care physician or specialty physician will typically initiate the surveillance request starting
the process. It is important to remember that MRSA can colonize skin and nares without
infection but it is only when the microbe penetrates into the body that infections can occur.
And these infections can occur throughout the body ranging from the bloodstream
(septicemia) to internal organs to IV catheters. Therefore, nearly any "specialty" physician
treating a patient for something else may also encounter a MRSA infection and require
diagnosis and surveillance. This adds significant complexity to the process since in the
organization layer the full range of specialty physicians, their nurses, and most importantly
their patients must be modeled. For simplicity only a primary care physician and a
"specialty" physician are modeled in the baseline process as representative of the
"organization" of physicians and the node has an additional "organization" property which
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it represents an entire organization. This facilitates modeling but also visualization in the
model, since it is not feasible to capture the detail of every organization the process
interacts with, but it is important to model the interfaces between the process and these
"organizations". In a network view the nodes with an "organization" property can be clearly
highlighted to indicate interfaces with other networks and the complexity measures of the
process can be adjusted to take into account the complexity that exists behind each of these
nodes.
MIRSA teoaton DNA Ebti n iamna Inumdna Illdmi * Mmsa M D nalys
Optimizatio Sequencing
Blood Cultr
Body Fluid]
Collection
Catheter
Collection
Lesion/Abs
Collection
Wound
Collection
Nasal
Collection
Nasopharynx
Collection
Throat
Colln
Bronchial
Request Sapl
Sure Tissue naota
EyeCollection
Vaginal
Urethra
Collection
I~IProce 
S Feces
Directionn
Cerebrospinal
Sputm
Figure 73 - Sample Collection Process Elements
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Another important observation from the process map is that since MRSA infections can
occur throughout the body, the collection of samples from each of these locations requires
specialized work instructions, knowledge (tacit in the form of nurse experience), and are
distinct activities significantly adding to the baseline complexity of the process. So for
example collection of a MRSA sample from blood is very different from the collection from
a deep tissue wound requiring different disinfection, collection, and preservation
procedures. This diversity of sample collection activities is shown in Figure 73. The proper
performance of these sample collection activities is critical because any contamination will
lead to an improper surveillance result either identifying an incorrect organism, failing to
detect MRSA, or incorrectly detecting MRSA when none is present.
The final step in the general sample collection category is the transport of the sample to the
clinical microbiology laboratory. While this may seem like a trivial activity, the timing of it
and handling during transport are also critical links in the process chain since delay in
delivery can damage the sample or introduce the potential for contamination or sample
misidentification. This is also a key observation for the importance of being able to "search"
an entire process network since any step along the chain can cause a problem and unless
the activities, individuals, and work instructions can be easily reached (or "searched") it is
very difficult to manage or troubleshoot a complex process.
Sample collection is predominantly performed in the clinical domain largely associated
with physicians, nursing staff, and other medical personnel interacting directly with the
patient. Additional external stakeholders exist in this part of the process, represented by
"organization" nodes such as the patient's insurance company, the hospital administration,
the American Medical Association, and others. These external stakeholders are however
not directly connected (in the organization domain) to many of the downstream process
nodes and a key effort in building a sustainable surveillance process will be to map and
maintain these connections.
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5.1.6.2 MRSA Isolation
The next macro process activity is the isolation of the MRSA microbe from the collected
samples which expands into a large number of detailed activities upon enumeration as
shown in Figure 74. The first activity upon delivery is the triage of the sample depending
upon what the suspected organism is, the collection method, and the intended assay as
shown in Figure 74. While automated laboratory management systems can direct many of
the samples to their appropriate preparation processes, a substantial amount of judgment
(tacit knowledge) is still required typically on the part of a senior laboratory coordinator,
manager, or technician. Once the sample has been appropriately routed, a specialty sample
preparation is often required to match the specialty collection procedure used by the
nursing staff. So for example a sample collected from bodily fluids may require
centrifugation and other preparation before it can be used to inoculate a culture assay. The
need for specialty preparations also adds significant complexity to the process but is again
reflective of the "real" complexity since simply describing this activity as "sample prep"
might simplify a process representation but would hide the real complexity behind it.
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Figure 74- MRSA Isolation Process Elements
Once the sample has been prepared and processed it can then be used to inoculate culture
media such that the MRSA microbes can be identified and isolated as shown following the
sample preparation steps in Figure 74. Significant operator discretion exists here as there
are numerous choices for the type of media to be used, each with particular benefits and
drawbacks. For example, selective media is designed to inhibit the growth of all other
microbes except for MRSA, and while this might seem useful it could eliminate microbes
critical for surveillance such as "near-MRSA" that are close to being resistant or have
certain key resistance genes from other organisms. Alternatively, using nonselective media
allows for the growth of all microbes and may hide the MRSA microbes in heavily
"contaminated" samples such as those coming from the digestive system. Only three
"choices" are modeled in the process enumeration for simplicity but in reality many more
choices exist. The existence of these choices is modeled in the information domain, where
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lab managers will be aware of these other choices even though they might not exist as
process domain choices since they may require specialized materials not routinely
available. However, the existence of these choices in the information domain better
represents the real complexity of these processes since it is possible that a lab manager
may decide to modify a process domain activity based on knowledge from these "choices"
(which may be thought of as design alternatives in traditional engineering). The inoculation
step is also heavily technique dependent as the sample must be "streaked" across the
media in a particular pattern, volume, and sterile technique. Poor technique will make it
difficult to identify MRSA during the isolation activity.
Once the appropriate culture media has been inoculated it must be grown, typically
overnight under specific conditions for temperature, agitation, and aeration. The resulting
media can then be examined for the presence of MRSA under the microscope or sometimes
visually if selective media was used. A single colony can then be isolated and used to
inoculate a second media container in order to grow sufficient material, although now from
a single MRSA isolate. Culture based diagnostics would stop here as the identification of
MRSA following the first culture step would be sufficient to render a diagnostic test result.
However, for any subsequent surveillance process the second growth step is necessary to
produce an archival sample that with the addition of glycerol can be frozen. Aliquots from
this frozen sample can then be taken and re-grown to produce additional material from the
original isolate. This renewable resource can then be used for a variety of processes
including DNA sequencing-based surveillance.
The organizational domain network associated with this part of the process was in its
baseline (original configuration) not connected to many of the other organization domain
networks. It so happened that at the Brigham and Women's Hospital, where this process
was developed there existed a strong set of ties between the Microbiology Lab Director,
who also happened to be a scientist in a research role at Harvard Medical School, and a
research Physician who was interested in MRSA mutation discovery and research. These
connections might not normally occur in other places where microbiology labs can be
disconnected from medical research in the organization domain (i.e. only reporting sample
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results without additional relationships). The existence and development of these
connections enabled this process to work but they were haphazard and often relied on the
author's interest in creating the process. An important goal of the MDPM model is to
enable future process designers to actively map the necessary relationships to manage
complex processes, and the enumeration of all individuals and organizations interacting
with the process is a key element of the MDPM model which will de described later in this
chapter.
5.1.6.3 DNA Extraction
Sample Ma lmn Data Analysis
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The next major macro process step is DNA extraction optimization, which was selected
over the "standard" DNA extraction as it was expected that this activity would require
significant optimization. The activity is called DNA extraction optimization recognizing that
some work will be needed to make it perform better than the standard and is a
"placeholder" activity as this macro process step did not exist prior to the development of
this process. This is an example of how the process feasibility may be used to identify key
process activities needed. The first detailed step in the decomposition of this process
activity is to take small aliquots from the frozen MRSA samples, thaw them, and re-grow
them to provide sufficient material for DNA extraction as shown in Figure 75. This re-
growth is in a larger volume and liquid solution rather than solid media as is typical for
diagnostic cultures. This part of the process starts to deviate from "standard" diagnostic
processes, as large-scale high-quality DNA extraction from Staphylococcus aureus is not a
routine procedure. While there are a number of protocols for Staphylococcus aureus DNA
extraction many of them are for less demanding processes such as PCR which does not
require large amounts of high molecular weight DNA (greater than 20 ug with average size
greater than 20kb). In addition, the objective of this process was to develop a high
throughput method that could use commercially available reagents were possible and
Page 230 of 385
. .......... . ...... . ..................
would require relatively little specialized operator technique (tacit knowledge). However
these requirements combined with significant variability in the MRSA microbes themselves
led to serious process design problems that required significant iteration and knowledge
sharing between the microbiology research team at Harvard, DNA extraction vendors, DNA
extraction scientists, and the author. The design problems, their representation in the
MDPM model, and their eventual resolution are described later in this chapter. However, it
is important to point out here as well that the connections between the microbiology
research group at Harvard, DNA extraction scientists, vendor organizations, and the
associated explicit knowledge (such as vendor instructions and literature) does not
normally exist and was developed as "scaffolding" to support the creation of this process.
Sample Sample Sample DNA E atraction DNA Bead DNA Pico D ti Sample DNA Sample DNA Sub
Sap DNA Extraction DN Col DNA OD
r- ESamplT e DNA Me0
at * a,
Process
ircton
Figure 75 - DNA Extraction Process Elements
Downstream analysis of the process data found significant impacts from the quality of the
DNA extraction emphasizing the need for a process network that can be easily reached and
"searched". The variability in Staphylococcus aureus cell wall thickness made it necessary
to optimize a protocol that would lyse the majority of these microbes (both very thick ones
and relatively thin ones) without damaging the DNA of the relatively thin ones that would
be exposed to much harsher conditions to ensure the very thick ones are always lysed. The
damaged DNA would then show up as "missing" parts of the genome or would require
significantly more material further complicating the extraction step. This is again an
example of seemingly innocuous process steps having significant impacts downstream in
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complex processes and the need to integrate all activities to ensure local activities meet the
global process constraints and requirements. Taking a page from Steve Spear's ideas in
(Spear 2008) and translating them into the MDPM model, this problem was rapidly
identified because there was a single "process owner", the author, who was only a few
network hops away from any given part of the process and it was rapidly "swarmed" by
bringing expert individuals and experimental attention to bear on the problem. This is
again an example of the value of explicitly enumerating the process activities, the
organizational elements, the information elements, and the connections (or lack thereof)
between them in the MDPM model.
In the baseline process map three lysis alternatives are shown in Figure 75, and in fact all
three are viable as tested in the development of this process and shown in the literature.
There is discretion as to which method might be best in a particular setting (another
hospital may prefer to optimize a different one) but the enzymatic lysis method was used in
this process. In order to capture the real process complexity all three are shown. In
addition to alternative DNA extraction methods, column and bead, are shown which also
represent feasible process choices although the optimization necessary to develop the final
work instructions (protocol) actually used is shown as "optimization documents" in the
information domain. This is typical of how many of these protocols are developed where a
series of design experiments and trial protocols will eventually lead to the final
"production" protocol. However, there is enormous knowledge captured in these
experiments and trial protocols that can guide troubleshooting or future design changes.
And that is only if the knowledge of the people involved in the optimizations and trial
protocols is formally captured as it otherwise resides as tacit knowledge with individuals in
the organizational layer. In this case the information was explicitly captured and is
represented by a "optimization documents" node with an additional knowledge base
"property" signifying the node represents a deep and complex knowledge set not explicitly
represented. In this sense the special knowledge base nodes are much like the
"organizational nodes" that represent additional complexity not modeled but whose
interface is critical to process operation. The special nodes can then be easily identified in
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the network representation such that the critical interfaces between the process and these
knowledge bases can be identified.
The extracted DNA must be purified to eliminate any other cellular debris and extraction
reagents. The DNA must then be quantified using one of a variety of methods to ensure the
extraction has been successful and deliver the DNA at a known concentration in a
stabilization buffer. Typically a smaller aliquot will be prepared for use in a sequencing
process in order to preserve the larger amount of DNA for future use, and this aliquot is
then handed off to start the next step of the process, library construction.
5.1.6.4 DNA Preparation
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The extracted DNA sample can then be put into the start of the sequencing process.
Because of the previous MCNF based feasibility selection, only a single DNA sequencing
process is shown in this process map, but the other alternatives described in the design
space shown in Figure 66 also exist. The major benefit of the design space reduction from
previous methodology steps is that now only this single process path need be considered as
part of the process. However, any of the existing and emerging sequencing technologies
could rapidly displace the one shown across multiple performance dimensions. This
multitude of design choices contributes to the effective complexity of the process since in
this rapidly changing environment that the other "design alternatives" must be
continuously considered by the organizational domain individuals responsible for the
sequencing portions as well as the overall "process owners". These design alternatives are
shown in the information domain as vendor documentation nodes and in the
organizational domain as nodes associated with the vendor organizations. The purpose of
these "alternative process" nodes is again to map the interfaces between the process and
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any other sources of information, organizational interaction, or in this case alternative
processes.
But even for the single sequencing process selected the complexity of the process is
substantial as measured by the number of individual steps necessary. Because of the high
degree of competition and rapid evolution between the sequencing technologies many of
these process steps are either semi-tested prototype protocols or for those fully tested
subject to change as improvements or system changes occur. This requires an enormous
amount of organizational "scaffolding" to test the changes, co-develop them with vendor
organizations, and implement them. In addition, for particular applications a number of
"integration" technologies must be developed in order to feed nonstandard samples such as
the MRSA ones into processes not initially designed to handle them, or handle them at the
high throughput necessary for a surveillance system.
The first step in DNA preparation for sequencing is to shear an aliquot of DNA from the
previous step using either acoustic or hydrodynamic forces in order to break up the
original 2.8 MB Staphylococcus aureus genome into small fragments that can be processed
by the sequencing technology. The enumeration of detailed process activities for DNA
preparation is shown in Figure 76. The particular choice of shearing technology and the
exact settings used in the protocol are (as with most of the sequencing process steps)
derived from significant optimization experiments and the knowledge base associated with
these is often tacit knowledge contained in the operator's minds, but there also exist
explicit optimization documents and protocols associated with them. In the MDPM model
the links between the organizational domain and these optimizations are explicitly shown
since in many cases the optimizations will have been performed by senior scientists and
research staff not directly working on the process but may be not be "reachable" by the
operator on the front lines through organizational connections. The operator however,
may need to troubleshoot or identify the impact of changes on this particular process step
and requires an efficient network to obtain the necessary information. Ensuring these
connections are available for complex processes is key to the rapid identification of
problems and also the "swarming" necessary to resolve them.
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Figure 76 - DNA Preparation Process Elements
Following shearing are a series of steps to further prepare the genomic DNA into molecules
that can be read by the selected sequencing technology as shown in Figure 76. It is
important to note that not all of the detailed activities shown in Figure 76 are from the
same vendor but are sourced from multiple vendors providing molecular biology "tools".
And although these tools are commonplace in molecular biology they still require
significant operator skill or tacit knowledge and it is common to find in organizations
dealing with molecular biology certain "golden hands" individuals who are especially
skilled and adept at using these "tools". Examples are the many "cleanups" necessary to
remove various undesirable post reaction products at various steps. These cleanups can
severely affect DNA yield, which can in turn affect the quality and amount of downstream
data produced. It is thus especially important to map not only the explicit vendor
instructions for these cleanups, the process steps at which they occur, but also the
individuals associated with these steps and their tacit knowledge.
Significant efforts to automate many of the steps in this upstream sample prep have
occurred in a number of genome sequencing Centers including the Broad Institute to match
the rapidly rising sequencing throughput and not directly associated with this thesis. And
from the MDPM model perspective these automation efforts transferred much of the tacit
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operator knowledge into explicit knowledge now codified in detailed robotic scripts and
protocols in the information domain. In general, this thesis has built on elements of rapidly
improving sequencing processes (intended for other uses such as cancer sequencing) and
focused on developing the necessary "connections" between these elements to forge them
into a MRSA focused surveillance process. These "connections" were primarily across
boundaries such as the optimizations needed for DNA extraction described earlier, the
molecular barcoding needed for multiplexing, and the mutation analysis algorithms. And
this is likely representative of the development of new complex diagnostic processes in
healthcare, which are built from parts of existing technologies and forged together by
developing the necessary "connection" technologies. From this perspective it is especially
important to have detailed process mapping methodologies such as the MDPM model,
which can be used to identify the "holes" in complex processes such that robust and
efficient "connection" technologies can be developed. This is a corollary to the "swarming"
problems and much more like Steve Spear's "first capability" in focusing organizations at
the start of a design process on the biggest and most important problems to ensure the
highest probability of success. This would for example show process designers that
additional "scaffolding" is needed around key "connections" that are not sourced from
existing processes and will require significant resources and connected development
iteration.
In many of the examples in this thesis of building this complex MRSA surveillance process
the phrase "connected development" has been used. This is an important concept directly
related to the fundamental goal of this thesis, which is to develop an analytical complex
process design framework. Connected development is meant to describe the need for rapid
local optimization but subject to global process constraints. So for example a team working
on the optimization of cleanup steps in library construction must be able to "reach"
downstream analysis individuals and data to ensure that any changes to not negatively
impact the process despite perhaps being a "local optimum" for that process step. These
connections are especially critical in lengthy complex processes such as the one described
here since development and improvement can be slow or even impossible unless there is
sufficient visibility from local teams into the overall process. Without this visibility it is
Page 236 of 385
likely that organizations will be very hesitant to make changes both on a global and local
level since the impact of changes cannot easily be identified or related back to the groups
making the changes. It is possible that the empirically observed "resistance to change" in
complex processes is due to a lack of sufficient "scaffolding" or connections across the
process to understand and manage changes leading to "complexity freezes" of processes in
certain suboptimal but working conditions. Rather than risk potential failures, unintended
behavior, or greater variability organizations will freeze processes as they may not have
the necessary additional resources to build the "scaffolding" necessary to improve them.
The remainder of the DNA preparation activity includes the repair of DNA molecule ends
following shearing such that adapters with known DNA sequences can be added to the
genomic DNA molecules in order to facilitate their manipulation and enrichment. These
steps are critical to one of the key "connecting" technologies in this process, the molecular
barcoding of each of the original MRSA samples collected and isolated from patients which
is describe next.
5.1.6.5 Molecular Barcoding
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This activity was also a "placeholder" activity in the initial design space, as many of the
procedures used in this step did not exist at the initial design and feasibility selection
stages. The rapid decreases in DNA sequencing costs are largely associated with enormous
increases in the amount of data produced for each instrument run. Where during the
human genome project the average yield per run might be 62,000 high-quality bases the
current (ca. 2009) average yield per run for the most efficient technologies is around 30
billion high-quality bases per run. This batch size is governed by the particular properties
of the technologies but can generally be thought of as moving from one dimension in
human genome project capillary technologies to two dimensions for current technologies.
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These two-dimensional surface technologies gain greater efficiency the more densely DNA
can be packed on them and the greater the surface area per run leading to larger and larger
batch sizes. For comparison, the Staphylococcus aureus genome is only about 2.8 million
bases compared to 30 billion bases (and growing) run sizes which means a single MRSA
sample would be read over 10,000 times in a single run. In order to detect mutations with
sufficient statistical significance each sample would only need to be read about 30 times.
Most of these technologies are designed for high throughput human genome sequencing
but this does not easily scale down to the relatively small microbial genomes. In order to
take advantage of these efficiencies a means of multiplexing many microbial genomes on a
single run is necessary, leading to the need for a "connecting" technology to accomplish
this. Methods exist to add molecular barcodes to genomic DNA fragments in order to
identify them, and this consists of ligating (joining) a known DNA fragment with a
particular sequence (the barcode) to the genomic DNA fragments. When this combined
DNA molecule is read the portion from the known fragment is the barcode and the actual
DNA sequence is read immediately afterwards. Of course this molecular barcode must be
added in such a way so as to not interfere with the other adapters and molecular
manipulations needed to run genomic fragments through the sequencing process. This
required a significant amount of "connected development" as not only did the molecular
biology need to be worked out but also the software analysis tools that would correctly
separate the barcodes in the downstream data such that the pooled samples could be
correctly identified and their data binned. An initial version from the sequencing vendor
was tested but this version proved to have problems in that adding the molecular barcodes
also prevented certain portions of the genome from continuing through the process leading
to holes in the sequence. These problems were only identified and a "swarm team"
assigned to fix them because of the connected development model, which rapidly fed back
results from the analysis (far downstream of the molecular biology) and this connected
iteration continued until an alternative process was developed. The MRSA surveillance
process used for the actual demonstration used this alternative method including the
necessary downstream steps (both molecular biology and software).
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Additional steps are needed for this molecular barcoding method to work such as removing
the unused barcodes, size selecting the fragments within a certain range, enriching these
fragments for the proper orientation of barcodes and adapters, additional cleanups, and a
quantification of the amount and size of the resulting products. Once individual samples
have received their molecular barcodes, these must be pooled together in equal molar
concentrations such that the data produced by the sequencing run is equally distributed
amongst all the samples barcoded as shown in Figure 77.
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Figure 77 - Molecular Barcoding Process Element Enumeration
The molecular barcoding shown in Figure 77 is a key "connecting" technology as precise
quantification and automation are needed to normalize each sample and pool in the correct
amounts prior to the preparation of a "library" for sequencing. This required a significant
amount of connected development as the readout for the pooling had to go through the
entire process all the way to downstream analysis steps and back to the team working on
the barcode pooling. Note that unlike abstract design processes, the particular order of
physical process steps cannot easily be changed and some of the techniques used in DSM to
re-order the sequence of process tasks may not apply directly as physical process activities
cannot be easily moved together. However, once these optimizations for complete and
automation developed barcode pools could be submitted to the next section of the process,
preparation of the now molecularly barcoded samples for sequencing.
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5.1.6.6 Sequencing Preparation
Sap MRSA Isolation DN o Mumina "* iDtnAayi
Once past molecular barcoding and pooling the process follows a relatively straightforward
linear sequence of steps to add the barcoded sample fragments onto a glass slide and
amplify them such that there are sufficient molecules to "see" on the sequencing
instrument when fluorescent nucleotides are incorporated. However, as with the rest of the
process most of the steps are still under substantial development as improvements are
made or problems resolved. This requires a substantial "scaffolding" here as well since
changes in the way these "DNA clusters" are made can have a very significant impact on the
downstream data. The physical process steps are enumerated in Figure 78, and on a
traditional flow-chart based process map would appear to be a relatively simple process.
However, when additional domains are mapped onto these process activities in the MDPM
model, such as the many individuals, work instructions, optimizations, vendor data, and
other elements that are associated with these activities, the actual complexity of the
process can be evaluated.
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Figure 78 - Sequencing Preparation Process Elements
Throughout the process it is necessary to carefully track the genealogy of every sample to
ensure the final downstream data can be precisely matched to the original sample without
any mixups or errors. The surveillance process as designed will have a very significant
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throughput, in the thousands of samples per year, and additional infrastructure is needed
to track these samples using standard (not molecular) barcodes on every sample container,
intermediate tubes, glass slides, and any other physical sample transfer in the process
starting with the initial sample collection. This laboratory information management system
(LIMS) must keep track of the genealogy (sample transfer history) of every sample from
patient to analysis data set. This adds significant complexity to the process but is not
usually mapped in traditional process flow maps that focus only on the progress of the
physical sample. The interaction of the organizational domain and the LIMS is essential in
ensuring that the process can be controlled and using the MDPM model is a way to identify
"holes" where the LIMS is not interacting with the process or the organization.
5.1.6.7 Sequencing
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Once the DNA has been deposited onto glass slides and amplified, the Illumina instrument
can be prepared to read the DNA molecules using a modified sequencing by synthesis
(Sanger) chemistry. One disadvantage of the next generation high throughput sequencing
technologies is that their final step, reading the DNA on the instrument, can be very long in
the range of 6 to 14 days. This places tremendous emphasis on the careful setup and
preparation of an instrument run since a failure during this time is often not recoverable
and requires that any rework start many steps back in the process. The design and
development of these instruments is continuously changing to address higher efficiency,
process issues, and data quality, which requires significant process infrastructure,
"scaffolding" to support. The sequencing portion of the process is also straightforward and
linear in the process domain, but again this hides the significant associated complexity due
to the ongoing change and optimization that will only be evident in the organizational and
information domains. There are a significant number of sequencing process activities
nevertheless as shown in Figure 79, and because of the length of a sequencing run, it is
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critical that all of these activities have high reliability and pass rates as rework is difficult or
impossible to perform for many steps (i.e. returning to the previous step). This places a
significant premium on ongoing process improvement to make the pass rate for each
activity as high as possible, but this in turn requires considerable attention to the tacit
knowledge operators may have as they perform these activities.
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Figure 79 - Sequencing Process Elements
The instrument is also where the interface between physical DNA molecules and sequence
data exists starting with the processing of images of the DNA molecules with fluorescent
nucleotides for each base into the DNA sequence of each molecule. The instrument optics,
image processing algorithms, and base calling (correlating a fluorescent signal to one of the
four nucleotides) all directly affect the quality of the data and the ability of the MRSA
surveillance process to correctly identify novel mutations and strains. Connected
development is necessary to iterate through many different versions of instrument optics,
image processing algorithms, and base calling algorithms. And once the raw base calls have
been made data must be filtered to make sure it is valid. So for example, the molecular
barcodes added many steps before must now be checked using error correcting algorithms
such that any barcodes that do not match those originally put in (due to sequencing errors
or bad quality in particular portions of the run) can be discarded. This requires that the
original molecular barcodes be designed in such a way that error-correcting (Hamming)
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algorithms can take advantage of properly separated nucleotide sequences. For example
one would not want barcodes to have nearly identical sequences as a single error would
make them indistinguishable from one another but rather they must be designed to have a
maximum information entropy such that every barcode is as different from another as
possible (which makes them much more tolerant of errors while still being identifiable
from one another). This shows the extent that a "connecting" technology must cover across
the process to fully integrate the various steps. An alternative view of these "connecting"
technologies is the technology invasiveness concept developed by (Smaling and de Weck
2007) but which here is applied to processes rather than product design.
5.1.6.8 Analysis
Colleo . as soaio DNA Extraction DmNA * Mclr Seqencing Illumina
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The final macro section in the process is the analysis of the raw data produced by the
sequencing process. This activity is also a "placeholder" as many of the algorithms and
software are under significant development. The analysis activity involves validating the
data and filtering for low quality and errors. Much of the technology here is under active
development and very much in the prototype stage as the very first versions were only
developed recently for the human genome project and have had to be essentially redone
for the new sequencing technologies as described in (Butler, MacCallum et al. 2008). In
addition to the software provided by vendors, a number of other software packages exist,
some commercial and some academic, with varying levels of support and emphasis for
microbial analysis. This is the final and perhaps most critical "connecting" technology in the
MRSA surveillance process since the algorithmic and computational problem is very
significant but it is equally important to condense and synthesize the information such that
end-users like physicians, epidemiologists, and clinical microbiologists can use this process
to make effective observations and decisions on MRSA control. The high complexity of this
first prototype process must eventually be reduced for broader implementation of
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surveillance. Yet, the process is still under active development and will continue to need
significant "scaffolding" as changes and improvements continue to be made. Potential
strategies to deal with this type of change in complex process are described in Chapter 7.
The enumeration of the analysis process steps is shown in Figure 80, which describes the
image analysis step that translates fluorescence from each nucleotide label into raw data to
be interpreted as one of the four bases by the basecalling step followed by a filtering of this
data to remove lower quality data. The filtered data can then be used to align individual
"reads" corresponding to 50-100 base segments the instrument is able to read. There are
millions of such reads, and a key limitation of next generation technologies is that the reads
are very short compared to the size of the genomes being studied (i.e. 50 bases versus a
2.8Mb MRSA genome). This means that in order to fully assemble a genome from these
short reads, over 30-10OX the size of the genome being studied are needed in order to have
enough overlap and statistical confidence in their correctness to put the pieces of the
"puzzle" together. This is what is done at the alignment and assembly stages. The
alignment step simply takes all of the reads and "places" them on top of a reference
genome, such as an already sequenced MRSA, such that differences can be identified.
Assembly is a much more demanding process where the reads are assembled de novo into a
"new"p genome without the assistance of a reference, and much of this algorithm technology
using next generation data is under development. With the alignments or a fully assembled
genome, biological, epidemiological, and surveillance activities can finally be performed as
shown in Figure 80.
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Figure 80 - Analysis Process Elements
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Any potential discoveries in the data must be verified biologically by performing
confirmatory experiments on preserved samples. These confirmatory experiments will be
critical to the larger adoption of the process as it must be "trusted" and verified
independently, but before this can happen it must also be transferred elsewhere such that
the results can be reproduced and the medical community can verify the results. This later
part of the process life cycle is beyond the scope of this thesis, but could conceptually also
be modeled using the MDPM process model to facilitate the transfer and independent
verification of this process.
5.2 Multi Domain Process Model (MDPM) Creation
Process Feasibility 4.Idniiainodeinseiiaisadcntrns
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
Procss Fasiblity 3.) Identify potential process alternatives and design space
and Eement 4.) Identification of design specifications and constraints
5.) Selection of macro level feasible processes against design specification
Enumeration requirements
6.) Enumeration of process elements onto detailed process map for
selected process
Network Analysis 7.) MDPM creation from detailed process map8.) Analysis of MDPM model
With the detailed enumeration of process elements developed in the previous sections it is
now possible to create the MDPM model for the MRSA surveillance process. To facilitate the
understanding of the model application, the baseline process (without any improvements)
is compared to the "V1" process (the one actually used in this thesis) in the following
narrative. However, the general methodology would have a process designer use the
MDPM methodology to first identify the "baseline" process elements and use this to
iteratively find necessary additional elements or connections to make an improved process
work. Thus, the "baseline" description below refers to the initial set of process elements
identified in each of the domains that would need to be assembled into the version 1 (V1)
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initial process. The baseline description is useful in understanding the range of different
elements that will need to be connected to form a working process and also provides a
reference as to which elements are already connected. A process designer can thus focus on
adding only new connections and elements rather than duplicating existing ones or adding
unnecessary complexity.
5.2.1 Process Domain
The first step in building the process domain is to translate the detailed process map
developed previously into an activity-on-node directed graph representing the process.
Note that the previous enumeration was designed to produce the set of elements but these
have to be connected to each other according to the process paths available through the
process network. These are design choices or processing alternatives that exist and can be
exercised. The design choices described here are specific to the particular macro process
selected using the MCNF feasibility and element enumeration. However, reflecting the
iterative nature of the MDPM methodology if new feasible detail level activities are found
during initial testing, these are also reflected in the process domain. So for example, design
alternatives for molecular barcoding, data analysis, and upstream DNA extraction are
shown here as they represent alternative paths at the detail level. Building the process
domain is relatively straightforward in that each activity corresponds to a node and it is
most important to properly represent which nodes are connected to others particularly at
branch points. Also, the baseline process layer network does not contain any rework loops
as these were still largely unknown in the initial baseline stage. The most important goal of
the initial iteration of the methodology is to capture all of the necessary activities and their
relationships especially "connecting" activities spanning boundaries between processes
joined together such as DNA extraction which connects MRSA isolation and downstream
sequencing steps. The resulting process domain directed network graph representing the
detailed enumeration of process activities carried out in section 5.1.6 is shown in Figure 81
along with the corresponding "macro" process activities.
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Figure 81 - Baseline MDPM Process Domain for Surveillance Process
As with many graph-based process representations, the baseline MRSA process domain has
a number of sequential steps that would at first glance appear to have relatively little
complexity. However, this is mainly because the design alternatives have been filtered out
to a single feasible preferred path previously using the MCNF algorithm such that the
construction of the MDPM model can be demonstrated and the complexity analysis focused
on the multi-domain interactions for a single process. The MDPM model could be extended
to include the other process paths, such as the Roche 454 design alternative, and this
should likely be done in an enterprise MDPM model where both paths might be utilized. So
for example, the speed advantages of the Roche 454 path might be combined with the
greater per Gb efficiency of the Illumina process to produce a hybrid process that had both
a fast cycle time for a subset of samples and a low overall cost. The process alternatives
filtered out previously in this methodology are still explicitly described in this single
process model in the information domain as they represent connections across the process
boundary to other information, organization, and process networks. These alternatives
(such as the Roche 454 process) are represented as information elements that process
participants (and owners) must be aware of and if a true alternative becomes available (i.e.
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is cost competitive or offers other advantages) then this process would be mapped as a
branch point and parallel path along with its information and organizational domain
elements.
Yet, even this single process contains enormous hidden complexity as will be shown in the
construction of the MDPM model for this single process path. In addition, the baseline
process domain graph shown in Figure 81 does not contain many of the real world features
of processes, such as rework or queues that can greatly increase the complexity of even this
single path. For comparison, the graph incorporating the potential rework loops is shown
in Figure 82. Note that rework loops can only occur back to certain "buffer" points where
the process may be restarted (i.e. MRSA can be re-grown from culture) but that most
activities cannot go back to their immediate predecessor as most of these process activities
are "irreversible" or do not have an available QC readout until much later in the process.
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Figure 82 - MDPM Baseline Process Layer with Rework for Surveillance Process
Its is now possible to apply the graph metrics developed in section 4.1 to the process
domain graphs developed in Figure 81 and Figure 82 which were built using Microsoft
NodeXL and are stored as adjacency matrices. The associated metrics for the baseline and
"rework" process domains are shown in Table 18 and the associated adjacency matrices
are included in the appendix.
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Metric Baseline W/Rework Description
Sv 130 130 Number of distinct activities following enumeration
SE 246 271 Number of connections between activities
A 0.015 0.016 Fraction of a complete graph
diam 69 71 Longest process path
T 27.811 32.073 Average path length between two activities
B 0.946 0.915 Distance weighted fragmentation
M 117 142 Number of processes (defined paths) in domain
Table 18 - MDPM Process Domain Metrics for Demonstration Process
Of particular interest in the process domain is the diameter of the network, which
represents the longest process path and is indicative of the process complexity. Note that
the addition of rework loops significantly increases the average path length as a much
larger set of potential processes is now available. The cyclomatic number is also
particularly useful in describing the process complexity as it describes the number of
linearly independent paths through the process layer, and adding rework loops greatly
increases these (from 117 to 142). Because the process considered in this thesis has a
relatively small number of decision points the cyclomatic number is relatively small, but
processes with significantly more rework loops or decision branches would have a
correspondingly higher cyclomatic number. As discussed previously the density of the
process layer is also relatively low mainly due to the process properties, which require a
certain precedence between nodes, directed relationships, and physical constraints for
rework (i.e. not every node can be connected to any other).
5.2.2 Organizational Domain
Building on the process element enumeration, all of the organizational domain elements
are also enumerated. Although in practice the organization and information elements are
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enumerated as part of the process element enumeration performed previously, only the full
enumeration is shown in Figure 83 to explicitly separate each of the domains in the
presentation of the methodology. The organizational map in Figure 83 shows the
cumulative set of organization domain elements corresponding to the enumeration of
process activities. As part of building the MDPM model, the individuals and organizations
associated with each process step are defined with the same process boundaries. Thus,
Figure 83 represents all of the individuals associated with the process layer but within the
process boundaries. Not every process activity must be associated with an organizational
or information domain node, but the lack of a connection between the process domain and
information or organization domains means that a process activity is "unsupervised" and a
problem in that activity or a change elsewhere in the process network affecting the activity
could be a problem. In graph terms this means that process domain nodes not connected to
the other two domains are not reachable and thus cannot be "seen" by other nodes on the
graph. For example, this could have serious implication for troubleshooting as a problem
associated with a node that was not "visible" would be difficult to identify or fix.
Conversely, a change (or improvement) in a node that is no "visible" may have serious
impacts elsewhere in the process, but that node itself may not be able to realize this impact.
An example might be that given previously of a technician working in one of the reagent
manufacturers is very far removed from the physician using the diagnostic which uses a
particular reagent the technician makes. A small change in the reagent may have a serious
consequence far downstream in the process. Note also that in Figure 83 there are a
number of individuals
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Figure 83 - Organization Domain Elements Enumerated from Macro Process
The organizational layer most closely represents traditional social network analysis as
their association with the process drives relationships between individuals, but
communication between them can also exist at random through friendships, peer
relationships, and other social structures. Complex processes such as the whole genome
MRSA surveillance process prototyped in this thesis can span numerous organizations and
individuals that would not normally be connected. By chance some connections may exist,
facilitating the integration of a process, but the goal of this thesis is to provide analytical
tools to understand the degree of communication needed across all the domains, including
the organizational one. Figure 84 shows the same set of enumerated individuals and
organizations but adds the connections between them for the baseline process (before the
MRSA surveillance process was built). It is readily apparent that the initial organizational
domain network is highly fractured with a number of disconnected groups, and weakly
connected individuals within these groups. The disconnectedness of the organizational
domain network is partly a function of the number of disciplines that must be connected to
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build the surveillance process ranging from medical practice to microbiology to computer
science. These "silos" represent significant barriers to the development of complex
healthcare processes as the increasing specialization of each discipline or technology
results in greater fragmentation of the network supporting a given process. This
fragmentation may also be the result of the way a hospital enterprise is set up with
departments and labs rather than structuring around processes which might improve the
alignment of individuals and facilitate communication. The "pre-existing" connections
between nodes shown here were found from interviews with the individuals enumerated
in Figure 83 and from observation of the process. Note that some nodes are
"organizational nodes" which represent multiple individuals, such as the set of physicians
or patients and are marked as such. The goal is to provide a representation of the actual
process in a feasible manner as detailed representation of all organizational nodes (i.e.
mapping the connections of all the nursing staff) is only warranted if initial analysis shows
those nodes to be particularly problematic (i.e. cannot easily be reached, contribute to long
path lengths, etc.).
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Figure 84 - Baseline MDPM Organization Domain for Demonstration Process
One of the most important steps in building the demonstration MRSA surveillance process
was to connect all of the various groups and individuals such that the organizational
domain could be a single connected network. Much like the example in Chapter 3, the
author of this thesis served as "process owner" to facilitate communication across various
"silos" and function as a hub for the design, initial tests, troubleshooting, and integrated
analysis of the process. In addition other connections were necessary to facilitate
communication across critical "connecting technologies" such as the communication
between the DNA extraction scientist and the clinical microbiology laboratory. Additional
connections were also needed for the molecular barcoding connecting technology as this
technology impacted not just the molecular biology sample prep but also the necessary
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downstream data analysis software that must disambiguate (pull out) the individual
barcodes in the data. All of the necessary additional connections are shown in red in Figure
85 below superimposed on the "baseline" fragmented organizational layer.
Figure 85 - V2 MDPM Organization Domain for Surveillance Process
The associated metrics for the organizational domain "baseline" and the first version
prototype process "V1" are shown in Table 19. Most significantly the V1 organizational
domain is a single connected component, which allows for the calculation of certain
network metrics such as average path length and directed efficiency. The density of the
organizational domain is also relatively low compared to the maximal density (1) of a
complete graph where every node is connected to every other one. However, this reflects
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the real-world sparseness of organizations especially "multi-silo" processes such as the one
assembled in this thesis.
Metric Baseline V1 Description
Sv 53 54 Number of organizational elements
SE 184 242 Number of connections between elements
A 0.0668 0.0846 Fraction of total possible connections
d 3.472 4.481 Average degree for a node
diam 7 8 Longest path between elements
i 2.980 3.556 Average path length between two nodes (reachable)
B 0.873 0.642 Distance weighted fragmentation
F 0.745 0.000 Fraction of nodes that cannot reach each other
Cn 7 1 Number of weakly connected components
M 132 189 Number of communications paths in domain
e - 0.35 Directed efficiency
Table 19 - Organization Domain Metrics for Baseline and V1 Processes
Of particular use in the analysis of organizational domain is the efficiency metric, which
gives a sense for how easy it is to communicate across the network in relatively few steps.
This metric which is the sum of the inverses of the individual node shortest paths (geodesic
distances) normalized by the maximum possible density better represents the "fall off' in
efficiency with longer paths between individuals in the organizational layer. So for example
a network with very long paths between nodes will have a very low efficiency compared to
one with relatively shorter path lengths. A fully connected network would have an
efficiency of 1.
Improved efficiency comes at some cost in terms of bandwidth as the average degree of
each node must necessarily increase. In computer communications networks where
bandwidth may not be limiting it is feasible to increase the number of connections for each
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node to improve efficiency, however in the "human" organizational domain this is likely not
feasible as complex processes may have hundreds of individuals and increasing the number
of connections for each node may not be possible. However, hierarchical structures such as
those discussed in Chapter 4 offer some solution as many "connections" can be accepted
with a relatively small increase in the number of additional nodes. Empirically this is a
common solution in complex enterprises such as healthcare and is observed here as well
with hierarchies of technicians, coordinators, supervisors, and managers. The metrics for
the V1 process show that the efficiency of the organizational domain is not high (0.35) and
the average path length would seem to be significantly long (3.556) making rapid
communication and troubleshooting difficult.
5.2.3 Information Domain
The detailed enumeration of all information domain elements is given in the appendix as
part of the adjacency matrix, but follows the enumeration of elements performed so far.
The number of elements for the baseline model is 251 elements and 292 for the "V1"
model. The information domain elements contain all of the protocols (work instructions)
needed to carry out the activities described in the process domain. However, the
information domain also contains the "genealogy" of these work instructions which are in
their great majority derived from guidelines given by regulatory agencies or professional
bodies such as the AMA, design documents which describe the choices made in selecting
the particular parameters the protocols use, or most commonly are special cases of
"general" instructions or protocols. In addition, the actual protocols routinely used in
healthcare or research laboratories generally incorporate commercial kits or reagents with
their own particular set of instructions (vendor instructions). Tracing all of these
"genealogies" within the process model boundaries is key to the MDPM model analysis
since the protocols describing an activity are often highly simplified work instructions
containing only the necessary information to carry out the activity. However, in cases
where the impact of a change elsewhere in the process might require modification to a
particular protocol, it is necessary to "trace back" the protocol back to design documents or
other reference documents to evaluate whether the change will require a change to the
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protocol. The design and reference documents are themselves not usually connected to the
individuals performing the activity using the protocol derived from them, but may require
specialized knowledge that only the activity designer may have.
An example might be the operation of a particular robotic liquid handling system in a
diagnostic laboratory. While the technician will likely be very familiar with the detailed
protocol to run the instrument, a change to the sample input material requirements might
require reviewing the design and optimization documents (the design space) to see if the
new input material changes are within the feasible design space. These design documents
may only be familiar to design engineers and scientists and not "accessible" to the
technician in a network sense. A connection would thus exist between the technician and
the protocol but not necessarily between the technician and the design documents. The
protocol would be shown in the information domain as having been derived from the
design documents by a directed arrow. The design documents would then have separate
connections to the scientists and engineers in the organizational domain. An important
point emphasize is that there may or may not be connections between the design scientists
and engineers and the technician, and if so change and troubleshooting will be much
harder since the path lengths from the design documents and the practical (tacit)
knowledge of the technician will be longer. This is an important feature of many process
improvement systems such as the Toyota production system, which fosters direct
communication between "frontline" workers and R&D knowledge and resources such that
problems (troubleshooting) can be resolved rapidly and with a minimum of steps (in a
network sense). The graphic in Figure 86 shows the baseline information domain with
blue triangles representing information domain elements. As with organizational domain,
the information domain also shows the high degree of fragmentation of information
(knowledge) associated with the surveillance process. This again is a function of the many
disciplines, technologies, and organizations spanned by the surveillance process and is
indicative of the "silos" commonly encountered in assembling complex processes from
highly specialized elements. Figure 86 should be viewed from the perspective of a "process
owner" or an individual responsible for ensuring that all of the variables, parameters, and
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design spaces in each of these separate information networks can be joined together in a
working fashion into a single process (and network).
4 \If/
At
Figure 86 - MDPM Information Domain for Baseline Surveillance Process
In order to verify that the parameters and design spaces of each protocol are either
adequate or need to be changed, the first thing a process designer might do is to perform a
detailed review of every protocol according to the process specifications. Because of the
many protocols that need to be reviewed and the multiple disciplines in which they fall, the
process designer might choose to do "hierarchical" reviews in each discipline followed by
an overall review integrating these into a single design document specifying what changes
are needed in the existing protocols or which new protocols are needed. This is in fact what
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was done in this thesis to build a surveillance specific process. Each of the existing
protocols was reviewed in their own area, such as sample prep protocols which were
reviewed in a "molecular biology review" which verified that existing protocols would
suffice or specified the new parameters that would have to be used in order to process
MRSA genomes. Each of these individual reviews were then tied together into a master
design document specifying the "V1" process which detailed whether existing protocols
could be kept "as is", needed changes, or entirely new protocols were needed. Where
protocols were kept "as is" a bidirectional connection between the review documents in the
protocol was made, which in a network sense means that no additional "steps" are needed
to reach these unrevised protocols. Where changes were needed, new protocols specific to
the MRSA process were added as nodes and connected from the review documents.
Similarly where entirely new protocols were needed, the review documents pointed to
design and experimentation records (such as those performed for the molecular
barcoding), which in turn produced the actual new protocols used. All of these items are
shown in the graphic below, where the red lines indicate connections to the "reviews" and
the maroon diamonds represent reviews and new protocols generated as part of the design
process.
Note that showing the intermediate "reviews" suggests that the information domain
network shown is the time evolution from the initial baseline network to the final network
and thus might not represent the actual "final" process. However, it is important to
recognize that the objective of the MDPM is to capture the real complexity of processes,
especially when they fail and require troubleshooting or changed and require redesign. In
both the troubleshooting and redesign cases the entire process network must be
"searched" for either the problem in the troubleshooting case or affected nodes in the
redesigned case. The search would extend to the original sources of the protocols in use
and require that all of the design decisions, design spaces, and original "generic" work
instructions be available on the network this can be accomplished in a manner similar to
the "versioning" of MDPM models described in Figure 64. As processes mature it is likely
that all of this extra "scaffolding" would no longer be needed, however in rapidly changing
environments explicitly showing the scaffolding represents the true complexity and allows
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for search. It is also important to note that it is not only when processes are rapidly
changing the scaffolding is needed, but likely also when a process must be implemented
into many different locations, organizations, and infrastructure. No two hospital systems
are alike and modifications will be needed to implement this process into each of those
unique environments, which will in turn require further "search" of the network.
Figure 87 - MDPM Information Domain for V1 Process
Using this "V1" network is possible to calculate the information domain metrics in
comparison to the baseline network as shown in Table 20. Of particular interest in the
information domain is the degree of fragmentation before and after the process design,
where the initial baseline fragmentation degree represents the fraction of the network in
"silos" as does the number of components. Note that the directed efficiency of the
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information domain (0.12) is significantly lower than the efficiency of the organizational
domain as short paths do not connect most elements. The low density of the information
domain network also reflects this.
251
296
0.0047
1.681
2
1.182
0.995
0.836
19
292
598
0.0070
2.048
5
3.865
0.879
0.000
1
307
0.12
Number of information elements
Number of connections between elements
Fraction of total possible connections
Average degree for a node
Longest path between information elements
Average path length between two nodes (reachable)
Distance weighted fragmentation
Fraction of nodes that cannot reach each other
Number of weakly connected components
Number of paths in domain
Directed efficiency
Table 20 - MDPM Information Layer Metrics for Demonstration Process
5.2.4 MDPM Analysis
1.) Description of process, stakeholders, and goals
2.) Identify macro process activities and define boundaries
Process Feasibility 3.) Identify potential process alternatives and design spaceProces e lty 4.) Identification of design specifications and constraints
and Element 5.) Selection of macro level feasible processes against design specification
Enumeration requirements
6.) Enumeration of process elements onto detailed process map for
selected process
Network Analysis 7.) MDPM creation from detailed process map8.) Analysis of MDPM model
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Having populated the process, organization, and information domains it is possible to
analyze the full MDPM matrix, which incorporates connections across domains as
described in the MDPM model development in Chapter 3. The full MDPM matrix (also called
the projection domain in this thesis) incorporates connections between elements
(individuals) in the organizational domain and information domain such as the familiarity
of a protocol by a technician or the familiarity of design documents by a research scientist.
Connections between all domains are shown in the projection domain and a corresponding
increase in the complexity of the network results, more closely approximating the "real"
process complexity. The initial "baseline" network includes only baseline nodes and
connections as developed in the previous sections. While the baseline organization and
information domains by themselves showed many disconnected elements, in the projection
domain they are connected through the process and across domains. This full baseline
process network is shown in Figure 88 representing the much greater complexity of
interaction across domains of process, organization, and information. This baseline
network contains 437 elements (nodes) and 3,338 connections (edges) with a diameter of
17 and an average path length of 6.3. The efficiency of this network is rather low, 0.227, in
comparison to the organization domain and the eventual "V1" network.
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Figure 88 - Baseline MDPM Projection Domain for Surveillance Process
To highlight the additional nodes and edges needed to form the initial "V1" network, Figure
89 shows the full V1 network with the additional nodes and edges from the baseline
network highlighted in red. At the center of Figure 89 is the process owner, but other nodes
such as the process reviews are clearly visible some in hierarchical arrangements. The V1
network contains 480 elements and 4,289 connections with a diameter of 7 and an average
path length of 3.6. The efficiency of the V1 network is much higher at 0.307, but additional
design improvements could be made to further increase this value.
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Figure 89 - MDPM Projection Domain Showing Baseline and V1 Processes
The individual domain elements can be highlighted on the full process network as shown in
Figure 90 where red squares represent process elements, blue diamonds represent
information elements, and green circles represent organization elements following the
convention in Chapter 3. Certain clustering patterns emerge when the full V1 process
network is shown highlighting each layer individually such as the concentration of
information elements around certain individuals and the responsibility for multiple
process steps by key individuals as well.
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Figure 90 - MDPM with Domains Highlighted for Surveillance Process
Comparing the metrics between the baseline and the "V1" model, the additional network
connections and notes needed to make the process work empirically (real world work to
produce the data described in Chapter 6) do result in measurable improvements to the
process network. Most notable is the increase in network efficiency and the reduction in
average path length as shown in Table 21. The additional nodes and connections in the
"V1" network were not added with the explicit goal of improving the network metrics, but
rather simply were connections and elements made necessary in the design and
development of the process to simply make it work. These connections were encountered
as part of the initial design, as problems surfaced, or as part of an initial optimization.
Because the objective of this thesis was to develop a network process analysis methodology
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by testing and validating against a real-world process, the MDPM model was developed
simultaneously with the "V1" surveillance process. However, having developed the MDPM
model it is possible to imagine using it to develop a process from "scratch". In this case the
MDPM model would be used as part of the initial design phase to find a process that
satisfied certain network metrics such as a minimum efficiency, average path length, and
cyclomatic number.
Metric Baseline V1 Description
Sv 437 480 Number of elements
SE 3,338 4,289 Number of connections
A 0.0175 0.0187 Fraction of total possible connections (cross-domain)
i 8.011 8.944 Average degree for a vertex
dmax 92 100 Maximum Vertex Degree
diam 17 7 Longest path (cross-domain)
T 6.343 3.636 Average path length between two nodes (reachable)
B 0.773 0.693 Distance weighted fragmentation
F 0.000 0.000 Fraction of nodes that cannot reach each other
Cn 1 1 Number of weakly connected components
M 2,902 3,810 Number of processes (defined paths) in domain
0.227 0.307 Directed efficiency
0.0030 0.0023 Network vulnerability
14.629 11.280 Average search information needed
I 3.9447 4.4065 Graph structure entropy
Table 21 - Projection Domain Metrics for MDPM Demonstration
The heavy reliance of the VF model on the "process owner", also the thesis author, as a hub
to effectively reduce the average path length is not necessarily a sustainable model for the
development of other processes in healthcare. In this case, the requirements for a process
owner familiar with molecular biology, microbiology, computer science, process design,
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genomics, and social network analysis allowed for the relatively rapid implementation and
integration of the disparate elements needed to make the surveillance process work.
However, this is not necessarily a common resource and presents significant barriers to
process improvement and change in healthcare unless specific enterprise structures are
designed to overcome the fragmentation of organizations, knowledge, and resources. A
clear view of this is Figure 91, which plots the betweenness centrality of each of the nodes
in the V1 process network calculated using UCINET (Borgatti, Everett et al. 2002) a social
network analysis program. The nodes with the highest betweenness centrality are
highlighted in red indicating they are on the shortest paths of the majority of the node pairs
in the network. Note that there are nodes in both the organization and information layers
with high betweenness centrality, such as the molecular biology process review
(information layer element) and the process owner (organization layer element, and also
the element highest value of betweenness centrality). A corollary of having these high
betweenness centrality nodes is that they are also likely the best "transfer" nodes such that
the surveillance process could be transferred to another organization and location as they
can best connect to the rest of the network to "get" any necessary information. The MDPM
model could in a transfer scenario be used to map the target organization for the transfer,
identify the key nodes in both (organization and information) such that transfer of the
process had the highest likelihood of success as measured by network metrics such as
average path length and efficiency over the combined "source" and "target" networks.
Because there are both organization and information nodes with the highest betweenness
centrality values, the transfer of a process to another organization would require access to
both the individuals perhaps in some formal training process, but also require the "target"
organization to systematically review (and understand) the design documents such as the
molecular biology process review and the sequencing sample prep process reviews such
that any changes specific to the target organization's structure could be evaluated by them.
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Figure 91 - Betweenness Centrality for the MDPM V1 Surveillance Process Model
An alternative view of the network is degree centrality, where network elements (nodes)
with the highest degree are highlighted, the premise being that in social structures high
degree nodes are well-connected and have high "brokerage" abilities. The figure below
shows the V1 network with node size as a function of degree centrality, and with the
highest degree centrality nodes highlighted in red. In the context of the projection domain
of the MDPM model high degree nodes may represent "network" nodes as described
previously in Chapter 3 such as a "nurse staff' representing the nursing organization at a
hospital rather than individually modeling each nurse. However, when individual nodes
that are not "network" nodes have high degree this may represent a bandwidth
overloading of that node where the hierarchical structure may better deal with an
excessive number of connections. For example, in the V1 model the "process development
scientist" node has the highest degree centrality partly because of the many dimensions of
the sequencing process that are changing simultaneously and the need to integrate them. In
some sense this process development scientist serves a similar role to the process owner
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but within the sequencing portion of the surveillance process. It is worth noting again that
the surveillance process is built on existing elements (and processes), which are in
continuous flux, the sequencing process being one of them. The management of this change
requires a significant amount of scaffolding, which would likely be removed as processes
were stabilized and a "V2" process was built that further simplified the complexity found in
the V1 process. A V2 process might therefore remove the process development scientist in
exchange for multiple nodes (additional staff) that could better deal with the many process
connections needed. These multiple nodes might be arranged in a hierarchical fashion with
the existing process scientist in the middle such that the individual "bandwidth" of each
node is not exceeded.
Figure 92 - Degree Centrality for the V1 MDPM Surveillance Process Model
Once a process has been described using the MDPM methodology, it is possible to apply a
wealth of network analysis algorithms to better understand the patterns and potential
weaknesses (and strengths) of the process. A particularly useful metric is the "search
information" required to traverse a network, as proposed by (Rosvall, Gronlund et al.
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2005). The basic idea is that in order to find another node within a network there are a
series of "yes/no" questions that must be asked at each node in order to pick the shortest
path route. This can be thought of as the product of the probabilities at each node along the
shortest path of picking the right shortest path edge. The negative base 2 log of the product
of these probabilities along the shortest path corresponds to the amount of information in
bits needed to find the shortest path. This search information can be calculated from every
node to every other node in the MDPM model such that the amount of information needed
for every node pair shortest path can be found. Nodes with a very high search information
value should correspond to nodes that are particularly difficult to manage in
troubleshooting or process change cases. As a reminder of how the search information is
calculated, Equation 20 - Average Search Information Metric is presented again.
|V {P4.b k, jE=P.,) k, -I
where k is the vertex degree, p(i,b) is the set of all shortest paths from i to b, and V is the set of
vertices in the graph
Equation 20 - Average Search Information Metric
A high search information value is interpreted to mean that the impact of a change at that
node on the rest of the network is difficult to assess and similarly the effect of a problem at
that node on the rest of the network will be difficult to identify. The search information for
every node in the baseline and V1 networks was calculated (methods shown in the
appendix) and the resulting values were plotted on the network nodes and edges as a color
scale with the lowest values in black and the highest values in red as shown in Figure 93.
The baseline network shows many nodes in each of the layers with high search information
values especially around some of the more fragmented (siloed) parts of the process such as
the upstream sample collection by a variety of nursing staff and parts of the DNA extraction
process. Overall the baseline network has a significantly higher average search information
requirement of 6,392 "questions" compared to 5,414 for the V1 network. These values
mean that on average each shortest path would require this many "questions" (i.e. asking at
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each node: is this edge the correct one on the shortest path to node Y?). While in practice,
the troubleshooter of a process would likely have a sense for which nodes are connected to
which, making the search an informed one rather than a blind one, the blind search
information values are valuable to identify which nodes should be better connected such
that they can be readily searched for impact or problems.
12,000 "questions"
3,000 "questions"
Figure 93 - Baseline MDPM Search Information
In comparison the V1 network has a much lower average search information value as can
be seen in the network plot in Figure 94 on the same scale as the baseline network plot. Of
note are certain process elements not immediately considered in the initial design, such as
the triage of samples coming into the clinical microbiology laboratory from collection
throughout the hospital. This activity has a significantly higher search information value
and upon reflection could correspond to a significant failure mode for the surveillance
process since improper triage could lead to missing or incorrectly processed samples, the
results of which would not be apparent until much later in the process. Similarly any
simple triage workflow changes or protocol changes could have a very significant
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downstream impact given the number possible paths downstream of that node. Note that
the term downstream only refers to the shortest path from that node to another rather
than an actual process direction. So for example the process design scientist also has a high
search information value suggesting that certain parts of the process, such as the nursing
and physician associated process steps are not readily "visible" from that node and yet
changes in sample collection practices or other "difficult to see" nodes could readily impact
process activities associated with the process scientist. Again this is a design tool that could
be used to design a V2 process that further reduced the search information necessary such
that troubleshooting and process change could be greatly facilitated.
12,000 "questions"
3,000 "questions"
Figure 94 - V2 MDPM Search Information
The properties that make networks robust are also likely to contribute to lower the search
information needed, although at the cost of additional "scaffolding" in terms of additional
nodes and edges. For example having multiple alternative shortest paths (i.e. same
Page 272 of 385
shortest path length but different routing) can decrease the search information needed as
there are now many more chances to find a shortest path and the sum of the products of
these probabilities along each path will greatly lower the average search information for
the network.
5.3 Comparison to Culture Based Diagnostics
For comparison, the process and organizational domains for culture based diagnostics are
shown in Figure 95. While this process has the same up front complexity in sample
collection and preparation, the downstream processes are much simpler and require
significantly less scaffolding than the DNA sequencing based process. There are a number
of reasons for this lower complexity, principal among them is that culture-based
diagnostics span fewer fields than DNA-based sequencing being almost entirely contained
within microbiology. During their development these culture-based diagnostics did of
course require the involvement of other disciplines, especially in the semi automated high
throughput versions found in clinical microbiology laboratories. However, most of these
processes are mature and there is limited need for the direct involvement of these other
disciplines (such as automation engineering) in the day-to-day operation of a clinical
microbiology lab. These processes are still connected to automation resources but through
much longer network distances such as the connections the service technician assigned to a
lab might have through his or her supervisors and across to the R&D group within the
particular vendors organization. Through continued improvement and targeted complexity
reduction however it is possible that the DNA sequencing based process could reach the
much lower complexity of this process as is described in Chapter 7.
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Figure 95 - Culture Based Diagnostics Process and Organizational Elements
5.4 Connecting Technologies
One of the most critical elements in building the V1 process was the identification and
development of the necessary connecting technologies such as DNA extraction, modular
bar coding, and data analysis to integrate the various existing process elements. In the
feasibility selection phase of the methodology these are also called "placeholder" activities,
as they describe process elements not yet available that are nevertheless necessary to
connect the entire process together. These can also be though of as technologies that will
be inserted into process to modify them to another purpose, and has similarities to the
work by (Smaling and de Weck 2007) relating the impact of technology insertion and
product design using DSM analysis. The key difference is that diagnostic process steps
cannot easily be rearranged and in some cases cannot physically be changed in terms of
their logical precedence. Similarly the organizations in which healthcare processes occur
have certain structures related to the performance of other processes (i.e. other diagnostics
or patient care procedures) that dictate certain organizational structures, which are
unlikely to be changed for the benefit of a single process. An expansion of the MDPM model
to the enterprise-level might allow for the global optimization necessary but in many cases
the critical connecting technology must be inserted within a "fixed" process and
organizational structure. It is especially important therefore to map the impact of a
connecting technology (or technology insertion) into the overall network. Figure 96 maps
each of the key surveillance process connecting technologies into the process network with
the corresponding edges colored in red showing the extent to which these technologies
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affect the rest of the network. The connecting technologies considered are DNA extraction
shown as green circles, modular barcoding shown as yellow squares, genomic data analysis
shown as blue diamonds, and process design shown as aqua triangles. Note that for this
figure the standard process, information, and organization symbols and colors are
different.
Figure 96 - MDPM Connecting Technologies for V1 Surveillance Process
DNA Extraction
Genomic Data Analysis
From Figure 96 it is apparent that the "connecting technologies" have a significant impact
on the rest of the process network and with each other, showing how widespread the
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impact of a new technology or change can be on a complex process. Descriptions of the
technical details of each of these connecting technologies along with their impact on the
MDPM network are given in the following sections.
5.4.1 DNA Extraction
One of the hardest problems in building the V1 process turned out to be what initially was
thought to be the easiest: DNA extraction from the MRSA microbes. Many clinical
microbiology labs routinely prepare MRSA samples for PCR-based assays but these are
significantly less demanding of the quality and quantity of DNA produced with pico grams
of fragmented DNA being sufficient to amplify the relatively small PCR targets (in the
hundreds of bases) these assays target. In contrast next generation DNA sequencing
requires 10 to 20 micro grams of DNA in large (greater than 20,000 base) single molecules.
The impact "footprint" of the DNA extraction connecting technology is shown in Figure 97,
where the DNA extraction related nodes in the organizational, information, and process
domains are highlighted as solid green circles and immediate connections in red.
Figure 97 - Direct Impact of DNA Extraction on V1 Surveillance Process
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A key observation from Figure 97 is that there are relatively few "long range" connections
to this technology in the process network and it would appear to be fairly "modular" as
most of the green nodes connect to each other with a few edges extending into the process
network. However, this "modularity" could also be interpreted as a silo, where the DNA
extraction portion of the process is not easily "reached" other than through a few
connections. An observation from the network analysis but also an empirical one from
developing the process is that these local "neighborhoods" must be formally tied together
rather than relying on informal ad hoc connections to convey critical information. This
means that instead of relying only on social network structures such as (Watts 2003)
"small worlds" or (Granovetter 1973) "strength of weak ties", formal mechanisms must be
put in place to also review elements of the information domain, and to actively "test" the
process using industrial design of experiments methods such as those in (Box and Liu
1999). This might mean that instead of the relatively isolated DNA extraction portion of
the process, that early identification of this key technology as an issue might allow for its
"packaging" as a much better integrated module with formal design reviews to connect the
information layer elements, a specific set of intra-process stakeholders, and a key set of
"connected" experiments to determine the impact of changes in this part of the process on
the rest of the process network. These ideas will be explored later in this chapter in
describing potential improvements to produce a "V2" process.
The very first iteration of the process used a "standard" molecular biology protocol based
on the leading vendor, Qiagen, which sells column based DNA extraction kits in routine use
throughout the world for high molecular weight DNA applications. The particular product
used was the Genomic tip 100/G and associated buffers from Qiagen. The 100/G product
comes with a detailed guidebook detailing how it should be used to prepare DNA samples
from a variety of sources, and how these samples can then be processed through the 100/G
tips. Despite the kit being sold as an easy to use product, there are a large number of steps
in the Qiagen DNA extraction process that require extreme user skill and tacit knowledge.
For example, one of critical steps in obtaining DNA is to carefully wash with ethanol a hard
to see and easily disturbed pellet on the side of a glass tube after centrifugation, which
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requires great skill on the part of the technician (as the author was able to verify in
performing a number of these extractions). The detailed process steps in the protocol are
shown in Figure 98 adapted from the vendor manual (Qiagen 2001). Steps requiring tacit
knowledge (and technician skill) highlighted in red.
Qiagen Procedure for Bacterial DNA Extraction
100/G Midi Prep (25-90ug DNA in 20-160Kb Yield)
* Grow Sample: MRSA Culture in LB Media (2.2 x 101 cells) [tacit] [variable]
- Prepare Necessary Reagents
* Pellet MRSA cells by centrifugation at 3000-5000g for 5-10 min. [tacit]
- Discard supernatant
- Resuspend pellets in 3.5ml of buffer B1 (w / Rnase A)
* Vortex to resuspend thoroughly [tacit]
e Add 80ul of lysozyme stock solution and 100ul of Proteinase K solution
* Incubate at 37C for at least 30 min. depending on how well resuspended [tacit]
- Add 1.2ml of buffer B2
* Mix or vortex thoroughly for few seconds [tacit]
s pee - Incubate at 50C for 30 min.
Verify lysate is clear, otherwise extend incubation and/or centrifuge [tacit]
- Equilibrate 100/G tip with 4ml buffer QBT and allow to empty by gravity flow
Vortex sample for 10s @ max. speed and apply it to tip [tacit]
- Wash tip with 2 x 7.5ml of buffer QC by gravity flow
- Perform additional wash with 1 x 7.5ml of buffer QC if needed [tacit]{ Elute genomic DNA with 1 x 5ml of buffer QF pre-warmed to 50C
- Collect in 10ml glass centrifuge tube
- Precipitate DNA by adding 3.5ml room temperature isopropanol
- Mix by inverting the tube 10-20 times [tacit]
- Mark outside of tube
- Centrifuge >50OOg for at least 15m at 4C
hpesmpmcan e Locate pellet, which may be difficult to see [tacit]
Carefully wash the loosely attached pellet with 2ml of cold 70% ethanol [tacit]
- Carefully wash again if needed with 2ml of cold 70% ethanol [tacit]
* Vortex briefly [tacit]
- Centrifuge at >5000g for 10 min. at 4C
* Carefully remove the supernatant without disturbing the pellet [tacit]
- Air dry for 5-10 min. without over-drying [tacit]
- Resuspend the DNA in 1ml TE carefully by rinsing walls to recover all DNA [tacit]
- Dissolve DNA on a shaker at 55C for 1-2h or overnight [tacit]
Figure 98 - Qiagen 100/G Genomic Tip Protocol Showing Tacit Knowledge Steps in Red
(Adapted from Qiagen)
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Figure 98 highlights the need to look across domains in complex processes, since despite
there being a documented protocol, or work instruction, in the information domain, the
organizational domain connections are critical (containing the tacit knowledge). This
become even more important in the transfer and scaling of complex processes, since it
would not be sufficient to simply hand over the protocol shown in Figure 98 without some
degree of training or interaction with the technicians that are familiar with the process and
know the "tricks" to make it work as part of their tacit knowledge. The steps in black in
Figure 98 represent explicit instructions with little or no judgment or skill required. A key
variable in the use of the QIAGEN system is to produce a cell culture without too many cells
(not more than 2.2 x 1010 for the 100/G) so that the genomic tip is not overloaded.
However, this requires careful calibration of the growth media to match the growth rate of
the particular cells and also depends on the type of cell being lysed, as the thick cell wall of
MRSA means there is more cellular debris, which can lead to clogging of the tip. Typically
the QIAGEN process can be optimized for a particular organism, where are all the cells will
be similar leading to similar yields. However, for this surveillance process the input MRSA
cells are expected to be different with varying growth rates and potentially cell wall
thicknesses. The many downstream tacit steps compound the initial sample variability, as
they require adjustment based on technician observations, skill, and judgment. All this
leads to a highly variable process. A key paragraph in the vendor manual is the following:
protocols are optimizedfor use with fixed cell densities corresponding to the
capacity of the QIAGEN Genomic-tip used. Overloading tips with DNA from an
excessive number of cells (too much culture volume) will lead to reduced performance
of the system. .... Please note that culture volumes may differfor other species of
bacteria."
The Qiagen method was initially used "off the shelf" to extract DNA from an initial panel of
MRSA microbes totaling 168 attempts on a panel of 150 distinct samples obtained with
anonymous labels from the Channing Laboratory at Harvard Medical School. The expected
DNA yield was in the range of 25-90ug of DNA per the manufacturer. Figure 99 shows the
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actual DNA extraction yield obtained in micro grams of DNA from each of these attempts
with the region in red denoting the acceptable yield range for the sequencing process.
While some samples performed within the expected range, most produced very little yield
and others produced none at all. The combination of input sample variability and a large
number of also variable (tacit) steps in the protocol produce a highly variable and difficult
to control process as shown in Figure 99 with only a few of the samples having sufficient
DNA to continue the process.
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Figure 99 - MRSA DNA Extraction Yield from Un-optimized Qiagen 100/G Process
However, one interesting observation resulting from this initial effort was that certain
samples appear to produce reproducible DNA yields suggesting certain properties of the
microbes themselves might be the cause for the observed variation rather than variability
in the technique or reagents. A possible explanation may be that each of these strains have
either different cell wall thicknesses or different growth rates that fall within the feasible
parameter range for the process. Different cell wall thicknesses would lead to some cells
lysing under a given set of conditions and others with thicker cell walls not lysing at all
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which would explain the zero yield results. The other hypothesis is that differential growth
rates will lead to some samples growing far more cells than others and potentially clogging
the DNA extraction filters also explaining the zero yield attempts. In order to identify the
root cause of the issue a design of experiments series was run testing each of the key
variables in this part of the process. A series of DOEs were eventually required to zero in
on conditions that would work for a variety of different samples, and a representative DOE
is shown in Figure 100 developed by a Marcia Lara, a scientist in the Broad Institute
specializing in DNA extraction along (also the DNA extraction scientist "node" in the
organizational domain) with the clinical microbiology laboratory staff at the Brigham and
Women's Hospital, and the thesis author.
harvest a few
colonies Combine into 1 a 80ml transfer Bird
into 8 x 15 ml
Falcon tubes
inoculate into 4 x 20ml LB
O/N growth, no shaking
50ml Falcon tubes
8mi tube > lyse @ 37C for lr Centrituge and load into column 25923A
Bn tube NO Centrifuge and load into column 259238
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Figure 100 - MRSA DNA
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The particular DOE shown in Figure 100 varied the incubation time following the addition
of lysostaphin to digest the thick MRSA cell wall, as well as centrifugation or not post
incubation. The 4 incubation conditions, and +/- centrifugation were attempted on each
of four MRSA samples, yet this experiment did not find a condition that worked for all four
samples. A large number of similar experiments were performed varying nearly all of the
parameters in Figure 98, and some conditions were found to deliver sufficient DNA yield,
but not sufficient quality as is described next.
A second key requirement in the DNA extraction process was the need for large size
fragments (>5Kb) as these may be needed for the downstream computational assembly.
Further optimization was required to deliver samples in the required size range with a
representative example of the results shown in Figure 101 showing the sizes DNA
delivered for a particular set of process parameters compared to the 5Kb desired.
Experiment - B1 without EDTA, lysostaphin
solution Sug for 5 min; lysis with B2 for 5 min, 10 min, 15 min or 25min
Gels 25uil of aliquots: Concluvons:
(1) After i no difference among 82 ysis for S. 10, 1S and 25 mins
(2) After 30min @50oC in 12
(3) Ekiate
07% agarose, UAE, M r strong HMW band after first lyss is lost
SyberGren stained, Ikb invitrogen DNA
ladder cm. No ISSI-O14 jHMW can be seen after B2 tysis and elution
ATCC25s23 /1s
- Skb
Figure 101 - MRSA DNA Extraction DOE Results
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The images in Figure 101 show the gel bands associated with each of 4 different MRSA
samples under several conditions of a DOE. The red 5Kb line denotes molecules of that size
and dark bands extending above the red line have higher molecular weight and are
preferable. One result of the optimization of lysis was that too strong of a lysis condition
would degrade the DNA presumably because thin-walled MRSA would lyse easily under the
more stringent conditions required to lyse the thicker cell walled organisms leading to DNA
damage for the relatively thin-walled MRSAs. Significant optimization of this process
eventually yielded a set of conditions that worked for 48 MRSAs in the original panel,
although significant work would be required to develop a "V2" process that could yield
sufficient DNA for any MRSA that could be input into the process. This is again, why DNA
extraction is a critical "connecting" technology, where a failure in delivering sufficient DNA
of adequate quality has significant impact throughout the process network all the way to
the eventual analysis of the genomic data.
The DOEs were conducted to test variables in the lysis portion of the process in Figure 98
and those tested are listed in Table 22 to find a set of conditions that would work for MRSA
samples.
Culture Volume (8, 10, 20 ml) Too many cells causing clogging
% of culture growth used (80%, 100%) Too many cells causing clogging, debris
Transfer of inoculate to new tube (y/n) Losing some cells due to transfer
Lysis buffer B1 with EDTA (y/n) EDTA may inhibit Lysostaphin
Lysostaphin conc. ug/ml (200, 100, 50, 10, 5, 1) Too much or too little Lysostaphin
Lysostaphin with 5 min. boiling (y/n) Boiling may be needed to open cells
Vortexing or inverting gently after B2 addition Vortexing may damage DNA
First B1 lysis time min. (0/N, 60, 45, 30, 25, 5, 1) Lysis time may not be sufficient, or too
long causing DNA damage
Second B2 lysis time (45m, 30m, 25m, 15m, Lysis time may not be sufficient, or too
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10m, 5m) long causing DNA damage
Centrifugation after second lysis (y/n) Centrifugation may damage DNA
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Table 22 - DOE Variables Tested for MRSA Lysis Optimization
The series of variables listed in Table 22 were used in a series of DOEs that eventually
produced the optimized process described in Figure 102 with steps that changed
highlighted in blue.
Final Optimized Procedure for MRSA DNA Extraction
100/G Midi Prep (25-40ug DNA in 15-30Kb Yield)
* Grow Sample: MRSA Culture in 20ml L.B Media O/N Growth 50ml Falcon Tube
* Prepare Necessary Reagents (add 200ug/ml RNase to 81 buffer w/o EDTA)
- Pellet MRSA cells by centrifugation at 50OOg for 10 min.
- Discard supernatant
- Resuspend pellets in 3.5ml of buffer B1 (w / RNase A w/o EDTA)
- Vortex to resuspend thoroughly
- Add Sug/mi of lysostaphin solution in 20mM sodium acetate and 100ul of Proteinase K solution
Sol* - Incubate at 37C for at least 5 min.
- Add 1.2ml of buffer B2
- -e ' Invert gently
sessaeedftw - Incubate at SOC for 5 min.
- No centrifugation
Equilibrate 100/G tip with 4ml buffer QBT and allow to empty by gravity flow
* Vortex sample for 10s @ max. speed and apply It to tip
eWash tip with 2 x 7.5m of buffer QC by gravity flow{ - Perform additional wash with 1 x 7.5ml of buffer QC if needed
- Elute genomic DNA with 1 x Sml of buffer QF pre-warmed to 50CJ Collect in 10ml glass centrifuge tube
- Precipitate DNA by adding 3.5ml room temperature isopropanol
* Mix by inverting the tube 10-20 times
- Mark outside of tube
* Centrifuge >5000g for at least 15m at 4C
' seso ss - Locate pellet, which may be difficult to see9 . * Carefully wash the loosely attached pellet with 2ml of cold 70% ethanol
ftW - Carefully wash again if needed with 2ml of cold 70% ethanol
e Vortex briefly
- Centrifuge at >50OOg for 10 min. at 4C
- Carefully remove the supernatant without disturbing the pellet
- Air dry for 5-10 min. without over-drying
- Resuspend the DNA in iml TE carefully by rinsing walls to recover all DNA
- Dissolve DNA on a shaker at 55C for 1-2h or overnight
Figure 102 - Optimized MRSA DNA Extraction Protocol (blue steps indicate a change)
While the technical work associated with the DOEs used to find feasible DNA extraction
conditions was a critical part of the process development, so was fostering the connection
of the Broad Institute DNA extraction scientist to the clinical microbiology laboratory at
BWH. Numerous discussions, e-mails, and data exchanges were required to bridge these
two "silos" of expertise, and it was only through the joint effort enabled by the "network
connection" that this was possible. This connection is shown in the V1 organization layer,
and through it, the clinical microbiology laboratory obtained the necessary DNA extraction
expertise (tacit) and protocols (explicit) in order to develop a MRSA specific protocol. This
is now a key resource for the community as it enables other researchers to perform
extractions for DNA sequencing on a variety of MRSA strains and provides a framework for
further optimization. The author of this thesis, functioning as the process owner and
process designer provided the necessary DOE expertise to ensure conditions could be
rapidly screened and promising conditions could be further refined without resorting to
one factor at a time experiments that would have taken much longer and been more
expensive than a DOE approach and may not have revealed interactions between factors
such as the impact of longer lysis times on DNA degradation (molecular weight). The V1
network allowed for this scaffolding to join 3 fields (silos): process design (DOEs),
microbiology, and molecular biology into a working process. Explicitly mapping these
interactions is one of the key advantages of the MDPM model.
5.4.2 Molecular Barcoding
The second key connecting technology was the development of molecular barcoding such
that multiple samples can be run on a single sequencing run. Because of the high data yield
per run of an instrument (>20Gb) and the relatively small genome size of a MRSA microbe
(-2.8Mb) it is necessary to barcode multiple samples such that they can be run
simultaneously. Note that it is not the entire genome being barcoded, but rather the DNA
fragments produced from the DNA preparation steps which are much smaller fragments
(200-400 bases) produced from the genomic DNA in the original MRSA sample culture.
These small fragments are the DNA molecules actually read by the instrument and because
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the technology is only able to read between 50-100 bases accurately, it is necessary to have
many overlapping fragments. However, if each of the DNA preparations can be barcoded,
then the fragments derived from these could be pooled together and placed on a single
instrument run. A conceptual schematic of two fragments each from two different samples,
but with unique barcodes corresponding to each sample is shown in Figure 103.
200 - 400 base MRSA dsDNA fragment
from sample "A"
8 base barcode + adapter 8 base barcode + adapter
200 - 400 base MRSA dsDNA fragment
from sample "B"
8 base barcode + adapter 8 base barcode + adapter
Figure 103 - DNA Fragment Barcoding Conceptual Schematic for Two Distinct Samples
Although the conceptual schematic in Figure 103 appears simple and straightforward,
molecular barcoding is fraught with potential problems and requires extensive support
throughout the process. For example, the downstream data analysis will have to be set up
such that it can identify individual barcodes accurately and can bin the data appropriately
according to the original sample ID. The barcodes themselves will have to be designed in
such a way that they do not overlap and are tolerant of sequencing errors (i.e. if one base is
mistakenly read, the remaining bases are still sufficient to identify the barcode)
accomplished with error correcting codes. The direct impact of molecular barcoding (i.e.
all nodes in all domains directly associated with barcoding) is shown in Figure 104 with
bar coding nodes labeled as yellow squares and 1-hop connections in red and the impact is
significant in multiple domains.
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Figure 104 - Direct Impact of Molecular Barcoding on V1 Surveillance Process
A fundamental requirement of the barcoding step is that it does not change or bias the DNA
sequence data in introducing the barcode. Also barcoding must be done in such a way that
each of the samples introduced into the pool are represented in equal molar concentrations
so that one sample doesn't dominate the data produced in a sequencing run. Thus if there
are 100 barcoded samples in a run, each sample should represent 1% of the data produced.
Because of its obvious benefits to pool multiple samples molecular barcoding is an active
area of development for many applications beyond MRSA surveillance and a commercially
available reagent kit is available from Illumina. This kit is labeled "method A" in the
MDPM process domain and the barcode labeling mechanism is shown in Figure 105.
8 http: / /www.illumina.com/ technology /multiplexing-sequencing-assay.ilmn
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Figure 105 - Illumina Multiplex Sequencing Barcode Labeling Mechanism (from Illumina)
The vendor kit relies on a 3 primer PCR, where adapters are added to DNA fragments,
followed by PCR with tailed primers, one of which in turn contains a priming site for a third
primer containing a barcode. This kit enables the barcode labeling of 12 individual
samples, and because each fun in an Illumina instrument is divided into 8 lanes,
corresponds to 96 individual samples per instrument run, which still corresponds to over
11OX coverage of each MRSA genome for a 30Gb run. This coverage is likely excessive for
mutation finding, but may not be for de novo assembly due to the large amount of "overlap"
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needed by the reads to uniformly cover the genome and assemble the overall puzzle.
However, as yields continue to increase for next generation sequencing technologies,
greater numbers of barcodes will be required than those initially provided.
The "method A" vendor kit was tested as part of the initial process verification, and one
concern appeared to be the number of PCR cycles needed to affix the 3rd primer barcode
onto the sample molecules, as high numbers of PCR cycles can introduce significant bias by
preferentially amplifying certain DNA molecules over others leading to a reduced diversity
of "unique" molecules. These vendor barcoding kits were intended for a number of
applications, but they were initially tested on the MRSA surveillance samples (and V1
process) developed here. In the first test pools of 12, 24, and 48 samples were sequenced
together (additional barcode primers were made to augment the vendor provided
number). The barcoded data was then separated into individual bins corresponding to
each sample and a typical result is shown in Figure 106 for a 50Kb region of the genome of
a single sample. Each grey bar represents the reading (sampling) of an individual DNA
fragment coming from the original sample measuring 75 bases each, the data was plotted
using the IGV viewers. The alignment algorithm then places these fragments onto their
correct location on the MRSA genome by comparing to a reference (this is why they "pile
up" as in this example the genome was covered over 10OX, which means that on average
100 individual "reads" should land at each corresponding position of the genome. The
colored lines in Figure 106 represent differences from the reference at each base location,
called single nucleotide polymorphisms (SNPs). The assembly process by comparison is
much harder as that algorithm attempts to put all of these puzzle pieces together without
the assistance of a reference (i.e. as if this were a de novo organism). In Figure 106 spikes
can clearly be seen where molecules "pile up" as part of the sequencing sample preparation
process, but the "spikiness" is made worse by the PCR-based method A, which relies on a
high number of PCR cycles to barcode label causing certain molecules that amplify with
slightly greater efficiency to be greatly over represented. Of greater concern is the opposite
9 Integrative Genomics Viewer (IGV) from the Broad Institute: http:/ /www.broadinstitute.org /igv
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case, where molecules that are not as efficient will not be represented leading to areas with
much lower coverage in the genome as shown by the dips in the coverage plot.
at agiven positeoad
Raw Data
(Each gray bar is a
75 base "read" from
the original MRSA
sample)
Figure 106 - Sequence Coverage from Vendor Barcoding Method
The dips in coverage did not occur throughout the genome but happened frequently
enough to be noticeable by eye as in Figure 106. Further zooming in to one of these regions
and comparing it to a sample sequenced without barcoding shows that in difficult to
sequence regions the PCR based barcoding can make coverage dips much worse, as can be
seen in Figure 107 comparing a 40Kb region of a MRSA sample sequenced without PCR-
based barcoding at the top and a PCR-based barcoded one at the bottom plotted using the
Argolo viewer. The barcoded sample has no molecules represented in certain regions, and
while the non-barcoded sample also shows a dip in this region, it is still able to provide
coverage in that region of the genome. These holes in coverage are obviously problematic
as no data can be obtained from them, and critical gene changes perhaps leading to
resistance or virulence would not be seen by the downstream analysis.
" Argo Genome Browser from the Broad Institute: http:/ /www.broadinstitute.org/annotation/argo/
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PCR-Based barcode method comparison to non-barcoded sequence:
Top: S. aureus reference lane (single lane high coverage >200X)
Bottom: S. aureus barcoded sample (~120X from 3 separate development lanes)
Difficult region but barcoding appears to make it worse
I
Figure 107 - 40Kb Sequence Coverage from PCR Based Barcoding Method (Bottom)
Compared to Non-Barcoded Sequence (Top)
Because of the issues found in the initial barcode "method A", which nevertheless has
certain workflow advantages, a barcode "method B" was developed which does not rely on
PCR for the barcode labeling but rather includes it as part of the standard adapter ligation
necessary as part of the sample prep. The "troubleshooting" and process change needed to
identify this problem, devise a solution, and test flowed through the various domains and
connections described in the V1 MDPM model, taking advantage of a number of cross-
organization and cross-domain connections to speed the development cycle as this method
is critical not just for the surveillance system but also for many other applications including
cancer sequencing. The results of the new process using adapters such that the barcode is
directly incorporated can be seen in a comparison of the amount of the genome captured as
data using both methods for the same sample in Figure 108. The adapter method captures
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10kb more than the original PCR based method. This difference in sequence length is likely
due to some marginally covered regions in normal sequencing dropping out with the PCR-
based method, but the same effect of reduced coverage in other sections can also affect the
ability to identify SNPs.
PCR-based barcoding method comparison to adapter based barcoding method:
Top: same sample adapter barcode method
Bottom: same sample PCR based barcoding method
~10Kb missing from PCR based barcoding method
26o76moo riow usOO MOoW us@O@ 9 OO 26900o O7000 moJo 271000 27moo m00 n2Oe
adapter method
MRSA30833_efconJasla
2676000 2670000 2686000 268t000 2696000 269t000 2706000 270000 2716000 271TO
W" PCR based based
- barcoding method
MRSA30833on-fasta
Figure 108 - Sequence Coverage from Adapter and PCR Based Methods for the Same Sample,
Showing PCR-Based Method Fails to Capture over 10Kb of MRSA Genome
5.4.3 MRSA Genome Analysis
A third key connecting technology is the analysis of the genomic data produced. This is an
area of enormous investment and development by everyone associated with DNA
sequencing as the rapid increase in data production has forced a related development of
new algorithms to handle the massive amounts of data but also the new properties of the
data as described in (Shendure and Ji 2008). New sequencing technologies produce much
smaller data fragments, or "reads" ranging from 25 bases up to 400 bases. The original
capillary based sequencing instruments (the Sanger technology) produced far fewer reads
but each was often in excess of 700 bases which greatly facilitated the putting together of
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the "puzzle pieces" of a genome which in the MRSA case is greater than 2.8 million bases.
This means that with the shorter reads there are far more puzzle pieces but also because
these pieces are shorter they are harder to place uniquely. The V1 surveillance process
developed here takes advantage of very recently developed algorithms (ca. 2008-2009)
such as the Maq aligner written by and described in (Li, Ruan et al. 2008) and the recently
developed velvet assembler described in (Zerbino and Birney 2008). As described in the
previous section an aligner places reads on an existing reference but cannot build "new
sequence" where the reference ends and thus is only useful to look at variation in
comparison to known genes and reference genomes.
The results of a Maq alignment were shown in Figure 106, Figure 107, and Figure 108 to
compare the PCR-based and adapter based barcoding methods. A detailed view of the raw
data coming from the process is illustrative as shown in Figure 109 which shows 75base
reads as gray bars corresponding to the top and bottom strand of the DNA sample. The
colored boxes represent differences from the reference genome and it is clear there is a
real SNP corresponding to an G to A change in the top strand shown by the green boxes in
the top strand (and the corresponding C to T blue boxes in the bottom strand). Note
however that the data is "noisy" with many errors towards the end of reads (random
colored boxes). The alignment software such as Maq must discriminate between the real
SNPs such as the G to A change in Figure 109 and the noise in found elsewhere. One way to
address this is through coverage or "reading" the genome multiple times such that
statistical models can filter out noise based on multiple observations. This is why
consistent and high coverage is so important and why the lower coverage due to the PCR-
based barcoding method is problematic, as in low coverage regions a noise error may look
like a read mutation without additional data to confirm.
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Figure 109 - Raw Sequencing Data From a Region of the MRSA Genome
An assembler is significantly more complex than an aligner as it must assemble the puzzle
pieces without any reference and only based on how they overlap and fit together. The
data shown in Figure 109 were aligned using a reference that places each of the reads
uniquely on a position in the reference. The conceptual differences between an aligner and
an assembler are shown in Figure 110, which compares the resulting genome from each.
Note that if there are no reads covering a reference position but this position lies within the
reference (an already sequenced MRSA genome) the missing bases can be "inferred".
However, if there are reads falling outside the reference, the aligner will not be able to
place them as there is no reference to map onto. In comparison, the assembler (velvet and
others) can stitch these reads together without the need for a reference although a much
more complex algorithm and additional data are needed.
Page 294 of 385
MRSA - Analysis
Data
(Reads)
Reference
Consensus Alignment
(Maq + Mauve)
Assembly
(Velvet)
Figure 110 - Conceptual Comparison of an Aligner and an Assembler in Producing Full MRSA
Genome Sequences
The Maq aligner used in this thesis were developed at the Sanger center in the UK, but is
still very much prototype code requiring significant development and in an MDPM network
sense an enormous amount of scaffolding. The velvet assembler was written at the
European Bioinformatics Institute (EMBL-EBI), which is part of the European Molecular
Biology Laboratory. Velvet is even more of a prototype with limited testing and support.
Other newer algorithms are rapidly emerging and these are labeled as methods A, B, and C
for each of the alignment process and assembly processes as placeholders for these new
developments. The impact of the genome analysis connecting technology is significant
covering all domains and spanning multiple process domain steps as can be seen in Figure
111.
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Figure 111 - Direct Impact of Genome Analysis Connecting Technology on V1 Surveillance
Process
Much more work will be needed to improve the alignment and assembly algorithms such
that they can reliably work at high throughput and on a wide range of clinical samples.
Currently the analysis of each genome must be manually fine tuned with a surprising
amount of tacit knowledge despite it being in a "software" and algorithms technology area.
Some of the suggested improvements are described in the V2 surveillance process later in
this chapter.
5.5 Process Analysis
A number of observations to improve the V1 process can be made based on the MDPM
analysis thus far including specific mechanisms to deal with troubleshooting, technology
change, transferability, and other process "ilities" such as modularity and scalability. These
observations are described using the MDPM matrix and graph concepts to devise structural
changes to the V1 process to improve its "big P" process performance across a number of
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system properties. Among the most important general observations of the V1 process are
the following:
Connected development
The insertion of new technology and process change are essential capabilities of modern
healthcare processes despite their complexity. It is important to recognize that any change
or new technology any particular portion of the process can have unforeseen consequences
elsewhere in the process outside the "visibility" of the individuals directly associated with
the change or technology insertion. It is critical to provide this general "system" visibility to
every part of the process to facilitate rapid improvement and minimal impact on the overall
process. Examples of connected development include the molecular barcoding and DNA
extraction technologies in this chapter, which were facilitated by design reviews including
all other "nodes" in the MDPM that were impacted by the particular technology.
Analytically this might be done by identifying the set of nodes in a MDPM associated with a
particular change, such as DNA extraction in Figure 97, and treating them as a "cluster" to
see whether the cluster is "well-connected" or not to the rest of the network.
Cross discipline, cross-group training
Beyond simply facilitating communication between individuals in the organizational
domain, there is a need for actual training and education across process disciplines,
organizations, and process activities. So for example it is very different for a sample
tracking software designer to sit in a meeting with laboratory personnel discussing the
features the software should have than for the software designer to actually spend some
time in the laboratory performing some of the work. Similarly educating the molecular
biologists on the analysis algorithms used can bring enormous rewards as the molecular
biology might then be adjusted to significantly improve the algorithm performance and
vice versa. In addition to cross discipline training, the particular ways in which groups
perform their work (both explicit in terms of policies and tacit in terms of culture) are
critical to the rapid communication and problem solving in a MDPM network. Despite the
increasing trend towards knowledge specialization and "silos" efforts on the part of
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complex process owners to educate individuals about the other "silos" they interact with is
a necessary activity.
Cross discipline, connected development, and organizational responsibility
In addition to training it is important to assign specific individuals to manage the interfaces
between disciplines, technology insertions, process change, and organizations. All of the
"connected technology" projects in this thesis to integrate the overall process were
managed by the thesis author, however this may not be feasible in many complex
processes. Yet, specific "ownership" is exceedingly important and could be accomplished
by assigning "project managers" to manage each of the connected development projects
and perhaps reporting to each other in a hierarchical structure such that efficient
communication could still be maintained. The boundaries between disciplines likely
require the same "ownership" such that education of individuals on either side of the
boundary can be maintained and directed. And similarly ownership of the boundaries
across organizations in the MDPM can also be exceedingly valuable. In some sense rather
than rely on ad hoc individuals that happen to have a high betweenness or network
centrality, these individuals could be "engineered" into the MDPM network to lie at the
boundaries of disciplines, organizations, and process change projects.
Cross discipline, connected development, and organizational information review
A key process management task is to perform design reviews to ensure that process
changes and cross discipline interfaces properly reflect the available information from
potentially impacted nodes. For example, the DNA extraction can impact a number of other
protocols and these should be carefully reviewed to ensure any changes in DNA extraction
are properly reflected. The difference here is proactive review of protocols (and other
information including policies) when implementing changes rather than assuming the
changes "modular" or has little impact. Forcing reviews is an element of the cross discipline
education, but also serves to ensure explicit information is connected in the information
domain and is consistent. If this is not done complex processes may rely on ad hoc
communications channels in the organizational domain to obtain information and
propagate, change which can be very difficult in large complex processes. This "review"
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process is what was done in going from the "baseline" to the V1 process and the specific
review documents, such as for molecular biology, become elements in the information
domain connecting baseline protocols and new versions that needed to change for the V1
process.
Process maps and troubleshooting communication
A related process infrastructure item is the need for detailed process maps, perhaps even
publishing the MDPM model within an organization such that individuals could rapidly
navigate the process network to find answers or identify problems. This could greatly
reduce the "search information" needed during troubleshooting or process change
scenarios since the paths would be mapped. In combination with specific "owners" of cross
discipline boundaries and other key individuals specifically identified to serve as "hubs" to
facilitate communication and the rapid deployment of resources to "swarm" problems the
MDPM model could be a very useful tool to ensure processes can be easily navigated.
Systematic Overall Process Testing
A final observation from the development of the V1 process is that many complex
processes rely on "passive" testing to identify problems or find process improvements. This
means that because of the complexity of a process troubleshooting only happens when
there are problems rather than purposely "testing" the process under controlled
circumstances to identify failure modes, performance limits, and potential improvements.
This is also true of technology insertions where a variety of conditions should likely be
tested against the response of the system in keeping with the "connected development"
ideas and to verify the overall system response to "local" changes. This would mean using
many of the ideas from design of experiments including (Box and Liu 1999) to iteratively
measure the response of the overall system to variables in particular activities and make
improvements. However, this requires much of the process infrastructure described
previously such as an overall process owner, a hierarchy of individuals at key interfaces,
efficient communication, and the identification of key process variables.
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5.5.1 Troubleshooting
One of the most important "nonstandard" tasks in complex processes is troubleshooting,
which because of the large number of elements increases significantly in probability and
time taken from process owners. The V1 process is an example of a complex process and in
routine operation would exhibit many failure modes not yet seen in the initial
demonstration in this thesis. However, it is possible to use the MDPM model to anticipate
the need for significant troubleshooting and to build in infrastructure to facilitate
communication and rapid resource deployment to resolve problems. In addition, the
learning from these troubleshooting events should be captured as an explicit information
element in the information domain. The V1 MDPM graph has a relatively long average path
length (3.636) as given in Table 21 and also a correspondingly low network efficiency
(0.307). The goal is to increase the network efficiency without resorting to excessive
numbers of costly to maintain links. So for example it is important that a technician in the
DNA extraction portion of the process be able to have a relatively short path length to
genome analysis in order to troubleshoot any potential missing parts of the genome due to
problems in DNA extraction. However, this does not need to be direct social connections,
but rather some systematic means of providing additional paths and hubs to facilitate
communication but also allow for systematic review.
One other important concept in troubleshooting is that the infrastructure to enable it
should be in place before a troubleshooting event rather than a reaction to a problem. The
suggested mechanism for doing this combines operational logs from chemical engineering
best practices, lean process improvement, and the graph ideas presented in the MDPM
model. The basic idea is to designate specific individuals that can serve as "hubs" that can
reach nodes in the MDPM graph within 1-2 hops. These individuals are then connected to
each other by weekly process review meetings where an overall process log built from
"troubleshooting problems" from each of their neighborhoods are discussed and resolved.
The process log provides for an explicit knowledge document describing the problems in
each area, but because it is visible to the entire process network within 1 to 2 hops (going
through the individuals acting as hubs) it serves to connect the entire process. In addition,
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the explicit assignment of individuals to serve as "hubs" or "troubleshooting
representatives" also greatly facilitates the search of the network for information. These
"troubleshooting representatives" might be the same ones identified to serve as cross
discipline or cross organization integration owners or could be distinct individuals.
Standard network clustering algorithms can readily be used to identify the "local"
neighborhoods that the troubleshooting representatives should serve, or alternately a
process designer could use the MDPM model to reorganize these clusters to further
facilitate communication. This overall idea is shown in Figure 112, which shows the MDPM
model, but with elements sorted such that the original macro process activities are grouped
together. It is then possible to add a troubleshooting representative and a review log to
each domain within the activity.
sg , RS Ioaton*DNA Extraction -44n * Sequencing -*Data Analysis
DNA Extraction
Troubleshooting
Review Log
DNA Extraction pk
Troubleshooting
Representative ~~~ ~
~ _____ __%W"
DNA Extraction /
Sample Collection
Troubleshooting
infrastructure and
Connections
Figure 112 - Use of MDPM Model to Build Troubleshooting Infrastructure and Connections
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Each of the process representatives in each activity can then be formally connected to
others, such as the sample collection example shown in Figure 112 such that they could
rapidly identify problems between each of their activities and serve as "hubs" to connect
other elements (in all 3 domains) to each other. The troubleshooting logs serve a similar
purpose in formally capturing the problems, and it is important that they also capture the
resolutions such that the organization can learn. The review logs also serve as an
important communication tool allowing for asynchronous communication not through the
organizational domain, such that anyone in the network can see issues as they come up. In
addition, the review logs serve as a critical source of information for process improvement
and change as they should describe things to improve but also insights into the
performance of the process. Much of this was done in developing the V1 process but a V2
process would significantly expand on the designation of key individuals in each "cluster"
(which will likely correspond to a process activity but may not) and also add explicit
review logs. Overall reviews (and connections) with the process owner and key
stakeholders would also be added.
5.5.2 Design for Change
One of the biggest difficulties in managing complex processes is caused by the differential
rates of technology improvement in each of the activities. For example in the surveillance
system designed in this thesis the rate of DNA sequencing technology change is incredibly
rapid, yet some of the process activities such as sample collection have remained fairly
stable for several decades. Strategies must be devised to take advantage of technology
improvement in complex processes where a single activity change can have unforeseen
consequences and costs to continuously evaluate the impact of a new technology on the
overall process and perhaps re-optimize around the change can be cost prohibitive and
infeasible. The amounts of "scaffolding" as described previously would have to significantly
increase in order to accommodate the rapid evaluation and insertion of new technologies.
This is still an issue for the surveillance process designed in this thesis since there are
significant improvements on the horizon for existing sequencing technologies but also
entirely new sequencing technologies.
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One solution to this problem might be to find process "invariants" that do not change either
because the technology is fairly mature or because they have purposely been designed that
way. So for example the existing V1 surveillance process could be "partitioned" such that
invariants were identified and grouped together such that they could be managed
separately from the rapidly changing parts of the process. This might mean taking the
sample collection, initial MRSA isolation, culture growth, sample storage, and other
infrastructure activities such as supply-chain management and designing a common
management structure, information sharing, and process review structure for these
"invariants". In addition, rather than duplicate certain activities within the rapidly changing
parts of the process, "sets" of elements across organizational, process, and information
domains could be identified to serve as connection points to the corresponding activities in
the rapidly changing portion. These sets (groups in the organizational domain) well
connected to each other and to the process invariants by design to serve as an
infrastructure on which rapidly changing process elements are added. This is similar to the
concept of "troubleshooting representatives" where individuals have responsibility to
communicate problems, but in this case organization and information domain elements are
grouped together to provide "hubs" to which new processes connect. New processes are
then brought in but required to connect to these hubs rather than develop new ad hoc
connections.
Figure 113 illustrates this idea where the MDPM matrix could be partitioned and
restructured to include "sets" around key disciplines such as molecular biology or activities
such as sample collection. Each of these sets is a "mini" MDPM containing organizational,
information, and process domain elements. The sets are designed to efficiently connect to
each other using many of the ideas developed so far such as cross discipline interaction and
process change and troubleshooting reviews. New processes can then be inserted as
modules that need to connect to the process infrastructure. In the MDPM methodology the
feasibility selection step using the MCNF algorithm was designed to filter out a number of
alternatives but it is possible an organization would want to simultaneously evaluate
processes or may need to operate multiple processes as the data from each may have
different properties. But most importantly in the case where an initial process has been
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selected and is operating but a new more efficient process must be evaluated the
organization must be able to insert the new process and if the technology is changing
rapidly this will happen very frequently. The area in red in Figure 113 could thus contain
all of the feasible design alternatives, such as the 454, SOLiD, Illumina, and other upcoming
technologies.
Figure 113 - MDPM Analysis to Identify Process Change Infrastructure and Invariants to
Support Rapid Change in a Subset of the Process
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This idea could also be used to develop a framework for "process options" where additional
investment might be made in infrastructure or "scaffolding" to support anticipated
technology change and ensure that the overall process was able to rapidly adapt and
improve. Net present value analysis could straightforwardly be performed in terms of the
time between technology insertion and the corresponding gain of additional "revenue"
from faster and more efficient adoption the change. The "change infrastructure" may even
be less than what would have existed if the overall process had not been rationalized
around invariants and rapid change. But if the cost were higher this would be subtracted
from the additional revenue gained to find whether the NPV is positive in which case the
"option" is worth it. "Process options" could also be used to value the additional
infrastructure associated with troubleshooting as described in the previous section where
the cost of the infrastructure would be weighed against improvements in performance and
reduced failures or downtime.
5.5.3 Other Process "ilities"
Other process properties can also be examined using the MDPM model such as scalability,
transferability, flexibility, adaptability, and modularity. Many of these parties rely on
efficient communication within the process both in the organizational and information
domains. In addition these properties also rely on the identification of "clusters" within the
MDPM matrix that are modular in nature. For example, one of the key process properties
for the surveillance system is the ease with which it can be transferred to other locations.
This transferability property is related to which nodes within the MDPM model are best
connected (have the highest betweenness centrality) such that these nodes can serve as the
interfaces to corresponding nodes in the target MDPM (the location where the process is to
be transferred). The nodes with the highest betweenness centrality for the V1 process were
identified previously in this chapter, but these were not purposely designed for ease of
transfer. With a MDPM model of a process it would be possible to identify key nodes to
serve as transfer connection points to the MDPM model of the target organization. These
"transfer nodes" in the organizational domain are very similar to, and likely the same as,
the "troubleshooting representatives" or the individuals responsible for change
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management in process "clusters". However, transfer will also require connections in the
information domain such as ensuring that the target organization has incorporated not just
the final activity protocols but also some of the design knowledge contained in process
design documents such as optimizations, process reviews, troubleshooting logs, and other
explicit knowledge.
Similarly, the modularity of a process could be improved by identifying the connections
associated with a "cluster" to the rest of the process and rewiring these such that they went
through a "hub" which ensured that the cluster remains efficiently connected but is
accessed through a specified set of "channels". In some sense the ideas in the previous
section of finding process invariants could be directly applied to redesigning a process to
be significantly more modular with benefits to technology insertion and process
improvement. Modularity is also related to the adaptability of the process to changing
inputs and deliverables. For example, the surveillance system designed in this thesis could
be used to monitor microbes other than MRSA and it is likely that the main changes that
would need to be made are in the sample collection, microbe isolation, and DNA extraction
"modules" such that the rest of the process would remain the same. The MDPM model
could thus be used to engineer in the necessary modularity and adaptability by designing
the process to contain "connected modules" that preserve efficient network
communication within the module and across the process to other modules.
5.6 Potential Improvements
There are a significant number of improvements that should be made to the "Vi"
surveillance process based on the technical insight gained in running it, but also based on
insight gained from modeling the process using the MDPM model. Six projects were
identified that would lead to a "V2" improved process that addressed key issues found with
the V1 process. In order to specify the technical and MDPM based integration "project
sheets" detailing various elements of the project were made and are shown in appendix 1,
based on the template in Table 23.
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Background on the project and key objectives
Who are the key internal stakeholders that must be directly involved
with the project? (within the MDPM network). Including any "change
owners" or "troubleshooting representatives"
Who are the key external stakeholders that must be directly involved
with the project?
What should the project accomplish?
Who within the MDPM network will be responsible for the project?
What process domain elements will be potentially affected by the
project? Where in the process domain does the project connect? What
additional process domain activities are needed?
ational In addition to key stakeholders what organizational domain elements
must be connected to ensure the project is "visible" in a few hops to
:lonl the rest of the MDPM network. What additional organizational domain
elements and connections are needed?
tion What information elements will be needed to ensure the project can be
visible to the MDPM network and what reviews (i.e. protocols) must
ioni be performed of existing knowledge domain elements to ensure
project is integrated?
What tests must be performed on the overall process to assess the
impact of variation from elements in the project and similarly what
variables within the project elements are affected by variation from
other process elements. (DOEs of expected variation in project
process domain elements against response variables in the overall
process.)
Table 23 - Process Improvement Project Template with MDPM Integration
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The template in Table 23 was filled out for each of the six projects identified for a V2
process, and these are detailed in appendix 1. A key goal of specifying these projects was
both to address technical improvements in a V2 surveillance process but also to show how
the MDPM model might be used to help speed the development cycle for process
improvement by "designing" projects from the start to integrate with the existing MDPM
network such that their impact can be well managed and all parts of a complex process be
aware of the potential impacts of the project (or technology insertion). Brief summaries of
each of the projects are provided here, with details in appendix 1.
Project 1: MRSA Sample Diversity
One of the main goals of the surveillance system is to provide a true representation of the
MRSA diversity that exists in hospital infections. The sampling used as an initial
demonstration in this thesis was confined to a single outbreak in a single hospital, however
a much broader sampling will be needed to support epidemiological analysis. The goal of
this project is thus to build a much more diverse collection of MRSA samples representing
multiple hospitals, regions, and case histories. This project would ideally reuse existing
infrastructure for strain typing performed at local hospital, state health department, and
national CDC levels. This collection would provide for a proper estimate of the "pan-
genome" of MRSA or the sum total of all mutations seen in MRSA throughout the country.
This would ideally be an ongoing process as MRSA will continue to evolve and a constantly
updated sampling should be performed.
Project 2: DNA Extraction Robustness
As described previously in this thesis DNA extraction is a highly variable process for MRSA
samples, and while it has been optimized for the particular set of samples used in this
thesis, it is likely that the variation seen in a much larger set would require re-optimization
of this process activity. The goal of this project would be to find a new optimized protocol
that can cover the widest possible range of MRSA samples. It is likely that additional
measurements may have to be taken such as carefully controlling cell growth, and
potentially automating a number of the steps to remove any operator variability. In
addition new technologies and processes should be explored as alternatives to the current
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protocol. This project would then perform a series of design of experiments runs to find a
robust set of parameters that could be used as a general protocol. Because of its impact on
the rest of the process the same "connected development" using change owners and other
mechanisms will be needed to make sure the impact of the project is well managed on the
rest of the surveillance process.
Project 3: Advanced Molecular Biology
One major limitation of the current "V1" surveillance process is the size of DNA fragments
used in preparing the DNA for sequencing, which are in the 300-500 base pair range.
However, in order to link genomic regions with high similarity and assemble the genomes
out of the short reads (100bp long) it is necessary to construct much longer specialty DNA
fragments that can span greater distances than 300-500 base pairs, ideally into the 4,000-
10,000 and even longer but which can still be read using the available sequencing
technology. Methods for doing this are so-called jumping libraries, but there may be
others. This has significant technical difficulty especially given the high throughput nature
of the surveillance process and will require tight integration with algorithms and other
process elements.
Project 4: Configure Process for Rapid DNA Sequencing Technology Change
There is expected to be significant technology change in the DNA sequencing portion of the
surveillance process and the V2 process should be configured to deal with this change. This
project would identify the process invariants such that these could be managed as a group
and efficient connections made to the new sequencing processes as they emerge rather
than ad hoc connections for each process. In addition "connection points" would be
identified within the MDPM matrix such that new technologies could be rapidly absorbed
without having to "make" new connections. This might mean the formation of "clusters"
around key disciplines such as molecular biology that could oversee related steps in each of
the new processes (rather than have each create a new one). Similarly each new process
would have explicit representatives for each area that were within 1-2 hop network reach
of the new process elements to facilitate integration.
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Project 5: Build Data Analysis Pipeline
Most of the data analysis performed in the V1 process was performed on prototype
software with significant manual intervention and little optimization. To make the
surveillance process truly useful a significant amount of work will have to go into building
robust and automated data analysis pipelines that have been extensively validated and
optimized for MRSA. These pipelines must be able to align data from these samples against
the entire set of MRSA genomes to date as well as perform a verification of the data through
assembly in order to find novel genes or horizontal gene transfer from other organisms
that simple alignment would not find. The overall accuracy and specificity of the algorithms
must be evaluated as a function of the data input to specify the degree of coverage (i.e. how
much oversampling of the genome is needed, 30X, etc.) to provide sufficient accuracy. Most
importantly the resulting data and analyses must be easy to use for epidemiological studies
such that outbreaks or new strains can be readily identified from the data. Another
requirement is that the data analysis must be entirely backwards compatible with existing
surveillance methods such as PFGE, MLST, and 16s such that data can be integrated with
existing databases and the transition to the new process can be greatly facilitated.
Attention to this final user interface is critical to help speed adoption of the process. In
addition, sample tracking must be provided such that original clinical histories can be
associated with the final surveillance data. All of this represents a very significant amount
of work and impacts many elements of the MDPM.
Project 6: Verify Biology
An essential part of the surveillance process must be to "close the loop" with the biology,
which is to compare actual biological results (phenotype) with the DNA data (genotype)
being produced. For example, measuring the Minimum Inhibitory Concentration (MIC) of
antibiotics for MRSA strains found to have mutations, is important to develop an
understanding of which mutations are important and which are not. Other biological tests
are also needed such as growth rates, cell wall thickness, and perhaps virulence measures.
Correlation of the phenotype with the genotype will help realize enormous value from the
surveillance process as new diagnostics can then be developed based on these correlations.
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This will require going back to samples stored in freezers as a product of the MRSA
isolation portion of the process.
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6 Case Study Results and Process Observations
This chapter examines the results from the initial set of MRSA samples run through the V1
process and derives policy recommendations based on the MDPM analysis performed in
Chapter 5 and the biological results. Much of the epidemiology of MRSA is believed to be
clonal in nature meaning that a few distinct MRSA strains dominate the populations found
in healthcare settings. The strain designations in use today come from a large-scale typing
effort by the CDC using pulsed field gel electrophoresis (PFGE) to characterize 957
oxacillin antibiotic resistant or susceptible S. aureus isolates chosen at random from the
CDC strain collection as described in (McDougal, Steward et al. 2003). These isolates
originally came from hospital outbreaks, food-borne disease, and community acquired
infections and at the limited resolution of PFGE grouped into 8 major clusters of isolates as
shown in Figure 114 where the restriction digest pattern of each major strain type is
shown along with the CDC assigned name for that pulse field type (PFT).
a ~ * *PFT
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Figure 114 - Major MRSA Pulse Field Type (PFT) CDC Names (from McDougal et. al. 2003)
Each row in Figure 114 corresponds to a cluster of genomes that have a similar PFGE
pattern. The dark bands are unique fragments of that genome cluster separated by size,
where the fragments have been cut by a restriction enzyme Smal that only cuts in the
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middle of the specific DNA sequence "CCCGGG". In comparison to the single nucleotide
resolution of the surveillance process developed in this thesis, the smallest fragment that
can be resolved in Figure 114 is >40,000 bases (the MRSA genome is -2.8Mb in size). An
enormous number of significant genetic changes can occur inside a 40,000 base fragment
with even single nucleotide changes leading to very different phenotypic characteristics. Of
the types classified by (McDougal, Steward et al. 2003), USA100 was the most prevalent at
the time (2003), but the USA300 type associated with Community Acquired MRSA (CA-
MRSA) is displacing others as the prevalent type as reported in (Gould 2006).
It is worth emphasizing that within a PFGE type "family" there can exist many specific
strains with varying characteristics of virulence and antibiotic resistance further
emphasizing the need for single nucleotide resolution. For example a recent study by
(Kennedy, Otto et al. 2008) looked at genome variation using a probe based genome
comparison method on 10 MRSA sample isolates finding that 8 of the 10 had very few
single nucleotide polymorphisms (SNPs) between them suggesting they were closely
related (likely having a common ancestor) and most importantly had a similar phenotype
in terms of their virulence. However, 2 of the isolates had significantly reduced mortality in
a mouse sepsis model despite also having relatively few changes (SNPs) from the others.
As (Kennedy, Otto et al. 2008) describes, this suggests that even a few genetic changes can
lead to significant phenotype changes despite all of the strains being classified as USA300
by PFGE. If small genetic changes can lead to significant genotype changes this suggests
that the current classification system may be inadequate to describe the real diversity that
exists and many of the surveillance policies which have to date assumed that relatively few
"types" accounted for much of the MRSA population will have to be revisited. However,
this cannot be known until a significant amount of data is gathered using a system such as
the improved "V2" surveillance process described in chapter 5, or perhaps another
technology. The first element of building a large-scale surveillance system will be to gather
a significant amount of data in a "pilot" process that can answer what the true variability of
the MRSA genome is at the nucleotide level. This chapter describes some of the initial
results obtained using the "proof of principle" V1 process, describes what changes would
need to be made for a "V2" process in further detail (including connections to the projects
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described in appendix 1), and describes a roadmap for further improvements in MRSA
surveillance taking into account the expected rapid technology change.
6.1 MRSA Genome
The Methicillin Resistant Staphylococcus aureus (MRSA) genome consists of a single
circular chromosome ranging from 2.8 to 2.9Mb in length, depending on the strain. The
typical genome contains approximately 2,600 genes and as with most bacteria the majority
of the genome represents coding sequence (-82%) as shown in Figure 115 for a genome of
the Community Associated (CA-MRSA) USA300 sub type. MRSA strains typically also
contain 1-3 circular plasmids of approximately 25Kb in length. Only a small set of genes
distinguishes MRSA from normal Staphylococcus aureus, including the necessary antibiotic
and virulence genes and many of these genes that are largely grouped in mobile genetic
elements such as chromosomal cassettes, plasmids, and pathogenicity islands. These
mobile elements can be exchanged between strains through horizontal gene transfer, and
represent a key mechanism in the spread of resistance and virulence genes in S. aureus
populations. Community associated MRSA (USA300) for example likely acquired many of
its initial virulence adaptations through horizontal gene transfer although the population
now appears to be clonal in nature as described in (Diep, Gill et al. 2006). A key difference
in CA-MRSA is the existence of Panton-Valentine leukocidin, which is a cytotoxin that
attacks leukocytes, the human white blood cells responsible for eliminating microbial
infections. The CA-MRSA USA300 is a relatively new microbe not seen before the year 2000
(Carleton, Diep et al. 2004), yet has rapidly spread into the community (outside healthcare
settings) as an apparent combination of hospital MRSA and "normal" S. aureus strains in
the community. The rapid emergence of the USA300 strain suggests surveillance methods
would need rapid identification (within weeks to months) of new strains such that
screening and isolation procedures might be put in place. Note also that many of the
techniques now in place such as PFGE can have difficulty differentiating even between
clones with the same PFGE profile (such as USA300) as can be seen by the long black lines
around the periphery of the genome in Figure 115 showing the cut sites for the PFGE
fragments and the very long fragments (containing many genes and potential differences
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that result. A recent example of this limitation is described in (Larsen, Goering et al. 2009)
who describe two phenotypically different clones with an identical USA300 PFGE profile
and recommend using sequence based identification methods such as MLST although this
method only looks for variation in a small fraction of the genome as shown in Figure 115.
2200000
1400000
Figure 115 - MRSA Genome Showing General Characteristics, Selected Resistance and
Virulence Genes in Red, Pathogenicity Islands in Blue, smaI Cut Sites in Black (corresponding
to PFGE fragments), and MLST Sequence Typing Loci in Green. Note the limited amount of
information provided by MLST and PFGE.
Fortunately the CA-MRSA USA300 type appears to be susceptible to antibiotics outside the
beta-lactam group (i.e. methicillin, oxacillin) such as clindamycin, which inhibits protein
synthesis. However, nosocomial MRSA continues to be resistant to nearly all common
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antibiotic classes except for Vancomycin, the current standard of treatment. The intense
focus on resistance has accelerated the development and approval of new antibiotics, but
many are still in early phases of development and FDA approval, and in the meantime
strains of MRSA have already been found with resistance to Vancomycin. These
Vancomycin Resistant Staphylococcus aureus (VRSA) strains appear to be derived from
MRSA (ST5-MRSA-II) as reported in (Enright 2003) and gained their Vancomycin
resistance genes through horizontal gene transfer from Vancomycin Resistant Enterococci
(VRE) an entirely different microbial species that emerged around 1985 and is increasingly
common in healthcare settings leading to higher likelihoods of gene transfer between VRE
and MRSA as has already been seen in patients with simultaneous infections as described
in (Chang, Sievert et al. 2003). The first VRSA cases were reported around 1996-1997
(Kuroda, Ohta et al. 2001; Hiramatsu 2004) and while the spread of VRSA appears to be
fairly limited, it may be due to its lack of the necessary virulence adaptations found in CA-
MRSA types such as USA300. The necessary set of genetic elements are "tested" and
available in each of VRSA, MRSA, and CA-MRSA to make a true super microbe resistant to
all common antibiotics including Vancomycin but also highly virulent and easily spread.
Approximately 75% of S. aureus genomes appear to be highly conserved part of the "core"
genome shared by all strains and containing essential functions such as metabolism as
described in (Lindsay and Holden 2004). However, fully 25% of the genome appears
contain accessory genes including mobile genetic elements such as pathogenicity islands,
chromosomal cassettes, plasmids, and transposons that can transfer horizontally between
strains. Most of the virulence and resistance genes are found on these mobile elements
facilitating their transmission between microbes and facilitating a higher adaptability of
the population as a whole rather than a single individual. Selected virulence and resistance
genes are detailed in Table 24 and a subset of CA-MRSA USA300 specific ones also shown in
Figure 115 for illustration. Numerous additional genes beyond those listed in Table 24 are
involved in resistance and virulence mechanisms including the regulation of key proteins.
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Gene Function Description
mecA penicillin binding protein 2 Low $ lactam affinity peptidoglycan
prime biosynthesis (cell wall construction, low affinity
neutralizes methicillin)
pbpA penicillin binding protein 1 peptidoglycan biosynthesis (cell wall
construction, antibiotic target)
pbp2 penicillin binding protein 2 peptidoglycan biosynthesis (cell wall
construction, antibiotic target)
msrA methionine sulfoxide cell wall stress stimulon (cell wall repair under
reductase A antibiotic stress)
lukF-PV Panton-Valentine leukocidin leukotoxin (white blood cell attack)
IukS-PV Panton-Valentine leukocidin leukotoxin (white blood cell attack)
lukE leukotoxin lukE leukotoxin (white blood cell attack)
lukD leukotoxin lukD leukotoxin (white blood cell attack)
blaZ beta-lactamase precursor beta lactamase production element (degrades
antibiotic)
sak staphylokinase precursor plasmin production element (disrupts host
fibrin clots that localize infection)
ermA rRNA methylase 23S rRNA modification (lowers macrolide
antibiotic affinity for 23S rRNA allowing
continued protein production. Neutralizes
erythromycin and clindamycin)
tetM tetracycline resistance ribosome protection from translation inhibition
protein (neutralizes tetracycline)
hysA hyaluronate lyase precursor hyaluronan cleavage (tissue invasion by
degradation of host connective tissue)
fosB fosfomycin resistance protein Cysteine addition to Fosfomycin (neutralizes
FosB antibiotic)
tcaB TcaB protein element of peptidoglycan terminal D-alanyl-D-
alaynine lipid II linked precursor modification
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(prevents teicoplanin antibiotic binding to cell
wall building blocks)
vanA vancomycin/teicoplanin A- element of peptidoglycan terminal D-alanyl-D-
type resistance protein VanA alaynine lipid II linked precursor modification
(prevents vancomycin antibiotic binding to cell
wall building blocks)
Table 24 - Selected Virulence and Resistance Genes in S. aureus
The ability of microbes to rapidly exchange genetic information is central to their
evolutionary success and the existence of numerous genetic elements encoding for many
different phenotype adaptations insures that there will always be a large "pool" to draw
from as illustrated in Table 24. Under appropriate conditions including antibiotic selection,
simultaneous infection of different pathogens, and increased infection rates the probability
of strains incorporating all of the resistance and virulence elements listed in Table 24 is
possible as has already been seen by VRSA strains, although fortunately these have not yet
included many of the virulence adaptations. A key goal of the surveillance system would be
to first identify the complete set of all genetic elements in all known strains of antibiotic
resistance Staphylococcus aureus including MRSA and VRSA. This catalog would provide
enormous insight into which genetic elements constitute the "core" genome and which are
the "accessory" genome not essential for the basic functioning of Staphylococcus aureus but
containing much of the specialized virulence and resistance machinery. Building a database
of all these genetic elements would also greatly facilitate the identification of any truly
novel mutations found in new strains as the existing elements from the database could be
"subtracted" from the new sequence to identify horizontal gene transfer or other novel
changes. The Staphylococcus aureus genome is also not infinitely variable as certain
essential genes and regulatory structures must exist for the microbe to function and
mutations are changes in these regions are mostly lethal. Building a database across many
strains of S. aureus would provide insight into what the "rules" for genome modification
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are perhaps allowing for the development of alternate control strategies not associated
with antibiotics. The database would certainly be a very valuable resource to antibiotics
development as new targets may be discovered or insight into modifications of existing
antibiotics may be obtained. This database can be thought of as the sum total of observed
changes in all S. aureus genomes, sometimes called the "pan-genome" as described in
(Medini, Donati et al. 2005).
6.2 MRSA Genome Comparison
To emphasize this point, four S. aureus genome sequences were compared in Figure 116
with the mauve color showing the shared "core" genome, areas in white correspond to
regions not aligned with the other genomes and unique that particular strain, and other
colors representing regions shared by genomes sharing that same color. As can be seen in
Figure 116 two strains TCH1516 and FPR3757 both classified as USA300 share most of
their genome but also have significant unique regions not shared with the other. Note that
the MRSA genome has extensive differences with the USA300 genomes, as would be
expected since the MRSA genome lacks much of the virulence machinery in USA 300 strains
such as Panton-Valentine leukocidins and in turn the USA300 genomes lack the additional
antibiotic resistance genes found in "standard" nosocomial MRSA. These genomes were
downloaded from the National Center for Biotechnology Information (NCBI) and aligned
using Mauve11 multiple alignment software. Also included in the alignment is a Methicillin
Sensitive Staphylococcus aureus (MSSA) at the top, and the shared regions with MRSA can
be seen light green although interestingly the MSSA genome also shares significant regions
with the USA300 strains. The MSSA genome also contains a re-arrangement where a
portion of its genome has "moved" to a different location and orientation (i.e. direction on
the DNA strand) in the MRSA genome as shown in Figure 116. It is worth noting that each
of these four genomes were sequenced using older generations of technology, the "Sanger
Sequencing" described as a design space alternative in chapter 5. This technology is
extremely expensive compared to the design goals for the proposed surveillance system,
" Mauve multiple genome alignment software from http:/ /asap.ahabs.wisc.edu/software /mauve /
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but it is capable of delivering fully detailed genomes without any gaps (i.e. missing
sequence) partly due to its longer read length, but also due to the extensive manual
curation performed on these genomes, which would not be feasible in the high throughput
process being proposed. The cost of producing each of the genomes to the level of detail
and annotation (i.e. verifying the identity and corresponding sequence of every gene) is
several orders of magnitude above what would be needed for a surveillance system. The
surveillance system proposed would need to deliver similar results but at a fraction of the
cost.
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Figure 116 - Comparative Multiple Alignment of Fully Annotated MSSA, MRSA, and USA300
Genomes from NCBI. Note areas in white are unique to that genome, mauve areas are
common to all genomes, and individual colors are common to each subset of genomes. Note
also the difference in total length of genomes with MSSA being the shortest and MRSA the
longest. Two USA300 genomes classified as identical by PFGE show significant differences.
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6.3 Case Study Data Set
The case study sample set used in this thesis was obtained from a MRSA collection at the
Channing Laboratory of Harvard Medical School consisting of anonymized MRSA patient
cases from the Brigham and Women's Hospital in Boston of which 150 samples were
selected at random from a year long time period. Samples were collected as pairs from both
the nares and patient bacteremia to evaluate any genetic differences between colonizing
and infecting MRSA strains. MRSA populations may be heterogeneous and only a few
microbes may lead to infection with particular adaptations, or it may be that under certain
selection conditions MRSA may evolve from a benign colonizing version to a more virulent
infection version. Although MRSA populations are clonal in nature, a cross section of
hospital cases is expected to show some variation, as some will be nosocomial clonal
strains and other strains contracted outside the hospital or during a previous intervention.
Sequencing the entire set would yield insight into the population dynamics especially in
terms of correlating the observed phenotypes with genotypes. Differing clinical outcomes
from the same MRSA genotype would suggest host or treatment differences are responsible
for the outcomes. And if the opposite is observed, differing genotypes should correlate to
varying clinical outcomes. It is important to note that all of these samples exhibited the
exact same phenotype and all are classified as MRSA by standard clinical microbiology
procedures where they showed growth in culture dishes containing methicillin antibiotic
and by would thus all be classified as the "same" by normal procedures.
6.4 Case Study Process Attempts
All 150 samples were run through the V1 process described in chapter 5, although
significant attrition resulted from the DNA extraction process steps as described in chapter
5. An initial set of 44 samples out of the 150 was chosen to test molecular barcoding
methods and each of these samples were sequenced with 75base paired end reads to a
coverage in excess of 10OX the average MRSA genome size. 12 experiments were
performed using the PCR-based barcoding method where each of the 44 samples were
pooled and normalized using 2 different methods of DNA quantification and normalization
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(qPCR and picogreen) as well as mixing different pools in different sets of 12, 22, and 44.
Both DNA measurement methods showed significant variability, and additional
development will be required to develop a method for pool normalization. The data
presented in the analysis sections that follow use the amalgamated data from each of these
experiments to deliver >100X coverage of each sample. Following evaluation of the data
and the development of an alternative barcoding method an additional set of experiments
was performed using a subset of 12 (out of the 44 used for PCR-based barcoding tests) to
verify the operation of the adapter-based barcoding process as described in chapter 5.
The analysis of these 12 samples is presented next as these were the best performing
product of the V1 process following optimization of DNA extraction and barcoding. The V2
process would be fully capable of sequencing all 150 samples using optimized procedures
based on the process learning from initial testing of the V1 process. The 12 samples
sequenced in the final iteration of the V1 process have in excess of 10OX average
sequencing coverage of each sample genome in 75 base paired end reads. Note that only a
single type of small insert library was made for the sequencing attempts, which requires
only -1-5ug of DNA, although significantly more DNA was specified out of the DNA
extraction process (>20ug). The reasons for this are that additional library types will likely
be required to fill in gaps in the assembly of the genomes, which would require significantly
more DNA. In addition, the need for rework can be significant which can require going
back to the sample DNA for successive attempts. This happened multiple times in the
testing of the barcode methods and shows the need for an integrated process network
where upstream and downstream steps can be coordinated.
The resulting data from the V1 process for each of the resulting 12 samples is summarized
in Table 25 showing the number of "passing filter reads" or passing signal processing QC
DNA molecules read from each sample, the number of these that were aligned to a
reference genome, the resulting raw coverage (unaligned), the aligned coverage (against a
reference genome), and the average error rate in each read. It is important to note that the
strain type of these samples was not known in advance (i.e. whether they were MRSA, CA-
MRSA USA300, or others), and in order to run the alignment process a single reference had
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to be chosen, which for convenience was an annotated USA300 type (genbank CP000730.1
corresponding to USA300_TCH1516 concatenated with plasmid pSR1 genbank
AF167161.1) also shown in Figure 116. One issue with choosing a single reference is that
only reads that are close matches to regions in the reference genome will be aligned and
others will be excluded. This is why assembly methods are likely the long-term solution, or
alternatively multiple alignments may be possible although this can be computationally
intensive as well. As more genomes are added to the databases, multiple alignments
become possible, although a key issue is that only a few of these genomes have been
carefully annotated (i.e. the structure and identity of every gene has been verified) and
using these greatly facilitates the finding of features on the genome.
In the case of the V1 process, most of the genomes aligned only matched the reference by
about -81% as shown in Table 25 although even despite these limitations, the variability
between strains can be seen as one of the genomes fully matched 85% of the USA300
reference suggesting it is closer to the reference and may have some of the virulence
adaptations in USA300. As part of a V2 process additional alignments should likely be
performed should assembly not be available, such that a "best match" can be found within
the known strains. As shown in Figure 116 the core genome of MRSA strains can be
relatively small with significant variation across major strain types but also between
supposedly identical ones such as USA300. And as mentioned previously as the database of
genomes grows (i.e. the pan-genome) the ease with which improved alignments can be
found also increases. Another thing to note in Table 25 is the variability in coverage
despite careful attempts at equimolar pooling. The DNA quantification QC measurements
are significantly variable and would have to be refined in a V2 process. This is a clear
example of the need for connected development as the solution to the variability would
require connections between the downstream analysis such as the one presented here and
the laboratory optimization and design of the barcoding process. The lack of robustness of
the V1 process is also apparent in the pooling error for one of the attempts where twice the
volume was added as a technician mistake resulting in double coverage and opportunities
for "troubleshooting representatives" to solve issues.
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1 4,624,214 3,745,828
2 5,135,974 4,130,735
3 5,809,068 4,739,816
4 5,108,604 4,133,021
5 6,887,632 5,576,740
6 10,574,792 8,669,612
7 4,843,010 3,938,483
8 7,411,530 5,937,507
9 3,549,962 2,860,380
10 2,638,954 2,093,008
11 4,794,760 4,071,487
12 2,610,898 2,000,266
335,993,336 272,170,199
372,910,467 299,922,530
423,522,838 345,566,677
371,422,767 300,492,678
502,000,525 406,457,024
771,074,261 632,155,665
352,736,257 286,855,850
542,065,159 434,257,930
254,652,958 205,186,486
189,184,539 150,046,099
348,584,752 296,001,945
190,391,314 145,862,945
Table 25 - Summary Data Results of Case Study Samples on V1 Process (alignment to
USA300.TCH1516)
6.5 Variation Found
All of the samples contained the mecA gene as would be expected based on their
phenotype. The mecA gene showed no modifications in any of the samples appearing in its
established conformation. As has been discussed previously, the raw data produced by the
process is noisy, containing errors towards the end of reads as the signal intensity
decreases relative to the background and it is harder to discriminate the signal from a
correct base. This leads to errors that can be overcome by statistical analysis using
multiple observations to confirm their validity. As an example a region around the mecA
gene in one of the samples is shown in Figure 117 with the underlying data and coverage
for the region. The noise from sequencing errors can be seen, randomly distributed as
colors through the reads, where grey represents the same sequence as the reference. To
emphasize the statistical approach, a true SNP is also shown in Figure 117 in blue, where
all raw data reads contain this difference from the reference making it unlikely that it is a
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random error and can be visually seen as a straight line connecting all reads. The initial
alignment of the reads was performed using Maq as shown in Figure 117, but these had to
be "collapsed" into a single "consensus" sequence where individual SNPs are statistically
evaluated against random error using the package SAMTOOLS2 developed by (Li,
Handsaker et al. 2009). This final consensus sequence is then used as the sequence for
each of the strains. Note that this approach has limitations in that only the sequence
aligned to the reference will appear in the consensus sequence and is the reason both more
references will be needed but also improved assembly algorithms that can piece together
genomes without the need for alignment. Both of these issues are addressed by projects
for the V2 process in Appendix 1.
441169 
-_ 
_
Figure 117 - Read Data Around mecA Gene for a Sample in the Case Study Showing Coverage
and a SNP. Colors indicate differences from reference sequence, color shading indicates
confidence of difference, and red boxes indicate pairing mismatches.
The mecA gene occurs as part of the Staphylococcus Chromosomal Cassette (SCCmec)
mobile genetic element, and is not considered part of the core genome. However, the
" SAMTOOLS from http:/ /samtools.sourceforge.net/
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SCCmec does exist in certain patterns defined as SCCmec types (I-V), which include the
mecA gene but also others such as the ccr complex of recombinase encoding genes that
provide mobility to the SCC cassette. In Figure 118 the 12 case study sample sequences
and the reference USA300 TCH1516 genome are aligned using Mauve showing the
sequence in common as mauve, the unique sequence to a particular genome as white, and
other colors showing sequence shared by a subset of genomes. The mecA gene is
highlighted and its corresponding location in all genomes highlighted by a box. The ccrB
gene is also highlighted and it is interesting to note that it is not found in all the samples
suggesting sample 31195 is a different strain with a different SCCmec region and type as
shown in Figure 118. Given the diversity of samples collected some variation between
strains expected although the change in SCCmec cassette is substantial and additional
comparison against other strains would be needed to determine the SCCmec type (or a
novel type if no existing match can be found).
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Figure 118 - Comparison of 12 Case Study Strains and Reference in the mecA region of the
SCCmec element. The mecA gene is highlighted in red and the ccrB gene in green. Common
regions to all genomes are in mauve, and other colors indicate shared regions to a subset of
genomes.
A multiple alignment was performed across the entire set of case study genomes and the
results are shown in Figure 119 with the standard Mauve color convention showing the
majority of case study genome sequences are shared with each other and with the USA300
reference. However, it appears that many of the initial case study samples are substantially
different than the USA300 reference, most likely hospital MRSA. This can be seen from the
difference in aligned length between the reference in Figure 119 at the bottom and the case
study samples. Reads from the case study samples that do not align to the reference will
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not be shown corresponding to the difference in length. The differences in the reference
can be seen as white sections unique to the reference relative to the case study samples.
Additional reference genomes or assembly based genome analysis would address this
issue. Nevertheless significant insight can be gained from this multiple alignment as has
already been seen in the SCCmec analysis previously. A large number of differences
between the genomes can be seen in the variation in aligned length, areas unique to each
genome, and sequence shared with a subset of genomes. It would likely be possible to
replace PFGE and MLST typing techniques with a method similar to the analysis performed
in this section to look for variation or SNPs in the conserved "core" region of the genome.
For example, boxes a, b, c, and d in Figure 119 highlight unique sequence in each of the
corresponding case study genomes. Box d shows regions only shared by each of the three
genomes highlighted which could be used as a "fingerprint" to type strains. Finally, box f
spanning all of the case study genomes shows very significant variation around a
pathogenicity island showing that certain regions of the S. aureus genome are hyper
variable and "designed" to mutate while others are highly conserved as described in
(Lindsay and Holden 2004). The ability of the S. aureus genome to rapidly adapt is essential
to its role as a "professional" pathogen able to rapidly vary the characteristics of virulence
and resistance mechanisms as well as its ability to rapidly incorporate novel genes from
other microbes and phages. However, it does not have unlimited ability to mutate and in an
engineering sense understanding the "design space" under which S. aureus can change its
genome and adapt would be invaluable to its control. An essential element of
understanding the design space is to catalogue many more genomes as well as to build
models for the gene interactions.
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Figure 119 - Comparison of 12 Case Study Samples and Reference Genome. Boxes a, b, c, d
highlight unique sequence to that particular genome, box e highlights shared sequence to a
subset of genomes, and box f highlights a hyper-variable region
The hyper variable region in box f in Figure 119 is magnified in Figure 120 showing only an
80,000 base region of the multiple alignment. The reference genome is a USA300 strain
that contains additional virulence genes such as Panton-Valentine leukocidin (PVL)
encoded by the lukF-PV and lukS-PV genes, which are also shown highlighted in red. Note
that the reference genome region where the PVL genes exist is shown as white "unique"
sequence only found in the reference, which suggests that the case study samples are not
community associated MRSA (CA-MRSA). However, despite not having PVL genes, the
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hyper variable region is immediately following the location of PVL in CA-MRSA and
significant differences can be seen in Figure 120. Many of the differences are shared as can
be seen from the coloring implying at least two genomes share each region, although some
regions are unique to each.
1 -1 8405000 K b0 1 5 3 0 0 W I '
00 14400 145400 145S00 1 44000 1 5 000 1471 14 1000 1490000 149M0 0 1500000 1500 1510000 15100 15200 152 000
MSRSA308453refon fasta (os annotdo
00 144 54000 1450 14 46000 -I4 149000 15000 15 000 1510000 5100 152 152000 1
RSA3047SJf ta (ne OtWn s
0000 1441000 14500 145 00 4 14610 147 000 14700 148000 14I M00 I 90015 00015 0 1 0 10 1 500
MRSA308507efcordf a &a(oantaW e)~ ^
000 144000 143000 1450000 145000 14700 0 14i 0 4 00 149000 14910 M0000  150000 1510 3315 000 150000 1
A
MR5A3"S76 refon fats (no annotao oaed
)0 1443100 1450000 1451000 146 1 46 00 000 147 000 14400 49 0 49 0 49 5 15000 15$30 5000 : 151 11000 152 3 000 1ss5
Ve
0 1441000 145000 1450h0o 16 0 140 0 4 1 1153
MRSA3j195,tfton-faita (no Annetass ) \
OO000 14400010 1450000 9 000 1j 0 70017$05000 40019 1000O 0001000 $00 590 $40 $40
A
40000 144000 140000 14 140 146000 147 140001 14W00014 490003 5 1000 151 1510001 155000
t5400 14000 14000 155000p w 161000 170W0 1? 1400 5001900 M600 1000 16S000 1I15000 162000 I62A0
".ast n
ILU
Figure 120 - Comparison of Case Study Genomes and Reference Around Hyper Variable
Virulence Region (box f). The Panton-Valentine leukocidin genes in the reference USA300
genome are highlighted although these are not found in the samples.
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Note that many sequence fragments are shared between the genomes, and they are
significantly re-arranged in a different order leading to the multi-color bands observed and
indicating that significant gene diversity exists but from a "building block" re-arrangement
rather than novel unique sequence, although some unique sequence is also seen in Figure
120. The particular region shared between the reference and the case study samples in
Figure 120 was searched for in the NCBI databases to determine if its function had been
elucidated or annotated, but most of the proteins encoded by the region are classified as
"hypothetical proteins" meaning the sequence is theoretically able to encode proteins but
their function or existence has not yet been confirmed. The ability of S. aureus to contain
hyper variable regions associated with virulence likely gives it a significant competitive
advantage as it seems to have been designed for rapid "trial and error" experimentation
where novel proteins (such as cytotoxins and others) can be produced and if successful
that particular clone will have competitive advantage. These regions have been described
as "gene nurseries" where novel changes can be tried. The successful clone will not be
satisfied with any temporary success however, and has the machinery for its offspring to
continue to experiment. Much like Toyota and other organizations that have adopted lean
techniques, S. aureus owes its evolutionary success to continuous process improvement.
And there is much to be learned from the way S. aureus manages change in that it has
grouped "invariants" or the core genome into well controlled and efficient gene sets, but
has also designated certain regions for rapid change and variation. It is interesting to
compare the change management ideas described in Figure 113 and shown again here with
the way S. aureus has also confined change to certain hyper variable regions as shown in
Figure 120. In the case of S. aureus the main objective is rapid adaptation to changing
conditions and because of its ability to quickly reproduce, many "experiments" are possible
in a relatively short amount of time. In large scale complex engineering systems it is not
possible to have many copies of the system to experiment, but it may be possible to confine
change to certain smaller manageable sections such that many more iterations of these
components or modules can be achieved in critical areas of system performance. S. aureus
appears to have optimized its core genome such that it is robust, shares genes with other
organisms so that it will not be susceptible to antibiotic attack (i.e. elements are not unique
to S. aureus), and is highly efficient such that the virulence and resistance machinery can be
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allowed to be very flexible and adaptable as a system design objective. Engineering
systems and processes might be designed in similar ways taking a page from millions of
years of evolution.
Figure 113 - MDPM Analysis to Identify Process Change Infrastructure and Invariants to
Support Rapid Change in a Subset of the Process
6.6 Implications for V2 Surveillance Process
The significant variation found in the case study samples and that reported elsewhere
(Monecke, Berger-Bachi et al. 2007; Mwangi, Wu et al. 2007; Kennedy, Otto et al. 2008)
support the urgent need for a whole genome high throughput surveillance system.
However, it is clear the V1 version designed as a proof of principle requires significant
improvement into a V2 version before it could be used as a "production process". This
follows the iterative development of engineering processes where an initial conceptual
design or model is formulated perhaps based on initial observations, this initial design is
tested to produce actual experimental data and results on its performance, and this
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information is then applied to develop an improved version and so on. This follows ideas
for statistical process improvement described in (Box 1999). In this case, the initial
conceptual V1 process design (models) followed the case study testing (data) as
conceptually shown in Figure 121.
Iterative Learning Process
Observations: Objectively Obtained Quantitative Data, Facts, Phenomena
VI Case Study V2 Test
Induction
se e 0see
\deduction
V1 Process V2 Process V3 Process
Design Designi Design
Model: Theory, Hypothesis, Design
Figure 121 -Iterative Learning Process for V1 Surveillance Process and Case Study (adapted
from Box 1999, Magee)
The lessons learned from the case study can be applied to refine the potential improvement
projects described in chapter 5 to produce a V2 process. The cycle would of course
continue, incorporating additional improvements in future versions. There are clear areas
for improvement based on the case study results and these are detailed in the next section
describing the improvement projects needed, which are also detailed using the MDPM
model to ensure these projects will be well integrated into the process. However, the
surveillance process will also need to integrate with the healthcare system and the external
stakeholders such as antibiotic researchers, CDC, and others who will need to interact with
the process and data produced. An extension of the ESM model to include the MDPM model
can be used to explicitly map the interactions with these external stakeholders such that
the process is well integrated with their needs and conversely receives input from these
external sources.
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6.6.1 Projects
The following set of projects necessary for the development of a V2 process were described
in terms of the MDPM model and process observations in chapter 5, but they are described
in more detail here based on the biological observations in the case study. The full detail of
each project is given in appendix 1.
Project 1: MRSA Sample Diversity
Having a larger database of sequenced MRSA genomes allows for improved alignment of
sequences as well as better identification of genetic differences between strains. As was
seen in the case study examples, variation between MRSAs and the likelihood that hospitals
will see multiple strains as patients can travel between hospitals or may be infected with
CA-MRSA, makes it essential that a much larger set of MRSA genomes be sequenced above
the less than 20 available in public databases. A larger set would also allow for the tracking
of geographical diversity, as well as an improved understanding of the degree of variation
that can exist across the entire MRSA genome, which will be important for both diagnostics
and antibiotics manufacturers. This project would necessarily have to occur before any
routine surveillance to test the majority of samples and conditions within a V2 process to
ensure they can be accurately identified and the process works for all sample types. For
example, the DNA extraction conditions would need to be worked out for all samples as
well as analysis tools to cope with the classification of many closely related organisms. A
potential source is CDC strain collection or other comprehensive set of MRSA samples
which contained the expected diversity in order to test the process. In addition it will be
valuable to collect samples from international sources in order to track the variation
outside the US, which through air travel could easily spread. Additionally sample
collections such as the one used in this thesis that compare MRSA samples that colonize
individuals versus those that actually produce the infection will be valuable. Finally, time
series sample collections for MRSAs exposed to multiple antibiotics would be extremely
valuable to identify the evolutionary mechanisms of MRSA.
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Project 2: DNA Extraction Robustness
Much more work will be needed to optimize the DNA extraction conditions for a wide
variety of samples, but it may be possible to use genetic information to correlate phenotype
changes (i.e. a thicker cell wall) with genotypic changes (modified genes or regulation).
Ensuring sufficient DNA of high quality is obtained is critical for the additional V2
processes needed to support assembly based surveillance processes that do not rely only
on alignment to known sequenced genomes, particularly in terms of finding novel
mutations. New technologies are available to do this such as the DNA extraction of MRSA
in a microfluidic chip as described in (Mahalanabis, Al-Muayad et al. 2009) a type of
approach which could completely transform the way current DNA extraction is performed
and ensuring robustness against a variety of samples.
Project 3: Advanced Molecular Biology
One of the main difficulties in assembling de novo genomes is the need to span long
distances (>2,000 bases) with molecules of DNA that are read at each end. The data in the
V1 process consisted of a 75-200 base molecule size as shown in Figure 122, which is not
sufficient to span certain regions of the genome that have a high similarity. This prevents
the logical ordering of DNA sequence such that only small fragments (<10,000 bases) can
be constructed from the reads. Developing the connecting technology to build high
throughput "libraries" of sequencing technology compatible DNA molecules that were
originally separated on the genome by >2,000 bases is a key technical challenge. Achieving
larger separation sizes is technically difficult due to problems in manipulating larger DNA
molecules and the need to convert these larger DNA molecules into smaller molecules (i.e.
<300 bases) that delete the intervening DNA and only retain the ends of the original
molecule (which were separated by a much longer distance i.e. >2,000). Complex
molecular biology development will be needed. This is a critical "connecting technology"
for the V2 process because it will involve molecular biology, algorithm development, and
DNA extraction. The importance of this will be seen in project 5 describing the algorithms
needed.
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Figure 122 - DNA Read Separation in V1 Process (distance between 75 base reads on a single
molecule)
Project 4: Configure Process for Rapid DNA Sequencing Technology Change
While a single sequencing technology was selected for the initial case study using the MCNF
selection process, it is likely that a V2 process could use multiple technologies each with
their own particular benefit. This places greater emphasis on the ability of the process to
incorporate change much like S. aureus confines change to certain "hyper variable" regions.
For example, a hierarchical process might be developed where samples are pooled together
initially under the expectation that they are similar using the Illumina process and only if
significant variation is seen in this set would more expensive sequencing processes be
deployed such as 454 or an Illumina hybrid method that captured longer sequences. It will
be important that technology change in sequencing occur as connected development to
projects 3 and 5 especially.
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Project 5: Build Data Analysis Pipeline
Perhaps the most important element of the V2 surveillance process will be the data
analysis software and infrastructure since much of the V1 process relied on prototype tools
or modify tools not primarily intended for microbial analysis. The many algorithms needed
to translate raw data into alignments with high confidence SNPs or complete genome
assemblies still require significant manual intervention and tuning in the V1 process. More
importantly the analysis of the data in the V1 process is still "raw" since even if all of the
SNPs are correct or the genome assembly is complete there is still no information about the
function of the encoded genes or their correlation to phenotypes. Thus, a fully integrated
V2 data analysis pipeline would not only process all the raw sequence data in automated
ways with no need for manual tuning but would also deliver interpretation of the results
such as classification of SCCmec types or correlation and genealogy with existing MRSA
strains. Backwards compatibility would also be needed such that users could verify results
using traditional techniques such as MLST and PFGE.
To highlight the additional development needed in the data analysis pipeline but also the
associated connected development the 12 case study samples were run through one of the
current state-of-the-art assembly programs called Velvets developed by (Zerbino and
Birney 2008). The results are shown at the top of Figure 123, where the resulting genome
from velvet is compared to a reference MRSA genome. The highly fragmented assembly is
evident from the many individual fragments that align in a disordered fashion. This is due
to the lack of longer insert libraries such as those that would result from project 3, which
could link all of these fragments into their logical order. The fragments from the raw velvet
assembly were then re-ordered using the reference to help identify their correct location
on the genome and the result is shown in the bottom of Figure 123, where it can also be
seen that the overall length of the genomes are similar. The assembly method recovers the
majority of the unaligned reads, which were discarded in the V1 process as shown in Figure
119. The re-ordering of fragments based on a reference was done here to illustrate the
value in assembly based methods but would not be recommended in practice as it would
" Velvet Assembler: http:/ /www.ebi.ac.uk/ -zerbino /velvet/
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encounter similar limitation to alignment based feature finding in that only things known a
priori are found, but not potentially novel re-arrangements or structures. Improved
similar methods combined with the advanced molecular biology in project 3 would enable
the routine production of high-quality assembled genomes such that novel mutations could
be found rather than differences to a reference. This is especially important for the
identification of horizontal gene transfer between organisms such as the exceedingly
dangerous VRSA strains that combine MRSA with the Enterococcus VRE vancomycin
resistance.
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Figure 123 - Velvet Assembly Alignment Showing Fragmentation Due to Lack of Linking
Information (Top) and Re-Ordering Based on Reference Order (Bottom) Red Bars
Correspond to Boundaries of Original Contigs (fragments) in the Raw Assembly.
But even with high-quality complete sequences, such as those in Figure 116, this data still
says very little about any potential correlations with phenotype or individual gene function
and also do not describe the relationships between sequenced organisms in terms of their
genealogy. A significant additional layer of software would be needed to transform this
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data into useful epidemiological and clinical information that could be acted upon by
hospitals and physicians. This would require the involvement of the external stakeholders
associated with this project as detailed in appendix 1 such that this additional software
layer could be well integrated internally through the MDPM but also externally to the
stakeholders.
Project 6: Verify Biology
Based on the variation seen, additional phenotype tests will likely be required to verify
biology encoded in the genome. For example, all of the case study strains contain the mecA
gene and will show the characteristic growth in the presence of antibiotic, however the
wide variation in virulence genes suggests additional tests may be required to determine
the extent of other virulence related properties such as tissue damage, colonization
potential, and others. Deeper understanding of the regulatory networks in S. aureus will
also help determine the effect of genome changes but these will also have to be verified in
the lab such as metabolic activity, growth rates, and others. Correlation of all of these
phenotype properties to genotype information will be a key feature in the usefulness of a
V2 process.
6.6.2 Healthcare System
Beyond the technical challenges to developing a V2 surveillance process exist challenges in
integrating the surveillance process with the larger health care system in terms of its
ownership, funding, locations, and perceived benefit. Because the currently feasible
surveillance process (even in an improved V2 configuration) spans many organizations,
disciplines, and process elements it is unlikely to spontaneously arise and would likely
require significant effort to initially develop it and continue to operate it. Securing the
support of external stakeholders through a detailed MDPM analysis would be an essential
additional "project" to make sure the necessary resources were available and any blocking
issues addressed. This might be done as a "cost-benefit" analysis where the links between
external stakeholders in the process were mapped to ensure a net positive benefit to
stakeholders and sufficient resources to build and operate the process. This is conceptually
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shown in Figure 124 where the Engineering Systems Matrix (ESM) has been modified to
include the MDPM but also the system drivers, stakeholders, and a new category called
"system blocks" associated with key external elements that may be blocking issues such as
regulation, public perception, and others. The area highlighted in green represents the
benefits of the process to stakeholders but also any impact from the process to system
drivers and system blocks. The area in red represents the cost to stakeholders of the
process, but also the impact of system drivers and system blocks on the process.
Figure 124 -ESM and MDPM Based Conceptual Stakeholder Cost Benefit Matrix
The framework conceptually illustrated in Figure 124 could be analytical in nature where
elements of the matrix have values corresponding to the actual benefits or costs created as
a non-dimensional dot product of normalized values and a vector of weights similar to the
costs developed for the MCNF model. This would allow for the analytical evaluation (but
also a framework for discussion) of the costs and benefits of the surveillance process. Thus,
difference between benefits and costs should identify a net benefit (or not). Ensuring that
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there are sufficient resources to develop and operate the process is part of the V2 process
development as the scope of the V2 process is significantly larger and likely cannot be
developed using just minimal resources as for the proof of principle V1 process in this
thesis. The ESM and MDPM based stakeholder cost benefit analysis is proposed as an
important analytical tool to secure the necessary resources and ensure a net benefit to
stakeholders. However, in addition to identifying the costs and benefits basic familiarity
and understanding of the surveillance process data will be needed for research physicians
and epidemiologists to use (and trust) the data. Their involvement and buy-in of the
projects detailed in appendix 1 will be necessary in addition to their contribution in terms
of analysis and use of the surveillance system.
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7 Future Work
Improvement in complex processes requires continuous iteration to identify necessary
changes, devise changes, and test them. The knowledge gained from the previous iteration
can then be used to design an improved process, which then serves as the next step in the
improvement cycle. The "V1" process developed in Chapter 5 and tested in Chapter 6,
allowed for the identification of necessary changes (such as the need for assembly based
methods), which were identified as the series of projects defined in appendix 1.
Implementation of these projects would lead to a "V2" version with much greater
capability. However, the iteration should not stop there, as MRSA surveillance will require
far more than a single prototype process addressing the needs of a hospital. The
surveillance processes should continue to expand in successive versions to address more
hospitals, communities, states, and eventually a nationwide system. Deployment of
surveillance processes to the much larger number and type of locations will require the
redesign of processes to be simpler, cheaper, and highly integrated with each other.
Additionally, emphasis on process and publication and cost reduction would likely lead
directly to the development of DNA sequencing based processes that could replace current
culture based MRSA diagnostics. This would allow for "real-time" surveillance as cases
appear, and while these systems may not be initially as comprehensive as "full"
surveillance that could serve to collect enormous quantities information not available
today. Perhaps most importantly, ongoing improvement and optimization could produce
robust and very low cost surveillance systems that could be deployed in Third World
locations providing true "frontline" surveillance in key areas where new pathogens may
emerge. The ultimate goal is then to integrate all these elements into a global surveillance
system that would allow for real-time tracking of MRSA evolution, outbreaks, and control
measures. A detailed roadmap for these successive process versions is presented in this
chapter.
However, many of the tools developed in this thesis could apply to other areas beyond
healthcare where the analysis of processes is essential. Complex manufacturing processes
such as those in aerospace, pharmaceuticals, semiconductors, and other industries could
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readily be modeled using the MDPM methodology in order to assess their complexity and
manage it. Application of these ideas is not limited to "physical" processes but could also be
used to understand "business processes" such as those in the financial services industry.
More generally existing research on enterprise architecture could be integrated with the
process specific models developed in this thesis to better understand both the enterprise
and its processes (i.e. many of the elements outside the boundary of the current analysis).
Additional research will likely be needed to apply the MDPM models developed in this
thesis and other related ones such as the ESM matrix to many additional cases in order to
identify general characteristics and design rules for complex systems (and processes). A
key general improvement is the development of software to facilitate the capture and
analysis of complex process elements in each of the domains as well as the need for
"versioning" to map the change of the network through time. The second key improvement
would be the explicit quantification of the additional "scaffolding" described in this thesis
to support either rapid process change or significant improvement. The scaffolding could
be described as "process options" which process designers and owners could evaluate in
terms of their return on overall process properties such as flexibility, adaptability, and NPV
for the process overall. These ideas for future work are also presented in this chapter.
7.1 Surveillance Roadmap
The proof of principle surveillance process developed in this thesis should be just the
starting point for a series of process iterations leading to first a comprehensive national
MRSA surveillance system and eventually to a global surveillance system. The high
interconnectedness of modern society means that new pathogens can emerge across the
country or across the planet and be transported very quickly to nearly any other point on
the planet through the air transportation system. However, despite the need for
substantially increased surveillance, the initial V1 case study suggests the process still
requires additional functionality despite its high complexity. Significant effort will be
needed to first add the additional functionality into a V2 process but looking beyond that it
would likely be possible to follow on with a V3 process that focused on simplifying the
process and removing much of the "scaffolding" needed for the V1 and V2 processes. And
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yet removing the scaffolding within itself require additional resources before the final
"streamlined" V3 process was fully deployed and tested. This suggests that much greater
process complexity will be required between the current proof of principle V1 to an
operational V3 process and this potentially large increase in the number of elements in
each domain may limit the speed and usability of developing these additional iterations
unless sufficient resources are secured. This might be thought of as a "complexity barrier"
where significant additional resources are needed to transform a current process into a
future one that may be simpler and more efficient but requires a temporary increase in
development and testing resources to "cross" the barrier. Table 26 describes additional
process versions to address the incorporation of radical new technologies (the proposed
V3 process assumes only existing commercially available technologies) and the need for 3rd
world surveillance. However, a conceptual representation of the "complexity barrier" for
these process iterations is shown in Figure 125 where the cyclomatic number (edges-
vertices+1) is plotted for the two data points in this thesis (the baseline and V1 processes)
and notionally for successive iterations of design, implementation, and testing.
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Description Process Knowledge MRSA Knowledge
V1 Proof of Principle Basic Performance Variation in Genome
Identify Improvements Diversity Observations
MDPM Model Analyses Needed
V2 Pilot Process Address V1 Issues MRSA Pan-Genome
Additional Features Sampling Rate Needed
High Throughput Operation Phenotype Correlations
V3 Production Ready Scaffolding Removal (Org/Info) Regional Variation
(Existing Robust Process Multi-Infection Studies
Technologies) Transferable Process Meta-Genomics
Multiple Location Network Related Organisms
V4 Production Ready Process Domain Optimization Host Interaction
(New Technologies) National Surveillance Population Dynamics
National Network Outbreak Tracking
V5 Diagnostic Culture Diagnostic Replacement Diagnostic Validation
Integration Surveillance Data Integration Prevalence (screening)
Integration with Network Correlation to Cases
3u woria
Surveillance
Low Cost, Robust Process
Surveillance Data Integration
Integration with Network
3rd World Variation
Selective Pressure
Horizontal Gene Transfer
V7 Global Surveillance Integrated Processes Global Changes
Surveillance Data Integration MRSA Evolution
Integration into Single Network Global Outbreak Tracking
Table 26 - Surveillance Process Roadmap of Future Versions
2,000
1,600
* M Process
* information Domain Elements
" Organizational Domain Elements
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M
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Figure 125 - Conceptual Representation of Cyclomatic Complexity Increases for Successive
Surveillance Process Versions. Process Networks at Same Density (0.02).
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The V1 process has already been extensively described in this thesis and the V2 process
would incorporate the projects described in chapters 5 and 6 to address issues found in the
testing of the V1 process and incorporate desired improvements. The V2 process would
allow for a vast increase in our knowledge of MRSA as it would have the scale and ability to
sequence entire collections of MRSA samples such as the CDC's. Obtaining the full sequence
of these diverse collections would allow for the first full MRSA "pan-genome" describing a
sampling of the variability seen to date across the United States. The pan-genome survey
would also provide an estimate of the sampling rate needed in a national surveillance
system based on the genetic divergence observed in the collections. Most importantly the
V2 process would enable the correlation of phenotype characteristics (such as virulence
measurements) with the genotype found such that only genetic information might be used
in future diagnostics. The V2 would only rely on existing commercially available
technology.
Continuing with the roadmap, a V3 process would take any lessons learned from the V2
operation and incorporate any additional desired functionality not perfected in the V2
process. But most importantly, the V3 would focus on simplification of the process by
removing much of the "scaffolding" in the organizational and information domains "left
behind" from the V1 and V2 processes. This reduction in complexity would be critical for
the transfer of this process to additional locations such as other hospitals or research
centers. The V2 process is not contemplated as a "multi-location" process due to the
significant complexity is likely to have and the need to have a correspondingly large and
complex network at a potential additional location. The V3 process would thus focus on
providing "transfer links" similar to the change representatives were troubleshooting
representatives described in Chapter 5 who would engage the transfer stations and ensure
most of the process was a few network hops away. Additionally, as this V3 process would
be focused on replication such that it could be transferred, it should also be made robust to
minimize the troubleshooting needed at destination organizations and would thus require
very significant "scaffolding" during its development to test a number of failure modes and
eliminate them. The V3 process would allow for the observation of regional variation in
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MRSA as well as the tracking of patients with multiple infections over time. Most
importantly the V3 would have sufficient additional capacity to sequence related organisms
that may be critical to the development of MRSA through horizontal gene transfer such as
Vancomycin resistant Enterococcus. Additionally, the V3 process could be used to perform
"meta genomics" surveillance where samples might be pooled together and sequenced to
greatly increase the number of samples that could be reserved. The pools would be
compared to the reference "pan genome" subtracting known genes and only flagging novel
sequence corresponding to new genes or gene is being transferred from other organisms.
The V3 process is also expected to only use commercially available current technology.
However, radical new technologies are being developed in early development stages that
could radically change the process domain of the surveillance process described in this
thesis. These new technologies include microfluidics based devices that could replace many
of the steps performed in the V1, V2, and V3 processes with highly integrated "chips" with
minimal operator involvement. For example, (Mahalanabis, Al-Muayad et al. 2009) describe
a microfluidics based device to lyse MRSA cells mechanically without the need for the
enzymatic processing that proved to be a key development problem and connecting
technology for DNA extraction described in Chapter 5. This device would replace many of
the steps and require perhaps the single technician with a corresponding decrease in the
number of organizational and information domain elements. Additionally, new DNA
sequencing technologies are becoming available that greatly increase the speed,
completeness, and quantity of data potentially making same-day results possible. These
technologies also have the potential to greatly reduce the number of process domain
elements with a corresponding reduction in information and organizational domain
elements. The development of processes using these technologies however would require
significant initial scaffolding as the technical complexity in building these new devices is
very significant although the resulting processes are much simpler. The incorporation of all
these new technologies with the specific aim of further complexity reduction and process
optimization is called the "V4" process as shown in Table 26. The V4 process would allow
for much more extensive deployment due to its reduced complexity (and reduced
infrastructure needs) leading to the potential for national surveillance. However, going
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along with national surveillance would be the need for a national system to collect and
process all of the relevant information and coordinates any changes or improvements in
each of the distributed processes. Thus, while the "local" process complexity may be greatly
reduced the overall "system" complexity could grow significantly and would have to be
carefully managed to avoid unnecessary complexity. The V4 might also allow for the
sequencing of hosts to identify any host-MRSA interactions not previously observed (i.e.
some individuals may be better able to resist MRSA or the reverse). The more excessive
deployment would also allow for outbreak tracking and the study of population dynamics
(i.e. how the overall MRSA population is changing).
The same technologies used for the V4 process might also be used for the development of
highly efficient diagnostics to replace current culture-based methods. These diagnostics
might be "simplified" lower performance processes than the full-scale surveillance
processes but nevertheless sufficient for diagnostic use, particularly when combined with
ongoing surveillance that could inform what the diagnostics should look for (i.e. new
virulence genes). While, PCR is currently available for this function, these tests only look for
the presence of a few select resistance genes to identify MRSA. A DNA sequencing-based
diagnostic would look in several of the pathogenic regions of the genome (if not the whole
genome itself) to identify the particular strain precisely and better tailor the therapy the
patient might receive. These diagnostics should be integrated with the overall surveillance
network providing even more information. The development of these diagnostics however
would require very significant "scaffolding" as the validation would need to be extensive
and the diagnostics would have to be proven as highly reliable.
One of the most important and often overlooked areas of surveillance is in poorer 3rd
world countries that suffer from an enormous burden of infectious disease. The high
prevalence of disease in these countries also makes them a breeding ground for new
strains of pathogens many of which could spread very rapidly. In addition to efforts to
improve health care in these countries, surveillance could be a valuable tool to improve the
ability of these countries to deal with epidemics but also serve as frontline surveillance
tools for the identification of new pathogens. However, the development of robust and low-
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cost surveillance processes for these countries would require significant effort to greatly
reduce the complexity of the processes such that they could operate in locations with very
limited infrastructure but which would nevertheless need to be connected to the overall
surveillance network. This process is called the "V6" process as shown in Table 26.
Finally, the ultimate goal must be to integrate all of these elements such as diagnostics, V4
new technology surveillance processes, and 3rd world surveillance into a single global
surveillance system. This would allow for the efficient use of resources to identify emerging
MRSA strains, limit their spread, and perhaps develop ways to eliminate them. The global
tracking of pathogen changes would be a powerful tool when integrated with not just MRSA
but other microbial pathogens such that coordinated efforts could be made to manage
global antibiotic distribution, management, and development. Global strategies to cycle
antibiotics might be effective in controlling the spread of resistance involving the use of
sophisticated supply-chain models to coordinate antibiotic distribution with surveillance
data.
The processes described thus far (V2-V7) are intended to be elements of large-scale
surveillance systems, which can have significant complexity just from the need to manage
and communicate with many surveillance locations. For example, a national surveillance
system would need to cover all major hospitals, key clinics in remote or high-risk areas
(low income or high drug use), and importantly cover animal production (cattle, swine,
etc.) which are exposed to antibiotics and could harbor resistant microbes. These locations
could be more than 10,000 alone without counting the possibility of including diagnostic
elements. A global surveillance system might increase this number by an order of
magnitude or more to cover 3rd world locations plus equivalent hospitals and clinics in
developed countries. The complexity of such a system could be very high causing
difficulties to manage, change, and quickly troubleshoot elements of the system in similar
ways to those described in this thesis. Two aspects of this global surveillance system
deserve further discussion in the context of this thesis. First, what should the control
infrastructure look like to manage such a system? And second, what is the impact of the
complexity of each individual process element on the overall complexity of the system?
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This is shown conceptually in Figure 126, where a hierarchical structure for control of the
system is used and the V1-V7 processes are each at multiple locations.
Surveillance
System
Individual V3, V4, VS, V6, V7
Processes at Multiple Locations
Figure 126 - Conceptual Diagram Showing a Hierarchical Structure for a Regional
Surveillance System
A hierarchical control system can connect a large number of elements just a few nodes
depending on the branching ratio and number of levels as given by Equation 26.
N=bl
N = b -_1b-i
where N is the number of Nodes, b is the branching ratio, and L is the number of levels
Equation 26 - Number of Nodes for a Hierarchical Structure
However, despite their advantages for connecting large numbers of nodes, hierarchical
structures are extremely sparse, rapidly falling below the network densities observed in
the MDPM model developed in this thesis. The density for a hierarchical structure can be
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derived from Equation 26 where the number of edges will be twice one less than the
number of nodes, and compared to the maximum density an equivalent number of nodes
could achieve in a complete graph. The density for a hierarchical structure was derived
and is given in Equation 27.
A 2(b-1)
hierarchical b L 1
where b is the branching ratio, and L is the number of levels. Bi-directional edges.
Equation 27 - Density of a Hierarchical Structure Compared to A Complete Graph with the
Same Number of Nodes
Compared to the observed densities in the MDPM of the V1 process, hierarchical structures
are exceedingly sparse, and for comparison the density of a hierarchical structure
compared to the -0.02 observed density of the V1 model is shown in Figure 127. Areas in
blue are the same or equal to or greater than a 0.02 density, while areas in red are below
this value and drop exponentially with increasing numbers of levels and branching ratios.
Levels
Branching 1 2 3 4 5 6 7 8 9 10
2
3
4
5
9
10
12
13
14
16
Figure 127 - Density of a Hierarchical Structure with Increasing Hierarchical Levels and
Branching Ratios. Areas in red are below (0.02) density.
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The degree to which the overall surveillance system might be connected is critically
important to its design. As has been shown in this thesis each process can have significant
complexity and a design question is how best to replicate these processes in multiple
locations such that the overall system complexity is reduced. For example, it may be that
each location has just a few MDPM elements (<5%) that are unique to that location due to
the particular organizational structure, available infrastructure, or stakeholder needs. The
rest of the elements could be identical in a "copy exactly" fashion. Yet even a 5% difference
in each location multiplied by 10,000 or more locations means there will be many elements
unique to each location making change and troubleshooting very difficult and requiring
significantly more overhead on the part of the surveillance system network. Shown in
Figure 126 is a hierarchical network, which can link all of the processes with relatively few
levels, however this network is exceedingly fragile and can quickly become congested since
all "messages" must travel up through the hierarchy potentially losing information in the
process and then back down to another process element. This would be problematic for the
management of complex processes and is likely that additional connections would be
needed to facilitate learning (i.e. incorporating improvements discovered at various
locations) across the network. Analyses similar to those in (Dodds, Watts et al. 2003),
where the communications performance of various control structures are evaluated should
be performed on the surveillance system. As found in (Dodds, Watts et al. 2003), multiscale
networks which combine the advantages of hierarchies with the shorter average paths of
"small world" networks where additional links are inserted will likely be the optimal
solution. This is shown conceptually in Figure 128.
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4Figure 128 - Conceptual Representation of a Multiscale Control Structure for the Surveillance
System Incorporating Hierarchical Structure Supplemented by Additional Links in Red
7.2 Additional Surveillance Dimensions
In addition to the microbial genome, which has been the emphasis of this thesis, there are a
number of other dimensions that should be considered in developing a "V2" and successive
versions of surveillance systems. Our knowledge of the microbial world we inhabit is very
limited as described in chapter 1, however new projects such as the Human Microbiome
Project to sequence all bacterial species associated with humans (living in our bodies) will
vastly increase our knowledge. In addition, sequencing of more human genomes will
provide insight into the role host immunity plays in infection. The true "microbial state" of
an individual will likely encompass not just the individual organism (i.e. MRSA) but also the
state of other organisms with which it might share genetic information, the genetic
composition of the host, environmental factors, and several other dimensions. An ideal
system would provide information on each of these additional dimensions beyond those
considered in this thesis such that an accurate representation of all factors associated with
infection can be formed. An ideal surveillance system would include the additional
dimensions listed below:
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Microbe: System pathogen target (i.e. MRSA)
* Phenotype: the observable physical characteristics of an organism including visual,
metabolic, and clinical properties resulting from its genotype and environment
* Genotype: the particular genetic composition of an individual organism
* Pangenotype: the genetic composition of closely related strains, species, and other
microbial organisms with which an organism can readily exchange genetic information
Host: Pathogen target (i.e. human)
" Phenotype: the observable physical characteristics of the host including visual,
metabolic, and clinical properties resulting from its genotype and environment.
" Genotype: the genetic and epigenetic composition of the host
* Microbiotype: the particular microorganism composition of the host (i.e. such as from
Human Microbiome Project Data)
Environment: Microbe and host
* Epidemiological State: the conditions including patient history, environment,
interaction, and current medical condition that affect infection
" Healthcare State: the set of policies related to treatment of bacterial infection including
type of antibiotic commonly prescribed (selective pressure)
This represents an ideal and complete representation (and data set) to satisfy the needs of
additional stakeholders, including individual physicians treating patients, but also enabling
system-wide control approaches. The feasibility of various surveillance system designs
should also be evaluated in terms of how completely they fulfill each of these dimensions.
Note that these would be "systems" rather than processes as the data for these dimensions
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would come from multiple sources. A systems approach for a microbial surveillance
system is essential. Further description of each dimension follows:
Microbial Pangenotype
One of the key mechanisms of antibiotic resistance in microbes is horizontal gene transfer
from one strain or even a different species whereby novel genes are acquired. This
happens routinely, and in fact the idea of a single "species" of microbe may not be correct
as microbes really exist as communities with a distributed genetic instruction set ensuring
the survival of the community if not individual species. The rapid development of
antibiotic resistance demonstrates this process very clearly and in order to develop a truly
effective surveillance system it may be necessary to also perform surveillance of other
bacteria closely associated or living in the same environment as the target pathogen (i.e.
MRSA). The recent start of the Human Microbiome Project, which aims to identify and
sequence all microbial species, will help identify many of these intermediaries although
some are likely to exist outside human hosts. This community of microbes is the
pangenotype, defined as: the set of microbes in contact with and able to exchange genetic
information with the target organism. Of particular interest currently are situations where
MRSA may come in contact with Vamcomycin resistant enterococci (VRE) with the
potential to exchange genetic information and become a staphylococcus strain resistant to
nearly all antibiotics (VRSA) as described previously. The only feasible technology to
perform surveillance of the pangenome are next generation sequencing methods such as
454 and Illumina, although significant work is needed to develop the upstream microbial
acquisition, isolation, and preparation prior to sequencing. The only currently available
approach is based on meta-genomic protocols where entire samples (i.e. blood) are
sequenced as a pool without regard for isolation of individual microbes to identify any
novel genes. This approach could help identify genes that may be in the microbial
community with the possibility for exchange, but does not allow for the isolation and
phenotypic evaluation of the microbe. The Human Microbiome Project is likely to develop
much of the necessary technology however as the needs are similar. The key pangenotype
identification processes required (some of which do not exist, except as prototypes) are:
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e Meta-genomic sequencing
* 16s sequencing
e Single cell isolation
* Single cell sequencing
Host Phenotype
A surveillance system will require correlation with the state of the patient, including all
clinical information to determine the effects of different populations, disease states, and co-
factors (smoking, etc.) on the original infection and outcome of treatment. The host
phenotype description consists of clinical observation and a complete medical record. The
key host phenotype identification process required is:
* Clinical observation and recording
Host Genotype
The genetic profile of a patient is likely to have a significant correlation to the incidence of
microbial infection, and a complete surveillance system would also provide this
information. It is possible certain metabolic or immune system changes may make hosts
better suited to fight off infection and this understanding would help develop both novel
antibiotics but also a vaccine. The technology to do this also relies on next generation
sequencing, but would also require new and not yet commonly available processes to read
both the DNA sequence but also the epigenetic state of cells. These epigenetic
modifications switch on or off the genes in cells and are responsible for the cell
differentiation. It is very likely that in addition to changes in the basic DNA sequence these
modifications may provide advantages to certain hosts that could be exploited for vaccine
or antibiotic development. A surveillance system will require correlation with the
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genotype of the host including both genomic and epigenomic information. The key host
genotype identification processes required are:
* Whole genome sequencing
* Whole epigenome sequencing
* Expression analysis
Host Microbiotype
Human beings co-exist with an enormous number of microbes, nearly 1015 cells containing
an order of magnitude more genes than are in the human genome by various estimates.
The Human Microbiome Project intends to catalog all of these species and eventually
catalog them. This project will likely change the definition of bacterial species, since the
entire population probably exists as a single pangenome with various strains and species
sharing significant similarity but diverging in small but critical ways. The particular
composition of an individual's microbiome is likely to have a very significant impact on
their susceptibility to disease and in particular microbial infection. Some species may "out-
compete" pathogens preventing them from infecting individuals. In others, a different
microbiome may assist infection if certain species are not present. A complete surveillance
system would also provide a catalog of the host microbiome such that the presence or
absence of certain species could be correlated with infection. The host microbiome is also
the prime reservoir of commensal microbes with which pathogenic microbes can exchange
information and is therefore an element of the "pangenotype". As with the pangenotype
the only feasible methods to produce a host catalog are sequencing based approaches using
either the conserved 16s region to serve as a "fingerprint" of the species, or full genome
sequencing. The key microbiotype identification processes required (some of which do not
exist, except as prototypes) are:
* Meta-genomic sequencing
" 16s sequencing
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e Single cell isolation
* Single cell sequencing
Epidemiological Environment
A surveillance system must also provide information on key epidemiological variables
occurring simultaneously either in time, location, population, or exposure. These variables
are collected in the host phenotype data set but include others that may be relevant such as
cohort (i.e. older patients), location (i.e. ICU patients), or exposure (i.e. a doctor not
washing hands regularly). The extensive data that could be collected in the other
dimensions is made more valuable by carefully collecting and correlating other variables to
the emergence of new or different pathogens (or pathogenic mutations). Key
epidemiological processes are:
* Epidemiological data collection
* Epidemiological data aggregation
Healthcare Environment
A surveillance system must provide the particular information of treatment and outcomes
for patient treatment. Knowledge of which antibiotics were prescribed in a particular case
but also as policy (affecting the pangenome) is necessary to draw correlations between
healthcare policies and observed effects in the surveillance data. Additionally, knowledge
of diagnostic tests performed help validate their accuracy. These variables are collected in
the healthcare environment data set but could include others such as hospital hand-
washing policies, clinical staff education, and others to help correlate the observed
surveillance data with healthcare policies. Key processes in this dimension are:
" Healthcare data collection
* Healthcare data aggregation
Page 358 of 385
7.3 Complex Processes
While the main focus of this thesis has been on microbial antibiotic resistance surveillance
as an example of a complex process there are many others in healthcare and many more in
other areas of engineering. For example, much of our modern infrastructure relies on
complex but largely unseen processes such as water treatment, power generation, and
petrochemical production. The technology and objectives of these processes may be
different but they all share the same types of elements as those described in the MDPM
model developed in this thesis. All these processes are composed of an intricate series of
activities that must be performed in order to deliver a product or service. Individuals and
organizations interact with each of these activities as operators, designers, and managers
providing a control structure for the process but also significant tacit information. These
processes also have explicit information in the form of protocols, work instructions, and
other documents. The interaction of all these elements across the three domains identified
in this thesis, organizational, information, and process could be analyzed using the same
MDPM methodology and model described in this thesis. Many of these processes will be
embedded in systems, which will require expansion of the scope of the MDPM to also
include external stakeholders and certain other elements not considered in the MDPM.
Connection of the MDPM with the additional dimensions considered in the Engineering
Systems Matrix (ESM) would facilitate the analysis of larger systems containing processes.
To extend the application of the MDPM model to some of these other processes additional
work would be needed to facilitate the entry and analysis of process data as well as
significantly improved visualization techniques. Most important are the abilities to
represent evolution of an MDPM model as changes occur and new versions of individual
elements are created. In the example developed in this thesis, successive process versions
were distinctly labeled but this was done manually, and software to manage change as
individual work instructions change or processes are reorganized will be needed.
Additionally in terms of troubleshooting there will also likely be a need to add a physical
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"equipment and infrastructure" domain to describe any machines or devices needed to
perform a particular activity as these may also contribute to failure modes and must be
"searched" across the network in much the same way as protocols or operators.
Further description of the connections between elements could also improve the MDPM
model as not all connections between individuals will be the same and could be highlighted
to represent this. Similarly, connections between information elements may be of different
types and have very different bandwidths, which could further improve the model. This
also partly addresses a need for a very robust methodology to capture the richness of all
these different connections including both computer science data mining methods for the
information domain and also formal interview methods from sociology. This may also
require the creation of a few additional element types such as nodes representing
organizations rather than individuals.
A concrete example of an alternative application of the MDPM model could be the design,
development, and manufacturing of Boeing's new 787 aircraft whose value chain was
explicitly designed to span multiple groups, disciplines, companies, and even continents. A
schematic of where each of the 787 components is made and which organization is
responsible for them is provided in Figure 129. While potentially more efficient in terms of
leveraging the resources of multiple suppliers to help with capital and design resources,
the complexity of the design and manufacturing process was greatly increased leading to
problems with supply chain coordination, change propagation, and design difficulties well
documented in the press. The program is now more than two years late and while many of
the difficulties may be attributable to the product complexity of this highly advanced and
technologically innovative jet, it is possible that these were compounded by a lack of
visibility into the complexity of the process designing and building it. Application of a
MDPM model to the 787 design and manufacture may have shown the need for much
shorter average path lengths between nodes and certain "hidden" nodes with very high
search information values that could be difficult to troubleshoot or conversely certain
nodes where changes will propagate through the entire system making them critically
important to manage. The breadth of organizations and disciplines also might have
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benefited from the "troubleshooting representatives" or "change owners" described in
chapters 5 and 6. These individuals could have served as long links with their counterparts
in other organizations to greatly reduce the average network distance but also to
proactively search for information their local network "neighborhood" might need. In the
information domain, a network-based change propagation tool such as the MDPM might
have helped to identify which changes had the most impact and which parts of the aircraft
could be "modularized" with less concern about changes elsewhere impacting those
systems. The careful monitoring of change requests to determine the true impact of each
change could also be performed using an MDPM model to identify "hot spots" of change or
alternatively to make sure areas not considered have been reviewed. This is analogous to
the protocol reviews performed in the surveillance system to make sure other protocols
were not impacted by a change in any particular one.
Partners Across The Globe Are Bringing
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Figure 129 - Boeing 787 Suppliers as an Example of a Complex Process (from Boeing)
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7.4 Process Options
Throughout this thesis there has been description of the additional elements needed to
create, design, and implement complex processes as "scaffolding" which can be greatly
reduced during the operation of a fully robust and tested process. However, this scaffolding
has an additional cost, which might be quantified using real options methods. The
scaffolding of a process can be thought of as an option "in" the process as it enables the
process owner to change or troubleshoot the process at some future date likely increasing
its value. The process owner has the option to exercise the change or not, but not the
obligation to do so. The MDPM model could be used to explicitly quantifying the additional
resources needed for the scaffolding, which might be compared to the potential value in
terms of flexibility and process availability. Integration of the MDPM model with process
based cost modeling where each activity in the process domain could have an associated
cost along with the "fixed cost" of the organizational and information domains could also
yield a powerful analysis methodology. And the Minimum Cost Network Flow (MCNF)
methodology developed in Chapter 5 could readily be used for cost analysis but also for the
valuation of real options where a comparison between the "cost" of producing a certain
amount of products can be compared under multiple scenarios such as one with
"scaffolding" and one without. The total cost across a given path can then be used as the
production function in a valuation model to understand the relative benefit of different
design approaches. The combination of the MDPM model in the MCNF based valuation tool
could yield an especially valuable area of future research in developing "process options"
that could quantify the value of additional flexibility in process areas with rapidly changing
technologies. Complex processes such as the one cited in this thesis are composed of
underlying process elements whose technologies are changing at different rates requiring
certain parts of the process to absorb much faster "clock speeds" (Fine 1998) than others
and requiring additional flexibility (and scaffolding) in those areas as shown in Figure 113.
The additional resources or scaffolding needed to ensure change in those areas can be well-
managed and integrated to the rest of the process is a process option since the future of the
technology is not known, but a process with additional resources to accommodate this
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change will be more adaptable and have a correspondingly higher value (which must be
balanced against the cost of the additional resources). This is the concept behind process
options and it is hoped additional research will be performed in this area.
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Appendices
Appendix 1: Potential Improvement Projects to Surveillance
Process
scription One of the main goals of the surveillance system is to provide a true
representation of the MRSA diversity that exists in hospital infections.
The sampling used as an initial demonstration in this thesis was
confined to a single outbreak in a single hospital, however a much
broader sampling will be needed to support epidemiological analysis.
The goal of this project is thus to build a much more diverse collection
of MRSA samples representing multiple hospitals, regions, and case
histories. This project would ideally reuse existing infrastructure for
strain typing performed at local hospital, state health department, and
national CDC levels. This collection would provide for a proper
estimate of the "pan-genome" of MRSA or the sum total of all
mutations seen in MRSA throughout the country. This would ideally be
an ongoing process as MRSA will continue to evolve and a constantly
updated sampling should be performed.
ernal Process Owner, Process Change Owners, Epidemiologists, Bacterial
ikeholders Genomics Scientists, Physicians, Clinical Microbiologists, Genome
Annotation Scientists
ternal CDC, NIH, IDSA, ASM, State Health Agencies, Bacterial Diagnostic
ikeholders Vendors, Antibiotic Researchers, Antibiotic Vendors
liverables Diverse collection of MRSA samples with associated case histories and
continuously updated
oject Owner As this project would lie largely outside the process boundaries, the
owner should be someone connected to the various external
stakeholders perhaps at CDC.
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This project would lie outside the process boundaries as currently
defined, but would require integration with sample tracking systems,
analysis, and potentially DNA extraction.
Some process changes may be required to re-optimize the DNA
extraction process to handle the wider diversity of samples, so
coordination with the "change owner" or "troubleshooting
representative" in that area would be needed.
A process review and integration document would need to exist in
order to ensure all parts of the process were aware of the potential
changes, could react to them, or confirm no changes needed in any of
the explicit work instructions (protocols) etc.
Because of the significant information exchange and tracking that
might be needed for this project, testing all of the systems with
"dummy" samples would likely be needed. This would verify that
sample histories, IDs, and physical samples could be processed
without error throughout the process incorporating this project. In
addition, characterization of the various samples to ensure they can be
run through the existing culture growth, DNA extraction, and
sequencing protocols would be necessary followed by a design review.
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As described previously in this thesis DNA extraction is a highly
variable process for MRSA samples, and while it has been optimized
for the particular set of samples used in this thesis, it is likely that the
variation seen in a much larger set would require re-optimization of
this process activity. The goal of this project would be to find a new
optimized protocol that can cover the widest possible range of MRSA
samples. It is likely that additional measurements may have to be
taken such as carefully controlling cell growth, and potentially
automating a number of the steps to remove any operator variability.
In addition new technologies and processes should be explored as
alternatives to the current protocol. This project would then perform a
series of design of experiments runs to find a robust set of parameters
that could be used as a general protocol. Because of its impact on the
rest of the process the same "connected development" using change
owners and other mechanisms will be needed to make sure the impact
of the project is well managed on the rest of the surveillance process.
Process Owner, Process Change Owners, DNA Extraction Scientist,
Clinical Microbiology Staff, Clinical Microbiology Researchers
DNA Extraction Vendors, Liquid Handling Automation Vendors, ASM,
Bacterial Diagnostic Vendors
Robust Protocol that Can Extract >20ug of DNA in >30Kb sizes for a
variety of MRSA samples
DNA Extraction Scientist
This project would replace the current DNA extraction connecting
technology with an improved process, however, it must be made
physically compatible with upstream and downstream activities (i.e.
the DNA must be useable to the downstream process and free of any
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contaminants from processing).
Process changes may be required to re-optimize upstream and
downstream of the DNA extraction process, so coordination with the
"change owner" or "troubleshooting representative" in that area
would be needed.
A process review and integration document would need to exist in
order to ensure all parts of the process were aware of the potential
changes, could react to them, or confirm no changes needed in any of
the explicit work instructions (protocols) etc.
Beyond the DOEs needed to optimize the DNA extraction process itself,
an additional set of DOEs will be needed to test the response of the
rest of the process to the expected variation (and any extreme
conditions) produced by this part of the process.
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One major limitation of the current "V1" surveillance process is the
size of DNA fragments used in preparing the DNA for sequencing,
which are in the 300-500 base pair range. However, in order to link
genomic regions with high similarity and assemble the genomes out of
the short reads (100bp long) it is necessary to construct much longer
specialty DNA fragments that can span greater distances than 300-500
base pairs, ideally into the 4,000-10,000 and even longer but which
can still be read using the available sequencing technology. Methods
for doing this are so-called jumping libraries, but there may be others.
This has significant technical difficulty especially given the high
throughput nature of the surveillance process and will require tight
integration with algorithms and other process elements.
Process Owner, Process Change Owners, Alignment Algorithm
Research Groups, Assembly Algorithm Research Groups, DNA
Sequencing Technology Vendors, DNA Sequencing Lab Staff
Other DNA Sequencing Technology Vendors, Genomics Researchers,
Molecular Biology Vendors
Parallel process that can deliver ready to sequence fragments with
ends of each molecule spanning >4,000 bases
DNA Sequencing Researcher (Molecular Biology)
This project would add a parallel process in addition to the current
DNA preparation and would then add an additional data type through
analysis. The activity must be mad compatible with existing upstream
processes (DNA extraction) and downstream analysis.
Process changes may be required to re-optimize upstream and
downstream of the DNA extraction process, so coordination with the
"change owner" or "troubleshooting representative" in that area
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would be needed.
A process review and integration document would need to exist in
order to ensure all parts of the process were aware of the potential
changes, could react to them, or confirm no changes needed in any of
the explicit work instructions (protocols) etc.
A significant number of DOEs will be needed to ensure the process is
robust, but further tests will be required to determine the impact of
variability and certain failure modes on downstream analysis and
similarly the impact of upstream variability and failure modes in DNA
extraction on this part of the process.
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There is expected to be significant technology change in the DNA
sequencing portion of the surveillance process and the V2 process
should be configured to deal with this change. This project would
identify the process invariants such that these could be managed as a
group and efficient connections made to the new sequencing
processes as they emerge rather than ad hoc connections for each
process. In addition "connection points" would be identified within the
MDPM matrix such that new technologies could be rapidly absorbed
without having to "make" new connections. This might mean the
formation of "clusters" around key disciplines such as molecular
biology that could oversee related steps in each of the new processes
(rather than have each create a new one). Similarly each new process
would have explicit representatives for each area that were within 1-2
hop network reach of the new process elements to facilitate
integration.
Process Owner, Process Change Owners, Alignment Algorithm
Research Groups, Assembly Algorithm Research Groups, DNA
Sequencing Technology Vendors, DNA Sequencing Lab Staff
Other DNA Sequencing Technology Vendors, Genomics Researchers,
Molecular Biology Vendors
Parallel process that can deliver ready to sequence fragments with
ends of each molecule spanning >4,000 bases
DNA Sequencing Researcher (Molecular Biology)
This project would add a parallel process in addition to the current
DNA preparation and would then add an additional data type through
analysis. The activity must be mad compatible with existing upstream
processes (DNA extraction) and downstream analysis.
Page 370 of 385
.............
Process changes may be required to re-optimize upstream and
downstream of the DNA extraction process, so coordination with the
"change owner" or "troubleshooting representative" in that area
would be needed.
A process review and integration document would need to exist in
order to ensure all parts of the process were aware of the potential
changes, could react to them, or confirm no changes needed in any of
the explicit work instructions (protocols) etc.
A significant number of DOEs will be needed to ensure the process is
robust, but further tests will be required to determine the impact of
variability and certain failure modes on downstream analysis and
similarly the impact of upstream variability and failure modes in DNA
extraction on this part of the process.
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Most of the data analysis performed in the V1 process was performed
on prototype software with significant manual intervention and little
optimization. To make the surveillance process truly useful a
significant amount of work will have to go into building robust and
automated data analysis pipelines that have been extensively validated
and optimized for MRSA. These pipelines must be able to align data
from these samples against the entire set of MRSA genomes to date as
well as perform a verification of the data through assembly in order to
find novel genes or horizontal gene transfer from other organisms that
simple alignment would not find. The overall accuracy and specificity
of the algorithms must be evaluated as a function of the data input to
specify the degree of coverage (i.e. how much oversampling of the
genome is needed, 30X, etc.) to provide sufficient accuracy. Most
importantly the resulting data and analyses must be easy to use for
epidemiological studies such that outbreaks or new strains can be
readily identified from the data. Another requirement is that the data
analysis must be entirely backwards compatible with existing
surveillance methods such as PFGE, MLST, and 16s such that data can
be integrated with existing databases and the transition to the new
process can be greatly facilitated. Attention to this final user interface
is critical to help speed adoption of the process. In addition, sample
tracking must be provided such that original clinical histories can be
associated with the final surveillance data. All of this represents a very
significant amount of work and impacts many elements of the MDPM.
Process Owner, Process Change Owners, Alignment Algorithm
Research Groups, Assembly Algorithm Research Groups, DNA
Sequencing Technology Vendors, Bio-Informatics Analysis Staff, Bio-
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Informatics Researchers, Genomic Data Analysis Research Groups,
Bacterial Genomics Researchers, Infectious Disease Researchers,
Epidemiologists, Physicians, Clinical Microbiology Researchers
CDC, IDSA, NIH, ASM, State Health Agencies, Genomic Data Analysis
Vendors, LIMS vendors, Bacterial Diagnostics Vendors, Hospital
Administration
Integrated data analysis pipeline that can identify MRSA strains, find
novel mutations, assemble full MRSA genomes to find novel genes or
transfers, correlate the data with case histories, provide backward
compatible surveillance data (i.e. PFGE fingerprints), and facilitate
epidemiological tracking.
Epidemiologist (with some training in genome analysis)
This project integrates all of the analysis activities and provides for
additional processing steps to deliver epidemiologically useful data.
Significant change to current process activities will be required as well
as adding new process activities. The algorithms changes may impact
upstream process activities as well.
Coordination with the "change owners" or "troubleshooting
representative" in each area will be essential as the algorithm changes
will require close coordination with upstream process activities and
the individuals responsible for them particularly in the molecular
biology areas.
A process review and integration document will need to exist in order
to ensure all parts of the process were aware of the potential changes,
could react to them, or confirm no changes needed in any of the
explicit work instructions (protocols) etc. In addition, visibility and
understanding of the necessary algorithm changes and types of data
needed must be communicated to the rest of the process perhaps
through online documentation, etc.
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Extensive testing with reference (i.e. known MRSAs) will be needed to
ensure the process is robust and delivers the correct information.
Tests to verify the performance of the analysis portion of the process
under potential upstream failure modes will be important to ensure
the algorithms and software are robust, but also that the overall
process can deal with both normal process variation and "out of
specification" conditions.
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An essential part of the surveillance process must be to "close the
loop" with the biology, which is to compare actual biological results
(phenotype) with the DNA data (genotype) being produced. For
example, measuring the Minimum Inhibitory Concentration (MIC) of
antibiotics for MRSA strains found to have mutations, is important to
develop an understanding of which mutations are important and
which are not. Other biological tests are also needed such as growth
rates, cell wall thickness, and perhaps virulence measures. Correlation
of the phenotype with the genotype will help realize enormous value
from the surveillance process as new diagnostics can then be
developed based on these correlations. This will require going back to
samples stored in freezers as a product of the MRSA isolation portion
of the process.
Process Owner, Process Change Owners, Bio-Informatics Analysis
Staff, Genomic Data Analysis Research Groups, Bacterial Genomics
Researchers, Infectious Disease Researchers, Epidemiologists,
Physicians, Clinical Microbiology Researchers
CDC, IDSA, NIH, ASM, State Health Agencies, Genomic Data Analysis
Vendors, Bacterial Diagnostics Vendors, Hospital Administration,
Antibiotics Researchers, Antibiotics Vendors
Database showing the correlation of genotype data from the
surveillance system to phenotype data obtained from strains.
Bacterial Genomics Researcher
This project adds additional process steps at the MRSA isolation step,
where an isolate would be grown and subjected to a variety of
phenotype assays such that these results could be later correlated.
These additional process activities would occur in parallel. And are not
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directly connected to downstream processing other than for the
correlation of the data and integration into a database.
Coordination with other parts of the process is not as essential for this
activity, but some information may be useful, such as cell wall
properties, and the owner of the project should connect in a reporting
mode to "change owners".
A process review document should exist for the project, which is made
visible to the rest of the process, but most importantly the data format
and sample tracking should integrate with the downstream genotype
analysis to build a database containing both sets of data.
Limited process testing is needed in that this will be a "parallel"
process other than to verify sample tracking accuracy (i.e. making sure
the same sample is tested for phenotype and genotype. Validation of
the accuracy of the phenotype assays is likely necessary to standardize
them across locations, and also to understand the tolerance of the data
(error bounds).
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Appendix 2 MATLAB Routines
%Process network variable calculator
%This program calculates the key graph metrics for process networks RNicol
addpath('/MATLAB/matlab-bgl','/MATLAB/Thesis');
process network=xlsread('/MATLAB/Thesis/baseline-wPO.xls');
%geodesic distance=graphallshortestpaths (sparse (process-network),'Directed',true)
geodesic-distance=all shortest-paths (sparse (process-network));
edges=num-edges (process-network)
vertices=numvertices(process network)
avg-dist=(1/((vertices)*(vertices-1)))*sum(sum(geodesic-distance))
glob-efficiency=(1/((vertices)*(vertices-
1)))*(sum(sum(ones(vertices,vertices)./(geodesic distance+eye(vertices))))-vertices)
undirecteddensity=(2*edges)/(vertices*(vertices-1))
%gcoor=circle-graphjlayout(process-network)
%gplot(process-network,gcoor)
for k=1:1:vertices;
minusvertex-geodesic-dist=geodesic-distance;
minusvertex-geodesic-dist(k,:)= [];
minusvertex-geodesic-dist(:,k)= [];
vertex-eff= (1/((vertices-1)*(vertices-2)))*(sum(sum(ones(vertices-1,vertices-
1)./(minus-vertex-geodesic-dist+eye(vertices-1))))-(vertices-1));
vulnerability(1,k)=(glob-efficiency-vertex-eff)/glob-efficiency;
end;
NetworkVulnerability=max(vulnerability)
degree(1,:)=sum(process-network,1); % in degree, sum of columns
degree(2,:)=sum(process-network,2); % out degree, sum of rows
degree(3,:)=degree(1,:)+degree(2,:);
degree-bins=[1:1:max(degree(3,:))];
degree-dist=histc(degree(3,:),degree-bins);
%Entropy
degree-nonzeros=nonzeros(degree-dist);
deg-dist-entropy=O;
for k=1:1:size(degree-nonzeros);
deg-dist-entropy=-((degree-nonzeros(k)/vertices)*log2(degree-nonzeros(k)/vertices))+deg-dist-entropy;
end;
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